<SEC-DOCUMENT>0001178913-25-002814.txt : 20250812
<SEC-HEADER>0001178913-25-002814.hdr.sgml : 20250812
<ACCEPTANCE-DATETIME>20250812163333
ACCESSION NUMBER:		0001178913-25-002814
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20250812
FILED AS OF DATE:		20250812
DATE AS OF CHANGE:		20250812

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TRINITY BIOTECH PLC
		CENTRAL INDEX KEY:			0000888721
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			L2
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-22320
		FILM NUMBER:		251207288

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		IDA BUSINESS PARK, BRAY, CO WICKLOW
		STREET 2:		IRELAND
		CITY:			DUBLIN IRELAND
		PROVINCE COUNTRY:   	L2
		BUSINESS PHONE:		01135312955111

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		3 ROCK ROAD
		STREET 2:		SANDYFORD INDUSTRIAL ESTATES
		CITY:			DUBLIN IRELAND
		PROVINCE COUNTRY:   	L2
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>zk2533582.htm
<DESCRIPTION>6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div><br>
      <div style="line-height: 1.25;">
        <div style="text-align: center; line-height: 1.25; font-weight: bold; font-size: 14pt;">SECURITIES AND EXCHANGE COMMISSION</div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">Washington, D.C.&#160; 20549</div>
      <div style="line-height: 1.25;">
        <div style="text-align: center; line-height: 1.25; font-weight: bold;"><u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u></div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold; font-size: 14pt;">FORM&#160;6-K</div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">UNDER THE SECURITIES EXCHANGE ACT OF 1934</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">For the month of August 2025</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: center; line-height: 1.25; font-weight: bold; font-size: 16pt;">TRINITY BIOTECH PLC</div>
      </div>
      <div style="text-align: center; line-height: 1.25;">(Name of Registrant)</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25;">IDA Business Park</div>
      <div style="text-align: center; line-height: 1.25;">Bray, Co. Wicklow, Ireland</div>
      <div style="text-align: center; line-height: 1.25;">&#160;(Address of Principal Executive Office)</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-indent: 72pt; line-height: 1.25; font-weight: bold;">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold; font-family: 'Times New Roman',Times,serif;">Form 20-F &#9746;&#160;&#160;&#160; Form 40-F &#9744;&#160;&#160;&#160;&#160;&#160;&#160;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-indent: 72pt; line-height: 1.25; font-weight: bold;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-indent: 72pt; line-height: 1.25; font-weight: bold;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-indent: 72pt; line-height: 1.25; font-weight: bold;">Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule
        12g3-2(b) under the Securities Exchange Act of 1934.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold; font-family: 'Times New Roman',Times,serif;">Yes &#9744;&#160;&#160;&#160; No &#9746;</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-indent: 72pt; line-height: 1.25; font-weight: bold;">If &#8220;Yes&#8221; is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-&#160;<u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</u></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-indent: 72pt; line-height: 1.25; font-weight: bold;">This Form 6-K is being incorporated by reference into our Registration Statements on Form S-8 (File Nos. 333-182279, 333-195232 and 333-253070).</div>
    </div>
    <br>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>
      <div style="text-align: center; line-height: 1.25;">&#160;<font style="font-weight: bold;">EXPLANATORY NOTE</font></div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25;">On August 12, 2025, the Company issued a press release announcing breakthrough clinical trial results for its redesigned CGM sensor. The Company and certain of its subsidiaries also amended and restated the credit
          agreement governing the companies&#8217; term loan facility with Perceptive Credit Holdings III, L.P on August 7, 2025. Copies of the press release, the amended and restated credit agreement and warrant certificate issued in connection therewith are
          filed herewith as Exhibits 99.1, 99.2 and 99.3.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="line-height: 1.25;"></div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">EXHIBIT INDEX</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <table cellspacing="0" cellpadding="2" border="0" id="z014ccf77b901477a9e0611912ecd5e06" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 6.53%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="line-height: 1.25;">Exhibit</div>
              </td>
              <td style="width: 0.55%; vertical-align: top;">&#160;</td>
              <td style="width: 92.92%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
                <div style="text-align: justify; line-height: 1.25;">Description</div>
              </td>
            </tr>
            <tr>
              <td style="width: 6.53%; vertical-align: top;">
                <div style="line-height: 1.25;"><a href="exhibit_99-1.htm">99.1</a></div>
              </td>
              <td style="width: 0.55%; vertical-align: top;"><br>
              </td>
              <td style="width: 92.92%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_99-1.htm">Trinity Biotech Achieves Breakthrough Clinical Trial Results for Redesigned CGM
                    Sensor.</a></div>
              </td>
            </tr>
            <tr>
              <td style="width: 6.53%; vertical-align: top;">
                <div style="line-height: 1.25;"><a href="exhibit_99-2.htm">99.2</a></div>
              </td>
              <td style="width: 0.55%; vertical-align: top;"><br>
              </td>
              <td style="width: 92.92%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_99-2.htm">Sixth Amended and Restated Credit Agreement and Guaranty, dated as of August 7,
                    2025.</a></div>
              </td>
            </tr>
            <tr>
              <td style="width: 6.53%; vertical-align: top;">
                <div style="line-height: 1.25;"><a href="exhibit_99-3.htm">99.3</a></div>
              </td>
              <td style="width: 0.55%; vertical-align: top;"><br>
              </td>
              <td style="width: 92.92%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_99-3.htm">Warrant to purchase American Depositary Shares of Trinity Biotech plc, dated
                    August 7, 2025.</a></div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;">&#160;</div>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25;">SIGNATURES</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
        authorized.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zec36b9477ced40719a8cf2812c0eaa6a">

          <tr>
            <td style="width: 49.83%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td colspan="2" style="vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;"><u>TRINITY BIOTECH PLC</u></div>
            </td>
            <td style="width: 18%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 49.83%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 29.4%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Trinity Biotech plc</div>
            </td>
            <td style="width: 18%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 49.83%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 29.4%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">(Registrant)</div>
            </td>
            <td style="width: 18%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 49.83%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 29.4%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 18%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 49.83%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">By:</div>
            </td>
            <td style="width: 29.4%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="text-align: justify; line-height: 1.25;">/s/ Susan O&#8217;Connor</div>
            </td>
            <td style="width: 18%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 49.83%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 29.4%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Susan O&#8217;Connor</div>
            </td>
            <td style="width: 18%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 49.83%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 29.4%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Interim Chief Financial Officer</div>
            </td>
            <td style="width: 18%; vertical-align: top;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; line-height: 1.25;">Date:&#160; August 12, 2025</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
      <div style="line-height: 1.25;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div class="BRPFPageHeader">
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
      <div style="line-height: 1.25; text-align: right;"><u><font style="font-weight: bold;">Exhibit 99.1</font></u><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="text-align: right; line-height: 1.25;"><img width="229" height="61" src="image0.jpg"></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="zf910c381e0b94bdb86d24cec73fbd97e">

          <tr>
            <td style="width: 10%;">
              <div>Contact:&#160; <br>
              </div>
            </td>
            <td style="width: 20%;">
              <div><font style="font-weight: bold;">Trinity Biotech plc</font>&#160; <br>
              </div>
            </td>
            <td style="width: 70%;">
              <div>
                <div style="text-align: left; line-height: 1.25;"><font style="font-weight: bold;">RedChip Companies
                      Inc.</font> <br>
                  </div>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%;">
              <div>&#160;</div>
            </td>
            <td style="width: 20%;">
              <div>Gary Keating, Ph.D <br>
              </div>
              <div>(353)-1-2769800</div>
              <div><br>
              </div>
              <div><br>
              </div>
            </td>
            <td style="width: 70%;">
              <div>
                <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">Dave Gentry, CEO</font></div>
                <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">(1)-407-644-4256</font></div>
                <div style="text-align: left; line-height: 1.25;">
                  <div>(1)-800-RED-CHIP (733-2447)</div>
                </div>
                <div style="text-align: left; line-height: 1.25;">
                  <div><font style="font-family: 'Times New Roman',Times,serif;"><u>TRIB@redchip.com</u>&#160; </font><br>
                  </div>
                </div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <u></u>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><font style="font-size: 12pt; font-family: 'Times New Roman',Times,serif; background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Trinity Biotech&#160;Achieves Breakthrough Clinical Trial Results for </font></div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><font style="font-size: 12pt; font-family: 'Times New Roman',Times,serif; background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Redesigned CGM Sensor</font></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-style: italic;">Clinical data confirms elimination of requirement for finger-stick calibration, de-risking pathway to
      commercialization for</div>
    <div style="text-align: center; line-height: 1.25; font-style: italic;"> the company&#8217;s next-generation CGM+ biosensor platform</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">DUBLIN, Ireland (August 12, 2025) -</font>
      Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced compelling positive clinical trial results demonstrating a
      major technical breakthrough and de-risking the commercial pathway for its next-generation continuous glucose monitoring (CGM) technology, called CGM+. For the first time, trial data confirms that Trinity Biotech&#8217;s redesigned proprietary needle-free
      glucose sensor delivers accurate glucose readings across a full 15-day wear period without the need for finger-stick calibration, while also facilitating an innovative CGM design that reduces disposable components, significantly lowering the cost of
      care compared to current leading market products.&#160; As the high cost of existing CGM devices continues to hinder widespread adoption, Trinity Biotech&#8217;s innovative approach is
        designed to enhance accessibility and increase utilization of CGM technology.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">&#8220;This milestone represents the most significant technical achievement since we began redevelopment of our acquired CGM technology,&#8221; said
      John Gillard, CEO of Trinity Biotech. &#8220;The elimination of the requirement for finger-stick calibration was achieved through a combination of sensor design modifications, refined signal processing, and proprietary enhancements to sensor operation.
      With this, we&#8217;ve successfully addressed the most uncertain technical hurdle and brought our glucose sensor in line with the standards of market leaders &#8212; but critically with a highly differentiated product architecture that promises to be more
      affordable, reusable, and sustainable while also supporting the single device integration of heart activity, body temperature and physical activity data.&#8221;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">New Trial Data Confirms:</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z5ea369ca61a648c7b4239ae690cd14dd" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>No finger-stick calibration required over a 15-day sensor wear period.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z210e8df76165457ea922082b04955d34" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Enhanced user convenience, comfort, and reliability through proprietary glucose sensor improvements.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="z4a4ed2644a514dd4b80a2ebcf47a41f7" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Successful technical de-risking which increases confidence in next-gen product performance and regulatory pathway.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">The clinical validation of the calibration-free sensor marks a critical step toward commercialization of Trinity Biotech&#8217;s
      next-generation CGM+ platform. The glucose sensor tested in this trial is integral to the Company&#8217;s modular CGM+ device, which is in the later stages of development, with a focus on scalability, cost-efficiency, and environmental impact &#8212; key factors
      that support broader market access and long-term adoption.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">The global CGM market is projected to grow from approximately $13billion in 2025 to approximately $28 billion by 2030<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup>,
      driven by rising diabetes prevalence and demand for real-time health data. Trinity Biotech&#8217;s differentiated, high-data &amp; low-waste platform is poised to expand access to CGM technology for millions of people priced out of current systems.</div>
    <div style="text-align: justify; line-height: 1.25;"><img width="600" height="338" src="image1.jpg"></div>
    <div style="text-align: center; line-height: 1.25;">Trinity Biotech&#8217;s CGM+ wearable biosensor designed to
        seamlessly integrate glucose, cardiovascular, temperature, and activity monitoring in one sleek modular device.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; font-weight: bold;">Forward-Looking Statements</div>
    <div style="text-align: justify; line-height: 1.25;">This release includes statements that constitute &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation
      Reform Act of 1995 (the &#8220;Reform Act&#8221;), including but not limited to statements related to Trinity Biotech&#8217;s cash position, financial resources and potential for future growth, market acceptance and penetration of new or planned product offerings, and
      future recurring revenues and results of operations. Trinity Biotech claims the protection of the safe harbor for forward-looking statements contained in the Reform Act. These forward-looking statements are often characterized by the terms &#8220;may,&#8221;
      &#8220;believes,&#8221; &#8220;projects,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; or words of similar import, and do not reflect historical facts. Specific forward-looking statements contained in this release may be affected by risks and uncertainties, including, but not limited
      to, our ability to capitalize on the Waveform transaction and of our recent acquisitions, our continued listing on the Nasdaq Stock Market, our ability to achieve profitable operations in the future, the impact of the spread of COVID-19 and its
      variants, the possible pause and/or disruption in U.S. Government funding for HIV tests produced by Trinity Biotech, potential excess inventory levels and inventory imbalances at the company&#8217;s distributors, losses or system failures with respect to
      Trinity Biotech&#8217;s facilities or manufacturing operations, the effect of exchange rate fluctuations on international operations, fluctuations in quarterly operating results, dependence on suppliers, the market acceptance of Trinity Biotech&#8217;s products
      and services, the continuing development of its products, required government approvals, risks associated with manufacturing and distributing its products on a commercial scale free of defects, risks related to the introduction of new instruments
      manufactured by third parties, risks associated with competing in the human diagnostic market, risks related to the protection of Trinity Biotech&#8217;s intellectual property or claims of infringement of intellectual property asserted by third parties and
      risks related to condition of the United States economy and other risks detailed under &#8220;Risk Factors&#8221; in Trinity Biotech&#8217;s annual report on Form 20-F for the fiscal year ended December 31, 2024 and Trinity Biotech&#8217;s other periodic reports filed from
      time to time with the United States Securities and Exchange Commission. Forward-looking statements speak only as of the date the statements were made. Trinity Biotech does not undertake and specifically disclaims any obligation to update any
      forward-looking statements.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">About Trinity Biotech</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Trinity Biotech is a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including
      wearable biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market and has recently entered
      the wearable biosensor industry, with the acquisition of the biosensor assets of Waveform Technologies Inc. and intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product. Our products
      are used to detect infectious diseases and to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. Trinity Biotech sells direct in the United States and through a network of international distributors
      and strategic partners in over 75 countries worldwide. For further information, please see the Company's website: <u>www.trinitybiotech.com</u>.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <br>
    <hr noshade="noshade" align="left" style="background-color: #000000; border: 0px; height: 1px; width: 2in; margin-left: 0pt; margin-right: auto; color: #000000;">
    <div style="line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup>&#160;<u>https://www.mordorintelligence.com/industry-reports/continuous-glucose-monitoring-market</u></div>
    <div style="line-height: 1.25;"><u> <br>
        </u></div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><u> </u></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>exhibit_99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: Arial; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-family: 'Times New Roman';"> </font>
  <div>
    <div class="BRPFPageHeader">
      <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;">
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
      <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;"><font style="font-variant: normal;"><u><font style="font-weight: bold;"> Exhibit 99.2</font></u></font><br>
      </div>
      <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;"> <br>
      </div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;">Sixth Amended and Restated Credit Agreement and Guaranty</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman';">dated as of</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman';">August 7<font style="font-variant: small-caps;">, 2025</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman';">among</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;">Trinity Biotech, Inc.,</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;">Clark Laboratories, Inc.&#160; (d/b/a Trinity Biotech (USA)),</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;">Biopool U.S., Inc. (d/b/a Trinity Biotech Distribution),</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;">Primus Corporation,</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;">MarDx Diagnostics, Inc. and</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;">IMMCO Diagnostics, Inc.</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-variant: small-caps;">TRIB Biosensors Inc.</font><br>
      as the Borrowers<font style="font-variant: small-caps;">,</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;">The Guarantors from Time to Time Party hereto,</div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-family: 'Times New Roman';">as Guarantors<br>
        <br style="line-height: 1.25;">
      </font></div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman';">and</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;">Perceptive Credit Holdings III, LP,</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman';">as Administrative Agent and as a Lender</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';"><br style="line-height: 1.25;">
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps; font-weight: bold;">Table of Contents</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">
      <table cellspacing="0" cellpadding="0" border="0" id="z3596f9ff86b0463f9ef36d05a395dc34" style="font-family: Arial; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Section</div>
            </td>
            <td style="width: 75%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman';"><br>
              </div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman';">Page</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';"><a href="#ArticleI">Article I</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';"><a href="#ArticleI">Definitions</a></div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman';">2</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section1.01.">Section&#160;1.01.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section1.01.">Certain Defined Terms</a></div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman';">2</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section1.02.">Section&#160;1.02.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section1.02.">Accounting Terms and Principles</a></div>
            </td>
            <td style="width: 5%; vertical-align: top;">
              <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman';">42</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section1.03.">Section&#160;1.03.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section1.03.">Interpretation</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">42<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section1.04.">Section&#160;1.04.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section1.04.">Divisions</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">42<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section1.05.">Section&#160;1.05.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section1.05.">Interest Rates</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">43<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';"><a href="#Article2">Article&#160;2</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';"><a href="#Article2">The Term Loans</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">43<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section2.01.">Section&#160;2.01.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section2.01.">Term Loans</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">43<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section2.02.">Section&#160;2.02.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section2.02.">Proportionate Shares</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">45<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section2.03.">Section&#160;2.03.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section2.03.">[Reserved]</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">45<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section2.04.">Section&#160;2.04.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section2.04.">Notes</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">45<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section2.05.">Section&#160;2.05.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section2.05.">Use of Proceeds</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">46<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';"><a href="#Article3">Article&#160;3</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';"><a href="#Article3">Payments of Principal and Interest</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">46<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section3.01.">Section&#160;3.01.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section3.01.">Repayment</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">46<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section3.02">Section&#160;3.02.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section3.02">Interest</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">46<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section3.03.">Section&#160;3.03.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section3.03.">Prepayments</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">50<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';"><a href="#Article4">Article&#160;4</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';"><a href="#Article4">Payments, Etc.</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">52<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section4.01.">Section&#160;4.01.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section4.01.">Payments</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">52<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section4.02.">Section&#160;4.02.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section4.02.">Computations</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">53<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section4.03.">Section&#160;4.03.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section4.03.">Notices</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">53<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section4.04.">Section&#160;4.04.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section4.04.">Set&#8209;Off</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">53<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';"><a href="#Article5">Article&#160;5</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';"><a href="#Article5">Yield Protection, Etc.</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">54<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section5.01">Section&#160;5.01.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section5.01">Additional Costs</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">54<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section5.02">Section&#160;5.02.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section5.02">Illegality</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">55<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section5.03.">Section&#160;5.03.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section5.03.">Taxes</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">55<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section5.04.">Section&#160;5.04.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section5.04.">Delay in Requests</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">61<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';"><a href="#Article6">Article&#160;6</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';"><a href="#Article6">Conditions Precedent</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">61<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section6.01.">Section&#160;6.01.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section6.01.">Conditions to Fifth Amendment Term Loan/Fifth Amendment Restatement Date</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">61<br>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';"><a href="#Article7">Article 7</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';"><a href="#Article7">Representations and Warranties</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">62<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.01.">Section&#160;7.01.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.01.">Power and Authority</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">62<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.02.">Section&#160;7.02.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.02.">Authorization; Enforceability</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">62<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.03.">Section&#160;7.03.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.03.">Governmental and Other Approvals; No Conflicts</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">63<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.04.">Section&#160;7.04.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.04.">Financial Statements; Projections; Material Adverse Change</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">63<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.05.">Section&#160;7.05.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.05.">Properties</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">64<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.06.">Section&#160;7.06.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.06.">No Actions or Proceedings</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">66<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.07.">Section&#160;7.07.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.07.">Compliance with Laws and Agreements</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">66<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.08.">Section&#160;7.08.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.08.">Taxes</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">67<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.09.">Section&#160;7.09.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.09.">Full Disclosure</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">68<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.10.">Section&#160;7.10.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.10.">Regulation</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">68<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.11.">Section&#160;7.11.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.11.">Solvency</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">68<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.12.">Section&#160;7.12.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.12.">Reserved</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">68<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.13.">Section&#160;7.13.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.13.">Indebtedness and Liens</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">68<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.14.">Section&#160;7.14.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.14.">Material Agreements</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">68<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.15.">Section&#160;7.15.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.15.">Restrictive Agreements</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">68<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.16.">Section&#160;7.16.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.16.">Real Property</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">68<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.17.">Section&#160;7.17.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.17.">Pension and Other Plans</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">69<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.18.">Section&#160;7.18.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.18.">Collateral; Security Interest</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">69<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.19.">Section&#160;7.19.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.19.">Regulatory Approvals</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">69<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.20.">Section&#160;7.20.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.20.">Capitalization</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">72<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.21.">Section&#160;7.21.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.21.">Insurance</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">72<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.22">Section&#160;7.22.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.22">Certain Fees</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">72<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.23.">Section&#160;7.23.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.23.">Sanctions Laws</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">72<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.24.">Section&#160;7.24.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.24.">Anti&#8209;Corruption Laws</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">72<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.25.">Section&#160;7.25.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.25.">Anti&#8209;Terrorism Laws</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">72<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.26.">Section&#160;7.26.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section7.26.">Royalty and Other Payments</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">72<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';"><a href="#Article8">Article&#160;8</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';"><a href="#Article8">Affirmative Covenants and Financial Covenants</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">73<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.01.">Section&#160;8.01.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.01.">Financial Statements and Other Information</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">73<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.02.">Section&#160;8.02.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.02.">Notices of Material Events</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">75<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.03">Section&#160;8.03.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.03">Existence; Maintenance of Properties, Etc</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">78<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.04.">Section&#160;8.04.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.04.">Payment of Obligations</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">79<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.05">Section&#160;8.05.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.05">Insurance</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">79<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.06.">Section&#160;8.06.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.06.">Books and Records; Inspection Rights</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">79<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.07.">Section&#160;8.07.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.07.">Compliance with Laws</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">80<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.08.">Section&#160;8.08.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.08.">Licenses</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">80<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.09.">Section&#160;8.09.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.09.">Action under Environmental Laws</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">80<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.10.">Section&#160;8.10.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.10.">Use of Proceeds</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">80<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.11.">Section&#160;8.11.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.11.">Certain Obligations Respecting Subsidiaries; Further Assurances</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">80<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.12.">Section&#160;8.12.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.12.">Termination of Non&#8209;Permitted Liens</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">82<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.13.">Section&#160;8.13.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.13.">Non-Commingling</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">82<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.14.">Section&#160;8.14.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.14.">Anti&#8209;Terrorism and Anti&#8209;Corruption Laws</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">83<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.15.">Section&#160;8.15.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.15.">Minimum Liquidity</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">83<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.16.">Section&#160;8.16.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.16.">Minimum Total Revenue</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">83<br>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.17.">Section&#160;8.17.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.17.">Maintenance of Regulatory Approvals, Contracts, Intellectual Property, Etc.</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">84<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.18.">Section&#160;8.18.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.18.">Cash Management</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">84<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.19.">Section&#160;8.19.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.19.">Post Sixth Amendment Restatement Date Obligations</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">85<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.20.">Section&#160;8.20.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.20.">COMI</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">85<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.21.">Section&#160;8.21.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.21.">Cashless Exercise of Warrant Certificate and Par Value</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">85<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.22.">Section&#160;8.22.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.22.">Canadian Pension Plans</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">85<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.23.">Section&#160;8.23.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section8.23.">Payment of Warrant Stamp Amount</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">85<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';"><a href="#Article9">Article 9</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';"><a href="#Article9">Negative Covenants</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">86<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.01">Section&#160;9.01.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.01">Indebtedness</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">86<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.02.">Section&#160;9.02.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.02.">Liens</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">88<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.03.">Section&#160;9.03.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.03.">Fundamental Changes and Acquisitions</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">89<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.04">Section&#160;9.04.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.04">Lines of Business</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">90<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.05.">Section&#160;9.05.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.05.">Investments</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">91<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.06.">Section&#160;9.06.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.06.">Restricted Payments</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">92<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.07.">Section&#160;9.07.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.07.">Payments of Indebtedness</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">93<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.08.">Section&#160;9.08.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.08.">Change in Fiscal Year</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">93<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.09.">Section&#160;9.09.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.09.">Sales of Assets, Etc</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">93<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.10.">Section&#160;9.10.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.10.">Transactions with Affiliates</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">94<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.11.">Section&#160;9.11.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.11.">Restrictive Agreements</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">95<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.12.">Section&#160;9.12.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.12.">Organizational Documents, Material Agreements</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">95<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.13.">Section&#160;9.13.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.13.">[Reserved]</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">95<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.14.">Section&#160;9.14.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.14.">Sales and Leasebacks</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">95<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.15.">Section&#160;9.15.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.15.">Hazardous Material</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">96<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.16.">Section&#160;9.16.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.16.">Accounting Changes</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">96<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.17.">Section&#160;9.17.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.17.">Compliance with ERISA</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">96<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.18.">Section&#160;9.18.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.18.">Deposit Accounts</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">96<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.19.">Section&#160;9.19.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.19.">Outbound Licenses</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">96<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.20.">Section&#160;9.20.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.20.">Inbound Licenses</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">96<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.21.">Section&#160;9.21.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.21.">Non-Commingling</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">96<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.22.">Section&#160;9.22.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section9.22.">Canadian Defined Benefit Pension Plans</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">96<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';"><a href="#Article10">Article 10</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';"><a href="#Article10">Events of Default</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">97<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section10.01.">Section&#160;10.01.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section10.01.">Events of Default</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">97<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section10.02.">Section&#160;10.02.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section10.02.">Remedies</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">100<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section10.03.">Section&#160;10.03.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section10.03.">Prepayment Premium and Redemption Price</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">100<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';"><a href="#Article11">Article&#160;11</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';"><a href="#Article11">Guarantee</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">101<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section11.01.">Section&#160;11.01.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section11.01.">The Guarantee</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">101<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section11.02.">Section&#160;11.02.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section11.02.">Obligations Unconditional</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">101<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section11.03.">Section&#160;11.03.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section11.03.">Reinstatement</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">103<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section11.04.">Section&#160;11.04.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section11.04.">Subrogation</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">103<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section11.05.">Section&#160;11.05.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section11.05.">Remedies</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">104<br>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section11.06.">Section&#160;11.06.</a></div>
            </td>
            <td style="width: 83%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section11.06.">Instrument for the Payment of Money</a></div>
            </td>
            <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman'; text-align: center;">104<br>
            </td>
          </tr>

      </table>
      <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div><br>
    </div>
    <div>
      <div style="line-height: 1.25; font-family: 'Times New Roman';">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section11.07.">Section&#160;11.07.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section11.07.">Continuing Guarantee</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">104</td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section11.08.">Section&#160;11.08.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section11.08.">Rights of Contribution</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">104</td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section11.09.">Section&#160;11.09.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section11.09.">General Limitation on Guarantee Obligations</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">105<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section11.10.">Section&#160;11.10.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section11.10.">Irish Limitation on Guarantee Obligations</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">105<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman';"><a href="#Article12">Article&#160;12</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman';"><a href="#Article12">Administrative Agent</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">106<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section12.01.">Section&#160;12.01.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section12.01.">Appointment</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">106<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section12.02">Section&#160;12.02.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section12.02">Rights as a Lender</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">106<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section12.03.">Section&#160;12.03.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section12.03.">Exculpatory Provisions</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">106<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section12.04.">Section&#160;12.04.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section12.04.">Reliance by Administrative Agent</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">107<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section12.05.">Section&#160;12.05.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section12.05.">Delegation of Duties</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">108<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section12.06.">Section&#160;12.06.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section12.06.">Resignation of Agent</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">108<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section12.07.">Section&#160;12.07.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section12.07.">Non&#8209;Reliance on Administrative Agent and Other Lenders</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">109<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section12.08">Section&#160;12.08.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section12.08">Administrative Agent May File Proofs of Claim</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">109<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section12.09.">Section&#160;12.09.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section12.09.">Collateral and Guaranty Matters; Appointment of Collateral Agent</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">110<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman';"><a href="#Article13">Article&#160;13</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman';"><a href="#Article13">Miscellaneous</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">111<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.01.">Section&#160;13.01.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.01.">No Waiver</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">111<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.02.">Section&#160;13.02.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.02.">Notices</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">111<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.03.">Section&#160;13.03.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.03.">Expenses, Indemnification, Etc</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">111<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.04">Section&#160;13.04.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.04">Amendments, Etc</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">112<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.05.">Section&#160;13.05.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.05.">Successors and Assigns</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">113<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.06.">Section&#160;13.06.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.06.">Survival</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">116<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.07.">Section&#160;13.07.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.07.">Captions</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">116<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.08.">Section&#160;13.08.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.08.">Counterparts</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">116<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.09">Section&#160;13.09.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.09">Governing Law</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">117<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.10.">Section&#160;13.10.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.10.">Jurisdiction, Service of Process and Venue</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">117<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.11.">Section&#160;13.11.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.11.">Waiver of Jury Trial</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">118<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.12.">Section&#160;13.12.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.12.">Waiver of Immunity</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">118<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.13.">Section&#160;13.13.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.13.">Entire Agreement</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">118<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.14.">Section&#160;13.14.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.14.">Severability</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">118<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.15.">Section&#160;13.15.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.15.">No Fiduciary Relationship</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">118<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.16.">Section&#160;13.16.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.16.">USA Patriot Act</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">118<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.17.">Section&#160;13.17.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.17.">Treatment of Certain Information; Confidentiality</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">119<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.18.">Section&#160;13.18.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.18.">Releases of Guarantees and Liens</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">120<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.19.">Section&#160;13.19.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.19.">Acknowledgement and Consent to Bail&#8209;In of EEA Financial Institutions</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">120<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.20.">Section&#160;13.20.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.20.">Judgment Currency</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">121<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.21">Section&#160;13.21.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.21">Administrative Borrower</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">121<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.22">Section&#160;13.22.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.22">Joint and Several Liability of Borrowers</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">122<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.23.">Section&#160;13.23.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.23.">Amendment and Restatement</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">123<br>
              </td>
            </tr>
            <tr>
              <td style="width: 12%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.24.">Section&#160;13.24.</a></div>
              </td>
              <td style="width: 83%; vertical-align: top;">
                <div style="line-height: 1.25; font-family: 'Times New Roman'; margin-left: 18pt;"><a href="#Section13.24.">Reaffirmation and Consent</a></div>
              </td>
              <td style="width: 5%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">123<br>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25; font-family: 'Times New Roman';"><br>
      </div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div><br>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;">
      <table cellspacing="0" cellpadding="0" border="0" id="z6fdb6096c31e49b7b0020f56dde7657f" style="font-family: Arial; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Schedules:</div>
            </td>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 87%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';"><a href="#Schedule1">Schedule&#160;1</a></div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';"><a href="#Schedule1">Sixth Amendment Term Loan Commitment</a></div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Schedule 2</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Notice Addresses</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Schedule 3</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Products</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Schedule 4</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Commercial Partners</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Schedule 7.01</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Power and Authority</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Schedule&#160;7.05(a)</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Obligor Owned Real Property</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Schedule&#160;7.05(b)</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Obligor Material Intellectual Property</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Schedule&#160;7.06(a)</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Litigation</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Schedule&#160;7.13A</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Existing Indebtedness</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Schedule&#160;7.13B</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Existing Liens</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Schedule&#160;7.14</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Material Agreements</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Schedule&#160;7.15</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Restrictive Agreements</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Schedule&#160;7.16</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Real Property</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Schedule&#160;7.17</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Pension Matters</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Schedule&#160;7.19(b)</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Regulatory Approvals</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Schedule&#160;7.19(e)</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Regulatory Authority Notices</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Schedule&#160;7.20</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Capitalization</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Schedule 7.22</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Broker&#8217;s Fee</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Schedule 7.23</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Trade Compliance</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Schedule 7.26</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Royalty and Other Payments</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Schedule 9.03</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Subsidiaries to be Dissolved</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Schedule&#160;9.05(a)</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Existing Investments</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Schedule&#160;9.10</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Transactions with Affiliates</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">&#160;</td>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 87%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Exhibits:</div>
            </td>
            <td style="width: 3%; vertical-align: top;">&#160;</td>
            <td style="width: 87%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Exhibit&#160;A</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Form of Guarantee Assumption Agreement</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Exhibit&#160;B</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">[Reserved]</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Exhibit&#160;C</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Form of Note</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Exhibit&#160;D</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Form of U.S. Tax Compliance Certificate</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Exhibit&#160;E</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Form of Compliance Certificate</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Exhibit&#160;F</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Form of Assignment Agreement</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Exhibit&#160;G-1</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Form of U.S. Security Agreement</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Exhibit&#160;G-2</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Form of Canadian Security Agreement</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Exhibit&#160;G-3</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Form of Irish Debenture</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Exhibit&#160;H-1</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Form of Patent and Trademark Security Agreement</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Exhibit&#160;H-2</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Form of Copyright Security Agreement</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Exhibit I</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Form of Collateral Questionnaire</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Exhibit J</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">[Reserved]</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Exhibit&#160;K</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Form of Intercompany Subordination Agreement</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Exhibit&#160;L</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Form of Investor Subordination Agreement</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Exhibit&#160;M</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Form of Effective Date Term Loan Borrowing Notice</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Exhibit&#160;N</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Form of Delayed Draw Term Loan Borrowing Notice</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Exhibit&#160;O</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Form of Third Amendment Term Loan Borrowing Notice</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Exhibit&#160;P</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Form of Fourth Amendment Term Loan Borrowing Notice</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Exhibit&#160;Q</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Form of Fifth Amendment Term Loan Borrowing Notice</div>
            </td>
          </tr>
          <tr>
            <td style="width: 10%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Exhibit&#160;R</div>
            </td>
            <td style="width: 3%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">&#8212;</div>
            </td>
            <td style="width: 87%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman';">Form of Sixth Amendment Term Loan Borrowing Notice</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <!--PROfilePageNumberReset%Num%1%- % -%-->
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-variant: small-caps;">Sixth Amended and Restated Credit Agreement And Guaranty,</font> dated as of August 7, 2025 (this <font style="font-style: italic;">&#8220;Agreement&#8221;</font>), among <font style="font-variant: small-caps;">Trinity Biotech, Inc</font>., a Delaware corporation (&#8220;<font style="font-style: italic;">U.S. Holdings</font>&#8221;), <font style="font-variant: small-caps;">Clark Laboratories, Inc</font>. (d/b/a Trinity Biotech (USA)), a New York corporation (&#8220;<font style="font-style: italic;">U.S. Clark</font>&#8221;),&#160; <font style="font-variant: small-caps;">Biopool U.S., Inc</font>., a Delaware corporation
      (d/b/a Trinity Biotech Distribution) (&#8220;<font style="font-style: italic;">U.S. Biopool</font>&#8221;), <font style="font-variant: small-caps;">Primus Corporation</font>, a Missouri corporation (&#8220;<font style="font-style: italic;">U.S. Primus</font>&#8221;),<font style="font-variant: small-caps;">&#160; MarDx Diagnostics, Inc., </font>a California corporation (&#8220;<font style="font-style: italic;">U.S. MarDx</font>&#8221;), <font style="font-variant: small-caps;">IMMCO Diagnostics, Inc</font>., a Delaware corporation
      (&#8220;<font style="font-style: italic;">U.S. Immco</font>&#8221;), <font style="font-variant: small-caps;">TRIB Biosensors Inc.</font>, a Delaware corporation (<font style="font-style: italic;">&#8220;U.S. TRIB&#8221;</font>, and together with U.S. Holdings, U.S.
      Fitzgerald, U.S. Clark, U.S. Biopool, U.S. Primus, U.S. MarDx and U.S. Immco, each a &#8220;<font style="font-style: italic;">Borrower</font>&#8221; and collectively, the <font style="font-style: italic;">&#8220;Borrowers&#8221;</font>), certain Guarantors from time to
      time parties hereto, the lenders from time to time party hereto (each, as a &#8220;<font style="font-style: italic;">Lende</font>r&#8221; and collectively, the &#8220;<font style="font-style: italic;">Lenders</font>&#8221;), and <font style="font-variant: small-caps;">Perceptive



        Credit Holdings III, LP</font>, a Delaware limited partnership (&#8220;<font style="font-style: italic;">Perceptive</font>&#8221;), as administrative agent for the Lenders (in such capacity, together with its successors and assigns, the &#8220;<font style="font-style: italic;">Administrative Agent</font>&#8221;).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps; font-weight: bold;">Witnesseth:</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps; font-weight: bold;"> <br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">The Borrowers, the Guarantors, the Administrative Agent and the Lenders are party to that certain Amended and Restated Credit Agreement and
      Guaranty, dated as of February 21, 2023 (as amended by that certain First Amendment to Amended and Restated Credit Agreement and Guaranty, dated as of April 20, 2023, the <font style="font-style: italic;">&#8220;Original Credit Agreement&#8221;</font>).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">The Borrowers, the Guarantors, the Administrative Agent and the Lenders amended and restated the Original Credit Agreement pursuant to that certain
      Second Amended and Restated Credit Agreement and Guaranty, dated as of January 30, 2024 (the <font style="font-style: italic;">&#8220;Second A&amp;R Credit Agreement&#8221;</font>).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">The Borrowers, the Guarantors, the Administrative Agent and the Lenders amended and restated the Second A&amp;R Credit Agreement pursuant to that
      certain Third Amended and Restated Credit Agreement and Guaranty, dated as of December 23, 2024 (the <font style="font-style: italic;">&#8220;Third A&amp;R Credit Agreement&#8221;</font>).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">The Borrowers, the Guarantors, the Administrative Agent and the Lenders amended and restated the Third A&amp;R Credit Agreement pursuant to that
      certain Fourth Amended and Restated Credit Agreement and Guaranty, dated as of February 27, 2025 (the <font style="font-style: italic;">&#8220;Fourth A&amp;R Credit Agreement&#8221;</font>).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">The Borrowers, the Guarantors, the Administrative Agent and the Lenders amended and restated the Fourth A&amp;R Credit Agreement pursuant to that
      certain Fifth Amended and Restated Credit Agreement and Guaranty, dated as of May 14, 2025 (the <font style="font-style: italic;">&#8220;Fifth A&amp;R Credit Agreement&#8221;</font>).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">The Borrowers have requested, and the Administrative Agent and the Lenders have agreed (i) to provide a new Sixth Amendment Term Loan and (ii) that
      certain other terms and conditions of the Fifth A&amp;R Credit Agreement be amended and, for the sake of clarity and convenience, that the Fifth A&amp;R Credit Agreement be restated in its entirety.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 1 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">It is the intent of the Obligors to confirm that all Obligations of the Obligors under the Loan Documents (as amended, modified or supplemented
      through the Sixth Amendment Restatement Date) shall continue in full force and effect.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">It is the intent of the parties hereto that this Agreement does not constitute a novation of the obligations and liabilities of the parties under
      the Fifth A&amp;R Credit Agreement and that this Agreement amend and restate in its entirety the Fifth A&amp;R Credit Agreement.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps; font-weight: bold;"><a name="ArticleI"><!--Anchor--></a>Article I<br>
      <br>
      Definitions</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;1.01.</font><font style="font-family: 'Times New Roman';"> <a name="Section1.01."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Certain Defined Terms</font>.&#160; As used herein, the following terms have the following respective meanings:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">510(k)</font>&#8221; means (a) any premarket notification and corresponding FDA clearance for a Device pursuant to FDA regulations, (b)
      all substantially equivalent or similar notifications, applications and clearances with respect to any other non-United States Regulatory Authority, including the EMA, HPRA, and Health Canada, ANVISA and (iii) all amendments, supplements and other
      additions and modifications thereto, and all documents, data and other information concerning any applicable Device which are necessary for, filed with, incorporated by reference in, or otherwise supportive of any of the foregoing.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Accounting Change&#8221;</font> has the meaning set forth in Section&#160;1.02.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Accounting Change Notice&#8221;</font> has the meaning set forth in Section&#160;1.02.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Acquisition&#8221;</font> means any transaction, or any series of related transactions, by which any Person directly or
      indirectly, by means of a take&#8209;over bid, tender offer, amalgamation, plan of arrangement, merger, purchase of assets, or similar transaction having the same effect as any of the foregoing, (a)&#160;acquires any business or all or substantially all of the
      assets of any Person engaged in any business, (b) acquires all or substantially all of a business line or unit or division of any other Person, (c)&#160;acquires Control of securities of a Person engaged in a business representing more than 50% of the
      ordinary voting power for the election of directors or other governing body if the business affairs of such Person are managed by a Board or other governing body, or (d)&#160;acquires Control of more than 50% of the ownership interest in any Person
      engaged in any business that is not managed by a Board or other governing body.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Act&#8221;</font> has the meaning set forth in Section&#160;13.16.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Administrative Agent&#8221;</font> has the meaning set forth in the introduction hereto.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Administrative Borrower&#8221; </font>has the meaning set forth in Section&#160;13.21.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;ADSs&#8221; </font>means American Depositary Shares.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 2 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#160;&#8220;ADS Ratio&#8221; </font>has the meaning set forth in the Existing Warrant Certificate and Effective Date Warrant
      Certificate.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Affected Financial Institution&#8221;</font> means (a) any EEA Financial Institution or (b) any U.K. Financial
      Institution.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Affiliate&#8221;</font> means, with respect to a specified Person, another Person that directly, or indirectly through
      one or more intermediaries, Controls or is Controlled by or is under common Control with the Person specified.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Agreement&#8221;</font> has the meaning set forth in the introduction hereto.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">American Depositary Receipts</font>&#8221; means the American Depositary Receipts (representing the American Depositary
      Shares) issued by The Bank of New York Mellon, as depositary of the American Depositary Shares and issuer of the American Depositary Receipts.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">American Depositary Shares</font>&#8221; means the American Depositary Shares (represented by American Depositary
      Receipts) of Trinity Biotech plc held by The Bank of New York Mellon, as depositary. </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Anti&#8209;Corruption Laws&#8221;</font> means all laws, rules and regulations of any jurisdiction applicable to the Obligors
      and their Affiliates concerning or relating to bribery or corruption, including, without limitation, the Foreign Corrupt Practices Act of 1977, as amended, and the <font style="font-style: italic;">Corruption of Foreign Public Officials Act </font>(Canada),


      as amended.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Anti&#8209;Terrorism Laws&#8221;</font> means any laws or regulations relating to terrorism or money laundering, including,
      without limitation the <font style="font-style: italic;">Bank Secrecy Act</font> (31 U.S.C. &#167;&#167;&#160;5311 <font style="font-style: italic;">et seq.</font>), the <font style="font-style: italic;">Money Laundering Control Act of 1986</font> (18 U.S.C.
      &#167;&#167;&#160;1956 <font style="font-style: italic;">et seq.</font>), USA Patriot Act, the <font style="font-style: italic;">Proceeds of Crime (Money Laundering) and Terrorist Financing Act </font>(Canada), Part II.1 of the <font style="font-style: italic;">Criminal



        Code </font>(Canada), regulations promogulated pursuant to the <font style="font-style: italic;">Special Economic Measures Act</font> (Canada), and the <font style="font-style: italic;">United Nations Act</font> (Canada), and any similar law
      enacted in any of the United States, Canada, or any other jurisdiction applicable to the Obligors and their Affiliates after the date of this Agreement.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">ANVISA</font>&#8221; means Ag&#234;ncia Nacional de Vigil&#226;ncia Sanit&#225;ria of Brazil and any successor thereto.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Applicable Margin&#8221;</font> means (a) from the Original Closing Date until the Effective Date, 11.25% per annum and
      (b) on and after the Effective Date, (i) 8.75% per annum on and after the day immediately following the date that the aggregate principal amount of the Term Loans is equal to or greater than $35,000,000 and (ii) 6.25% per annum on and after the day
      immediately following the date that the aggregate principal amount of the Term Loans is less than $35,000,0000.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 3 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Approved Fund&#8221; </font>means any Person (other than a natural person) that is engaged in making, purchasing,
      holding or investing in bank loans and similar extensions of credit in the ordinary course of its business and that is administered or managed by (a) a Lender, (b) an Affiliate of a Lender or (c) an entity or an Affiliate of an entity that
      administers or manages a Lender.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Asset Sale&#8221;</font> has the meaning set forth in Section&#160;9.09.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Assignment Agreement&#8221; </font>means an assignment and assumption entered into by a Lender and an assignee of such
      Lender in substantially the form of Exhibit&#160;F.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Available Tenor</font>&#8221; means, as of any date of determination and with respect to the then current Benchmark, as
      applicable (a) if the then current Benchmark is a term rate, any tenor for such Benchmark that is or may be used for determining the length of an Interest Period or (b) otherwise, any payment period for interest calculated with reference to such
      Benchmark, as applicable, pursuant to this Agreement as of such date; not including, for the avoidance of doubt, any tenor for such Benchmark that is then-removed from the definition of &#8220;Interest Period&#8221; pursuant to Section 3.02(c)(iv).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Bail&#8209;In Action&#8221;</font> means the exercise of any Write&#8209;Down and Conversion Powers by the applicable Resolution
      Authority in respect of any liability of an Affected Financial Institution.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Bail&#8209;In Legislation&#8221;</font> means (a) with respect to any EEA Member Country implementing Article 55 of Directive
      2014/59/EU of the European Parliament and of the Council of the European Union, the implementing law, regulation, rule or requirement for such EEA Member Country from time to time which is described in the EU Bail-In Legislation Schedule and (b) with
      respect to the United Kingdom, Part I of the United Kingdom Banking Act 2009 (as amended from time to time) and any other law, regulation, rule or requirement applicable in the United Kingdom relating to the resolution of unsound or failing banks,
      investment firms or other financial institutions or their affiliates (other than through liquidation, administration or other Insolvency Proceedings).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Bankruptcy Code&#8221;</font> means Title&#160;11 of the United States Code entitled &#8220;Bankruptcy.&#8221;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Benchmark</font>&#8221; means, initially, the Term SOFR Reference Rate; <font style="font-style: italic;">provided</font>
      that if a Benchmark Transition Event has occurred with respect to the Term SOFR Reference Rate or the then-current Benchmark, then &#8220;Benchmark&#8221; means the applicable Benchmark Replacement to the extent that such Benchmark Replacement has replaced such
      prior benchmark rate pursuant to Section 3.02(c).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Benchmark Replacement</font>&#8221; means the first alternative set forth in the order below that can be determined by
      the Administrative Agent for the applicable Benchmark Replacement Date:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Daily Simple SOFR; or</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';"> <br>
    </div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">
      <div style="line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; the sum of: (i) the alternate benchmark rate that has been selected by the Administrative Agent and the Administrative Borrower giving due consideration to (A) any selection or recommendation of a
        replacement benchmark rate or the mechanism for determining such a rate by the Relevant Governmental Body or (B) any evolving or then-prevailing market convention for determining a benchmark rate as a replacement to the then-current Benchmark for
        Dollar-denominated syndicated credit facilities and (ii) the related Benchmark Replacement Adjustment.</div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 4 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman';">If the Benchmark Replacement as determined pursuant to clause (a) or (b) above would be less than the Floor, the Benchmark Replacement will be deemed to be the Floor
      for the purposes of this Agreement and the other Loan Documents.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Benchmark Replacement Adjustment</font>&#8221; means, with respect to any replacement of the then-current Benchmark
      with an Unadjusted Benchmark Replacement, the spread adjustment, or method for calculating or determining such spread adjustment, (which may be a positive or negative value or zero) that has been selected by the Administrative Agent and the Borrower
      giving due consideration to (a) any selection or recommendation of a spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of such Benchmark with the applicable Unadjusted Benchmark Replacement&#160; by
      the Relevant Governmental Body or (b) any evolving or then-prevailing market convention for determining a spread adjustment, or method for calculating or determining such spread adjustment, for the replacement of such Benchmark with the applicable
      Unadjusted Benchmark Replacement for Dollar-denominated syndicated credit facilities at such time.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Benchmark Replacement Date&#8221; </font>means a date and time determined by the Administrative Agent, which date
      shall be no later than the earliest to occur of the following events with respect to the then&#8209;current Benchmark:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;in the case of clause&#160;(a)&#160;or (b)&#160;of the definition of &#8220;Benchmark Transition Event,&#8221; the later of
        (i)&#160;the date of the public statement or publication of information referenced therein and (ii)&#160;the date on which the administrator of such Benchmark (or the published component used in the calculation thereof) permanently or indefinitely ceases to
        provide all Available Tenors of such Benchmark (or such component thereof); or</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; in the case of clause&#160;(c) of the definition of &#8220;Benchmark Transition Event&#8221;, the first date on which such
      Benchmark (or the published component used in the calculation thereof) has been determined and announced by the regulatory supervisor for the administrator of such Benchmark (or such component thereof) to be non&#8209;representative; <font style="font-style: italic;">provided</font> that such non&#8209;representativeness will be determined by reference to the most recent statement or publication referenced in such clause&#160;(c) and even if any Available Tenor of such Benchmark (or such
      component thereof) continues to be provided on such date.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman';">For the avoidance of doubt, the &#8220;Benchmark Replacement Date&#8221; will be deemed to have occurred in the case of clause&#160;(a) or (b) with respect to any Benchmark upon the
      occurrence of the applicable event or events set forth therein with respect to all then&#8209;current Available Tenors of such Benchmark (or the published component used in the calculation thereof).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Benchmark Transition Event&#8221;</font> means the occurrence of one or more of the following events with respect to
      the then&#8209;current Benchmark:</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 5 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 36pt;"><font style="font-family: 'Times New Roman';">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; a public statement or publication of information by or on behalf of the administrator of such Benchmark (or the published
        component used in the calculation thereof) announcing that such administrator has ceased or will cease to provide all Available Tenors of such Benchmark (or such component thereof), permanently or indefinitely; <font style="font-style: italic;">provided</font>
        that, at the time of such statement or publication, there is no successor administrator that will continue to provide any Available Tenor of such Benchmark (or such component thereof);</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 36pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 36pt;"><font style="font-family: 'Times New Roman';">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; a public statement or publication of information by the regulatory supervisor for the administrator of such Benchmark (or
        the published component used in the calculation thereof), the Federal Reserve Board, the Federal Reserve Bank of New&#160;York, an insolvency official with jurisdiction over the administrator for such Benchmark (or such component), a resolution
        authority with jurisdiction over the administrator for such Benchmark (or such component) or a court or an entity with similar insolvency or resolution authority over the administrator for such Benchmark (or such component), which states that the
        administrator of such Benchmark (or such component) has ceased or will cease to provide all Available Tenors of such Benchmark (or such component thereof) permanently or indefinitely; <font style="font-style: italic;">provided</font> that, at the
        time of such statement or publication, there is no successor administrator that will continue to provide any Available Tenor of such Benchmark (or such component thereof); or</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">&#160;(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a public statement or publication of information by the regulatory supervisor for the administrator of such Benchmark
        (or the published component used in the calculation thereof) announcing that all Available Tenors of such Benchmark (or such component thereof) are not, or as of a specified future date will not be, representative.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman';">For the avoidance of doubt, a &#8220;Benchmark Transition Event&#8221; will be deemed to have occurred with respect to any Benchmark if a public statement or publication of
      information set forth above has occurred with respect to each then&#8209;current Available Tenor of such Benchmark (or the published component used in the calculation thereof).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Benchmark Unavailability Period&#8221;</font> means, the period (if any) (a)&#160;beginning at the time that a Benchmark
      Replacement Date has occurred if, at such time, no Benchmark Replacement has replaced the then&#8209;current Benchmark for all purposes hereunder and under any Loan Document in accordance with Section&#160;3.02(c) and (b)&#160;ending at the time that a Benchmark
      Replacement has replaced the then&#8209;current Benchmark for all purposes hereunder and under any Loan Document in accordance with Section&#160;3.02(c).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman'; font-style: italic;">&#8220;Beneficial Ownership Regulation&#8221; has the meaning set forth in Section 13.16.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Benefit Plan&#8221;</font> means any employee benefit plan as defined in Section&#160;3(3) of ERISA to which any Obligor or
      Subsidiary thereof incurs or otherwise has any obligation or liability, contingent or otherwise.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Board</font>&#8221; means, with respect to any Person, the board of directors or managers (as applicable) (or
      equivalent governing body) of such Person or any committee thereof.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 6 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Borrower&#8221;</font> and &#8220;<font style="font-style: italic;">Borrowers</font>&#8221; have the meaning set forth in the
      introduction hereto; <font style="font-style: italic;">provided</font> that upon the completion of the Fitzgerald and Benen Sale, U.S. Fitzgerald shall no longer be a Borrower hereunder.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Borrowing&#8221;</font> means collectively, (i) the Funding Date Term Loan made by the Lenders on the Funding Date,
      (ii) the Tranche B Term Loan made by the Lenders on the Tranche B Term Loan Borrowing Date, (iii) the Effective Date Term Loan made by the Lenders on the Effective Date, (iv) the Delayed Draw Term Loan made on the Delayed Draw Term Loan Borrowing
      Date, (v) the Third Amendment Term Loan made by the Lenders on the Third Amendment Restatement Date, (vi) the Fourth Amendment Term Loan made by the Lenders on the Fourth Amendment Restatement Date, (vii) the Fifth Amendment Term Loan made by the
      Lenders on the Fifth Amendment Restatement Date and (viii) the Sixth Amendment Term Loan made by the Lenders on the Sixth Amendment Restatement Date.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Bray Leases</font>&#8221; means (a) that certain Lease Agreement between Ronan O&#8217;Caoimh and Jim Walsh with Trinity
      Biotech Manufacturing Limited for the office in Bray, Co. Wicklow Ireland dated November 26, 2004, (b) that certain Indenture between Jim Walsh and Trinity Biotech Manufacturing Limited dated December 20, 2007 and (c) that certain Lease between
      O&#8217;Caoimh, O&#8217;Boyle and Trinity Biotech Manufacturing Limited dated July 2016.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Brazilian Subsidiary</font>&#8221; means Trinity Biotech Do Brasil LTDA.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Business Day&#8221;</font> means a day (other than a Saturday or Sunday) on which commercial banks are not authorized
      or not required to close in New&#160;York City.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Canadian Bankruptcy Legislation</font>&#8221; means the <font style="font-style: italic;">Bankruptcy and Insolvency
        Act</font> (Canada), the <font style="font-style: italic;">Companies&#8217; Creditors Arrangement Act</font> (Canada), the <font style="font-style: italic;">Winding-Up and Restructuring Act</font> (Canada), and all other liquidation, winding-up,
      bankruptcy, assignment for the benefit of creditors, conservatorship, moratorium, receivership, insolvency, plan of arrangement, reorganization, proposal or similar statutes, laws, rules and regulations of Canada, or any province or territory thereof
      or any other applicable jurisdictions, in effect from time to time.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Canadian Defined Benefit Pension Plan</font>&#8221; means a pension plan for the purposes of any applicable pension
      benefits standards, statute or regulation in Canada, which contains a &#8220;defined benefit provision,&#8221; as defined in subsection 147.1(1) of the <font style="font-style: italic;">Income Tax Act </font>(Canada).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Canadian Intellectual Property Security Agreements&#8221;</font> means Trademark security agreements, dated as of the
      Funding Date, entered into by U.S. Primus and Phoenix Bio-Tech Corp, in favor of the Administrative Agent for the benefit of the Lenders, each in form and substance satisfactory to the Administrative Agent.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Canadian Obligor</font>&#8221; means an Obligor incorporated or organized under the laws of Canada.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 7 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Canadian Pension Plan</font>&#8221; means a &#8220;registered pension plan&#8221; (as defined in subsection 248(1) of the <font style="font-style: italic;">Income Tax Act</font> (Canada) sponsored or administrated by one or more of the Obligors or any of their Subsidiaries.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Canadian Pledge Agreement&#8221;</font> means the Canadian Pledge Agreement, dated as of the Funding Date, among
      Parent, the Lenders and the Administrative Agent, pledging 100% of the Equity Interests in Phoenix Bio-Tech Corp. in favor of the Administrative Agent for the benefit of the Lenders.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Canadian Security Agreement&#8221;</font> means the Canadian Security Agreement, dated as of the Funding Date, in
      substantially the form of Exhibit G-2, among the Obligors organized under the laws of Canada, the Lenders and the Administrative Agent, granting a security interest in the personal Property constituting Collateral thereunder in favor of the
      Administrative Agent for the benefit of the Lenders.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Capital&#160;Lease Obligations</font>&#8221;&#160;means, as to any Person, the obligations of such Person to pay rent or other
      amounts under a lease of (or other agreement conveying the right to use) real and/or personal Property which obligations are required to be classified and accounted for as a&#160;capital&#160;lease on a balance sheet of such Person under IFRS and, for purposes
      of this Agreement, the amount of such obligations shall be the&#160;capitalized amount thereof, determined substantially in accordance with IFRS;&#160;<font style="font-style: italic;">provided&#160;</font>that&#160;any lease that would have been considered an operating
      lease under IFRS as in effect as of December 31, 2018 shall be treated as an operating lease&#160;for all purposes&#160;under this Agreement and the other Loan Documents, and all obligations in respect thereof shall be excluded from the definition of
      Indebtedness.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Casualty Event&#8221;</font> means any actual or constructive loss, condemnation, destruction, confiscation,
      requisition, seizure or forfeiture of any asset of the Borrowers or any other Obligor, with a fair market value as of the date of such event, individually or in the aggregate, of greater than $1,000,000 in any calendar year.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Cayman Subsidiary</font>&#8221; means Trinity Biotech Investment Limited.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Change of Control&#8221; </font>means and shall be deemed to have occurred if:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160; any &#8220;person&#8221; or &#8220;group&#8221; (within the meaning of Rule 13d-5 of the Exchange Act as in effect on the date hereof) shall
      own, directly or indirectly, beneficially or of record, shares representing 40% or more of the aggregate ordinary voting power represented by the issued and outstanding Equity Interests of Parent;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160; during any period of twelve&#160;(12) consecutive calendar months, the occupation of a majority of the seats (other than
      vacant seats) on the Board of Parent by Persons who were neither (i)&#160;nominated or approved by the Board of Parent, nor (ii)&#160;appointed by directors on the Board on the Original Closing Date or so nominated;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160; Parent shall cease to own directly or indirectly, determined on a fully diluted basis, 100% of the issued and
      outstanding Equity Interests of the Obligors; and</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 8 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(d)&#160;&#160;&#160;&#160;&#160;&#160; each Obligor (other than Parent) shall cease to own directly, beneficially and of record, determined on a fully
      diluted basis, 100% of the issued and outstanding Equity Interests of its Subsidiaries (except an Immaterial Foreign Subsidiary).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Claims&#8221; </font>includes claims, litigation, demands, complaints, grievances, actions, applications, suits,
      causes of action, orders, charges, indictments, prosecutions, information (brought by a public prosecutor without grand jury indictment) or other similar processes, assessments or reassessments.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;CLIA&#8221;</font> means the Clinical Laboratory Improvement Amendments (CLIA) of 1988, as amended from time to time,
      and the rules, regulations, guidelines, guidance documents and compliance policy guides issued or promulgated thereunder.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Code&#8221;</font> means the Internal Revenue Code of 1986, as amended from time to time.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Collateral&#8221;</font> means any Property in which a Lien is purported to be granted under any of the Security
      Documents (or all such Property, as the context may require).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Collateral Questionnaire&#8221;</font> means that certain Collateral Questionnaire and certification by a Responsible
      Officer of the Obligors substantially in the form of attached hereto as Exhibit I and otherwise in form reasonably satisfactory to the Administrative Agent.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">COMI&#8221;</font> means center of main interests within the meaning, and for the purposes, of the EU Insolvency
      Regulation.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Commercial Partner&#8221;</font> means each of the parties set out on Schedule 4 attached hereto.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Commitment&#8221;</font> means with respect to each Lender, such Lender&#8217;s Sixth Amendment Term Loan Commitment; and <font style="font-style: italic;">&#8220;Commitments&#8221;</font> means all such Commitments of all Lenders.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Commodity Account&#8221;</font> has the meaning set forth in the U.C.C.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Compliance Certificate&#8221;</font> has the meaning set forth in Section&#160;8.01(d).</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"> <br>
    </div>
    <div style="line-height: 1.25;">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Conforming Changes</font>&#8221; means, with respect to either the use or administration of Term SOFR or the use,
        administration, adoption or implementation of any Benchmark Replacement, any technical, administrative or operational changes (including changes to the definition of &#8220;Business Day,&#8221; the definition of &#8220;U.S. Government Securities Business Day,&#8221; the
        definition of &#8220;Interest Period&#8221; or any similar or analogous definition (or the addition of a concept of &#8220;interest period&#8221;), timing and frequency of determining rates and making payments of interest, timing of borrowing requests or prepayment,
        conversion or continuation notices, the applicability and length of lookback periods and other technical, administrative or operational matters) that the Administrative Agent decides may be appropriate to reflect the adoption and implementation of
        any such rate or to permit the use and administration thereof by the Administrative Agent in a manner substantially consistent with market practice (or, if the Administrative Agent decides that adoption of any portion of such market practice is not
        administratively feasible or if the Administrative Agent determines that no market practice for the administration of any such rate exists, in such other manner of administration as the Administrative Agent decides is reasonably necessary in
        connection with the administration of this Agreement and the other Loan Documents).</div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 9 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Connection Income Taxes&#8221; </font>means Other Connection Taxes that are imposed on or measured by net income
      (however denominated) or that are franchise Taxes or branch profits Taxes.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Contracts&#8221;</font> means any contract, license, instrument, lease, agreement, obligation, promise, undertaking,
      understanding, arrangement, document, commitment, entitlement or engagement under which a Person has, or will have, any liability or contingent liability (in each case, whether written or oral, express or implied, and whether in respect of monetary
      or payment obligations, performance obligations or otherwise), excluding the Loan Documents.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Control&#8221;</font> means, with respect to any particular Person, the possession by one or more other Persons,
      directly or indirectly, of the power to direct or cause the direction of the management or policies of such particular Person, whether through the ability to exercise voting power, by contract or otherwise.&#160; <font style="font-style: italic;">&#8220;Controlling&#8221;


      </font>and <font style="font-style: italic;">&#8220;Controlled&#8221;</font> have meanings correlative thereto.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Controlled Account&#8221;</font> has the meaning set forth in Section&#160;8.18(a).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Convertible Notes</font>&#8221; means those certain exchangeable senior notes issued pursuant to the Indenture dated as
      April 9, 2015, by the Cayman Subsidiary and guaranteed by Parent.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Copyrights&#8221;</font> means all copyrights, copyright registrations and applications for copyright registrations,
      including all renewals and extensions thereof, all rights to recover for past, present or future infringements thereof and all other rights whatsoever accruing thereunder or pertaining thereto.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"> <br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">
      <div style="text-indent: 36pt; line-height: 1.25;">&#8220;<font style="font-style: italic;">Daily Simple SOFR</font>&#8221; means, for any day (a &#8220;SOFR Rate Day&#8221;), a rate per annum equal to the greater of (a) SOFR for the day (such day, a &#8220;SOFR Determination
        Day&#8221;) that is two (2) U.S. Government Securities Business Days prior to (i) if such SOFR Rate Day is a U.S. Government Securities Business Day, such SOFR Rate Day or (ii) if such SOFR Rate Day is not a U.S. Government Securities Business Day, the
        U.S. Government Securities Business Day immediately preceding such SOFR Rate Day, in each case, as such SOFR is published by the SOFR Administrator on the SOFR Administrator&#8217;s Website, and (b) the Floor.&#160; If by 5:00 p.m. (New York City time) on the
        second (2nd) U.S. Government Securities Business Day immediately following any SOFR Determination Day, SOFR in respect of such SOFR Determination Day has not been published on the SOFR Administrator&#8217;s Website and a Benchmark Replacement Date with
        respect to the Daily Simple SOFR has not occurred, then SOFR for such SOFR Determination Day will be SOFR as published in respect of the first preceding U.S. Government Securities Business Day for which such SOFR was published on the SOFR
        Administrator&#8217;s Website; <font style="font-style: italic;">provided</font> that, any SOFR determined pursuant to this sentence shall be utilized for purposes of calculation of Daily Simple SOFR for no more than three (3) consecutive SOFR Rate
        Days; <font style="font-style: italic;">provided further</font>, Daily Simple SOFR shall be rounded upwards to the next 1/100% (if necessary).&#160; Any change in Daily Simple SOFR due to a change in SOFR shall be effective from and including the
        effective date of such change in SOFR without notice to the Administrative Borrower.</div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 10 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Default&#8221;</font> means any Event of Default and any event that, upon the giving of notice, the lapse of time or
      both, would constitute an Event of Default.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Default Rate&#8221;</font> has the meaning set forth in Section&#160;3.02(d).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Delayed Draw Term Loan&#8221; </font>means the loan advanced by a Lender pursuant to Section 2.01(d). For purposes of
      clarification, any calculation of the aggregate outstanding principal amount of the Delayed Draw Term Loan on any date of determination shall mean the aggregate principal amount of the Delayed Draw Term Loan made pursuant to Section 2.01(d) that has
      not yet been repaid as of such date.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Delayed Draw Term Loan Borrowing Date&#8221; </font>means with respect to the Delayed Draw Term Loan, the Business Day
      on which a Delayed Draw Term Loan was made pursuant to Section 2.01(d) of the Second A&amp;R Credit Agreement.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Delayed Draw Term Loan Borrowing Notice&#8221; </font>means a notice requesting a Delayed Draw Term Loan substantially
      in the form of Exhibit N.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Deposit Account&#8221;</font> has the meaning set forth in the U.C.C. (and includes, for greater certainty, any deposit
      account maintained with a bank or other financial institution in any Canadian jurisdiction).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Designated Person&#8221;</font> means a person or entity:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)&#160; &#160; &#160; &#160; listed in the annex to, or otherwise targeted by the provisions of, the Executive Order (as disclosed by World&#8209;Check
      or another reputable commercially available database);</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)&#160;&#160;&#160;&#160; named as a &#8220;Specially Designated National and Blocked Person&#8221; on the most current list published by OFAC at its
      official website or any replacement website or other replacement official publication of such list (as disclosed by World&#8209;Check or another reputable commercially available database); or</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160; with which the Lenders are prohibited from dealing or otherwise engaging in any transaction by any Economic
      Sanctions Laws or Irish Economic Sanctions Laws.</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';"> <br>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">
        <div style="line-height: 1.25;"><font style="font-style: italic;">&#8220;Device&#8221;</font> means any product that meets the definition of &#8220;device&#8221; as set forth in Section 321 of the FD&amp;C Act, including (a) any medical instrument, apparatus, implement,
          machine, contrivance, implant, in vitro reagent or other similar or related item, including any component, part or accessory, that (i)&#160;is intended for use in the diagnosis of disease, malady or other conditions or in the cure, mitigation,
          treatment or prevention of disease or malady, in man or other animals, or is intended to affect the structure or any function of the body of man or other animals, (ii)&#160;does not achieve its primary intended purpose or purposes through chemical
          action within or on the body of man or other animals and (iii)&#160;is not dependent upon being metabolized for the achievement of its primary intended purpose or purposes and (b) any other product that meets the definition of &#8220;device&#8221; as set forth in
          Section 321 of the FD&amp;C Act.
          <div style="text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25;"> </div>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 11 -</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"> <font style="font-style: italic;">&#8220;Device Clearance Application&#8221;</font> means (a)&#160;any premarket approval application submitted under Section&#160;515
      of the FD&amp;C Act (21 U.S.C. &#167;&#160;360e) (a <font style="font-style: italic;">&#8220;PMA&#8221;</font>), (b)&#160;any de novo request submitted under Section&#160;513(f) of the FD&amp;C Act (21 U.S.C. &#167;&#160;360c(f)), (c)&#160;any 510(k) submitted under Section&#160;510(k) of the
      FD&amp;C Act (21 U.S.C. &#167;&#160;360(k)) seeking clearance from the FDA for a Device that is substantially equivalent to a legally marketed predicate Device, as defined in the FD&amp;C Act, (d)&#160;any corresponding or substantially equivalent notification,
      application or clearance of a non&#8209;United States Regulatory Authority including, with respect to the European Union, any equivalent submission to a Standard Body pursuant to an applicable directive of the European Council with respect to CE marking
      (or, if applicable, a self&#8209;certification of conformity with respect to any such directive through a &#8220;declaration of conformity&#8221;) and (e)&#160;all amendments, variations, extensions and renewals of any of the foregoing.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"> <br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Disqualified Equity Interests</font>&#8221; means, with respect to any Person, any Equity Interest of such Person that,
      by its terms (or by the terms of any security or other Equity Interest into which it is convertible or for which it is exchangeable upon exercise or otherwise), or upon the happening of any event or condition (a) matures or is mandatorily redeemable
      (other than solely for Qualified Equity Interests), including pursuant to a sinking fund obligation or otherwise, (b) is redeemable at the option of the holder thereof (other than solely for Qualified Equity Interests), in whole or in part, (c)
      provides for the scheduled payments of dividends or other distributions in cash or other securities that would constitute Disqualified Equity Interests, or (d) is or becomes convertible into or exchangeable for Indebtedness or any other Equity
      Interests that would constitute Disqualified Equity Interests, in each case, prior to the date that is one hundred and eighty (180) days after the Stated Maturity Date; <font style="font-style: italic;">provided</font> that, if such Equity Interests
      are issued pursuant to any plan for the benefit of directors, officers, employees or consultants of such Person or by any such plan to such directors, officers, employees or consultants, such Equity Interests shall not constitute Disqualified Equity
      Interests solely because they may be required to be repurchased by such Person upon the death, disability, retirement or termination of employment or service of such director, officer, employee or consultant.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Dollars&#8221;</font> and <font style="font-style: italic;">&#8220;$&#8221;</font> means lawful money of the United States.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Domestic Subsidiary&#8221; </font>means any Subsidiary that is organized under the laws of the United States, any
      state thereof or the District of Columbia.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Economic Sanctions Laws</font>&#8221; means (a) the Executive Order, the International Emergency Economic Powers Act
      (50 U.S.C. &#167;&#167; 1701 et seq.), the Trading with the Enemy Act (50 U.S.C. App. &#167;&#167; 1 et seq.), any other law or regulation promulgated thereunder from time to time and administered by OFAC and any similar law enacted in the United States after the date
      of this Agreement and (b) any other similar applicable law now or hereafter enacted in any other applicable jurisdiction, including, without limitation, the <font style="font-style: italic;">Special Economic Measures Act </font>(Canada), the <font style="font-style: italic;">United Nations Act </font>(Canada), the <font style="font-style: italic;">Freezing Assets of Corrupt Foreign Officials Act </font>(Canada), Part II.1 of the <font style="font-style: italic;">Criminal Code </font>(Canada),


      and the<font style="font-style: italic;"> Export and Import Permits Act </font>(Canada), and any regulations thereunder.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 12 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;EEA Financial Institution&#8221; </font>means (a)&#160;any credit institution or investment firm established in any EEA
      Member Country which is subject to the supervision of an EEA Resolution Authority, (b)&#160;any entity established in an EEA Member Country which is a parent of an institution described in clause&#160;(a) of this definition, or (c)&#160;any financial institution
      established in an EEA Member Country which is a subsidiary of an institution described in clauses&#160;(a) or (b) of this definition and is subject to consolidated supervision with its parent.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;EEA Member Country&#8221; </font>means any of the member states of the European Union, Iceland, Liechtenstein, and
      Norway.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">EEA Obligor</font>&#8221; means an Obligor which is incorporated or established in, or under the laws of, an EEA Member
      Country.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;EEA Resolution Authority&#8221;</font> means any public administrative authority or any person entrusted with public
      administrative authority of any EEA Member Country (including any delegee) having responsibility for the resolution of any EEA Financial Institution.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Effective Date</font>&#8221; means January 30, 2024.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Effective Date Acquisition&#8221;</font> means the acquisition by U.S. TRIB and Konamite of certain assets of WaveForm
      and WaveForm Holdings (including, without limitation, the Equity Interests of WaveForm Slovenia to be transferred subsequent to the closing under the Effective Date Acquisition Agreement) pursuant to the terms of the Effective Date Acquisition
      Agreement and the WaveForm Slovenia Side Agreement.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Effective Date Acquisition Agreement&#8221;</font> means that certain Asset and Share Purchase Agreement, dated as of
      January 30, 2024, among U.S. TRIB, as buyer, WaveForm and WaveForm Holdings, as sellers, and WaveForm Slovenia.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Effective Date Term Loan&#8221;</font> means the loan advanced by a Lender pursuant to Section 2.01(c).&#160; For purposes
      of clarification, any calculation of the aggregate outstanding principal amount of the Effective Date Term Loan on any date of determination shall mean the aggregate principal amount of the Effective Date Term Loan made pursuant to Section 2.01(c)
      that has not yet been repaid as of such date.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Effective Date Term Loan</font>&#160;<font style="font-style: italic;">Borrowing Notice</font>&#8221; means a notice
      substantially in the form attached hereto as Exhibit M.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Effective Date Warrant Certificate&#8221;</font> means the Warrant, dated as of the Effective Date, as amended by the
      First Amendment to the Effective Date Warrant Certificate, that, among other things, grants the holder thereof the right to purchase the number of American Depositary Shares (represented by American Depositary Receipts) of Parent as indicated on the
      Warrant Shares table on Schedule&#160;1.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">EMA</font>&#8221; means the European Medicines Agency and any successor thereto.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 13 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Environmental Law&#8221;</font> means any federal, state, provincial, territorial, or local governmental law, rule,
      regulation, order, writ, judgment, injunction or decree relating to pollution or protection of the environment or the treatment, storage, disposal, release, threatened release or handling of Hazardous Materials, and all local laws and regulations
      related to environmental matters and any specific agreements entered into with any competent authorities which include commitments related to environmental matters.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Equity Interest&#8221;</font> means, with respect to any Person, any and all shares (including all American Depositary
      Shares represented by American Depositary Receipts), interests, participations or other equivalents, including membership interests (however designated, whether voting or nonvoting), of equity of such Person, including, if such Person is a
      partnership, partnership interests (whether general or limited) and any other interest or participation that confers on a Person the right to receive a share of the profits and losses of, or distributions of property of, such partnership, but
      excluding debt securities convertible or exchangeable into such equity.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;ERISA&#8221;</font> means the United States Employee Retirement Income Security Act of 1974, as amended.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;ERISA Affiliate&#8221;</font> means, collectively, any Obligor, Subsidiary thereof, and any Person treated as a single
      employer, with any Obligor or Subsidiary thereof, within the meaning of Section&#160;414(b), (c), (m) or (o) of the Code.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;ERISA Event&#8221;</font> means (a)&#160;a reportable event as defined in Section&#160;4043 of ERISA with respect to a Title&#160;IV
      Plan, excluding, however, such events as to which the PBGC by regulation has waived the requirement of Section&#160;4043(a) of ERISA that it be notified within thirty (30) days of the occurrence of such event; (b)&#160;the applicability of the requirements of
      Section&#160;4043(b) of ERISA with respect to a contributing sponsor, as defined in Section&#160;4001(a)(13) of ERISA, to any Title&#160;IV Plan where an event described in paragraph&#160;(9), (10), (11), (12) or (13) of Section&#160;4043(c) of ERISA is reasonably expected
      to occur with respect to such plan within the following thirty (30) days; (c)&#160;a withdrawal by any Obligor or any ERISA Affiliate thereof from a Title&#160;IV Plan or the termination of any Title&#160;IV Plan resulting in liability under Sections&#160;4063 or 4064
      of ERISA; (d)&#160;the withdrawal of any Obligor or any ERISA Affiliate thereof in a complete or partial withdrawal (within the meaning of Section&#160;4203 and 4205 of ERISA) from any Multiemployer Plan if there is any potential liability therefore, or the
      receipt by any Obligor or any ERISA Affiliate thereof of notice from any Multiemployer Plan that it is insolvent or in critical status pursuant to Section&#160;4241 or 4245 of ERISA; (e)&#160;the filing of a notice of intent to terminate, the treatment of a
      plan amendment as a termination under Section&#160;4041 or 4041A of ERISA, or the commencement of proceedings by the PBGC to terminate a Title&#160;IV Plan or Multiemployer Plan; (f)&#160;the imposition of liability on any Obligor or any ERISA Affiliate thereof
      pursuant to Sections&#160;4062(e) or 4069 of ERISA or by reason of the application of Section&#160;4212(c) of ERISA; (g)&#160;the failure by any Obligor or any ERISA Affiliate thereof to make any required contribution to a Title IV Plan, or the failure to meet the
      minimum funding standard of Section&#160;412 of the Code with respect to any Title&#160;IV Plan (whether or not waived in accordance with Section&#160;412(c) of the Code) or the failure to make by its due date a required installment under Section&#160;430 of the Code
      with respect to any Title&#160;IV Plan or the failure to make any required contribution to a Multiemployer Plan; (h)&#160;the determination that any Title&#160;IV Plan is considered an at&#8209;risk plan or a plan in endangered to critical status within the meaning of
      Sections&#160;430, 431 and 432 of the Code or Sections&#160;303, 304 and 305 of ERISA; (i)&#160;an event or condition which might reasonably be expected to constitute grounds under Section&#160;4042 of ERISA for the termination of, or the appointment of a trustee to
      administer, any Title&#160;IV Plan or Multiemployer Plan; (j)&#160;the imposition of any liability under Title&#160;I or Title&#160;IV of ERISA, other than PBGC premiums due but not delinquent under Section&#160;4007 of ERISA, upon any Obligor or any ERISA Affiliate thereof;
      (k)&#160;an application for a funding waiver under Section&#160;303 of ERISA or an extension of any amortization period pursuant to Section&#160;412 of the Code with respect to any Title&#160;IV Plan; (l)&#160;the occurrence of a non&#8209;exempt prohibited transaction under
      Sections&#160;406 or 407 of ERISA for which any Obligor or any Subsidiary thereof may be directly or indirectly liable which may give rise to the imposition of fines or penalties thereon; (m)&#160;a violation of the applicable requirements of Section&#160;404 or
      405 of ERISA or the exclusive benefit rule under Section&#160;401(a) of the Code with respect to any Plan by any fiduciary or disqualified person for which any Obligor or any ERISA Affiliate thereof would be directly or indirectly liable; (n)&#160;the
      occurrence of an act or omission which gives rise to the imposition on any Obligor or any ERISA Affiliate thereof of fines, penalties, Taxes or related charges under Chapter&#160;43 of the Code or under Sections&#160;409, 502(c), (i) or (1) or 4071 of ERISA;
      (o)&#160;the assertion of a material claim (other than routine Claims for benefits) against any Plan or the assets thereof, or against any Obligor or any Subsidiary thereof in connection with any such plan; (p)&#160;receipt from the IRS of notice of the
      failure of any Qualified Plan to qualify under Section&#160;401(a) of the Code, or the failure of any trust forming part of any Qualified Plan to fail to qualify for exemption from taxation under Section&#160;501(a) of the Code; (q)&#160;the imposition of any Lien
      (or the fulfillment of the conditions for the imposition of any Lien) on any of the rights, properties or assets of any Obligor or any ERISA Affiliate thereof, in either case pursuant to Title&#160;I or IV, including Section&#160;302(f) or 303(k) of ERISA or
      to Section&#160;401(a)(29) or 430(k) of the Code; or (r)&#160;the establishment or amendment by any Obligor or any Subsidiary thereof of any &#8220;welfare plan,&#8221; as such term is defined in Section&#160;3(1) of ERISA, that provides post&#8209;employment welfare benefits in a
      manner that would increase the liability of any Obligor, other than those benefits required under the Consolidated Omnibus Budget Reconciliation Act.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 14 -</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;ERISA Funding Rules&#8221;</font> means the rules regarding minimum required contributions (including any installment
      payment thereof) to Title&#160;IV Plans, as set forth in Sections&#160;412, 430, 431, 432 and 436 of the Code and Sections&#160;302, 303, 304 and 305 of ERISA.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;EU Bail&#8209;In Legislation Schedule&#8221; </font>means the EU Bail&#8209;In Legislation Schedule&#160;published by the Loan Market
      Association (or any successor Person), as in effect from time to time.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;EU Insolvency Regulation&#8221; </font>means Regulation (EU) 2015/848 of the European Parliament and of the Council of
      20 May 2015 on insolvency proceedings (recast).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Event of Default&#8221;</font> has the meaning set forth in Section&#160;10.01.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Excess Funding Guarantor&#8221;</font> has the meaning set forth in Section&#160;11.08.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Excess Payment&#8221;</font> has the meaning set forth in Section&#160;11.08.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Exchange Act&#8221;</font> means the Securities Exchange Act of 1934, as amended, and the rules and regulations
      promulgated thereunder.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Excluded Accounts&#8221;</font> means (a) Deposit Accounts exclusively used for payroll, payroll Taxes and other
      employee wage and benefit payments to or for the benefit of the employees of the Obligors, (b) Deposit Accounts with aggregate balances of $250,000 or less at any time and (c) Deposit Accounts that are Segregated Health Care Accounts.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Excluded Taxes&#8221;</font> means any of the following Taxes imposed on or with respect to a Recipient or required to
      be withheld or deducted from a payment to a Recipient: (a)&#160;Taxes imposed on or measured by the overall net income (however denominated), franchise Taxes and branch profits Taxes in each case (i)&#160;imposed on such Recipient by the jurisdiction (or any
      political supervision thereof) under the laws of which such Recipient is organized, or having its principal office or, in the case of a Lender, its applicable lending office located in, the jurisdiction imposing such Tax or (ii)&#160;that are Other
      Connection Taxes, (b)&#160;any United States&#160;federal withholding Taxes that are imposed on amounts payable to Lender to the extent that the obligation to withhold amounts existed on the date that (i)&#160;Lender became a &#8220;Lender&#8221; under this Agreement or
      (ii)&#160;Lender changes its lending office, except in each case to the extent Lender is a direct or indirect assignee of any other Lender that was entitled, at the time the assignment of such other Lender became effective, to receive additional amounts
      under Section&#160;5.03 or Lender was entitled to receive additional amounts under Section&#160;5.03 immediately before it changed its lending office, (c)&#160;any Taxes imposed in connection with FATCA, and (d)&#160;Taxes attributable to such Recipient&#8217;s failure to
      comply with Section&#160;5.03(f).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Executive Order&#8221;</font> means the US Executive Order No.&#160;13224 on Blocking Property and Prohibiting Transactions
      with Persons who commit, Threaten to Commit, or Support Terrorism.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Existing Warrant Certificate&#8221;</font> means the Warrant, dated as of the Funding Date, that, among other things,
      grants the holder thereof the right to purchase the number of American Depositary Shares (represented by American Depositary Receipts) of Parent as indicated on the Warrant Shares table on Schedule 1, as amended by the Existing Warrant Certificate
      Amendments and as may be further amended, replaced or otherwise modified pursuant to the terms thereof.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Existing Warrant Certificate Amendments</font>&#8221; means that First Amendment to Existing Warrant Certificate, that
      Second Amendment to Warrant Certificate and that Third Amendment to Warrant Certificate.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;FATCA&#8221;</font> means Sections 1471 through 1474 of the Code, as of the date of this Agreement (or any amended or
      successor version that is substantively comparable and not materially more onerous to comply with), any current or future regulations or official interpretations thereof, any agreements entered into pursuant to Section 1471(b)(1) of the Code and any
      fiscal or regulatory legislation, rules or practices adopted pursuant to any intergovernmental agreement, treaty or convention among Governmental Authorities entered into in connection with the implementation of the foregoing.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 15 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;FD&amp;C Act&#8221;</font> means the United States Food, Drug and Cosmetic Act of 1938 (or any successor thereto), as
      amended from time to time, and the rules, regulations, guidelines, guidance documents and compliance policy guides issued or promulgated thereunder.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;FDA&#8221;</font> means the United States Food and Drug Administration and any successor entity.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;FDA Laws&#8221;</font> means all applicable statutes, rules, regulations and orders administered or issued by the FDA,
      including without limitation, the FD&amp;C Act and its implementing regulations.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Federal Health Care Program&#8221; </font>means (i) a &#8220;Federal Health Care Program&#8221; as defined in Section&#160;1128B(f) of
      the Social Security Act, and includes the programs commonly known as Medicare, Medicaid, TRICARE and CHAMPVA; and (ii) a health care plan pursuant to the provincial plans under the <font style="font-style: italic;">Canada Health Act</font>.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Fifth A&amp;R Credit Agreement&#8221;</font> has the meaning set forth in the recitals hereto.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Fifth Amendment Restatement Date&#8221;</font> means May 15, 2025.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Fifth Amendment Term Loan&#8221;</font> means the loan advanced by a Lender pursuant to Section 2.01(g).&#160; For purposes
      of clarification, any calculation of the aggregate outstanding principal amount of the Fifth Amendment Term Loan on any date of determination shall mean the aggregate principal amount of the Fifth Amendment Term Loan made pursuant to Section 2.01(g)
      that has not yet been repaid as of such date.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Fifth Amendment Term Loan</font>&#160;<font style="font-style: italic;">Borrowing Notice</font>&#8221; means a notice
      substantially in the form attached hereto as Exhibit Q.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Financial Plan</font>&#8221; has the meaning set forth in Section 8.01(i).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;First Amendment to Effective Date Warrant Certificate&#8221;</font> means that certain First Amendment to Warrant
      Certificate, dated as of the Third Amendment Restatement Date, by and among Parent and Perceptive.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;First Amendment to Existing Warrant Certificate&#8221;</font> means that certain First Amendment to Warrant
      Certificate, dated as of February 21, 2023, by and among Parent and Perceptive.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Fitzgerald and Benen Sale&#8221; </font>means the sale by (a) U.S. Holdings of all of the Equity Interests of U.S.
      Fitzgerald to Biosynth International Inc. and (b) Parent and Trinity Biotech Manufacturing Limited of all of the Equity Interests of Benen Trading Limited to Aalto Bio Holdings Limited, for an aggregate purchase price of approximately $30,000,000,
      subject to adjustment.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"> <br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">
      <div style="text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">&#8220;Flash Financial Report&#8221;</font> means a financial report prepared by management based on the Obligors&#8217; books and records, prepared without the review necessary to
        make all adjustments necessary for presentation of the financial statements to be delivered with the Officer&#8217;s Certificate to be delivered pursuant to Section 8.01(b)(i) or the Audit Report to be delivered pursuant to Section 8.01(c).</div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 16 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Floor&#8221; </font>means a rate of interest equal to 4.00%.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Foreign Lender&#8221;</font> means a Lender that is not a U.S. Person.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Foreign Subsidiary&#8221; </font>means any Subsidiary that is not a Domestic Subsidiary.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Fourth A&amp;R Credit Agreement&#8221; </font>has the meaning set forth in the recitals hereto.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Fourth Amendment Restatement Date&#8221;</font> means February 27, 2025.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Fourth Amendment Term Loan&#8221;</font> means the loan advanced by a Lender pursuant to Section 2.01(f).&#160; For purposes
      of clarification, any calculation of the aggregate outstanding principal amount of the Fourth Amendment Term Loan on any date of determination shall mean the aggregate principal amount of the Fourth Amendment Term Loan made pursuant to Section
      2.01(f) that has not yet been repaid as of such date.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Fourth Amendment Term Loan</font>&#160;<font style="font-style: italic;">Borrowing Notice</font>&#8221; means a notice
      substantially in the form attached hereto as Exhibit P.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Funding Date&#8221;</font> means January 27, 2022.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Funding Date Term Loan&#8221;</font> means the loan made by a Lender pursuant to Section&#160;2.01(a).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Governmental Approval&#8221;</font> means any consent, authorization, approval, order, license, franchise, permit,
      certification, accreditation, registration, clearance, exemption, filing or notice, that is issued or granted by or from (or pursuant to any act of) any Governmental Authority, including any application or submission related to any of the foregoing.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Governmental Authority&#8221;</font> means any nation, government, branch of power (whether executive, legislative or
      judicial), state, province, territory, municipality or other political subdivision thereof and any entity exercising executive, legislative, judicial, monetary, regulatory or administrative functions of or pertaining to government, including without
      limitation Regulatory Authorities, governmental departments, agencies, commissions, bureaus, officials, ministers, courts, bodies, boards, tribunals and dispute settlement panels, and other law&#8209;, rule&#8209; or regulation&#8209;making organizations or entities
      of any State, province, territory, county, city or other political subdivision of the United States, Ireland, Canada, or any foreign country.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 17 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Guarantee&#8221;</font> of or by any Person (the <font style="font-style: italic;">&#8220;guarantor&#8221;</font>) means any
      obligation, contingent or otherwise, of the guarantor guaranteeing or having the economic effect of guaranteeing any Indebtedness or other obligation of any other Person (the <font style="font-style: italic;">&#8220;primary obligor&#8221;</font>) in any manner,
      whether directly or indirectly, and including any obligation of the guarantor, direct or indirect, (a)&#160;to purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness or other obligation or to purchase (or to advance
      or supply funds for the purchase of) any security for the payment thereof, (b)&#160;to purchase or lease property, securities or services for the purpose of assuring the owner of such Indebtedness or other obligation of the payment thereof, (c)&#160;to
      maintain working capital, equity capital or any other financial statement condition or liquidity of the primary obligor so as to enable the primary obligor to pay such Indebtedness or other obligation or (d)&#160;as an account party in respect of any
      letter of credit or letter of guaranty issued to support such Indebtedness or obligation; <font style="font-style: italic;">provided </font>that the term Guarantee shall not include endorsements for collection or deposit in the Ordinary Course of
      Business.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Guarantee Assumption Agreement&#8221;</font> means a Guarantee Assumption Agreement substantially in the form of
      Exhibit&#160;A by an entity that, pursuant to Section&#160;8.11(a), is required to become a &#8220;Guarantor&#8221;.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Guaranteed Obligations&#8221;</font> has the meaning set forth in Section&#160;11.01.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Guarantor&#8221;</font> means (a) initially, Parent and each Subsidiary of Parent listed as a Guarantor on the
      signature pages hereto and (b) any other Subsidiary of Parent joined as a Guarantor from time to time pursuant to Section 8.11; <font style="font-style: italic;">provided </font>that upon the completion of the Fitzgerald and Benen Sale, Benen
      Trading Limited shall no longer be a Guarantor hereunder.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Hazardous Material&#8221;</font> means any substance, element, chemical, compound, product, solid, gas, liquid, waste,
      by&#8209;product, pollutant, contaminant or material which is hazardous or toxic, and includes, without limitation, (a)&#160;asbestos, polychlorinated biphenyls and petroleum (including crude oil or any fraction thereof) and (b)&#160;any material classified or
      regulated as &#8220;hazardous&#8221; or &#8220;toxic&#8221; or words of like import pursuant to an Environmental Law.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Health Canada</font>&#8221; means Health Canada, including all of the respective divisions, departments, bureaus,
      directorates, and agencies thereof (including, without limitation, the Medical Services Bureau and the Therapeutic Products Directorate), and any successors thereto.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Health Canada Laws</font>&#8221; means all applicable statues, rules, regulations and orders administered or issued by
      Health Canada, including without limitation, the <font style="font-style: italic;">Food and Drugs Act </font>(Canada) and the regulations thereunder (including, without limitation, the Medical Devices Regulations thereunder).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Health Care Compliance Program&#8221;</font> has the meaning set forth in Section&#160;7.07(d).</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 18 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Healthcare Laws&#8221;</font> means, collectively, all Laws applicable to the business of the Borrowers, any other
      Obligor regulating the manufacturing, sale, distribution, labeling, marketing, or promotion, the export, or the provision of and payment for, health care products (including diagnostic products), items and services, including but not limited to
      (a)&#160;all applicable laws in any jurisdiction relating to the privacy or security of consumer information, including but not limited to the Health Insurance Portability and Accountability Act of 1996 (Pub. L. No.&#160;104&#8209;191) (<font style="font-style: italic;">&#8220;HIPAA&#8221;</font>) and any similar state laws; (b)&#160;all applicable federal and state fraud and abuse laws, and equivalent laws in any other jurisdiction, including but not limited to the federal Anti&#8209;Kickback Statute (42 U.S.C. &#167;1320a&#8209;7b(b)
      and any similar state laws), the federal Physician Self&#8209;Referral Prohibition (commonly referred to as the <font style="font-style: italic;">&#8220;Stark Law&#8221;</font>) (42 U.S.C. &#167;&#160;1395nn and any similar state laws), the Civil Monetary Penalties Act (42
      U.S.C. &#167;1320a&#8209;7a), and the civil False Claims Act (31 U.S.C. &#167;3729 <font style="font-style: italic;">et&#160;seq.</font> and any similar state laws); (c)&#160;all applicable FDA Laws and equivalent laws under in other jurisdiction; (d) CLIA; (e)&#160;all
      applicable laws regarding the provision of health care supplies, items or services to Federal Health Care Program beneficiaries or the billing of the Federal Health Care Programs, and equivalent laws in any other jurisdiction; (f) all applicable
      Health Canada Laws; and (g)&#160;all rules and regulations promulgated under or pursuant to any of the foregoing.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Hedging Agreement&#8221;</font> means any interest rate exchange agreement, foreign currency exchange agreement,
      commodity price protection agreement or other interest or currency exchange rate or commodity price hedging arrangement.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">HPRA</font>&#8221; means the Health Products Regulatory Authority of Ireland and any successor thereto.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;IDE&#8221;</font> means an application, including an application filed with any Regulatory Authority, for authorization
      to commence human clinical studies with respect to any Device, including (a)&#160;an Investigational Device Exemption as defined in the FD&amp;C Act or any successor application or procedure filed with the FDA, (b)&#160;an abbreviated Investigational Device
      Exemption as specified in FDA regulations in 21 C.F.R. &#167;&#160;812.2(b), (c)&#160;any equivalent of any of the foregoing pursuant to or under any non&#8209;United States country or regulatory jurisdiction, (d)&#160;all amendments, variations, extensions and renewals of
      any of the foregoing that may be filed with respect thereto, and (e)&#160;all documents and correspondence with Institutional Review Boards, whether United States or non&#8209;United States, or equivalent.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">IFRS</font>&#8221; means international accounting standards within the meaning of IAS Regulation 1606/2002 to the
      extent applicable to the relevant financial statements delivered under or referred to herein. Subject to Section&#160;1.02, all references to &#8220;IFRS&#8221; shall be to IFRS applied consistently with the principles used in the preparation of the financial
      statements described in Section&#160;7.04(a).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">imaware Convertible Note Investment&#8217;</font> means that certain investment by Trinity Biotech Manufacturing
      Limited in up to $1,500,000 of convertible promissory notes issued by imaware, Inc., a Delaware corporation.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 19 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Immaterial Foreign Subsidiary</font>&#8221; means, as of any date, any Foreign Subsidiary for which (a) the
      consolidated total assets of such Foreign Subsidiary and its Subsidiaries is not in excess of 5.0% of the consolidated total assets of Parent and its Subsidiaries, (b) the aggregate amount of the Net Revenue of such Foreign Subsidiary and its
      Subsidiaries on a consolidated basis is not in excess of 5.0% of Net Revenue of Parent and its Subsidiaries, (c) the consolidated total assets of such Foreign Subsidiary and its Subsidiaries, when taken together with the consolidated total assets of
      all other Immaterial Foreign Subsidiaries and their Subsidiaries, is not in excess of 10.0% of the consolidated total assets of Parent and its Subsidiaries and (d) the aggregate amount of the Net Revenue of such Foreign Subsidiary and its
      Subsidiaries on a consolidated basis, when taken together with the contribution to Net Revenue of all other Immaterial Foreign Subsidiaries and their Subsidiaries on a consolidated basis, is not in excess of 10.0% of Net Revenue of Parent and its
      Subsidiaries in each case as of the last day of any four quarter period;<font style="font-style: italic;"> provided </font>that notwithstanding the foregoing, at no time shall any Guarantor existing on the Original Closing Date or joined hereto
      pursuant to Section 8.11 subsequently be deemed an Immaterial Foreign Subsidiary; <font style="font-style: italic;">provided further</font>, that as of the Original Closing Date, the Brazilian Subsidiary, Swedish Subsidiaries, Cayman Subsidiary and
      U.K. Subsidiary are Immaterial Foreign Subsidiaries; <font style="font-style: italic;">provided further</font>, that the Luxembourg Subsidiary is not an Immaterial Foreign Subsidiary.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Indebtedness&#8221;</font> of any Person means, without duplication, (a)&#160;all obligations of such Person for borrowed
      money, (b)&#160;all obligations of such Person evidenced by bonds, debentures, notes, loan agreements or similar instruments, (c) all obligations of such Person under conditional sale or other title retention agreements relating to Property acquired by
      such Person (excluding amounts related to inventory which are incurred in the Ordinary Course of Business), (d)&#160;all obligations of such Person (i) in respect of the deferred purchase price of Property or services or (ii) upon which interest charges
      are customarily paid&#160; (excluding, in each case of (i) and (ii),&#160; current accounts payable which are incurred in the Ordinary Course of Business and except if subject to bona fide dispute contested in good faith by appropriate proceedings and for
      which such Obligor has set aside on its books adequate reserves with respect thereto substantially in accordance with IFRS, not overdue by more than two hundred ten (210) days), (e)&#160;all Indebtedness of others secured by (or for which the holder of
      such Indebtedness has an existing right, contingent or otherwise, to be secured by) any Lien on Property owned or acquired by such Person, whether or not the Indebtedness secured thereby has been assumed, (f)&#160;all Guarantees by such Person of
      Indebtedness of others, (g)&#160;all Capital Lease Obligations of such Person, (h)&#160;all obligations, contingent or otherwise, of such Person as an account party in respect of letters of credit and letters of guaranty, (i)&#160;obligations under any Hedging
      Agreement, currency swaps, forwards, futures or derivatives transactions, (j)&#160;all obligations, contingent or otherwise, of such Person in respect of bankers&#8217; acceptances, (k)&#160;all obligations of such Person under license or other agreements containing
      a guaranteed minimum payment or purchase by such Person, (l) any Disqualified Equity Interests of such Person, (m) any earnout obligation at the time such obligation is both required to be reflected as a liability on the balance sheet of such Person
      in accordance with IFRS and not paid after becoming due and payable and (n) all other obligations required to be classified as indebtedness of such Person under IFRS. The Indebtedness of any Person shall include, without duplication, the Indebtedness
      of any other entity (including any partnership in which such Person is a general partner) to the extent such Person is liable therefor as a result of such Person&#8217;s ownership interest in or other relationship with such entity, except to the extent the
      terms of such Indebtedness provide that such Person is not liable therefor.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Indemnified Party&#8221;</font> has the meaning set forth in Section&#160;13.03(b).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Indemnified Taxes&#8221;</font> means (a)&#160;Taxes, other than Excluded Taxes, imposed on or with respect to any payment
      made by or on account of any Obligation and (b)&#160;to the extent not otherwise described in clause&#160;(a), Other Taxes.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Industrial Designs</font>&#8221; means all rights, title and interests arising under any Laws in or relating to all
      industrial designs, intangibles of like nature, and any work subject to the design laws of the United States, Canada, Ireland or any other country or any political subdivision thereof.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 20 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Ineligible Assignee</font>&#8221; means (a) a natural person or (b) the Obligors or any of their respective
      Subsidiaries and Affiliates.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Information&#8221;</font> has the meaning set forth in Section&#160;13.17.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Insolvency Proceeding&#8221;</font> means (a)&#160;any case, action or proceeding before any court or other Governmental
      Authority relating to bankruptcy, reorganization, examinership (in the case of an Irish Obligor, or an Obligor with a COMI in Ireland), insolvency, liquidation, receivership, dissolution, winding&#8209;up or relief of debtors, or (b)&#160;any general assignment
      for the benefit of creditors, composition, marshaling of assets for creditors, or other similar arrangement in respect of any Person&#8217;s creditors generally or any substantial portion of such Person&#8217;s creditors, in each case undertaken under any of
      United States federal, state or foreign law, or the laws of any other jurisdiction applicable to the Obligors, including, without limitation, the Bankruptcy Code or any Canadian Bankruptcy Legislation.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Intellectual Property&#8221;</font> means, with respect to any Person, all of such Person&#8217;s rights, title and interest
      in and to all Patents, Trademarks, Copyrights, Industrial Designs, Technical Information, whether registered or not and whether existing under United States or non-United States Law or jurisdiction, including, without limitation, all:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160; applications, registrations, amendments and extensions relating to such Intellectual Property;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160; rights and privileges arising under any applicable Laws with respect to any Intellectual Property;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160; rights to sue for or collect any damages from any past, present or future infringements of any Intellectual
      Property; and</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160; rights under Product Agreements related to such Intellectual Property.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Intercompany Subordination Agreement&#8221;</font> means that certain Intercompany Subordination Agreement, dated as of
      the Funding Date, among the Obligors, the Immaterial Foreign Subsidiaries and the Administrative Agent.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Interest Period&#8221;</font> means, (a)&#160;initially, the period beginning on (and including) the Funding Date and ending
      on (and including) the last day of the calendar month in which the Funding Date occurs, and (b)&#160;thereafter, the period beginning on (and including) the first day of each succeeding calendar month and ending on the earlier of (and including) (i)&#160;the
      last day of such calendar month and (ii)&#160;the Maturity Date.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Invention&#8221;</font> means any novel, inventive or useful art, apparatus, method, process, machine (including any
      article or Device), manufacture or composition of matter, or any novel, inventive and useful improvement in any art, method, process, machine (including any article or Device), manufacture or composition of matter.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 21 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Investment&#8221;</font> means, for any Person: (a)&#160;the acquisition (whether for cash, Property, services or securities
      or otherwise) of Equity Interests, bonds, notes, debentures, partnership or other ownership interests or other securities of any other Person or any agreement to make any such acquisition (including any &#8220;short sale&#8221; or any sale of any securities at a
      time when such securities are not owned by the Person entering into such sale); (b)&#160;the making of any deposit with, or advance, loan, assumption of debt, other extension of credit to, any other Person (including the purchase of Property from another
      Person subject to an understanding or agreement, contingent or otherwise, to resell such Property to such Person), but excluding any such advance, loan or extension of credit in the nature of an ordinary course trade receivable having a term not
      exceeding one hundred twenty (120) days arising in connection with the sale of services, inventory or supplies by such Person in the Ordinary Course of Business; (c)&#160;the entering into of any Guarantee of, or other contingent obligation with respect
      to, Indebtedness or other liability of any other Person and (without duplication) any amount committed to be advanced, lent or extended to such Person; (d) the entering into any joint venture; or (e)&#160;the entering into of any Hedging Agreement.&#160; The
      amount of an Investment will be determined at the time the Investment is made without giving effect to any subsequent changes in value.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Investor</font>&#8221; means MiCo IVD Holdings, LLC, a Delaware limited liability company.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Investor Convertible Note&#8221; </font>means that certain junior convertible note, in favor of Investor, in form and
      substance satisfactory to the Administrative Agent.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Investor Subordination Agreement&#8221;</font> means that certain Subordination Agreement, in substantially the form of
      Exhibit L, among the Investor and the Administrative Agent and acknowledged by the Obligors.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Ireland</font>&#8221; means Ireland, excluding Northern Ireland (and &#8220;Irish&#8221; shall be construed accordingly).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Irish Anti-Corruption Laws</font>&#8221; means the Criminal Justice (Corruption Offences) Act 2018 of Ireland.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Irish Anti-Terrorism Laws</font>&#8221; means the Criminal Justice (Money Laundering and Terrorist Financing) Act 2010.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Irish Debenture&#8221;</font> means the Irish law debenture, dated as of the Funding Date, in substantially the form of
      Exhibit G-3, among the Irish Obligors, the Lenders and the Administrative Agent, granting a security interest in the personal Property constituting Collateral thereunder in favor of the Administrative Agent for the benefit of the Lenders.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Irish Economic Sanctions Laws&#8221; </font>means the Financial Transfers Act 1992 and all Irish laws and regulations
      which implement EU and UN trade and/or financial sanctions.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Irish Obligor</font>&#8221; means an Obligor incorporated or organized under the laws of Ireland; <font style="font-style: italic;">provided </font>that upon the completion of the Fitzgerald and Benen Sale, Benen Trading Limited shall no longer be an Irish Obligor hereunder.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 22 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;IRS&#8221;</font> means the United States Internal Revenue Service or any successor agency, and to the extent relevant,
      the United States Department of the Treasury.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Judgment Currency</font>&#8221; has the meaning set forth in Section 13.20.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Judgment Currency Conversion Date</font>&#8221; has the meaning set forth in Section 13.20.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Key Employee&#8221;</font> means an employee engaged in product development or another function with access to
      significant Obligor Intellectual Property.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Konamite</font>&#8221; means Konamite Limited, a company organized under the laws of Ireland.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Laws&#8221;</font> means, collectively, all international, foreign, federal, state, provincial, territorial, municipal
      and local statutes, treaties, rules, regulations, ordinances, codes and administrative or judicial precedents or authorities, including the interpretation or administration thereof by any Governmental Authority charged with the enforcement,
      interpretation or administration thereof, and all applicable administrative orders, directed duties, requests, licenses, authorizations and Permits of, and agreements with, any Governmental Authority, in each case whether or not having the force of
      law.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Lenders&#8221;</font> has the meaning set forth in the introduction hereto.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Lien&#8221;</font> means any mortgage, lien, pledge, charge or other security interest, or any lease, title retention
      agreement, mortgage, restriction, easement, right&#8209;of&#8209;way, option or adverse Claim (of ownership or possession) or other encumbrance of any kind or character whatsoever or any preferential arrangement that has the practical effect of creating a
      security interest.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Loan Documents&#8221;</font> means, collectively, this Agreement, the Security Documents, any Guarantee Assumption
      Agreement, the Warrant Certificates, the Existing Warrant Certificate Amendments, the First Amendment to the Effective Date Warrant Certificate, any intercompany notes and any subordination agreement, intercreditor agreement or other present or
      future document, instrument, agreement or certificate delivered to any Lender in connection with this Agreement or any of the other Loan Documents, in each case, as amended, restated, supplemented or otherwise modified.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Loan Exposure&#8221;</font> means, with respect to any Lender, as of any date of determination, the outstanding
      principal amount of such Lender&#8217;s portion of the Term Loans; <font style="font-style: italic;">provided,</font> at any time prior to the making of the Term Loans, the Loan Exposure of any Lender shall be equal to such Lender&#8217;s Commitment.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Loss&#8221;</font> means judgments, debts, liabilities, expenses, costs, damages or losses, contingent or otherwise,
      whether liquidated or unliquidated, matured or unmatured, disputed or undisputed, contractual, legal or equitable, including loss of value, reasonable professional fees, including fees and disbursements of legal counsel on a full indemnity basis, and
      all reasonable costs incurred in investigating or pursuing any Claim or any proceeding relating to any Claim.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 23 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Luxembourg Subsidiary</font>&#8221; means Trinity Biotech Luxembourg SARL.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Luxembourg Subsidiary Intercompany Subordination Agreement&#8221;</font> means that certain Luxembourg Intercompany
      Subordination Agreement, dated as of Funding Date, among the Obligors, the Luxembourg Subsidiary and the Administrative Agent on terms and provisions satisfactory to the Administrative Agent.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Majority Lenders&#8221;</font> means, at any time, one or more Lenders having or holding Loan Exposure and representing
      more than 50% of the aggregate Loan Exposure of all Lenders.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Margin Stock&#8221;</font> means &#8220;margin stock&#8221; within the meaning of Regulations U and X.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Material Adverse Change&#8221;</font> and <font style="font-style: italic;">&#8220;Material Adverse Effect&#8221;</font> mean a
      material adverse change in or effect on (a)&#160;the business, financial condition, operations, performance or Property of the Obligors taken as a whole, (b)&#160;the ability of any Obligor to perform its obligations under any Loan Document as and when they
      become due, (c)&#160;the value of the Property comprising Collateral (taken as a whole), or (d)&#160;the legality, validity, binding effect or enforceability of the Loan Documents or the rights and remedies of any Lender under any of the Loan Documents.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Material Agreement&#8221;</font> means (a)&#160;any Contract which is listed in Schedule&#160;7.14, (b)&#160;any other Contract to
      which any Obligor is a party or a beneficiary from time to time, or to which any assets or properties of any Obligor is bound, the loss or termination of which would reasonably be expected to result in a Material Adverse Effect, (c) the Investor
      Convertible Note, (d) the Investor Subordination Agreement and (e) any other Contract to which any Obligor is a party or a guarantor (or equivalent) whether existing as of the Original Closing Date or in the future that during any period of twelve
      (12) consecutive months is reasonably expected to (1) result in payments or receipts (including royalty, licensing or similar payments) made to any Obligor in an aggregate amount in excess of $2,500,000 or (2) require payments or expenditures
      (including royalty, licensing or similar payments) made by any Obligor in an aggregate amount in excess of $2,500,000; <font style="font-style: italic;">provided</font> that for the avoidance of doubt routine purchase orders entered into in the
      Ordinary Course of Business shall not be deemed to be Material Agreements.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Material Indebtedness&#8221;</font> means, at any time, any Indebtedness of any Obligor, the outstanding principal
      amount of which exceeds $500,000.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Material Intellectual Property&#8221;</font> means all Obligor Intellectual Property, including the&#160; Obligor
      Intellectual Property described in Schedule&#160;7.05(b) (as such schedule shall be updated by the Obligors from time to time, pursuant to Section 8.01(d)), whether currently owned or licensed, or acquired, developed or otherwise licensed or obtained
      after the Original Closing Date, (a) necessary for the operation of the business of any Obligor as currently conducted or as currently contemplated to be conducted, (b)&#160;the loss of which would reasonably be expected to have or result in a Material
      Adverse Effect or (c) that has a fair market value in excess of $2,500,000 (as such fair market value is determined in the reasonable judgment of the Obligors) but excluding, in each case, WaveForm IP.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 24 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Material WaveForm IP&#8221;</font> means all WaveForm IP (a) necessary for the operation of the business of any Obligor
      as currently conducted or as currently contemplated to be conducted, (b)&#160;the loss of which would reasonably be expected to have or result in a Material Adverse Effect or (c) that has a fair market value in excess of $2,500,000 (as such fair market
      value is determined in the reasonable judgment of the Obligors).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Maturity Date&#8221;</font> means the earlier to occur of (a)&#160;the Stated Maturity Date and (b)&#160;the date on which the
      Term Loans are accelerated pursuant to Section&#160;10.02.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Multiemployer Plan&#8221;</font> means any multiemployer plan, as defined in Section&#160;400l(a)(3) of ERISA, to which any
      ERISA Affiliate incurs or otherwise has any obligation or liability, contingent or otherwise.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Net Cash Proceeds&#8221;</font> means,</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160; with respect to the incurrence or issuance of any Indebtedness incurred by a Person and not permitted under
      Section&#160;9.01, the excess, if any, of (i)&#160;the sum of the cash received in connection with such incurrence or issuance over (ii)&#160;the investment banking fees, underwriting discounts, commissions, costs and other reasonable expenses and other customary
      expenses (including reasonable attorney&#8217;s, accountant&#8217;s and other similar professional advisor&#8217;s fees), incurred by such Person in connection with such incurrence or issuance to third parties (other than any other Obligor or any of their respective
      Affiliates);</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160; with respect to any Casualty Event, the amount of cash proceeds actually received from time to time by or on behalf
      of such Obligor after deducting therefrom only (i)&#160;actual costs and expenses related thereto incurred by such Obligor and (ii)&#160;Taxes paid or payable in each case, in connection therewith or as a result thereof; and</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160; with respect to any Asset Sale, the excess, if any, of (i) cash proceeds received in respect of such Asset Sale
      (including cash proceeds subsequently received (as and when received)) over (ii) the sum of (A) the direct costs of such Asset Sale then payable by the recipient of such proceeds excluding amounts payable to any Obligor or any of its Subsidiaries,
      (B) Taxes paid or payable by such recipient in connection therewith or as a result thereof, (C) amounts required to be applied to repay principal, interest and prepayment premiums and penalties on Indebtedness secured by a Permitted Lien on the
      properties subject to such Asset Sale and (D) amounts reserved or deposited in escrow with respect to indemnity payments or price adjustments until such amounts are released to the applicable Obligor or any of its Subsidiaries.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Net Partnership Agreement Proceeds</font>&#8221; means the Net Cash Proceeds received from Asset Sales pursuant to
      Section 9.09(l) net of any payments of &#8220;Contingent Consideration&#8221; that are required to be paid by an Obligor pursuant to the Effective Date Acquisition Agreement.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Net Revenue</font>&#8221; means, with respect to any Person, all amounts paid to and received by such Person in the
      Ordinary Course of Business that, in accordance with IFRS, would be classified as net revenue.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 25 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 18pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Non-EEA Obligor</font>&#8221; means an Obligor which is not an EEA Obligor.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Note&#8221;</font> means a promissory note executed and delivered by the Borrowers to any Lender in the form attached
      hereto as Exhibit C.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Obligations&#8221;</font> means, with respect to any Obligor, all amounts, obligations (including, without limitation,
      all Warrant Obligations), liabilities, covenants and duties of every type and description owing by such Obligor to any Lender or any other Indemnified Party hereunder, arising out of, under, or in connection with, any Loan Document, whether direct or
      indirect (regardless of whether acquired by assignment), absolute or contingent, due or to become due, whether liquidated or not, now existing or hereafter arising and however acquired, and whether or not evidenced by any instrument for the payment
      of money, including, without duplication, (a)&#160;the principal amount of the Term Loans, (b)&#160;all interest on the Term Loans (including accrued but uncapitalized PIK Interest and interest accruing at the Default Rate), whether or not accruing after the
      filing of any petition in bankruptcy or after the commencement of any insolvency, reorganization or similar proceeding, and whether or not a Claim for post&#8209;filing or post&#8209;petition interest is allowed in any such proceeding, (c)&#160;any Prepayment Premium
      and (d)&#160; all other fees, expenses, interest, commissions, charges, costs, disbursements, indemnities and reimbursement of amounts paid and other sums chargeable to such Obligor under any Loan Document (including, without limitation, all unpaid fees
      and expenses payable under Section 13.03); <font style="font-style: italic;">provided </font>that with respect to each EEA Obligor the term Obligations shall exclude the Relevant Warrant Obligations; <font style="font-style: italic;">provided</font>&#160;<font style="font-style: italic;">further </font>that (and for avoidance of doubt) with respect to each non-EEA Obligor the term Obligations does include, without limitation, the Relevant Warrant Obligations.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Obligor Intellectual Property&#8221;</font> means Intellectual Property owned by or licensed to any of the Obligors.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Obligors&#8221;</font> means, collectively, the Borrowers, each Guarantor and each of their respective successors and
      permitted assigns.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;OFAC&#8221;</font> means the Office of Foreign Assets Control of the United States Department of the Treasury (or any
      successor thereto).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Ordinary Course of Business&#8221;</font> means, with respect to any Person, the ordinary course of business generally
      consistent with the Person&#8217;s market or custom and practice (including with respect to nature, scope, magnitude, quantity and frequency).</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 26 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Organizational Documents&#8221;</font> means (a)&#160;with respect to any corporation (other than a corporation organized
      under the laws of Canada or any province or territory thereof), its certificate of or articles of incorporation or organization, or memorandum and articles of association, as amended, or constitution, as amended, and its by&#8209;laws, as amended, (b) with
      respect to any corporation, company, unlimited liability company, or unlimited liability corporation organized under the laws of Canada or any province or territory thereof, its certificate of incorporation, amalgamation, or continuance, its articles
      of incorporation, amalgamation, or continuance, its notice of articles, its articles, and/or any shareholders&#8217; agreement or declaration with respect to it, in each case as amended, as applicable, (c)&#160;with respect to any limited partnership, its
      certificate of limited partnership, as amended, and its partnership agreement, as amended, (d)&#160;with respect to any general partnership, its partnership agreement, as amended, and (e)&#160;with respect to any limited liability company, its&#160; certificate of
      formation or articles of organization, as amended, or its constitution, as amended, and its operating agreement, as amended.&#160; In the event any term or condition of this Agreement or any other Loan Document requires any Organizational Document to be
      certified by a secretary of state or similar government official, the reference to any such &#8220;Organizational Document&#8221; shall only be to a document of a type customarily certified by such government official.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Original Closing Date&#8221;</font> means December 15, 2021.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Original Credit Agreement</font>&#8221; has the meaning set forth in the recitals hereto.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Other Connection Taxes&#8221;</font> means, with respect to any Recipient, Taxes imposed as a result of a present or
      former connection between such Recipient and the jurisdiction imposing such Tax (other than connections arising solely from such Recipient having executed, delivered, become a party to, performed its obligations under, received payments under,
      received or perfected a security interest under, engaged in any other transaction pursuant to or enforced any Loan Document, or sold or assigned an interest in the Term Loans or any Loan Document).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Other Taxes&#8221;</font> means all present or future stamp, court or documentary, intangible, recording, filing or
      similar Taxes that arise from any payment made under, from the execution, delivery, performance, enforcement or registration of, from the receipt or perfection of a security interest under, or otherwise with respect to, any Loan Document, except any
      such Taxes that are Other Connection Taxes imposed with respect to an assignment (other than an assignment made pursuant to Section&#160;5.03(h)).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Outstanding Convertible Notes&#8221;</font> means those Convertible Notes that remain outstanding after the Funding
      Date in an aggregate principal amount not to exceed $275,000 plus accrued and unpaid interest.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Parent</font>&#8221; means Trinity Biotech plc, a company organized under the laws of Ireland (company registration
      number: 183476).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Participant&#8221;</font> has the meaning set forth in Section&#160;13.05(e).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Participant Register&#8221;</font> has the meaning set forth in Section&#160;13.05(f).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Partner Agreement&#8221;</font> means a written agreement with a Commercial Partner to enter into commercial activities
      involving any continuous glucose management product.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 27 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Patents&#8221;</font> means all patents and patent applications, including the inventions and improvements described
      and claimed therein together with the reissues, divisions, continuations, renewals, extensions and continuations in part thereof, all income, royalties, damages and payments now or hereafter due and/or payable with respect thereto, all damages and
      payments for past or future infringements thereof and rights to sue therefor, and all rights corresponding thereto throughout the world, in each case, relating to a Product.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Payment Date&#8221;</font> means the last day of each Interest Period; <font style="font-style: italic;">provided</font>
      that if such last day of such Interest Period is not a Business Day, then the Payment Date for such Interest Period will be the next succeeding Business Day.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;PBGC&#8221;</font> means the United States Pension Benefit Guaranty Corporation referred to and defined in ERISA and
      any successor entity performing similar functions.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Perceptive</font>&#8221; has the meaning set forth in the introduction hereto.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Periodic Term SOFR Determination Day</font>&#8221; has the meaning specified in the definition of &#8220;Term SOFR.&#8221;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Permits&#8221;</font> means all permits, licenses, registrations, certificates, orders, approvals, authorizations,
      consents, waivers, franchises, variances and similar rights issued by or obtained from any Governmental Authority or any other Person, including, without limitation, those relating to Environmental Laws.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Permitted Acquisition&#8221;</font> means any Acquisition by any Obligor or any of their wholly-owned Subsidiaries, by
      (a)&#160;purchase, merger, amalgamation, plan of arrangement, license or otherwise, of all or substantially all of the assets of, all of the Equity Interests of, or a business line or unit or a division of, any Person or (b)&#160;license arrangement for the
      rights to use, develop, market or otherwise commercialize any Patents, Trademarks, Copyrights or other Intellectual Property (other than ordinary course, over the counter software license arrangements), including, for the avoidance of doubt, any
      Partner Agreement; <font style="font-style: italic;">provided</font> that:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;immediately prior to, and immediately after giving effect thereto, no Default or Event of Default
        shall have occurred and be continuing or would result therefrom;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(ii)&#160;&#160;&#160;&#160;&#160; all transactions in connection therewith shall be consummated, in all material respects, in
        accordance with all applicable Laws and in conformity in all material respects with all applicable Governmental Approvals;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(iii)&#160;&#160;&#160;&#160;&#160; in the case of the Acquisition of all of the Equity Interests of such Person, all of the Equity
        Interests (except for any such securities in the nature of directors&#8217; qualifying shares required pursuant to applicable Law) acquired, or otherwise issued by such Person or any newly formed Subsidiary of such Obligor in connection with such
        Acquisition, shall be owned 100% by an Obligor, and the Obligor shall have taken, or caused to be taken, as of the date such Person becomes a Subsidiary of an Obligor, each of the actions set forth in Section&#160;8.11, if applicable;</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 28 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(iv)&#160;&#160;&#160;&#160;&#160;&#160; such Person (in the case of an Acquisition of Equity Interests) or assets (in the case of an
        Acquisition of assets or a division) (A)&#160;shall be engaged or used, as the case may be, in the same business or lines of business in which the Obligors and/or their Subsidiaries are engaged or a business reasonably and substantially related thereto
        or (B)&#160;shall have a similar customer base as the Borrowers and/or their Subsidiaries;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160; the Administrative Borrower shall have provided the Administrative Agent with at least ten&#160;(10)
        Business Days&#8217; prior written notice of any such Acquisition, together with summaries, prepared in reasonable detail, of all due diligence conducted by or on behalf of an Obligor, or the applicable Subsidiary, prior to such Acquisition;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(vi)&#160;&#160;&#160;&#160;&#160; the Acquisition shall have been approved by the Board or other governing body or controlling Person
        of the Person acquired or the Person from whom such assets or division is acquired; and</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(vii)&#160;&#160;&#160;&#160;&#160; on a <font style="font-style: italic;">pro forma</font> basis after giving effect to such
        Acquisition, the Obligors and their Subsidiaries shall be in compliance with Section&#160;8.15.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Permitted Cash Equivalent Investments&#8221;</font> means (a)&#160;marketable direct obligations issued or unconditionally
      guaranteed by the United States or any agency or any State thereof having maturities of not more than two&#160;(2) years from the date of acquisition, (b)&#160;commercial paper with an average maturity of no more than one&#160;(1) year and having the highest rating
      from either Standard &amp; Poor&#8217;s Ratings Group or Moody&#8217;s Investors Service, Inc., (c)&#160;any money market funds or other investment vehicles whose principal investments are in investments described in clauses&#160;(a) or (b) and (d)&#160;certificates of deposit
      maturing no more than one (1) year after issue.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Permitted Indebtedness&#8221;</font> means any Indebtedness existing as of the Original Closing Date.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Permitted Licenses&#8221;</font> are (a)&#160;licenses of over&#8209;the&#8209;counter software that is commercially available to the
      public, (b)&#160;inbound licenses for the use of any Patents, Trademarks, Copyrights, Industrial Designs and Technical Information of any third party and (c) non&#8209;exclusive licenses for the use of Obligor Intellectual Property, in each case, entered into
      in the Ordinary Course of Business or as otherwise may be approved by the applicable Obligor&#8217;s Board and so long as (i)&#160;no Event of Default has occurred and is continuing at the time such license is entered into and (ii)&#160;such license does not
      materially impair the Lenders from exercising their rights under any of the Loan Documents.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Permitted Liens&#8221;</font> means any Liens permitted under Section&#160;9.02.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Permitted Refinancing&#8221;</font> means, with respect to any Indebtedness permitted to be refinanced, extended,
      renewed or replaced hereunder, any refinancing, extensions, renewals and replacements of such Indebtedness; <font style="font-style: italic;">provided </font>that such refinancing, extension, renewal or replacement shall not (a) increase the
      outstanding principal amount of the Indebtedness, being refinanced, extended, renewed or replaced, (b)&#160;contain terms relating to outstanding principal amount, amortization, interest rate or equivalent yield, maturity, collateral security (if any),&#160;
      subordination (if any), or other material terms that, taken as a whole are less favorable in any material respect to any Obligor and its Subsidiaries&#160; or any Lender than the terms of any agreement or instrument governing the Indebtedness being
      refinanced, and (c)&#160;contain any new requirement to grant any Lien or to give any Guarantee that was not an existing requirement of such Indebtedness.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 29 -</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Person&#8221;</font> means any individual, corporation, company, voluntary association, partnership, limited liability
      company, unlimited liability company, unlimited liability corporation, joint venture, trust, unincorporated organization or Governmental Authority or other entity of whatever nature.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;PFIC&#8221;</font> has the meaning set forth in Section&#160;8.01(j).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;PIK&#160;Interest&#8221; </font>shall mean payment&#8209;in&#8209;kind of interest in respect of the Term Loans by increasing the
      outstanding principal amount of each Term Loan to which such interest relates by an amount equal to such portion of interest, rather than paying such portion of interest in cash.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Plan&#8221;</font> means any employee pension benefit plan (other than a Multiemployer Plan) subject to the provisions
      of Title&#160;IV of ERISA or Section&#160;412 of the Code or Section&#160;302 of ERISA, and in respect of which the Borrowers or any ERISA Affiliate is (or, if such plan were terminated, would under Section&#160;4069 of ERISA be deemed to be) an &#8220;employer&#8221; as defined in
      Section&#160;3(5) of ERISA.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Pledge Agreements</font>&#8221; means the U.S. Pledge Agreement and the Canadian Pledge Agreement.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">PPSA</font>&#8221; means the <font style="font-style: italic;">Personal Property Security Act </font>(Ontario) and
      the regulations thereunder, as from time to time in effect; <font style="font-style: italic;">provided, however</font>, that if by reason of mandatory provisions of law, any or all of the attachment, perfection or priority of the Administrative
      Agent and/or any Lender&#8217;s security interests in any item or portion of the Collateral are governed by the personal property security laws as in effect in any jurisdiction in Canada other than the laws of the Province of Ontario, then &#8220;<font style="font-style: italic;">PPSA</font>&#8221; means those personal property security laws (including the Civil Code of Qu&#233;bec) as in effect in such other jurisdiction in Canada for the purposes of the provisions hereof relating thereto.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Prepayment Premium&#8221;</font> has the meaning set forth in Section&#160;3.03(a).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Pro Rata Share&#8221;</font> has the meaning set forth in Section&#160;11.08.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Product&#8221;</font> means (a)&#160;those Devices set forth (and described in reasonable detail) on Schedule&#160;3 attached
      hereto, and (b)&#160;any current or additional Device subject, as of the date of determination, to any Product Development and Commercialization Activities by any Obligor, including any such Device currently in development.&#160; For the avoidance of doubt,
      separate stock keeping units (SKUs) by reference to package size or country of sale constitute one Product.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 30 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Product Agreement&#8221;</font> means, with respect to any Product, any Contract, license, document, instrument,
      interest (equity or otherwise) or the like under which one or more Persons grants or receives (a)&#160;any right, title or interest with respect to any Product Development and Commercialization Activities of such Product, or (b)&#160;any right to exclude any
      other Person from engaging in, or otherwise restricting any right, title or interest as to, any Product Development and Commercialization Activities with respect to such Product, including any Contract with suppliers, manufacturers, distributors,
      clinical research organizations, hospitals, group purchasing organizations, wholesalers, pharmacies or any other Person related to such entity.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Product Assets&#8221;</font> means, with respect to any Product, (a)&#160;any and all rights, title and interest of the
      Obligors in any assets relating to such Product or any Product Development and Commercialization Activities with respect to such Product, (b)&#160;all Product Related Information with respect to such Product or any related Product Development and
      Commercialization Activities, (c)&#160;any Product Agreement related to such Product or any such Product Development and Commercialization Activities, (d)&#160;any Intellectual Property, Regulatory Approvals and similar assets with respect to such Product or
      any such Product Development and Commercialization Activities, and (e)&#160;all rights, title and interests in any other property, tangible or intangible, manifesting or otherwise in respect of such Product or any such Product Development and
      Commercialization Activities, including, without limitation, inventory, accounts receivable or similar rights to receive money or payment pertaining thereto and all proceeds of the foregoing.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Product Authorizations&#8221;</font> means any and all Regulatory Approvals (including all applicable IDEs, Device
      Clearance Applications, supplements, amendments, governmental price and reimbursement approvals and approvals of applications for regulatory exclusivity), clearances, licenses, notifications, registrations, safety or quality specifications and
      standards, or any other authorizations of any applicable Regulatory Authority in each case necessary for the manufacturing, development, distribution, ownership, use, storage, import, export, transport, promotion, marketing, sale or other
      commercialization of any Product or for any Product Development and Commercialization Activities with respect thereto in any country or jurisdiction, whether United States or non&#8209;United States.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Product Development and Commercialization Activities&#8221;</font> means, with respect to any Product, any combination
      of research, development, manufacture, import, use, sale, licensing, importation, storage, design, labeling, marketing, promotion, supply, distribution, testing, packaging, purchasing or other commercialization activities, receipt of payment in
      respect of any of the foregoing (including, without limitation, in respect of licensing, royalty or similar payments), or any similar or other activities the purpose of which is to commercially exploit such Product.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 31 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Product Related Information&#8221; </font>means, with respect to any Product, all books, records, lists, ledgers,
      files, manuals, Contracts, correspondence, reports, plans, drawings and data (in any form or medium), and all techniques and other know&#8209;how, owned or possessed by the Obligors that are necessary or required for any Product Development and
      Commercialization Activities relating to such Product, including (a)&#160;brand materials, packaging and other trade dress, customer targeting and other marketing, promotion and sales materials and information, referral, customer, supplier and other
      contact lists and information, product, business, marketing and sales plans, research, studies and reports, sales, maintenance and production records, training materials and other marketing, sales and promotional information, (b)&#160;clinical data,
      information included or supporting any Product Authorization or other Regulatory Approval, any regulatory filings, updates, notices and correspondence (including adverse event and other pharmacovigilance and other post&#8209;marketing reports and
      information, etc.), technical information, product development and operational data and records, and all other documents, records, files, data and other information relating to product development, manufacture and use, (c)&#160;litigation and dispute
      records, and accounting records, (d)&#160;all documents, records and files relating to Intellectual Property, including all correspondence from and to third parties (including Intellectual Property counsel and patent, trademark and other Intellectual
      Property registries, including the United States Patent and Trademark Office and the Canadian Intellectual Property Office), and (e)&#160;all other information, techniques and know&#8209;how necessary or required in connection with the Product Development and
      Commercialization Activities for any Product.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Prohibited Payment&#8221;</font> means any bribe, rebate, payoff, influence payment, kickback or other payment or gift
      of money or anything of value (including meals or entertainment) made by any Person to any officer, employee or ceremonial office holder of any government or instrumentality thereof, political party or supra&#8209;national organization (such as the United
      Nations), any political candidate, any royal family member or any other person who is connected or associated personally with any of the foregoing that is prohibited under any Requirement of Law.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Projections&#8221;</font> means the Confidential - Group EBITDA TO 2025 with Bal Sheet December 2021.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Property&#8221;</font> of any Person means any property or assets, or interest therein, of such Person.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Proportionate Share&#8221;</font> means, with respect to any Lender, the percentage obtained by dividing (a)&#160;the Loan
      Exposure of such Lender then in effect by (b)&#160;the aggregate Loan Exposure of all Lenders then in effect.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Publicly Reporting Company&#8221;</font> means an issuer generally subject to the public reporting requirements of the
      Exchange Act.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Qualified Equity Interest</font>&#8221; means, with respect to any Person, any Equity Interest of such Person that is
      not a Disqualified Equity Interest.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Qualified Plan&#8221;</font> means an employee benefit plan (as defined in Section&#160;3(3) of ERISA) other than a
      Multiemployer Plan (a)&#160;that is or was at any time maintained or sponsored by any Obligor or any ERISA Affiliate thereof or to which any Obligor or any ERISA Affiliate thereof has ever made, or was ever obligated to make, contributions, and (b)&#160;that
      is intended to be Tax qualified under Section&#160;401(a) of the Code.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#160;&#8220;Recipient&#8221;</font> means any Lender or the Administrative Agent or, in the case of the Warrant Indemnified Taxes,
      the Warrant Holder.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Redemption Date&#8221;</font> has the meaning set forth in Section&#160;3.03(a)(i).</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 32 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Redemption Price&#8221;</font> has the meaning set forth in Section&#160;3.03(a)(i).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Referral Source&#8221; </font>has the meaning set forth in Section 7.07(b)(i).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Register&#8221;</font> has the meaning set forth in Section&#160;13.05(d).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Regulation&#160;T&#8221;</font> means Regulation&#160;T of the Board of Governors of the Federal Reserve System, as amended.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Regulation&#160;U&#8221;</font> means Regulation&#160;U of the Board of Governors of the Federal Reserve System, as amended.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Regulation&#160;X&#8221;</font> means Regulation&#160;X of the Board of Governors of the Federal Reserve System, as amended.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Regulatory Approvals&#8221;</font> means any Governmental Approval relating to any Product or any Product Development
      and Commercialization Activities related to such Product, including any Product Authorizations with respect thereto.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Regulatory Authority&#8221;</font> means any Governmental Authority that is concerned with or has regulatory or
      supervisory oversight with respect to any Product or any Product Development and Commercialization Activities relating to any Product, including the FDA, EMA, HPRA, Health Canada, ANVISA, and all equivalent Governmental Authorities, whether United
      States or non&#8209;United States.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Relevant ADSs</font>&#8221; has the meaning set forth in Section 8.21.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Relevant Governmental Body</font>&#8221; means the Federal Reserve Board and/or the Federal Reserve Bank of New York,
      or a committee officially endorsed or convened by the Federal Reserve Board and/or the Federal Reserve Bank of New York or any successor thereto.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Relevant Warrant Obligations&#8221; </font>means the obligations under Section 8.21<font style="font-style: italic;">&#160;</font>(<font style="font-style: italic;">Cashless Exercise of Warrant Certificate and Par Value</font>) and Article 11 (<font style="font-style: italic;">Guarantee</font>) to the extent such obligations relate, directly or indirectly, to a Warrant Certificate.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Representatives&#8221;</font> has the meaning set forth in Section&#160;13.17.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Requirement of Law&#8221;</font> means, as to any Person, any Law applicable to or binding upon such Person or any of
      its Properties or revenue.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Resignation Effective Date&#8221;</font> has the meaning set forth in Section 12.06(a).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Responsible Officer&#8221;</font> of any Person means each of the president, chief executive officer, chief financial
      officer or titles equivalent to the foregoing.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 33 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Restricted Payment&#8221;</font> means any dividend or other distribution (which shall include any management fees)
      (whether in cash, securities or other Property) with respect to any Equity Interest of an Obligor or any of its Subsidiaries, or any payment (whether in cash, securities or other Property), including any sinking fund or similar deposit, on account of
      the purchase, redemption, retirement, acquisition, cancellation or termination of any Equity Interests of an Obligor or any of its Subsidiaries or any option, warrant or other right to acquire any Equity Interests of an Obligor or any of its
      Subsidiaries.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Restrictive Agreement&#8221;</font> means any indenture, agreement, instrument or other binding arrangement that
      prohibits, restricts or imposes any condition upon (a)&#160;the ability of an Obligor or any Subsidiary to create, incur or permit to exist any Lien upon any of its Property (other than (i)&#160;customary provisions in Contracts (including without limitation
      leases and in&#8209;bound licenses of Intellectual Property) restricting the assignment thereof, (ii)&#160;restrictions or conditions imposed by any agreement governing secured Permitted Indebtedness permitted under Section&#160;9.01(h), to the extent that such
      restrictions or conditions apply only to the Property securing such Indebtedness and (iii)&#160;software and other Intellectual Property licenses pursuant to which an Obligor or a Subsidiary thereof is the licensee of the relevant software or Intellectual
      Property, as the case may be (in which case, any prohibition or limitation shall relate only to the assets or rights subject to the applicable license and/or the license itself)), or (b)&#160;the ability of any Subsidiary to pay dividends or other
      distributions with respect to any shares of its Equity Interests or to make or repay loans or advances to an Obligor or any other Subsidiary or to Guarantee Indebtedness of an Obligor or any other Subsidiary.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Resolution Authority</font>&#8221; means an EEA Resolution Authority or, with respect to any U.K. Financial
      Institution, a U.K. Resolution Authority.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Revenue Claim&#8221;</font> has the meaning set forth in Section&#160;5.03(i).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Sanctions&#8221;</font> means economic or financial sanctions, requirements or trade embargoes imposed, administered or
      enforced from time to time by Governmental Authorities (including, but not limited to, OFAC, the United States Department of State, the United States Department of Commerce, and the government of Canada and respective departments and agencies
      thereof, including Foreign Affairs, Trade and Development Canada, and Public Safety Canada).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Sanctions Laws&#8221;</font> means all laws, rules, regulations and requirements of any jurisdiction applicable to the
      Obligors or any party to the Loan Documents concerning or relating to Sanctions, terrorism or money laundering.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;SEC&#8221;</font> means United States Securities and Exchange Commission.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Second A&amp;R Credit Agreement</font>&#8221; has the meaning set forth in the recitals hereto.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Second Amendment to Warrant Certificate&#8221;</font> means that certain Second Amendment to Warrant Certificate, dated
      as of the Effective Date, by and among Parent and Perceptive.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Securities Account&#8221;</font> has the meaning set forth in the U.C.C. and the PPSA, as applicable.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 34 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Security Agreements&#8221;</font> means the U.S. Security Agreement, the Canadian Security Agreement and the Irish
      Debenture.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Security Documents&#8221;</font> means, collectively, the Security Agreements, each Short&#8209;Form IP Security Agreement,
      the Canadian Intellectual Property Security Agreements, the Pledge Agreements and each other security document, control agreement or financing statement executed to perfect Liens in favor of the Administrative Agent for the benefit of the Lenders.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Segregated Health Care Account&#8221;</font> means, a Deposit Account of an Obligor in the name of such Obligor and
      under the sole dominion and control of such Obligor maintained in accordance with the requirements of Section 8.18(c) hereof, the only funds on deposit in which constitute the direct proceeds of payments made by Federal Health Care Programs.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Short&#8209;Form IP Security Agreements&#8221;</font> means short&#8209;form Copyright, Patent or Trademark (as the case may be)
      security agreements, dated as of the Funding Date, in substantially the form of Exhibits H-1 and H-2, entered into by one or more Obligors in favor of the Administrative Agent for the benefit of the Lenders, each in form and substance satisfactory to
      the Administrative Agent.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Sixth Amendment Restatement Date&#8221;</font> means August 7, 2025.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Sixth Amendment Term Loan&#8221;</font> means the loan advanced by a Lender pursuant to Section 2.01(h).&#160; For purposes
      of clarification, any calculation of the aggregate outstanding principal amount of the Sixth Amendment Term Loan on any date of determination shall mean the aggregate principal amount of the Sixth Amendment Term Loan made pursuant to Section 2.01(h)
      that has not yet been repaid as of such date.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Sixth Amendment Term Loan</font>&#160;<font style="font-style: italic;">Borrowing Notice</font>&#8221; means a notice
      substantially in the form attached hereto as Exhibit R.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Sixth Amendment Term Loan Commitment&#8221;</font> means the commitment of a Lender to make or otherwise fund the Sixth
      Amendment Term Loan and <font style="font-style: italic;">&#8220;Sixth Amendment Term Loan Commitments&#8221;</font> means such commitments of all Lenders in the aggregate.&#160; The amount of each Lender&#8217;s Sixth Amendment Term Loan Commitment is set forth on
      Schedule&#160;1.&#160; The aggregate amount of the Sixth Amendment Term Loan Commitments as of the Sixth Amendment Restatement Date is $2,000,000.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Sixth Amendment Warrant Certificate&#8221;</font> means the Warrant, dated as of the Sixth Amendment Restatement Date,
      that, among other things, grants the holder thereof the right to purchase the number of American Depositary Shares (represented by American Depositary Receipts) of Parent as indicated on the Warrant Shares table on Schedule&#160;1.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">SOFR</font>&#8221; means a rate equal to the secured overnight financing rate as administered by the SOFR
      Administrator.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 35 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">SOFR Administrator</font>&#8221; means the Federal Reserve Bank of New York (or a successor administrator of the
      secured overnight financing rate).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Solvent&#8221;</font> means, with respect to any Person at any time, that (a)&#160;the present fair saleable value of the
      Property of such Person is greater than the total amount of liabilities (including contingent liabilities) of such Person, (b)&#160;the present fair saleable value of the Property of such Person is not less than the amount that will be required to pay the
      probable liability of such Person on its debts as they become absolute and matured, and (c)&#160;such Person: (i) (where such is not an Irish Obligor) has not incurred and does not intend to, and does not believe that it will, incur debts or liabilities
      beyond such Person&#8217;s ability to pay as such debts and liabilities mature; and (ii) (where such Person is an Irish Obligor) is not &#8220;unable to pay its debts&#8221; (within the meaning of Section 570 of the Companies Act 2014 of Ireland (as amended)).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Standard Body&#8221;</font> means any of the organizations that create, sponsor or maintain safety, quality or other
      standards, including ISO, ANSI, CEN and SCC and the like.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;State&#8221;</font> means any state or territory of the United States.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Stated Maturity Date&#8221;</font> means October 1, 2026; <font style="font-style: italic;">provided</font> that if
      any such date shall occur on a day that is not a Business Day, then the Stated Maturity Date shall be the immediately succeeding Business Day.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Subsidiary&#8221;</font> means, with respect to any Person (the <font style="font-style: italic;">&#8220;parent&#8221;</font>) at
      any time of determination, any other Person of which more than 50% of the outstanding capital stock of such other Person having ordinary voting powers, determined on a fully diluted basis, is at the time directly or indirectly owned or Controlled by
      the parent.&#160; Unless the context otherwise specifically requires, the term &#8220;Subsidiary&#8221; shall be a reference to a Subsidiary of an Obligor.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Swedish Subsidiaries</font>&#8221; means Fiomi Diagnostics Holding AB and Fiomi Diagnostics AB.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Sweep Agreement</font>&#8221; means an agreement, in form and substance reasonably satisfactory to Agent, between the
      Obligor maintaining a Segregated Health Care Account, Administrative Agent and applicable bank or other financial institution at which such Segregated Health Care Account is maintained, pursuant to which such bank or financial institution (i) agrees
      to automatically sweep amounts deposited in such Segregated Health Care Account to another account of an Obligor subject to a tri-party account control agreement in favor of Administrative Agent satisfying the requirements set forth in Section
      8.18(c) hereof, as and when funds clear and become available in accordance with such bank&#8217;s or financial institution&#8217;s standard practices and procedures, and (ii) agrees not to change such standing sweep instructions until the date at least five (5)
      days (or such lesser period as Administrative Agent may agree in its sole discretion or as may be required by applicable Federal Health Care Program laws or policies after receipt of notice from such Obligor maintaining such Segregated Health Care
      Account by Administrative Agent and such bank or financial institution of the termination of such standing sweep instruction).</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 36 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Taxes&#8221;</font> means all present or future taxes, levies, imposts, duties, (including stamp duties), deductions,
      withholdings (including backup withholding), assessments, fees or other charges imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Technical Information&#8221;</font> means all trade secrets and other proprietary or confidential information, which
      may include any proprietary information of a scientific, technical, or business nature in any form or medium, standards and specifications, conceptions, ideas, innovations, discoveries, Invention disclosures, all documented research, developmental,
      demonstration or engineering work, data, plans, specifications, reports, summaries, experimental data, manuals, models, samples, know&#8209;how, technical information, systems, methodologies, computer programs or information technology.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Term Loans&#8221;</font> means collectively, the Funding Date Term Loan, the Tranche B Term Loan, the Effective Date
      Term Loan, the Delayed Draw Term Loan, the Third Amendment Term Loan, the Fourth Amendment Term Loan, the Fifth Amendment Term Loan and the Sixth Amendment Term Loan.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Term SOFR</font>&#8221; means the Term SOFR Reference Rate for a tenor comparable to the applicable Interest Period on
      the day (such day, the &#8220;Periodic Term SOFR Determination Day&#8221;) that is two (2) U.S. Government Securities Business Days prior to the first day of such Interest Period, as such rate is published by the Term SOFR Administrator; <font style="font-style: italic;">provided</font>, <font style="font-style: italic;">however,</font> that if as of 5:00 p.m. (New York City time) on any Periodic Term SOFR Determination Day the Term SOFR Reference Rate for the applicable tenor has not
      been published by the Term SOFR Administrator and a Benchmark Replacement Date with respect to the Term SOFR Reference Rate has not occurred, then Term SOFR will be the Term SOFR Reference Rate for such tenor as published by the Term SOFR
      Administrator on the first preceding U.S. Government Securities Business Day for which such Term SOFR Reference Rate for such tenor was published by the Term SOFR Administrator so long as such first preceding U.S. Government Securities Business Day
      is not more than three (3) U.S. Government Securities Business Days prior to such Periodic Term SOFR Determination Day; <font style="font-style: italic;">provided</font>, <font style="font-style: italic;">further,</font> Term SOFR shall be rounded
      upwards to the next 1/100% (if necessary), <font style="font-style: italic;">provided</font>, <font style="font-style: italic;">further</font>, however; if Term SOFR as so determined shall ever be less than the Floor, then Term SOFR shall be deemed
      to be the Floor.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Term SOFR Administrator</font>&#8221; means CME Group Benchmark Administration Limited (CBA) (or a successor
      administrator of the Term SOFR Reference Rate selected by the Administrative Agent in its reasonable discretion).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Term SOFR Reference Rate</font>&#8221; means the forward-looking term rate based on SOFR.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Third A&amp;R Credit Agreement</font>&#8221; has the meaning set forth in the recitals hereto.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Third Amendment Restatement Date</font>&#8221; means December 23, 2024.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 37 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Third Amendment Term Loan&#8221;</font> means the loan advanced by a Lender pursuant to Section 2.01(e).&#160; For purposes
      of clarification, any calculation of the aggregate outstanding principal amount of the Third Amendment Term Loan on any date of determination shall mean the aggregate principal amount of the Third Amendment Term Loan made pursuant to Section 2.01(e)
      that has not yet been repaid as of such date.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Third Amendment Term Loan</font>&#160;<font style="font-style: italic;">Borrowing Notice</font>&#8221; means a notice
      substantially in the form attached hereto as Exhibit O.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Third Amendment Warrant Certificate&#8221;</font> means the Warrant, dated as of the Third Amendment Restatement Date,
      that, among other things, grants the holder thereof the right to purchase the number of American Depositary Shares (represented by American Depositary Receipts) of Parent as indicated on the Warrant Shares table on Schedule&#160;1.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Third Amendment to Warrant Certificate&#8221;</font> means that certain Third Amendment to Warrant Certificate, dated
      as of the Third Amendment Restatement Date, by and among Parent and Perceptive.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Title&#160;IV Plan&#8221;</font> means an employee benefit plan (as defined in Section&#160;3(3) of ERISA) other than a
      Multiemployer Plan (a)&#160;that is or was at any time during the six year period ending on the Funding Date maintained or sponsored by any Obligor or any ERISA Affiliate thereof or to which any Obligor or any ERISA Affiliate thereof has ever made, or was
      obligated to make, contributions, and (b)&#160;that is or was subject to Section&#160;412 of the Code, Section&#160;302 of ERISA or Title&#160;IV of ERISA.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Trademarks&#8221;</font> means all trade names, trademarks and service marks, logos, trademark and service mark
      registrations, and applications for trademark and service mark registrations, including all renewals of trademark and service mark registrations, all rights to recover for all past, present and future infringements thereof and all rights to sue
      therefor, and all rights corresponding thereto throughout the world, together, in each case, with the product lines and goodwill of the business connected with the use thereof (excluding any application for registration of a trademark filed on an
      intent to use basis solely to the extent that the grant of a security interest in any such trademark application would materially adversely affect the validity or enforceability of the resulting trademark registration or result in cancellation of
      such trademark application).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Tranche B Term Loan&#8221;</font> means the loan advanced by a Lender pursuant to Section 2.01(b).&#160; For purposes of
      clarification, any calculation of the aggregate outstanding principal amount of the Tranche B Term Loan on any date of determination shall mean the aggregate principal amount of the Tranche B Term Loan made pursuant to Section 2.01(b) that has not
      yet been repaid as of such date.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Tranche B Term Loan Borrowing Date&#8221;</font> means February 21, 2023.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Transactions&#8221;</font> means the execution, delivery and performance by each Obligor of this Agreement and the
      other Loan Documents to which such Obligor is a party, the consummation of the Effective Date Acquisition and the other transactions contemplated hereby and thereby, including disbursement and application of the proceeds of the Term Loans.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 38 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;U.C.C.&#8221;</font> means the Uniform Commercial Code as in effect in the State of New&#160;York; <font style="font-style: italic;">provided, however</font>, that if by reason of mandatory provisions of law, any or all of the attachment, perfection or priority of the Administrative Agent&#8217;s security interest in any item or portion of the Collateral is governed by the
      Uniform Commercial Code as in effect in a jurisdiction other than the State of New&#160;York, the term <font style="font-style: italic;">&#8220;U.C.C.&#8221;</font> means the Uniform Commercial Code as in effect in such other jurisdiction for purposes of the
      provisions hereof relating to such attachment, perfection or priority and for purposes of definitions relating to such provisions.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">U.K. Financial Institution</font>&#8221; means any BRRD Undertaking (as such term is defined under the PRA Rulebook (as
      amended from time to time) promulgated by the United Kingdom Prudential Regulation Authority) or any person falling within IFPRU 11.6 of the FCA Handbook (as amended from time to time) promulgated by the United Kingdom Financial Conduct&#160;Authority,
      which includes certain credit institutions and investment firms, and certain affiliates of such credit institutions or investment firms.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">U.K. Resolution Authority</font>&#8221; means the Bank of England or any other public administrative authority having
      responsibility for the resolution of any U.K. Financial Institution.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">U.K. Subsidiary</font>&#8221; means Trinity Biotech (UK) Limited.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Unadjusted Benchmark Replacement</font>&#8221; means the applicable Benchmark Replacement excluding the related
      Benchmark Replacement Adjustment.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Unrestricted Cash&#8221;</font> means the balance of unencumbered cash (other than cash encumbered by the Liens granted
      to the Lenders pursuant to the Loan Documents) and Permitted Cash Equivalent Investments (which for greater certainty shall not include any undrawn credit lines), in each case, to the extent held in a Controlled Account.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;U.S.&#8221; </font>means the United States of America.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;U.S. Biopool&#8221; </font>has the meaning set forth in the introduction hereto.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;U.S. Clark&#8221; </font>has the meaning set forth in the introduction hereto.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">U.S. Fitzgerald</font>&#8221;<font style="font-style: italic;">&#160;</font>means Fitzgerald Industries International, Inc.,
      a Delaware corporation.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">U.S. Government Securities Business Day</font>&#8221; means any day except for (a) a Saturday, (b) a Sunday or (c) a
      day on which the Securities Industry and Financial Markets Association recommends that the fixed income departments of its members be closed for the entire day for purposes of trading in United States government securities.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;U.S. Holdings&#8221;</font> has the meaning set forth in the introduction hereto.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;U.S. Immco&#8221;</font> has the meaning set forth in the introduction hereto.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">U.S. MarDx</font>&#8221; has the meaning set forth in the introduction hereto.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 39 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;U.S. Person&#8221;</font> means a &#8220;United States person&#8221; within the meaning of Section&#160;7701(a)(30) of the Code.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;U.S. Primus&#8221;</font> has the meaning set forth in the introduction hereto.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;U.S. Pledge Agreement&#8221;</font> means the U.S. Pledge Agreement, dated as of the Funding Date, among Parent, the
      Lenders and the Administrative Agent, pledging 100% of the Equity Interests in U.S. Holdings in favor of the Administrative Agent for the benefit of the Lenders.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;U.S. Security Agreement&#8221;</font> means the U.S. Security Agreement, dated as of the Funding Date, in substantially
      the form of Exhibit&#160;G-1 among the Borrowers, the Lenders and the Administrative Agent, granting a security interest in the personal Property constituting Collateral thereunder in favor of the Administrative Agent for the benefit of the Lenders.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;U.S. Tax Compliance Certificate&#8221;</font> has the meaning set forth in Section&#160;5.03(f)(ii)(B)(3).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;U.S. TRIB&#8221; </font>has the meaning set forth in the introduction hereto.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Warrant Certificates</font>&#8221; means the Effective Date Warrant Certificate, the Third Amendment Warrant
      Certificate, the Sixth Amendment Warrant Certificate and the Existing Warrant Certificate.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Warrant Indemnified Taxes</font>&#8221; means any Indemnified Taxes payable or paid by the Warrant Holder or required
      to be withheld or deducted from a payment to Warrant Holder and/or any reasonable costs and expenses arising therefrom or with respect thereto (including, but not limited to, any costs arising from a dispute with the relevant Government Authority in
      respect of such Indemnified Taxes) in each case to the extent it relates to the grant of a Warrant Certificate to the Warrant Holder and/or the exercise of a Warrant Certificate by a Warrant Holder and/or the issue of the American Depositary Receipts
      and/or American Depositary Shares to any Warrant Holder in accordance with a Warrant Certificate.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Warrant Holder</font>&#8221; means the person or entity to whom a Warrant Certificate is issued, or any transferee or
      assignee thereof (to the extent such transfer is permitted by the applicable Warrant Certificate).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Warrant Obligations&#8221; </font>means, with respect to Parent, all of its Obligations arising out of, under or in
      connection with, the Warrant Certificates.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Warrant Stamp Amount&#8221;</font> means an amount denominated in EUR (&#8364;) credited to the client account of Irish
      counsel to the Administrative Agent on the date of execution of the Sixth Amendment Warrant Certificate by any one or more of the Non-EEA Obligors out of its (or their) existing cash resources (being cash other than cash borrowed pursuant to the
      terms of this Agreement), which amount (the source of which shall not require verification, assessment or confirmation by or from the Administrative Agent) shall be sufficient to discharge the Irish stamp duty liability due upon execution of the
      Sixth Amendment Warrant Certificate (as such liability is agreed between the Administrative Agent and the Administrative Borrower on such date).</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 40 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;WaveForm&#8221;</font> means WaveForm Technologies, Inc., a Delaware corporation.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;WaveForm Holdings&#8221;</font> means WaveForm Holdings, LLC, a Delaware limited liability company.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">"WaveForm IP</font>&#8221; means Intellectual Property acquired pursuant to the Effective Date Acquisition.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">"Waveform Slovenia Side Agreement&#8221; </font>means that certain WaveForm Side Agreement, dated as of the date
      hereof, among WaveForm, WaveForm Slovenia and U.S. TRIB.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;WaveForm Slovenia&#8221;</font> means Waveform EU d.o.o., a Slovenian company.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;WHO&#8221;</font> means the World Health Organization and any successor thereto.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">&#8220;Withdrawal Liability&#8221;</font> means, at any time, any liability incurred (whether or not assessed) by any ERISA
      Affiliate and not yet satisfied or paid in full at such time with respect to any Multiemployer Plan pursuant to Section&#160;4201 of ERISA.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">&#8220;<font style="font-style: italic;">Write&#8209;Down and Conversion Powers&#8221; </font>means, (a) with respect to any EEA Resolution Authority, the write&#8209;down
      and conversion powers of such EEA Resolution Authority from time to time under the Bail&#8209;In Legislation for the applicable EEA Member Country, which write&#8209;down and conversion powers are described in the EU Bail&#8209;In Legislation Schedule&#160; and (b) with
      respect to the United Kingdom, any powers of the applicable Resolution Authority under the Bail-In Legislation to cancel, reduce, modify or change the form of a liability of any U.K. Financial Institution or any contract or instrument under which
      that liability arises, to convert all or part of that liability into shares, securities or obligations of that person or any other person, to provide that any such Contract or instrument is to have effect as if a right had been exercised under it or
      to suspend any obligation in respect of that liability or any of the powers under that Bail-In Legislation that are related to or ancillary to any of those powers.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 41 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;1.02.<a name="Section1.02."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-style: italic;">Accounting Terms and Principles</font>.&#160; All accounting determinations required to be made pursuant hereto shall, unless expressly otherwise provided herein, be made substantially in accordance with IFRS.&#160; If, after
        the date hereof, any change occurs in IFRS or in the application thereof (an <font style="font-style: italic;">&#8220;Accounting Change&#8221;</font>)<font style="font-style: italic;">&#160;</font>and such change would cause any amount required to be determined
        for the purposes of the covenants to be maintained or calculated pursuant to Article&#160;8 or 9 to be materially different than the amount that would be determined prior to such change, then the Administrative Borrower will provide a detailed notice of
        such change (an <font style="font-style: italic;">&#8220;Accounting Change Notice&#8221;</font>) to the Administrative Agent in conjunction with the next required delivery of financial statements pursuant to Section&#160;8.01.&#160; If the Administrative Borrower
        requests an amendment to any provision hereof to eliminate the effect of any Accounting Change occurring after the Sixth Amendment Restatement Date or in the application thereof on the operation of such provision, regardless of whether any
        Accounting Change Notice is given before or after such Accounting Change or in the application thereof, then the Administrative Agent and the Administrative Borrower agree that they will negotiate in good faith amendments to the provisions of this
        Agreement that are directly affected by such Accounting Change with the intent of having the respective positions of the Administrative Agent and the Administrative Borrower after such Accounting Change conform as nearly as possible to their
        respective positions as of the date of this Agreement and, until any such amendments have been agreed upon, (i)&#160;the provisions in this Agreement shall be calculated as if no such Accounting Change had occurred and (ii) the Administrative Borrower
        shall provide to the Administrative Agent a written reconciliation in form and substance reasonably satisfactory to the Administrative Agent, between calculations of any baskets and other requirements hereunder before and after giving effect to
        such Accounting Change.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">All components of financial calculations made to determine compliance with this Agreement shall be adjusted to include or exclude, as the case may
      be, without duplication, such components of such calculations attributable to any Acquisition or disposition of assets consummated after the first day of the applicable period of determination and prior to the end of such period, as determined in
      good faith by the Administrative Borrower based on assumptions expressed therein and that were reasonable based on the information available to the Administrative Borrower at the time of preparation of the Compliance Certificate setting forth such
      calculations.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;1.03.<a name="Section1.03."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;
        <font style="font-style: italic;">Interpretation</font>.&#160; For all purposes of this Agreement, except as otherwise expressly provided herein or unless the context otherwise requires, (a)&#160;the terms defined in this Agreement include the plural as well
        as the singular and vice versa; (b)&#160;words importing gender include all genders; (c)&#160;any reference to a Section, Article, Annex, Schedule or Exhibit refers to a Section or Article of, or Annex, Schedule or Exhibit to, this Agreement; (d)&#160;any
        reference to &#8220;this Agreement&#8221; refers to this Agreement, including all Annexes, Schedules and Exhibits hereto, and the words herein, hereof, hereto and hereunder and words of similar import refer to this Agreement and its Annexes, Schedules and
        Exhibits as a whole and not to any particular Section, Article, Annex, Schedule, Exhibit or any other subdivision; (e)&#160;references to days, months and years refer to calendar days, months and years, respectively; (f)&#160;all references herein to
        &#8220;include&#8221; or &#8220;including&#8221; shall be deemed to be followed by the words &#8220;without limitation&#8221;; (g)&#160;the word &#8220;from&#8221; when used in connection with a period of time means &#8220;from and including&#8221; and the word &#8220;until&#8221; means &#8220;to but not including&#8221;; and
        (h)&#160;accounting terms not specifically defined herein shall be construed substantially in accordance with IFRS (except for the term &#8220;property,&#8221; which shall be interpreted as broadly as possible, including, in any case, cash, securities, other
        assets, rights under contractual obligations and Permits and any right or interest in any property, except where otherwise noted).&#160; Unless otherwise expressly provided herein, references to Organizational Documents, agreements (including the Loan
        Documents) and other contractual instruments shall be deemed to include all subsequent amendments, restatements, extensions, supplements and other modifications thereto permitted by the Loan Documents.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;1.04.<a name="Section1.04."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Divisions</font>.&#160; For all purposes under the Loan Documents, in connection with any division or plan of division under Delaware law (or any comparable event under a different jurisdiction&#8217;s laws): (a)&#160;if any
        asset, right, obligation or liability of any Person becomes the asset, right, obligation or liability of a different Person, then it shall be deemed to have been transferred from the original Person to the subsequent Person and (b)&#160;if any new
        Person comes into existence, such new Person shall be deemed to have been organized on the first date of its existence by the holders of its Equity Interests at such time.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 42 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;1.05.<a name="Section1.05."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Interest Rates</font>.&#160; The Administrative Agent does not warrant or accept responsibility for, and shall not have any liability with respect to (a) the continuation of, administration of, submission of,
        calculation of or any other matter related to the Term SOFR Reference Rate, Term SOFR, or any component definition thereof or rates referred to in the definition thereof, or any alternative, successor or replacement rate thereto (including any
        Benchmark Replacement), including whether the composition or characteristics of any such alternative, successor or replacement rate (including any Benchmark Replacement) will be similar to, or produce the same value or economic equivalence of, or
        have the same volume or liquidity as, the Term SOFR Reference Rate, Term SOFR or any other Benchmark prior to its discontinuance or unavailability, or (b) the effect, implementation or composition of any Conforming Changes.&#160; The Administrative
        Agent and its affiliates or other related entities may engage in transactions that affect the calculation of the Term SOFR Reference Rate, Term SOFR,&#160; any alternative, successor or replacement rate (including any Benchmark Replacement) or any
        relevant adjustments thereto, in each case, in a manner adverse to the Borrowers.&#160; The Administrative Agent may select information sources or services in its reasonable discretion to ascertain the Term SOFR Reference Rate, Term SOFR or any other
        Benchmark, in each case pursuant to the terms of this Agreement, and shall have no liability to the Borrowers, any Lender or any other person or entity for damages of any kind, including direct or indirect, special, punitive, incidental or
        consequential damages, costs, losses or expenses (whether in tort, contract or otherwise and whether at law or in equity), for any error or calculation of any such rate (or component thereof) provided by any such information source or service.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps; font-weight: bold;"><a name="Article2"><!--Anchor--></a>Article&#160;2<br>
      <br>
      The Term Loans</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;2.01.</font><font style="font-family: 'Times New Roman';"> <a name="Section2.01."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Term Loans</font>.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; Funding Date Term Loan</font>.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On the Funding Date, the Funding Date Term Loan was made to the Borrowers pursuant to Section
        2.01(a) of the Original Credit Agreement.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to Section 3.03, all amounts owed hereunder with respect to the Funding Date Term Loan
        shall be paid in full no later than the Maturity Date.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; Tranche B Term Loan</font>.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On the Tranche B Term Loan Borrowing Date, the Tranche B Term Loan was made to the Borrowers
        pursuant to Section 2.01(b) of the Original Credit Agreement.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to Section 3.03, all amounts owed hereunder with respect to the Tranche B Term Loan shall
        be paid in full no later than the Maturity Date.</font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 43 -</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; Effective Date Term Loan.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On the Effective Date, the Effective Date Term Loan was made to the Borrowers pursuant to Section
        2.01(c) of the Second A&amp;R Credit Agreement.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to Section 3.03, all amounts owed hereunder with respect to the Effective Date Term Loan
        shall be paid in full no later than the Maturity Date.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; margin-left: 18pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Delayed Draw Term Loan.</font></font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On the Delayed Draw Term Loan Borrowing Date, the Delayed Draw Term Loan was made to the Borrowers
        pursuant to Section 2.01(d) of the Second A&amp;R Credit Agreement.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to Section 3.03, all amounts owed hereunder with respect to the Delayed Draw Term Loan
        shall be paid in full no later than the Maturity Date.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Third Amendment Term Loan</font>.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On the Third Amendment Restatement Date, the Third Amendment Term Loan was made to the Borrowers
        pursuant to Section 2.01(e) of the Third A&amp;R Credit Agreement.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to Section 3.03, all amounts owed hereunder with respect to the Third Amendment Term Loan
        shall be paid in full no later than the Maturity Date.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Fourth Amendment Term Loan</font>.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On the Fourth Amendment Restatement Date, the Fourth Amendment Term Loan was made to the Borrowers
        pursuant to Section 2.01(f) of the Fourth A&amp;R Credit Agreement.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to Section 3.03, all amounts owed hereunder with respect to the Fourth Amendment Term
        Loan shall be paid in full no later than the Maturity Date.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Fifth Amendment Term Loan</font>.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On the Fifth Amendment Restatement Date, the Fifth Amendment Term Loan was made to the Borrowers
        pursuant to Section 2.01(g) of the Fifth A&amp;R Credit Agreement.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to Section 3.03, all amounts owed hereunder with respect to the Fifth Amendment Term Loan
        shall be paid in full no later than the Maturity Date.</font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 44 -</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Sixth Amendment Term Loan</font>.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 38.7pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to the terms and conditions of this Agreement and relying on the representations and
        warranties set forth herein, each Lender, severally and not jointly, agrees to provide its share of the Sixth Amendment Term Loan to the Borrowers on the Sixth Amendment Restatement Date in Dollars in a principal amount equal to such Lender&#8217;s Sixth
        Amendment Term Loan Commitment.&#160; No Lender shall have an obligation to make a Sixth Amendment Term Loan in excess of such Lender&#8217;s Sixth Amendment Term Loan Commitment.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 38.7pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Borrowers may make one Borrowing under the Sixth Amendment Term Loan Commitment which shall
        be on the Sixth Amendment Restatement Date.&#160; Subject to Section 3.03, all amounts owed hereunder with respect to the Sixth Amendment Term Loan shall be paid in full no later than the Maturity Date.&#160; Each Lender&#8217;s Sixth Amendment Term Loan
        Commitment shall terminate immediately and without further action on the Sixth Amendment Restatement Date after giving effect to the funding of such Lender&#8217;s Sixth Amendment Term Loan Commitment.</font></div>
    <div style="text-align: justify; text-indent: 38.7pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';"> <br>
      </font></div>
    <div style="text-align: justify; text-indent: 38.7pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to the terms and conditions of this Agreement (including Section 6.01), the
        Administrative Borrower shall deliver to the Administrative Agent a fully executed Sixth Amendment Term Loan Borrowing Notice no later than 5 p.m. (New York City time) at least one (1) Business Day in advance of the Sixth Amendment Restatement
        Date.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(i)<font style="font-style: italic;">Certain Acknowledgements</font>.&#160; Each Obligor acknowledges that as of August 1, 2025, the
      aggregate outstanding principal amount of the Term Loans prior to giving effect to the Fifth Amendment Term Loan, but including all accrued and capitalized PIK Interest on such date was equal to $87,789,122.30.&#160; The amounts in this clause (i) do not
      include fees, expenses and other amounts that are chargeable or otherwise reimbursable under the Loan Documents.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman';">Any principal amount of the Term Loans borrowed under Section 2.01(a), Section 2.01(b), Section 2.01(c), Section 2.01(d), Section 2.01(e), Section 2.01(f), Section
      2.01(g) and Section 2.01(h) hereof and subsequently repaid or prepaid may not be reborrowed.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;2.02.</font><font style="font-family: 'Times New Roman';"><a name="Section2.02."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Proportionate Shares</font>.&#160; Each Term Loan shall be made, and all participations purchased, by the Lenders simultaneously and proportionately to their respective Proportionate Shares, it being understood that no
        Lender shall be responsible for any default by any other Lender in such other Lender&#8217;s obligation to make a Term Loan hereunder or purchase a participation required hereby nor shall the Commitment of any Lender be increased or decreased as a result
        of a default by any other Lender in such other Lender&#8217;s obligation to make a Term Loan requested hereunder or purchase a participation required hereby.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;2.03.</font><font style="font-family: 'Times New Roman';"> <a name="Section2.03."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160; &#160;
        <font style="font-style: italic;">[Reserved]</font>.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;2.04.<a name="Section2.04."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Notes</font>.&#160; Upon the request of any Lender, the Borrowers shall prepare, execute and deliver to such Lender one or more Notes evidencing the portion of the Term Loans payable to such Lender (or if requested by it,
        to it and its registered assigns).</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 45 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;2.05.</font><font style="font-family: 'Times New Roman';"><a name="Section2.05."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Use of Proceeds</font>.&#160; The Borrowers shall use the proceeds of the Effective Date Term Loan, (a) to fund the Effective Date Acquisition, (b) to pay, in accordance with the funds flow attached to the Effective Date
        Term Loan Borrowing Notice, fees, costs and expenses incurred in connection with this Agreement and (c) for general corporate purposes permitted herein.&#160; The Borrowers shall use the proceeds of the Delayed Draw Term Loan, (a) for general corporate
        purposes permitted herein and (b) to pay, in accordance with the funds flow attached to the Delayed Draw Term Loan Borrowing Notice, fees, costs and expenses incurred in connection with the applicable Borrowing.&#160; The Borrowers shall use the
        proceeds of the Third Amendment Term Loan for general corporate purposes permitted herein.&#160; The Borrowers shall use the proceeds of the Sixth Amendment Term Loan for general corporate purposes permitted herein.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps; font-weight: bold;"><a name="Article3"><!--Anchor--></a>Article&#160;3<br>
      <br>
      Payments of Principal and Interest</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;3.01.<a name="Section3.01."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Repayment</font>.&#160; There will be no scheduled repayments of principal on the Term Loans prior to the Maturity Date.&#160; The entire outstanding principal amount of the Term Loans (including accrued and uncapitalized
        PIK&#160;Interest on the Term Loans), together with all accrued and unpaid interest thereon, will be due and payable on the Maturity Date.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;3.02<a name="Section3.02"><!--Anchor--></a>.</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Interest</font>.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Interest Generally.&#160; </font>The Borrowers agree to pay to the Lenders interest
      in cash on the outstanding principal amount of the Term Loans for each Interest Period at a rate per annum equal to the sum of (i)&#160;Term SOFR plus (ii)&#160;the Applicable Margin<font style="font-style: italic;"> provided</font> that interest payable on
      the Term Loans for the Interest Periods of September 2024, October 2024, November 2024, December 2024, January 2025, February 2025, March 2025, April 2025, May 2025, June 2025, July 2025 and August 2025 shall be paid on the applicable Payment Date as
      PIK Interest.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Term SOFR Conforming Changes</font>.&#160; In connection with the use or
      administration of Term SOFR, the Administrative Agent will have the right to make Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such Conforming
      Changes will become effective without any further action or consent of any other party to this Agreement or any other Loan Document.&#160; The Administrative Agent will promptly notify the Administrative Borrower and the Lenders of the effectiveness of
      any Conforming Changes in connection with the use or administration of Term SOFR.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 46 -</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Effect of Benchmark Transition Event</font>.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Benchmark Replacement</font>.&#160; Notwithstanding anything to the
        contrary herein or in any other Loan Document, if a Benchmark Transition Event and its related Benchmark Replacement Date have occurred prior to any setting of the then&#8209;current Benchmark, then (x)&#160;if a Benchmark Replacement is determined in
        accordance with clause&#160;(a) of the definition of &#8220;Benchmark Replacement&#8221; for such Benchmark Replacement Date, such Benchmark Replacement will replace such Benchmark for all purposes hereunder and under any Loan Document in respect of such Benchmark
        setting and subsequent Benchmark settings without any amendment to, or further action or consent of any other party to, this Agreement or any other Loan Document and (y)&#160;if a Benchmark Replacement is determined in accordance with clause&#160;(b) of the
        definition of &#8220;Benchmark Replacement&#8221; for such Benchmark Replacement Date, such Benchmark Replacement will replace such Benchmark for all purposes hereunder and under any Loan Document in respect of any Benchmark setting at or after 5:00&#160;p.m.
        (New&#160;York City time) on the fifth (5<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>) Business Day after the date notice of such Benchmark Replacement is provided to the Lenders without any amendment to, or
        further action or consent of any other party to, this Agreement or any other Loan Document so long as the Administrative Agent has not received, by such time, written notice of objection to such Benchmark Replacement from Lenders comprising the
        Majority Lenders.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Benchmark Replacement Conforming Changes</font>. In connection
        with the implementation of a Benchmark Replacement, the Administrative Agent will have the right to make Benchmark Replacement Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document,
        any amendments implementing such Benchmark Replacement Conforming Changes will become effective without any further action or consent of any other party to the Loan Documents.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Notices; Standards for Decisions and Determinations</font>.
        The Administrative Agent will promptly notify the Administrative Borrower and the Lenders of (x)&#160;the implementation of any Benchmark Replacement and (y)&#160;the effectiveness of any Benchmark Replacement Conforming Changes in connection with the use,
        administration, adoption or implementation of a Benchmark Replacement.&#160; Any determination, decision or election that may be made by the Administrative Agent or the Lenders pursuant to this Section&#160;3.02(c) including any determination with respect to
        a tenor, rate or adjustment or of the occurrence or non&#8209;occurrence of an event, circumstance or date and any decision to take or refrain from taking any action, will be conclusive and binding absent manifest error and may be made in its or their
        sole discretion and without consent from any other party hereto, except, in each case, as expressly required pursuant to this Section&#160;3.02(c).</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 47 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Unavailability of Tenor of Benchmark</font>.&#160; Notwithstanding
        anything to the contrary herein or in any other Loan Document, at any time (including in connection with the implementation of a Benchmark Replacement), (x)&#160;if the then&#8209;current Benchmark is a term rate (including the Term SOFR Reference Rate) and
        either (A)&#160;any tenor for such Benchmark is not displayed on a screen or other information service that publishes such rate from time to time as selected by the Administrative Agent in its reasonable discretion or (B)&#160;the regulatory supervisor for
        the administrator of such Benchmark has provided a public statement or publication of information announcing that any tenor for such Benchmark is not or will not be representative, then the Administrative Agent may modify the definition of
        &#8220;Interest Period&#8221; (or any similar or analogous definition) for any Benchmark settings at or after such time to remove such unavailable or non&#8209;representative tenor and (y)&#160;if a tenor that was removed pursuant to clause&#160;(x) above either (A)&#160;is
        subsequently displayed on a screen or information service for a Benchmark (including a Benchmark Replacement) or (B)&#160;is not, or is no longer, subject to an announcement that it is not or will not be representative for a Benchmark (including a
        Benchmark Replacement), then the Administrative Agent may modify the definition of &#8220;Interest Period&#8221; (or any similar or analogous definition) for all Benchmark settings at or after such time to reinstate such previously removed tenor</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(d)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Default Interest.</font>&#160; Notwithstanding the foregoing, upon the occurrence and
      during the continuance of any Event of Default, the Applicable Margin shall increase automatically by 3.00% per annum (the interest rate, as increased pursuant to this Section 3.02(c), being the, the <font style="font-style: italic;">&#8220;Default Rate&#8221;</font>).&#160;


      Notwithstanding any other provision herein, if interest is required to be paid at the Default Rate, it shall also be paid entirely in cash.&#160; If any Obligation is not paid when due (giving effect to any applicable grace period) under the applicable
      Loan Document, the amount thereof shall accrue interest at a rate equal to 3.00% per annum (without duplication of interest payable at the Default Rate).&#160; Payment or acceptance of the increased rates of interest provided for in this Section 3.02(c)
      is not a permitted alternative to timely payment and shall not constitute a waiver of any Default or otherwise prejudice or limit any rights or remedies of the Administrative Agent or any Lender.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(e)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Payment Dates.</font>&#160; Accrued interest on the Term Loans shall be payable in
      arrears on each Payment Date with respect to the most recently completed Interest Period in cash (other than PIK Interest), and upon the payment or prepayment of the Term Loans (on the principal amount being so paid or prepaid); <font style="font-style: italic;">provided</font> that interest payable at the Default Rate shall be payable from time to time on demand by the Majority Lenders. PIK&#160;Interest on the Term&#160;Loans shall be capitalized and added to the outstanding principal
      amount of the Term&#160;Loans by increasing the outstanding principal amount of each Term Loan to which such interest relates on each Payment Date with respect to the most recently completed Interest Period.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 48 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(f)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Maximum Rate; Interest at a Criminal Rate.</font>&#160; Notwithstanding any other
      provision of this Agreement, in no event will any interest or rates referred to herein exceed the maximum interest rate permitted by applicable Law.&#160; If such maximum interest rate would be exceeded by the terms hereof, the rates of interest payable
      hereunder will be reduced to the extent necessary so that such rates (together with any fees or other amounts which are construed by a court of competent jurisdiction to be interest or in the nature of interest) equal the maximum interest rate
      permitted by applicable Law and any overpayment of interest received by the Lenders before such rates are so construed will be applied, forthwith after determination of such overpayment, to pay all then outstanding interest, and thereafter to pay
      outstanding principal. Without limiting the generality of the foregoing, <font style="font-weight: bold;">&#160;</font>in the event that any provision of this Agreement or any other Loan Document would oblige any Obligor to make any payment of interest
      or any other payment which is construed by a court of competent jurisdiction to be interest in an amount or calculated at a rate which would result in a receipt by any of the Administrative Agent or any Lender of interest at a criminal rate (as such
      terms are construed under the&#160;<font style="font-style: italic;">Criminal Code</font>&#160;(Canada)), then notwithstanding such provision, such amount or rate shall be deemed to have been adjusted&#160;<font style="font-style: italic;">nunc pro tunc</font>&#160;to
      the maximum amount or rate of interest, as the case may be, as would not so result in a receipt by the Lender of interest at a criminal rate, such adjustment to be effected, to the extent necessary as follows:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; margin-left: 67.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">&#160;(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; first, by reducing the amount or rate of interest required to be paid under this Agreement or such
        other Loan Document; and</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 9pt;">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; margin-left: 67.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">&#160;(ii)</font> &#160;&#160; <font style="font-family: 'Times New Roman';">thereafter, by reducing any fees, commissions,
        premiums or other amounts required to be paid which would constitute interest for the purposes of&#160;Section 347 of the&#160;<font style="font-style: italic;">Criminal Code</font>&#160;(Canada).</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">If, notwithstanding the provisions immediately above&#160;and after giving effect to all adjustments contemplated thereby, any of the Administrative
      Agent or any Lender shall have received an amount in excess of the maximum permitted by Law, then such excess shall be applied to the reduction of the balance of outstanding principal and not to the payment of interest, or if such excessive interest
      exceeds such principal balance, such excess shall be refunded to the Obligor, as applicable.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(g)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Interest Act </font>(Canada). For the purposes of the&#160;<font style="font-style: italic;">Interest Act</font>&#160;(Canada)&#160;and disclosure under such&#160;Act only:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;wherever interest to be paid under this Agreement is to be calculated on the basis of any period
        of time that is less than a calendar year (a "<font style="font-style: italic;">deemed year</font>"), such rate of interest shall be expressed as a yearly rate by multiplying such rate of interest for the deemed year by the actual number of days in
        the calendar year in which the rate is to be ascertained and dividing it by the number of days in the deemed year; and</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;each Obligor confirms that it fully understands and is able to calculate the rate of interest
        applicable to each of the credit facilities made available hereunder based on the methodology for calculating per annum rates provided for in this Agreement. The Administrative Agent agrees that, if requested in writing by the Administrative
        Borrower, it shall calculate the nominal and effective per annum rate of interest on any advance outstanding hereunder at any time and provide such information to the Administrative Borrower promptly following such request; <font style="font-style: italic;">provided</font> that any error in any such calculation, or any failure to provide such information on request, shall not relieve any Obligor of any of its obligations under this Agreement or any other Loan Document,
        nor result in any liability to the Administrative Agent. Each Obligor hereby irrevocably agrees not to plead or assert, whether by way of defense or otherwise, in any proceeding relating to the Loan Documents, that the interest payable under the
        Loan Documents and the calculation thereof has not been adequately disclosed to the Obligors, whether pursuant to&#160;Section 4 of the&#160;<font style="font-style: italic;">Interest Act</font>&#160;(Canada)&#160;or any other applicable law or legal principle.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 49 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;3.03.</font><font style="font-family: 'Times New Roman';"> <a name="Section3.03."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Prepayments</font>.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Optional Prepayments.</font></font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Borrowers shall have the right to optionally prepay in whole or in part (in a minimum amount
        of $500,000 and integral multiples of $100,000 in excess of that amount for each partial prepayment, or, if less, the entire outstanding principal amount of the Term Loans) the outstanding principal amount of the Term Loans on any Business Day (a <font style="font-style: italic;">&#8220;Redemption Date&#8221;</font>) for an amount equal to the sum of (x)&#160;the aggregate principal amount of the Term Loans being prepaid, (y)&#160;the applicable Prepayment Premium in respect of the aggregate principal amount of the
        Term Loans being prepaid and (z)&#160;any accrued but unpaid interest in respect of the aggregate principal amount of the Term Loans being prepaid (such aggregate amount, the <font style="font-style: italic;">&#8220;Redemption Price&#8221;</font>).&#160; The applicable
        &#8220;<font style="font-style: italic;">Prepayment Premium</font>&#8221; shall be an amount calculated pursuant to Section&#160;3.03(a)(ii).</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If the Redemption Date occurs:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 99pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(A)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;after the first anniversary of the Funding Date and on or prior to the second anniversary of the
        Funding Date, the Prepayment Premium shall be an amount equal to four and one-half percent (4.5%) of the aggregate outstanding principal amount of the Term Loans being prepaid on such Redemption Date;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 99pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(B)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;after the second anniversary of the Funding Date and on or prior to the third anniversary of the
        Funding Date, the Prepayment Premium shall be an amount equal to four percent (4%) of the aggregate outstanding principal amount of the Term Loans being prepaid on such Redemption Date; and</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 99pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(C)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;after the third anniversary of the Funding Date and prior to the Stated Maturity Date, the Prepayment
        Premium shall be an amount equal to three and one-half percent (3.5%) of the aggregate outstanding principal amount of the Term Loans being prepaid on such Redemption Date.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Mandatory Prepayments.</font>&#160; The Borrowers shall prepay the Term Loans in
      amounts as provided below, it being agreed that the relevant payment date shall be deemed to be the &#8220;Redemption Date&#8221; for purposes of such calculation), as follows:</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 50 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In the event of any Casualty Event, an amount, inclusive of any Prepayment Premium, any accrued
        but unpaid interest (including interest on the amount of the principal being prepaid) and fees then due and owing, equal to 100% of the Net Cash Proceeds received by any Obligor or any of its Subsidiaries with respect thereto; <font style="font-style: italic;">provided, however,</font> so long as no Default&#160; or Event of Default has occurred and is continuing, within one hundred eighty (180) days after receipt of such Net Cash Proceeds, the Obligors may apply the Net Cash
        Proceeds of any casualty policy up to, but not exceeding $4,000,000 for all losses in the aggregate during the term of this Agreement toward the replacement or repair of destroyed or damaged property; <font style="font-style: italic;">provided,
          further,</font> that any such replaced or repaired property shall be Collateral in which the Administrative Agent for the benefit of the Lenders has been granted a security interest under the Security Documents.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In the event any Obligor or any of its Subsidiaries incurs Indebtedness other than Indebtedness
        that is permitted by Section&#160;9.01 hereof, an amount, inclusive of any Prepayment Premium, any accrued but unpaid interest (including interest on the amount of the principal being prepaid) and fees then due and owing, equal to 100% of the Net Cash
        Proceeds thereof received by such Person.&#160; For the avoidance of doubt, any prepayment made pursuant to this Section&#160;3.03(b)(ii) shall not be deemed to be a consent to any such incurrence of Indebtedness or a cure or waiver of any Event of Default
        which occurs in connection therewith, it being understood that any such Event of Default may only be waived with the express consent of the Majority Lenders.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In the event any Obligor or any of its Subsidiaries consummates an Asset Sale other than an
        Asset Sale that is permitted by Section 9.09 hereof (other than Section 9.09(j)), an amount, inclusive of any Prepayment Premium, any accrued but unpaid interest (including interest on the amount of the principal being prepaid) and fees then due
        and owing, equal to 100%&#160; of the Net Cash Proceeds received by such Obligor in connection with such Asset Sale. For the avoidance of doubt, any prepayment made pursuant to this Section 3.03(b)(iii) shall not be deemed to be a consent to any Asset
        Sale or a cure or waiver of any Event of Default which occurs in connection therewith, it being understood that any such Event of Default may only be waived with the express consent of the Majority Lenders.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In the event any Obligor or any of its Subsidiaries consummates an Asset Sale pursuant to Section
        9.09(l), an amount (not subject to any Prepayment Premium) equal to 75%&#160;of the Net Partnership Agreement Proceeds received by such Obligor in connection with such Asset Sale.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Prepayment Premium.</font>&#160; Payment of any Prepayment Premium under this Section
      3.03 constitutes liquidated damages, not unmatured interest or a penalty, as the actual amount of damages to the Lenders as a result of the relevant triggering event, prepayment or repayment would be impracticable and extremely difficult to
      ascertain.&#160; Accordingly, any Prepayment Premium hereunder is provided by mutual agreement of the Obligors and the Lenders as a reasonable estimation and calculation of such actual lost profits and other actual damages of the Lenders.&#160; Without
      limiting the generality of the foregoing, it is understood and agreed that upon the occurrence of any prepayment event, any Prepayment Premium shall be automatically and immediately due and payable as though any prepaid or repaid portion of the Term
      Loans was voluntarily prepaid as of such date and shall constitute part of the Obligations secured by the Collateral.&#160; Any Prepayment Premium shall also be automatically and immediately due and payable if the Term Loans are satisfied or released by
      foreclosure (whether by power of judicial proceeding or otherwise), deed in lieu of foreclosure or by any other means.&#160; EACH OBLIGOR HEREBY EXPRESSLY WAIVES (TO THE FULLEST EXTENT IT MAY LAWFULLY DO SO) THE PROVISIONS OF ANY PRESENT OR FUTURE STATUTE
      OR OTHER LAW THAT PROHIBITS OR MAY PROHIBIT THE COLLECTION OF THE FOREGOING PREPAYMENT PREMIUM IN CONNECTION WITH ANY SUCH EVENTS.&#160; The Obligors expressly agree (to the fullest extent it and they may lawfully do so) that with respect to any
      Prepayment Premium payable under the terms of this Agreement: (i) such Prepayment Premium is reasonable and is the product of an arm&#8217;s length transaction between sophisticated business parties, ably represented by counsel; (ii) such Prepayment
      Premium shall be payable notwithstanding the then-prevailing market rates at the time payment is made; (iii) there has been a course of conduct between the Lenders and the Obligors giving specific consideration in this transaction for such agreement
      to pay such Prepayment Premium; and (iv) the Obligors shall be estopped hereafter from claiming differently than as agreed to in this paragraph.&#160; The Obligors expressly acknowledge that their agreement to pay such Prepayment Premium as herein
      described is a material inducement to the Lenders to provide the Commitments and to make the Term Loans.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 51 -</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps; font-weight: bold;"><a name="Article4"><!--Anchor--></a>Article&#160;4<br>
      <br>
      Payments, Etc.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;4.01.</font><font style="font-family: 'Times New Roman';"> <a name="Section4.01."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Payments</font>.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Payments Generally.</font>&#160; Each payment of principal, interest and other
      amounts to be made by the Obligors under this Agreement or any other Loan Document shall be made in Dollars, in immediately available funds, without deduction, set off or counterclaim, to an account of the Administrative Agent specified to the
      Administrative Borrower from time to time, not later than 2:00&#160;p.m. (Eastern time) on the date on which such payment shall become due (each such payment made after such time on such due date to be deemed to have been made on the next succeeding
      Business Day).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Application of Payments.</font>&#160; Each payment under this Agreement or any other
      Loan Document (other than any payment made pursuant to Section 3.01, which shall be applied to the principal amount of the Term Loans on a ratable basis and any applicable Prepayment Premium) shall be applied in the following order of priority, with
      proceeds being applied to a succeeding level of priority only if amounts owing pursuant to the immediately preceding level of priority have been paid in full in cash:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">first</font>, to the payment of any unpaid costs and expenses
        referred to in Section&#160;13.03(a) then due and owing;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(ii)&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">second</font>, in reduction of the Borrowers&#8217; obligation to pay
        any unpaid interest and any fees then due and owing including, without limitation, (x)&#160;interest payable pursuant to Section&#160;3.02(c) and (y) any Prepayment Premium;</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 52 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">third</font>, in reduction of the Borrowers&#8217; obligations to
        pay any Claims or Losses referred to in Section&#160;13.03(b) then due and owing;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-style: italic;">fourth</font>, to the payment of unpaid principal of the Term
        Loans on a pro rata basis;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(v)&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160; <font style="font-style: italic;">fifth</font>, in reduction of any other Obligation then due
        and owing; and</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;"> sixth</font>, to the Borrowers or such other Persons as may
        lawfully be entitled to or directed by the Borrowers to receive the remainder.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 18pt; line-height: 1.25; font-family: 'Times New Roman';">Unless otherwise directed by the Majority Lenders, all payments of principal, interest and fees under this Agreement and the other Loan Documents
      shall be made by the Obligors to the Lenders in accordance with the Lenders&#8217; respective Proportionate Shares of such payments.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Non&#8209;Business Days.</font>&#160; If the due date of any payment under this Agreement
      (whether in respect of principal, interest, fees, costs or otherwise) would otherwise fall on a day that is not a Business Day, such date shall be extended to the next succeeding Business Day, and, in the case of any payment accruing interest,
      interest thereon shall be payable for the period of such extension.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;4.02.</font><font style="font-family: 'Times New Roman';"><a name="Section4.02."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Computations.</font>&#160; All computations of interest and fees hereunder shall be computed on the basis of a year of 360 days and actual days elapsed during the period for which payable.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;4.03.</font><font style="font-family: 'Times New Roman';"><a name="Section4.03."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Notices.</font>&#160; Each notice of optional prepayment shall be effective only if received by the Lenders not later than 2:00&#160;p.m. (Eastern time) on the date three&#160;(3) Business Days prior to the date of prepayment.&#160;
        Each notice of optional prepayment shall specify the amount to be prepaid and the date of prepayment.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;4.04.</font><font style="font-family: 'Times New Roman';"> <a name="Section4.04."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Set&#8209;Off</font>.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">Set&#8209;Off Generally.</font>&#160; Upon the occurrence and during the continuance of any Event of
      Default, the Administrative Agent, the Lenders and each of their respective Affiliates are hereby authorized at any time and from time to time, to the fullest extent permitted by Law, to set off and apply any and all deposits (general or special,
      time or demand, provisional or final) at any time held and other Indebtedness at any time owing by the Lenders or such Affiliates to or for the credit or the account of any Obligor against any and all of the Obligations, whether or not the Lenders
      shall have made any demand and although such Obligations may be unmatured.&#160; The Lenders agree promptly to notify the Administrative Borrower after any such set&#8209;off and application, <font style="font-style: italic;">provided</font> that the failure
      to give such notice shall not affect the validity of such set&#8209;off and application.&#160; The rights of the Lenders and their respective Affiliates under this Section&#160;4.04 are in addition to other rights and remedies (including other rights of set&#8209;off)
      that the Lenders and their respective Affiliates may have.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 53 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Exercise of Rights Not Required.</font>&#160; Nothing contained herein shall require
      the Administrative Agent, the Lenders or any of their respective Affiliates to exercise any such right or shall affect the right of such Persons to exercise, and retain the benefits of exercising, any such right with respect to any other Indebtedness
      or obligation of any Obligor.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps; font-weight: bold;"><a name="Article5"><!--Anchor--></a>Article&#160;5<br>
      <br>
      Yield Protection, Etc.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;5.01<a name="Section5.01"><!--Anchor--></a>.</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Additional Costs</font>.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Change in Requirements of Law Generally.</font>&#160; If, on or after the Original
      Closing Date, the adoption of any Requirement of Law, or any change in any Requirement of Law, or any change in the interpretation or administration thereof by any court or other Governmental Authority charged with the interpretation or
      administration thereof, or compliance by any Lender (or its lending office) with any request or directive (whether or not having the force of law) of any such Governmental Authority, shall impose, modify or deem applicable any reserve (including any
      such requirement imposed by the Board of Governors of the Federal Reserve System), special deposit, contribution, insurance assessment or similar requirement, in each case that becomes effective after the Original Closing Date, against assets of,
      deposits with or for the account of, or credit extended by, a Lender (or its lending office) or shall impose on a Lender (or its lending office) any other condition affecting the Term Loans or the Commitment, not as a result of any action or inaction
      on the part of such Lender, and the result of any of the foregoing is to increase the cost to any Lender of making or maintaining its portion of the Term Loans, or to reduce the amount of any sum received or receivable by any Lender under this
      Agreement or any other Loan Document, by an amount reasonably deemed by such Lender in good faith to be material (other than (i)&#160;Indemnified Taxes, (ii)&#160;Taxes described in clauses&#160;(b) through (d) of the definition of <font style="font-style: italic;">&#8220;Excluded Taxes&#8221;</font> and (iii)&#160;Connection Income Taxes), then the Borrowers shall promptly pay to such Lender on demand such additional amount or amounts as will compensate such Lender for such increased cost or reduction.&#160;
      Notwithstanding anything herein to the contrary, (x)&#160;the Dodd&#8209;Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith and (y)&#160;all requests, rules, guidelines
      or directives promulgated by the Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case pursuant to Basel&#160;III, shall
      in each case be deemed to constitute a change in Requirements of Law for all purposes of this Section&#160;5.01, regardless of the date enacted, adopted or issued.</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';"> <br>
    </div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">
      <div style="line-height: 1.25;">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Change in Capital Requirements.</font>&#160; If a Lender shall have determined that, on or after the Original Closing Date, the adoption of any Requirement of Law regarding
        capital adequacy, or any change therein, or any change in the interpretation or administration thereof by any Governmental Authority charged with the interpretation or administration thereof, or any request or directive regarding capital adequacy
        (whether or not having the force of law) of any such Governmental Authority, in each case that becomes effective after the Original Closing Date, has or would have the effect of reducing the rate of return on capital of a Lender (or its parent) as
        a consequence of a Lender&#8217;s obligations hereunder or the Term Loans to a level below that which a Lender (or its parent) could have achieved but for such adoption, change, request or directive by an amount reasonably deemed by it to be material,
        then the Borrowers shall pay to such Lender on demand such additional amount or amounts as will compensate such Lender (or its parent) for such reduction.</div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 54 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Notification by Lender.</font>&#160; The Lenders will promptly notify the
      Administrative Borrower of any event of which it has knowledge, occurring after the Original Closing Date which will entitle a Lender to compensation pursuant to this Section&#160;5.01.&#160; Before giving any such notice pursuant to this Section&#160;5.01(c) such
      Lender shall designate a different lending office if such designation (x)&#160;will, in the reasonable judgment of such Lender, avoid the need for, or reduce the amount of, such compensation and (y)&#160;will not, in the reasonable judgment of such Lender, be
      materially disadvantageous to such Lender.&#160; A certificate of the Lender claiming compensation under this Section&#160;5.01, setting forth the amount or amounts to be paid to it hereunder, shall be conclusive and binding on the Borrowers in the absence of
      manifest error.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;5.02<a name="Section5.02"><!--Anchor--></a>.</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Illegality.</font>&#160; Notwithstanding any other provision of this Agreement, in the event that on or after the Original Closing Date, the adoption of or any change in any Requirement of Law or in the interpretation
        or application thereof by any competent Governmental Authority shall make it unlawful for a Lender or its lending office to make or maintain the Term Loans (and, in the opinion of such Lender, the designation of a different lending office would
        either not avoid such unlawfulness or would be disadvantageous to such Lender), then such Lender shall promptly notify the Administrative Borrower thereof following which, if such Requirement of Law shall so mandate, the Term Loans shall be prepaid
        by the Borrowers on or before such date as shall be mandated by such Requirement of Law in an amount equal to the Redemption Price applicable on the date of such prepayment in accordance with Section&#160;3.03(a).</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;5.03.<a name="Section5.03."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Taxes</font>.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Payments Free of Taxes.</font>&#160; Any and all payments by or on account of any
      Obligation shall be made without deduction or withholding for any Taxes, except as required by applicable Law.&#160; If any applicable Law requires the deduction or withholding of any Tax from any such payment by an Obligor, then such Obligor shall be
      entitled to make such deduction or withholding, and shall timely pay the full amount deducted or withheld to the relevant Governmental Authority in accordance with applicable Law and, if such Tax is an Indemnified Tax, then the sum payable by such
      Obligor shall be increased as necessary so that after such deduction or withholding for Indemnified Taxes has been made (including such deductions and withholdings for Indemnified Taxes applicable to additional sums payable under this Section&#160;5.03)
      the applicable Recipient receives an amount equal to the sum it would have received had no such deduction or withholding for Indemnified Taxes been made.&#160; For purposes of this Section 5.03, the term &#8220;applicable Law&#8221; includes FATCA.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Payment of Other Taxes by the Borrowers.&#160; </font>The<font style="font-style: italic;">&#160;</font>Borrowers shall timely pay to the relevant Governmental Authority in accordance with applicable Law, or at the option of the Administrative Agent, timely reimburse it for, Other Taxes.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 55 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Evidence of Payments.</font>&#160; As soon as practicable after any payment of Taxes
      by the Borrowers to a Governmental Authority, as a withholding Tax pursuant to this Section&#160;5.03, the Borrowers shall deliver to the Administrative Agent the original or a certified copy of a receipt issued by such Governmental Authority evidencing
      such payment, or a copy of the return reporting such payment or other evidence of such payment reasonably satisfactory to the Administrative Agent.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Indemnification.&#160; </font>The Borrowers shall reimburse and indemnify each
      Recipient, within ten (10)&#160;days after demand therefor, for the full amount of any Indemnified Taxes and Warrant Indemnified Taxes (including Indemnified Taxes imposed or asserted on or attributable to amounts payable under this Section&#160;5.03) payable
      or paid by such Recipient or required to be withheld or deducted from a payment to such Recipient and/or any reasonable costs and expenses arising therefrom or with respect thereto (including, but not limited to, any costs arising from a dispute with
      the relevant Government Authority in respect of such Indemnified Taxes or Warrant Indemnified Taxes), whether or not such Indemnified Taxes&#160; (or Warrant Indemnified Taxes) were correctly or legally imposed or asserted by the relevant Governmental
      Authority; <font style="font-style: italic;">provided that</font>, notwithstanding any other provision of this Agreement or any other Loan Document, no EEA Obligor shall be liable (whether as principal or surety or otherwise) for any Warrant
      Indemnified Taxes.&#160; A certificate as to the amount of such payment or liability delivered to the Administrative Borrower by a Lender (with a copy to the Administrative Agent), or by the Administrative Agent on its own behalf or on behalf of a Lender
      shall be conclusive absent manifest error.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Indemnification by the Lenders.&#160; </font>Each Lender shall severally indemnify
      the Administrative Agent, within ten (10)&#160;days after demand therefor, for (i)&#160;any Indemnified Taxes attributable to such Lender (but only to the extent that the Borrowers have not already indemnified the Administrative Agent for such Indemnified
      Taxes and without limiting the obligation of any Borrower to do so), and (ii)&#160;any Taxes attributable to such Lender, in each case, that are payable or paid by the Administrative Agent in connection with any Loan Document, and any reasonable expenses
      arising therefrom or with respect thereto, whether or not such Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority.&#160; A certificate as to the amount of such payment or liability delivered to any Lender by the
      Administrative Agent shall be conclusive absent manifest error.&#160; Each Lender hereby authorizes the Administrative Agent to set off and apply any and all amounts at any time owing to such Lender under any Loan Document or otherwise payable by the
      Administrative Agent to such Lender from any other source against any amount due to the Administrative Agent under this paragraph&#160;(e).</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 56 -</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Status of Lenders.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any Lender that is entitled to an exemption from, or reduction of withholding Tax with respect to
        payments made under any Loan Document shall deliver to the Administrative Borrower and the Administrative Agent, at the time or times reasonably requested by the Administrative Borrower or the Administrative Agent, such properly completed and
        executed documentation reasonably requested by the Administrative Borrower or the Administrative Agent as will permit such payments to be made without withholding or at a reduced rate of withholding.&#160; In addition, any Lender, if reasonably
        requested by the Administrative Borrower or the Administrative Agent, shall deliver such other documentation prescribed by applicable Law or as reasonably requested by the Administrative Borrower or the Administrative Agent as will enable the
        Administrative Agent Borrower or the Administrative Agent to determine whether or not such Lender is subject to backup withholding or information reporting requirements.&#160; Notwithstanding anything to the contrary in the preceding two sentences, the
        completion, execution and submission of such documentation (other than such documentation set forth in Section&#160;5.03(f)(ii)(A), (B) or (D)) shall not be required if in the Lender&#8217;s reasonable judgment such completion, execution or submission would
        subject such Lender to any material unreimbursed cost or expense or would materially prejudice the legal or commercial position of such Lender.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Without limiting the generality of the foregoing:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 99pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(A)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any Lender that is a U.S. Person shall deliver to the Administrative Borrower and the Administrative
        Agent on or prior to the date on which such Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable request of the Administrative Borrower or the Administrative Agent), duly completed, valid, executed
        copies of IRS Form&#160;W&#8209;9 (or successor form) certifying that such Lender is exempt from United States federal backup withholding Tax;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 99pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(B)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any Foreign Lender shall, to the extent it is legally entitled to do so, deliver to the Administrative
        Borrower and the Administrative Agent (in such number of copies as shall be requested by the Recipient) on or prior to the date on which such Foreign Lender becomes a Lender under this Agreement (and from time to time thereafter upon the reasonable
        request of the Administrative Borrower or the Administrative Agent), whichever of the following is applicable:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 135pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; in the case of a Foreign Lender claiming the benefits of an income Tax treaty to which the United
        States is a party (x)&#160;with respect to payments of interest under any Loan Document, duly completed, valid executed copies of IRS Form W&#8209;8BEN (or successor form) or IRS Form W&#8209;8BEN&#8209;E (or successor form) establishing an exemption from, or reduction
        of, United States federal withholding Tax pursuant to the &#8220;interest&#8221; article of such Tax treaty and (y)&#160;with respect to any other applicable payments under any Loan Document, duly completed, valid, executed originals of IRS Form W&#8209;8BEN (or
        successor form) or IRS Form W&#8209;8BEN&#8209;E (or successor form) establishing an exemption from, or reduction of, United States federal withholding Tax pursuant to the &#8220;business profits&#8221; or &#8220;other income&#8221; article of such Tax treaty;</font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 57 -</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 135pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(2)&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160; duly completed, valid, executed copies of IRS Form W&#8209;8ECI (or successor form);</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 135pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(3)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; in the case of a Foreign Lender claiming the benefits of the exemption for portfolio interest under
        Section&#160;881(c) of the Code, (x)&#160;a certificate substantially in the form of Exhibit&#160;D to the effect that such Foreign Lender is not a &#8220;bank&#8221; within the meaning of Section&#160;881(c)(3)(A) of the Code, a &#8220;10 percent shareholder&#8221; of the applicable
        Borrower within the meaning of Section&#160;881(c)(3)(B) of the Code, or a &#8220;controlled foreign corporation&#8221; described in Section&#160;881(c)(3)(C) of the Code (a <font style="font-style: italic;">&#8220;U.S. Tax Compliance Certificate&#8221;</font>) and (y)&#160;executed
        copies of IRS Form W&#8209;8BEN (or successor form) or IRS Form W&#8209;8BEN&#8209;E (or successor form); or</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 135pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(4)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to the extent a Foreign Lender is not the beneficial owner, duly completed, valid, executed copies
        of IRS Form W&#8209;8IMY (or successor form), accompanied by IRS Form W&#8209;8ECI (or successor form), IRS Form W&#8209;8BEN (or successor form), IRS Form W&#8209;8BEN&#8209;E (or successor form), a U.S. Tax Compliance Certificate, IRS Form&#160;W&#8209;9 (or successor form), and/or
        other certification documents from each beneficial owner, as applicable; <font style="font-style: italic;">provided</font>&#160; that if the Foreign Lender is a partnership and one or more direct or indirect partners of such Foreign Lender are claiming
        the portfolio interest exemption, such Foreign Lender may provide a U.S. Tax Compliance Certificate on behalf of each such direct and indirect partner;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any Foreign Lender shall, to the extent it is legally entitled to do so, deliver to the
        Administrative Borrower and the Administrative Agent (in such number of copies as shall be requested by the Recipient) on or prior to the date on which such Foreign Lender becomes a Lender under this Agreement (and from time to time thereafter upon
        the reasonable request of the Administrative Borrower or the Administrative Agent), executed copies of any other form prescribed by applicable Law as a basis for claiming exemption from or a reduction in United States federal withholding Tax, duly
        completed, together with such supplementary documentation as may be prescribed by applicable Law to permit the Administrative Borrower or the Administrative Agent to determine the withholding or deduction required to be made; and</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 58 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;if a payment made to a Lender under any Loan Document would be subject to United States federal
        withholding Tax imposed by FATCA if such Lender were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the Code, as applicable), such Lender shall deliver to the
        Administrative Borrower and the Administrative Agent at the time or times prescribed by Law and at such time or times reasonably requested by the Administrative Borrower or the Administrative Agent such documentation prescribed by applicable Law
        (including as prescribed by Section&#160;1471(b)(3)(C)(i) of the Code) and such additional documentation reasonably requested by the Administrative Borrower or the Administrative Agent as may be necessary for the Administrative Borrower or the
        Administrative Agent to comply with its obligations under FATCA and to determine that such Lender has complied with such Lender&#8217;s obligations under FATCA or to determine the amount, if any, to deduct and withhold from such payment.&#160; Solely for
        purposes of this clause&#160;(D), &#8220;FATCA&#8221; shall include any amendments made to FATCA after the date of this Agreement.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">Each Recipient agrees that if any form or certification it previously delivered expires or becomes obsolete or inaccurate in any respect, it shall
      promptly update such form or certification or promptly notify the Administrative Borrower and the Administrative Agent in writing of its legal inability to do so.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(g)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Treatment of Certain Refunds.</font>&#160; If any party to this Agreement determines,
      in its sole discretion exercised in good faith, that it has received a refund of any Taxes as to which it has been indemnified pursuant to this Section&#160;5.03 (including by the payment of additional amounts pursuant to this Section&#160;5.03), it shall pay
      to the indemnifying party an amount equal to such refund (but only to the extent of indemnity payments made under this Section 5.03 with respect to the Taxes giving rise to such refund), net of all out&#8209;of&#8209;pocket expenses (including Taxes) of such
      indemnified party and without interest (other than any interest paid by the relevant Governmental Authority with respect to such refund).&#160; Such indemnifying party, upon the written request of such indemnified party, shall repay to such indemnified
      party the amount paid over pursuant to this paragraph (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) in the event that such indemnified party is required to repay such refund to such Governmental
      Authority.&#160; Notwithstanding anything to the contrary in this Section&#160;5.03(g), in no event will the indemnified party be required to pay any amount to an indemnifying party pursuant to this Section&#160;5.03(g) the payment of which would place the
      indemnified party in a less favorable net after&#8209;Tax position than the indemnified party would have been in if the Tax subject to indemnification and giving rise to such refund had not been deducted, withheld or otherwise imposed and the
      indemnification payments or additional amounts giving rise to such refund had never been paid.&#160; This Section&#160;5.03(g) shall not be construed to require any indemnified party to make available its Tax returns (or any other information relating to its
      Taxes that it deems confidential) to the indemnifying party or any other Person.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 59 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(h)<font style="font-style: italic;"><font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Mitigation Obligations.</font>&#160; If the
      Borrowers are required to pay any Indemnified Taxes or additional amounts to any Lender or to any Governmental Authority for the account of any Lender pursuant to Section&#160;5.01 or this Section&#160;5.03, then such Lender shall (at the request of the
      Administrative Borrower) use commercially reasonable efforts to designate a different lending office for funding or booking the Term Loans hereunder or to assign and delegate its rights and obligations hereunder to another of its offices, branches or
      Affiliates if, in the sole reasonable judgment of such Lender, such designation or assignment and delegation would (i)&#160;eliminate or reduce amounts payable pursuant to Section&#160;5.01 or this Section&#160;5.03, as the case may be, in the future, (ii)&#160;not
      subject such Lender to any unreimbursed cost or expense and (iii)&#160;not otherwise be disadvantageous to such Lender.&#160; The Borrowers hereby agree to pay all reasonable costs and expenses incurred by any Lender in connection with any such designation or
      assignment and delegation.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(i)<font style="font-style: italic;"><font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Revenue Challenge to Warrant Stamp
        Amount</font>. In the event of any written communication issued by the Irish Revenue Commissioners to a Recipient concerning the amount of Irish stamp duty liability due upon the execution of a Warrant Certificate (a &#8220;<font style="font-style: italic;">Revenue Claim&#8221;</font>), the Recipients shall (if the total amount of stamp duty due on such Warrant Certificate is likely to exceed $50,000):</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;promptly provide a copy of such written communication from the Irish Revenue Commissioners to the
        Parent;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(ii)&#160;&#160;&#160;&#160; &#160; &#160; if requested by the Parent, provide to the Parent (at the Parent&#8217;s expense) copies of any material
        correspondence to and from the Irish Revenue Commissioners relating to the Revenue Claim (subject to legal professional privilege and any obligations of confidence that are binding on the Recipients);</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;keep the Parent reasonably informed of the progress of the Revenue Claim and of any material
        developments in relation to the Revenue Claim; and</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;use reasonable endeavors to consult with the Obligors regarding the conduct of the Revenue Claim.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman';">If the total amount of stamp duty due on a Warrant Certificate would exceed $50,000, no Recipient shall agree any compromise or settlement, or make any payment in
      relation to, a Revenue Claim without the prior written consent of the Obligors.&#160;Notwithstanding any other provision of this Agreement, any failure by a Recipient to comply with its obligations under this Section 5.03(i) shall reduce the amount of any
      claim under Section 5.03(d) with respect to a Revenue Claim to the extent that such failure to comply increased or gave rise to the Taxes to which such claim relates.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(j)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Survival</font>.&#160; Each party&#8217;s obligations under this Article&#160;5 shall survive
      the resignation or replacement of the Administrative Agent or any assignment of rights by, or the replacement of, a Lender, the termination of the Commitments and the repayment, satisfaction or discharge of all Obligations under any Loan Document.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 60 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;5.04.<a name="Section5.04."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Delay in Requests</font>.&#160; Failure or delay on the part of any Lender to demand compensation pursuant to this Article&#160;5 shall not constitute a waiver of such Lender&#8217;s right to demand such compensation; <font style="font-style: italic;">provided</font> that the Borrowers shall not be required to compensate a Lender pursuant to this Article 5 for any increased costs incurred or reductions suffered more than&#160; nine (9) months prior to the date that such
        Lender notifies the Administrative Borrower of the change in Law giving rise to such increased costs or reductions, and of such Lender&#8217;s intention to claim compensation therefor (except that, if the change in Law giving rise to such increased costs
        or reductions is retroactive, then the nine (9) month period referred to above shall be extended to include the period of retroactive effect thereof).</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps; font-weight: bold;"><a name="Article6"><!--Anchor--></a>Article&#160;6<br>
      <br>
      Conditions Precedent</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;6.01.</font><font style="font-family: 'Times New Roman';"><a name="Section6.01."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Conditions to Sixth Amendment Term Loan; Sixth Amendment Restatement Date.</font>&#160; The obligation of each Lender to make the Sixth Amendment Term Loan on the Sixth Amendment Restatement Date shall not become effective
        until the following conditions precedent shall have been reasonably satisfied or waived in writing by the Administrative Agent (which satisfaction or waiver may be made simultaneously with the making of the Sixth Amendment Term Loan hereunder):</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; margin-left: 18pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Sixth Amendment Term Loan Borrowing Notice.</font>&#160; The
        Administrative Agent shall have received a Sixth Amendment Term Loan Borrowing Notice in accordance with Section 2.01(h)(iii) requesting the Borrowing of the Sixth Amendment Term Loan duly executed by a Responsible Officer of the Administrative
        Borrower, in form and substance reasonably satisfactory to the Administrative Agent.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; margin-left: 18pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Representations and Warranties</font>.&#160; The representations and
        warranties of the Obligors contained in Article 7 or any other Loan Document shall be true and correct in all material respects on and as of the Sixth Amendment Restatement Date; <font style="font-style: italic;">provided</font> that to the extent
        that such representations and warranties specifically refer to an earlier date, they shall be true and correct in all material respects as of such earlier date; <font style="font-style: italic;">provided further</font> that any representation and
        warranty that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse Effect&#8221; or similar language shall be true and correct (after giving effect to any qualification therein) in all respects.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; margin-left: 18pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">No Default</font>.&#160; No Default shall have occurred and be
        continuing, or would result from such proposed Borrowing or from the application of the proceeds therefrom.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 27.35pt; margin-left: 18pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Organizational Documents.</font>&#160; The Administrative Agent shall
        have received (a) certified copies of the Organizational Documents of each Irish Obligor (or, with respect to any Irish Obligor, to the extent that such Organizational Documents have not been amended, restated or otherwise modified since the
        Original Closing Date, a certification by a Responsible Officer to that effect), (b) resolutions of the Board of each Irish Obligor approving and authorizing the execution, delivery and performance of this Agreement and the Sixth Amendment Warrant
        Certificate, certified as of the Sixth Amendment Restatement Date by the secretary or a Responsible Officer of such Irish Obligor as being in full force and effect without modification or amendment, (c) a good standing certificate and/or compliance
        certificate from the applicable Governmental Authority of each Obligor&#8217;s jurisdiction of incorporation, each dated a recent date prior to Sixth Amendment Restatement Date and (d) a certificate of each Irish Obligor as to the authority, incumbency
        and specimen signatures of the Persons who have executed this Agreement and any other documents in connection herewith on behalf of the Irish Obligors.</font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 61 -</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; margin-left: 18pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Documentary Deliveries</font>. The Administrative Agent shall have
        received the following documents, each of which shall be in form and substance satisfactory to the Administrative Agent:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 45pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Agreement.</font>&#160; This Agreement duly executed and delivered by the
        Borrowers and each of the other parties hereto.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 45pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Warrants.&#160; </font>The Sixth Amendment Warrant Certificate duly
        executed and delivered by the Parent</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 45pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;">Reaffirmation</font>.&#160; Reaffirmation confirming the security
        interest granted in the Irish Debenture.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">The Borrowing shall constitute a certification by the Administrative Borrower to the effect that the conditions set forth in Section 6.01 have been
      fulfilled as of the Sixth Amendment Restatement Date.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps; font-weight: bold;"><a name="Article7"><!--Anchor--></a>Article 7<br>
      <br>
      Representations and Warranties</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">In order to induce the Lenders to enter into this Agreement and to extend the Term Loans hereunder, each Obligor represents and warrants to the
      Lenders and the Administrative Agent, on the Sixth Amendment Restatement Date that the following statements are true and correct:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;7.01.<a name="Section7.01."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Power and Authority.</font>&#160; Except as described in Schedule 7.01, each Obligor (a)&#160;is duly organized, validly existing and in good standing (to the extent such concept exists in the relevant jurisdiction) under the
        Laws of its jurisdiction of organization, (b)&#160;has all requisite corporate (or equivalent) power, and has all material governmental licenses, authorizations, consents and approvals necessary to own its assets and carry on its business as now being
        or as proposed to be conducted except to the extent that failure to have the same would not reasonably be expected to have a Material Adverse Effect, (c)&#160;is qualified to do business and is in good standing in all jurisdictions in which the nature
        of the business conducted by it makes such qualification necessary except where failure to so qualify would not (either individually or in the aggregate) reasonably be expected to have a Material Adverse Effect, and (d)&#160;has full power, authority
        and legal right to make and perform its obligations under each of the Loan Documents to which it is a party and, in the case of the Borrowers, to borrow the Term Loans hereunder.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;7.02.</font><font style="font-family: 'Times New Roman';"><a name="Section7.02."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Authorization; Enforceability.</font>&#160; The Transactions are within each Obligor&#8217;s corporate (or equivalent) powers and have been duly authorized by all necessary corporate (or equivalent) action and, if required,
        by all necessary shareholder or other equity holder action.&#160; The Loan Documents have been duly executed and delivered by each Obligor party thereto and constitutes, and each of the other Loan Documents to which it is a party when executed and
        delivered by such Obligor will constitute, a legal, valid and binding obligation of such Obligor, enforceable against each Obligor in accordance with its terms, except as such enforceability may be limited by (a)&#160;bankruptcy, insolvency,
        reorganization, moratorium or similar Laws of general applicability affecting the enforcement of creditors&#8217; rights and (b)&#160;the application of general principles of equity (regardless of whether such enforceability is considered in a proceeding in
        equity or at law).</font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 62 -</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;7.03.<a name="Section7.03."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Governmental and Other Approvals; No Conflicts.</font>&#160; Except for the FDI Clearance (as defined in the WaveForm Slovenia Side Agreement), and the obligations set out in the WaveForm Slovenia Side Agreement, the
        Transactions (a)&#160;do not require any consent or approval of, registration or filing with, or any other action by, any Governmental Authority or any other Person, except for (i)&#160;such as have been obtained or made and are in full force and effect and
        (ii)&#160;filings and recordings in respect of perfecting or recording the Liens created pursuant to the Security Documents, (b)&#160;will not violate any applicable Requirement of Law or the Organizational Documents of any Obligor or any applicable order of
        any Governmental Authority, in each case, other than any such violations that, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect, (c)&#160;will not violate or result in a default under any Material
        Agreement, or give rise to a right thereunder to require any payment to be made by any such Person, and (d)&#160;will not result in the creation or imposition of any Lien (other than Permitted Liens) on any asset of any Obligor</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;7.04.</font><font style="font-family: 'Times New Roman';"><a name="Section7.04."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Financial Statements; Projections; Material Adverse Change</font>.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;"><font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Financial Statements.&#160; </font>The
      Obligors have heretofore furnished to the Administrative Agent consolidated financial statements for the Parent and its consolidated Subsidiaries for the period ended June 30, 2021.&#160; Such financial statements present fairly, in all material respects,
      the financial position and results of operations and cash flows of the Obligors as of such dates and for such periods substantially in accordance with IFRS, subject to quarterly or year&#8209;end adjustments and the absence of footnotes.&#160; As of June 30,
      2021, no Obligor has any material contingent liabilities or liabilities for taxes, long&#8209;term lease or unusual forward or long&#8209;term commitments not disclosed in the aforementioned financial statements.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;"><font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Projections.</font>&#160; On and as of the
      Original Closing Date, the Projections were based on good faith estimates and assumptions made by the management of the Obligors; <font style="font-style: italic;">provided,</font> the Projections are not to be viewed as facts and that actual
      results during the period or periods covered by the Projections may differ from such Projections and that the differences may be material; <font style="font-style: italic;">provided, further,</font> as of the Original Closing Date, the management of
      the Obligors believed that the Projections are reasonable and attainable.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;"><font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>No Material Adverse Change.</font>&#160;
      Since December 31, 2020, no event, circumstance or change has occurred that has caused or evidences, either in individually or in the aggregate, a Material Adverse Change.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 63 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;7.05.</font><font style="font-family: 'Times New Roman';"> <a name="Section7.05."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Properties</font>.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;"><font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Property Generally.</font>&#160; Each
      Obligor has good and marketable fee simple title to, or valid leasehold interests in, all its real and personal Property material to its business, including all Product Assets, subject only to Permitted Liens and except as would not reasonably be
      expected to materially interfere with its ability to conduct its business as currently conducted or to utilize such properties for their intended purposes.&#160; Schedule 7.05(a) lists, with respect to each Obligor, owned real property as of the Original
      Closing Date.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Intellectual Property.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Schedule&#160;7.05(b) lists, with respect to each Obligor, all United States and foreign registrations
        of and applications for Patents, Trademarks, Copyrights, and Industrial Designs that are Obligor Intellectual Property as of the Original Closing Date, including the applicable jurisdiction, registration or application number and date, as
        applicable thereto, a designation as to whether such Obligor Intellectual Property is Material Intellectual Property,<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#160;</sup>and a designation as to whether it is licensed or
        owned by such Obligor.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each Obligor (A)&#160;owns or possesses all legal equitable rights, title and interest in and to the
        Material Intellectual Property designated on Schedule&#160;7.05(b) as being owned by such Obligor (excluding, for the avoidance of doubt, Material Intellectual Property transferred pursuant to the Fitzgerald and Benen Sale) and (B)&#160;has the right to use
        the Material Intellectual Property licensed to such Obligor, in each case with good and marketable title, free and clear or any Liens or Claims of any kind other than Permitted Liens, in each case, except as described in Schedule 7.05(b).</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To each Obligor&#8217;s knowledge, the Material Intellectual Property does not violate any license or
        infringe any valid and enforceable Intellectual Property right of another.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other than with respect to the Material Agreements, or as permitted by this Agreement, the
        Obligors have not assigned or otherwise transferred ownership of, or agreed to assign or otherwise transfer ownership of, any Material Intellectual Property, in whole or in part, to any Person who is not an Obligor.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other than as set forth on Schedule&#160;7.05(b), the Obligors have not received any written
        communications, nor is there any pending or, to each Obligor&#8217;s knowledge, threatened action in writing, suit, proceeding or Claim in writing by another, alleging that any of the Obligors has violated, infringed, diluted or misappropriated any
        Intellectual Property of another.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;There is no pending or, to any Obligor&#8217;s knowledge, threatened action in writing, suit,
        proceeding or Claim in writing by another: (A)&#160;challenging an Obligor&#8217;s rights in or to any Material Intellectual Property owned by such Obligor; or (B)&#160;challenging the validity, enforceability or scope of any Material Intellectual Property owned
        by an Obligor.</font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 64 -</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(vii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each Obligor has taken commercially reasonable precautions to protect the secrecy,
        confidentiality and value of the Material Intellectual Property (including without limitation, by requiring that all current and former Key Employees of that Obligor or its Subsidiaries and all consultants engaged by that Obligor or its
        Subsidiaries with access to Material Intellectual Property execute written confidentiality and Invention assignment Contracts).</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(viii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each current Key Employee has signed a written agreement assigning to the applicable Obligor
        all Intellectual Property rights that are related to such Obligor&#8217;s business as now conducted and as presently proposed to be conducted and confidentiality provisions protecting trade secrets and confidentiality information of the Obligors.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(ix)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each Obligor has complied in all material respects with the terms of each Material Agreement
        pursuant to which Intellectual Property has been licensed to the Obligors (which terms shall include, but not be limited to, pricing and duration of the agreement).</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(x)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;All maintenance fees, annuities, and the like due or payable on the Patents included in the
        Material Intellectual Property have been timely paid or the failure to so pay was the result of an unintentional failure to pay by the applicable Obligor, which would not reasonably be expected to result in a Material Adverse Change.&#160; All documents
        and instruments necessary to register or apply for or renew registration of all Material Intellectual Property have been validly executed, delivered and filed in a timely manner with the United States Patent and Trademark Office, the United States
        Copyright Office, the Canadian Intellectual Property Office, or the equivalent office in any other applicable jurisdiction, as applicable.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(xi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To each Obligor&#8217;s knowledge, (A) there are no material defects in any of the Patents included in
        the Material Intellectual Property and (B) no such Patents have ever been finally adjudicated to be invalid, unpatentable or unenforceable for any reason in any administrative, arbitration, judicial or other proceeding.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(xii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To each Obligor&#8217;s knowledge, no Obligor has received any written notice asserting that any
        Patent included in the Material Intellectual Property is invalid, unpatentable or unenforceable and, to each Obligor&#8217;s knowledge, no Obligor has engaged in any conduct, or omitted to perform any necessary act, the result of which would invalidate
        or render unpatentable or unenforceable any such Patent, except as described in Schedule 7.05(b).</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(xiii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To the knowledge of each Obligor, no third party is materially infringing upon or
        misappropriating any Material Intellectual Property, and no counterparty is materially violating any license or agreement with such Obligor relating to any Material Intellectual Property.</font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 65 -</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;7.06.</font><font style="font-family: 'Times New Roman';"><a name="Section7.06."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">No Actions or Proceedings</font>.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Litigation.</font>&#160; Except as described in Schedule 7.06(a), there is no
      litigation, investigation or enforcement proceeding pending or threatened in writing with respect to any Obligor or any of its Subsidiaries by or before any Governmental Authority or arbitrator (i)&#160;that either individually or in the aggregate would
      reasonably be expected to have a Material Adverse Effect or (ii)&#160;that involves this Agreement or the Transactions.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;"><font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Environmental Matters.</font>&#160; The
      operations and the real Property of the Obligors and their Subsidiaries comply with all applicable Environmental Laws, except to the extent the failure to so comply, either individually or in the aggregate, would not reasonably be expected to have a
      Material Adverse Effect.&#160; To each Obligor&#8217;s knowledge, there have been no conditions, occurrences or release of Hazardous Materials which would reasonably be expected to have a Material Adverse Effect.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Labor Matters.</font>&#160; No Obligor has engaged in unfair labor practices and there
      is no pending or, to any Obligor&#8217;s knowledge, threatened in writing labor actions, disputes, grievance or arbitration proceedings involving the employees of any Obligor, in each case that would reasonably be expected to have a Material Adverse
      Effect.&#160; There is no material strike or work stoppage in existence or threatened in writing against any Obligor and to the knowledge of such Obligor, no union organization activity is taking place.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;7.07.<a name="Section7.07."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Compliance with Laws and Agreements</font>.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each Obligor and each of its Subsidiaries is in compliance with all
      Requirements of Law (including Healthcare Laws and Environmental Laws) and all Contracts binding upon it or its Property, except (other than with respect to Material Intellectual Property) where the failure to do so, individually or in the aggregate,
      would not reasonably be expected to result in a Material Adverse Effect.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Without limiting the generality of the foregoing:</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 66 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;To the best of each Obligor&#8217;s knowledge, any financial relationships between or among the
        Borrowers or any other Obligor, on the one hand, and any Person who is in a position to refer patients or other health care business to the Borrowers or any other Obligor (collectively a <font style="font-style: italic;">&#8220;Referral Source&#8221;</font>),
        on the other hand, (A)&#160;comply in all material respects with all applicable Healthcare Laws, (B)&#160;reflect fair market value, have commercially reasonable terms and were negotiated at arm&#8217;s length; and (C)&#160;do not obligate the Referral Source to
        purchase, use, recommend or arrange for the use of any products or services of the Borrowers or any other Obligor, in any manner that could reasonably be expected to constitute a violation of a state, federal or foreign health care fraud and abuse
        law.&#160; No Obligor directly or indirectly, has guaranteed a loan, made a payment toward a loan or otherwise subsidized a loan for any Referral Source including, without limitation, any loans related to financing the Referral Source&#8217;s ownership,
        investment or financial interest in any Obligor</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Except as disclosed in Schedule 7.19(e), all Products have been developed, tested, manufactured,
        distributed, marketed and sold in compliance in all material respects with (A) all applicable FDA Laws, including, without limitation, all requirements relating to pre&#8209;market notification, good manufacturing practices/quality system regulations (21
        CFR Part 820), labeling, advertising, record&#8209;keeping, and adverse event reporting; and (B) all applicable Health Canada Laws.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Borrowers and each other Obligor are in compliance in all material respects with the
        Physician Payments Sunshine Act (Section 6002 of the Affordable Care Act of 2010) and its implementing regulations and any applicable state disclosure and transparency laws.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>To the extent any Obligor shall participate or receive reimbursement from
      any Federal Health Care Program or other third&#8209;party payor program, (i)&#160;each Obligor shall have the requisite provider number or authorization necessary to bill any third&#8209;party payor program in which it participates and (ii)&#160; there shall be no
      audits, inquiries, adjustments, appeals or recoupment efforts by any third&#8209;party payor programs of or against any Obligor with respect to any prior Claims, reports or billings that, individually or in the aggregate, would reasonably be expected to
      result in a Material Adverse Effect.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(d)<font style="font-style: italic;"> &#160; &#160;&#160;&#160;&#160;&#160; </font>Each Obligor will maintain and adhere to, in all material respects, a
      reasonable compliance program designed to promote compliance with and to detect, prevent and address violations of all material Healthcare Laws (a <font style="font-style: italic;">&#8220;Health Care Compliance Program&#8221;</font>).&#160; No Obligor is aware of
      any complaints from any employees, independent contractors, vendors, physicians, customers, patients or other persons that could reasonably be considered to indicate a violation of Healthcare Laws which would be reasonably expected to result
      individually, or in the aggregate, in a Material Adverse Effect.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;7.08.</font><font style="font-family: 'Times New Roman';"> <a name="Section7.08."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Taxes.</font>&#160; Each Obligor has filed or caused to be filed which are true and correct in all material respects,&#160; all United States federal income and other material Tax returns and reports required to have been
        filed and has paid or caused to be paid all United States federal income and other material Taxes required to have been paid by it prior to the date on which material penalties attach thereto, except Taxes that are being contested in good faith by
        appropriate proceedings and for which such Obligor has set aside on its books adequate reserves with respect thereto substantially in accordance with IFRS.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 67 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;7.09.<a name="Section7.09."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Full Disclosure. </font>The Obligors have disclosed to the Lenders all Material Agreements to which any Obligor is party, and all other matters to their knowledge, that, individually or in the aggregate, would
        reasonably be expected to result in a Material Adverse Effect.&#160; None of the reports, financial statements, certificates or other written information furnished by or on behalf of the Obligors to the Lenders in connection with the negotiation of this
        Agreement and the other Loan Documents or delivered hereunder or thereunder (as modified or supplemented by other information so furnished) contains any material misstatement of material fact or omits to state any material fact necessary to make
        the statements therein, taken as a whole, in the light of the circumstances under which they were made, not misleading; <font style="font-style: italic;">provided</font> that, with respect to Projections, the Obligors represent only that such
        information was prepared in good faith based upon assumptions believed to be reasonable at the time.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;7.10.</font><font style="font-family: 'Times New Roman';"><a name="Section7.10."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Regulation</font>.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;"><font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Investment Company Act.</font>&#160; No
      Obligor is an &#8220;investment company&#8221; as defined in, or subject to regulation under, the Investment Company Act of 1940.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160; Margin Stock.</font>&#160; No Obligor is engaged principally, or as one of its important
      activities, in the business of extending credit for the purpose, whether immediate, incidental or ultimate, of buying or carrying Margin Stock and no part of the proceeds of the Term Loans will be used to buy or carry any Margin Stock in violation of
      Regulation&#160;T, U or X.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;7.11.</font><font style="font-family: 'Times New Roman';"> <a name="Section7.11."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Solvency.</font>&#160; (a) The Obligors, when taken as a whole and (b) the Borrowers when taken as a whole, are and immediately after giving effect to the Borrowing of the Term Loans, the use of proceeds thereof, and
        the consummation of the Transactions, will be, Solvent.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;7.12.</font><font style="font-family: 'Times New Roman';"><a name="Section7.12."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;
        &#160; <font style="font-style: italic;">[Reserved].</font>&#160;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;7.13.</font><font style="font-family: 'Times New Roman';"> <a name="Section7.13."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Indebtedness and Liens.</font> Set forth on Schedule&#160;7.13A is a complete and correct list of each item of Permitted Indebtedness of each Obligor that exceeds $50,000 as of October 31, 2021; <font style="font-style: italic;">provided, that</font> in no event shall an aggregate amount in excess of $500,000 of Permitted Indebtedness be excluded from Schedule 7.13A.<font style="font-style: italic;">&#160;</font>Set forth on Schedule&#160;7.13B is a
        complete and correct list of each Permitted Lien described in Section 9.02(b) granted by the Borrowers and other Obligors with respect to their respective Property that exceeds $50,000 and is outstanding as of October 31, 2021; <font style="font-style: italic;">provided</font>, that in no event shall an aggregate amount in excess of $500,000 of Permitted Liens be excluded from Schedule 7.13B.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;7.14.</font><font style="font-family: 'Times New Roman';"><a name="Section7.14."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Material Agreements.</font>&#160; Set forth on Schedule&#160;7.14 (as such Schedule may be updated by the Obligors from time to time, pursuant to Section 8.01(d)) is a complete and correct list of (a)&#160;each Material Agreement
        and (b)&#160;each Contract creating or evidencing any Material Indebtedness, together with a summary reference to the product or purpose of each such Material Agreement and such Contract, to which an Obligor is a party.&#160; Accurate and complete copies of
        each such Contract listed on such schedule have been made available to the Lenders.&#160; No Obligor is in default under any such Material Agreement or such Contract creating or evidencing any Material Indebtedness listed on such schedule, and no
        Obligor has knowledge of any default by any counterparty to such Material Agreement or such Contract, in each case, other than bona fide disputes and defaults which could not, individually or in the aggregate, be reasonably expected to have a
        Material Adverse Effect.&#160; Except as otherwise disclosed on Schedule&#160;7.14 (as such Schedule may be updated by the Borrowers from time to time), all material vendor purchase agreements and provider Contracts of the Obligors, and all Material
        Agreements including a grant of rights under any Intellectual Property to an Obligor, are in full force and effect without material modification from the form in which the same were disclosed to the Lenders.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;7.15.</font><font style="font-family: 'Times New Roman';"><a name="Section7.15."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Restrictive Agreements.</font>&#160; None of the Obligors is party to any Restrictive Agreement, except (a)&#160;those listed on Schedule 7.15 or otherwise permitted under Section&#160;9.11, (b)&#160;restrictions and conditions
        imposed by Law or by the Loan Documents, (c)&#160;any stockholder agreement, investor rights agreement or other Organizational Documents of an Obligor and (d)&#160;limitations associated with Permitted Liens.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;7.16.</font><font style="font-family: 'Times New Roman';"> <a name="Section7.16."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Real Property.</font>&#160; No Obligor owns or leases (as tenant thereof) any real Property on the date hereof, except as described on Schedule&#160;7.16.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 68 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;7.17.</font><font style="font-family: 'Times New Roman';"> <a name="Section7.17."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Pension and Other Plans</font>.&#160; (a) Schedule&#160;7.17 sets forth, as of the Original Closing Date, a complete and correct list of, and that separately identifies, (a)&#160;all Title&#160;IV Plans, (b)&#160;all Multiemployer Plans
        and (c)&#160;all material Benefit Plans.&#160; Each Benefit Plan, and each trust thereunder, intended to qualify for tax exempt status under Section&#160;401 or 501 of the Code has received a favorable IRS determination as its tax exempt status, and to the
        knowledge of any Obligor, no event has occurred or circumstances exist that would cause the loss of such status.&#160; Except for those that would not, in the aggregate, have a Material Adverse Effect, (i)&#160;each Benefit Plan is in compliance with
        applicable provisions of ERISA, the Code and other Requirements of Law, (ii)&#160;there are no existing or pending (or to the knowledge of any Obligor, threatened) Claims (other than routine Claims for benefits in the normal course), sanctions, actions,
        lawsuits or other proceedings or investigations involving any Benefit Plan to which any Obligor incurs or otherwise has or would have an obligation or any liability or Claim and (iii)&#160;no ERISA Event is reasonably expected to occur prior to the
        Maturity Date.&#160; The Borrowers and each of their ERISA Affiliates have met all applicable requirements under the ERISA Funding Rules with respect to each Title&#160;IV Plan, and no waiver of the minimum funding standards under the ERISA Funding Rules has
        been applied for or obtained.&#160; As of the most recent valuation date for any Title&#160;IV Plan, the funding target attainment percentage (as defined in Section&#160;430(d)(2) of the Code) is at least 60%, and neither the Borrowers nor any of their ERISA
        Affiliates know of any facts or circumstances that would reasonably be expected to cause the funding target attainment percentage to fall below 60% as of the most recent valuation date.&#160; To each Obligor&#8217;s knowledge, as of the Original Closing Date,
        no ERISA Event has occurred in connection with which obligations and liabilities (contingent or otherwise) remain outstanding.&#160; No ERISA Affiliate would have any Withdrawal Liability as a result of a complete withdrawal from any Multiemployer Plan
        on the date this representation is made. (b) The Obligors do not maintain, administrate, or contribute to any Canadian Defined Benefit Pension Plans, or, except as disclosed on Schedule 7.17, any other Canadian Pension Plans. With respect to
        Canadian Pension Plans:&#160; (i)&#160;no steps have been taken to terminate any Canadian Pension Plan (wholly or in part) which could result in any Obligor being required to make a material additional contribution to any Canadian Pension Plan; (ii)&#160;no
        contribution failure has occurred with respect to any Canadian Pension Plan sufficient to give rise to a lien or charge under any applicable pension benefits laws of any other jurisdiction (for certainty, not including payments in respect of
        contributions payable but not yet due); and (iii)&#160;no condition exists and no event or transaction has occurred with respect to any Canadian Pension Plan which is reasonably likely to result in any Obligor incurring any material liability, fine or
        penalty.&#160; Each Canadian Pension Plan is in compliance (other than immaterial non-compliance) with all applicable pension benefits and tax laws; (i)&#160;all contributions (other than immaterial amounts) (including employee contributions made by
        authorized payroll deductions or other withholdings) required to be made to the appropriate funding agency in accordance with all Applicable Laws (other than immaterial non-compliance) and the terms of each pension plan have been made in accordance
        with all applicable Laws (other than immaterial non-compliance) and the terms of each Canadian Pension Plan (other than immaterial non-compliance); (ii)&#160;all liabilities under each Canadian Pension Plan are funded in accordance with the terms of the
        respective Canadian Pension Plans, the requirements of applicable pension benefits laws and of applicable regulatory authorities (other than immaterial non-compliance) and (iii)&#160;no event has occurred and no conditions exist with respect to any
        Canadian Pension Plan that has resulted or could reasonably be expected to result in any Canadian Pension Plan having its registration revoked or refused by any administration of any relevant pension benefits regulatory authority or being required
        to pay any taxes (other than taxes the amounts of which are immaterial) or penalties under any applicable pension benefits or tax laws.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;7.18.<a name="Section7.18."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Collateral; Security Interest.</font>&#160; Each Security Document is effective to create in favor of the Administrative Agent for the benefit of the Lenders a legal, valid and enforceable security interest in the
        Collateral subject thereto and each such security interest is perfected to the extent required by (and has the priority required by) the applicable Security Document, subject to Permitted Liens.&#160; The Security Documents collectively are effective to
        create in favor of the Administrative Agent for the benefit of the Lenders a legal, valid and enforceable security interest in the Collateral, which upon the filing of financing statements and other similar statements filed in the appropriate
        offices, such security interests are perfected security interests (subject only to Permitted Liens) to the extent that such perfection may be obtained by such filing.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;7.19.</font><font style="font-family: 'Times New Roman';"><a name="Section7.19."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;



        <font style="font-style: italic;">Regulatory Approvals</font>.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>With respect to all Products, each Obligor holds either directly or
      through licensees and agents, all Regulatory Approvals and Permits necessary or required for that Obligor to conduct all material Product Development and Commercialization Activities with respect to the Products.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Set forth on Schedule&#160;7.19(b) is a complete and accurate list as of the
      Original Closing Date of all Regulatory Approvals referred to in clause&#160;(a) above that are with the FDA, WHO, CE-Mark EMA, HPRA, Health Canada, ANVISA or any other similar Regulatory Authority and identifying the Product related to such Regulatory
      Approval.&#160; All such Regulatory Approvals are (i)&#160;legally and/or beneficially owned exclusively by the Obligor identified on Schedule 7.19(b), free and clear of all Liens other than Permitted Liens, (ii)&#160;validly registered and on file with the
      applicable Regulatory Authority, in material compliance with all registration, filing and maintenance requirements (including any fee requirements) thereof, and (iii)&#160;in good standing, valid and enforceable with the applicable Regulatory Authority.&#160;
      All required and material notices, registrations and listings, supplemental applications or notifications, reports (including annual reports, field alerts, Device reports or other reports of adverse experiences) and all other required and material
      filings with respect to the Products or any related Product Development and Commercialization Activities have been filed with the FDA, WHO, CE-Mark EMA, HPRA, Health Canada, ANVISA and all other applicable Governmental Authorities.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 69 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>(i)&#160;All material regulatory filings required by any Regulatory Authority
      or in respect of any Regulatory Approval or Product Authorization with respect to any Product or any Product Development and Commercialization Activities have been made, and all such filings are complete and correct in all material respects and have
      complied in all material respects with all applicable Requirements of Law, (ii)&#160;all clinical and pre&#8209;clinical trials, if any, of investigational Products have been and are being conducted by each Obligor according to all applicable Requirements of
      Law in all material respects along with appropriate monitoring of clinical investigator trial sites for their compliance, and (iii)&#160;each Obligor has disclosed to the Lenders all such material regulatory filings and, to the extent requested by any
      Lender, any written material communications relating thereto between representatives of each Obligor and any Regulatory Authority.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(d)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each Obligor and, to each Obligor&#8217;s knowledge, each of its agents are in
      compliance in all material respects with all applicable statutes, rules and regulations (including all Regulatory Approvals and Product Authorizations) of all applicable Governmental Authorities, including the FDA, WHO, CE-Mark EMA, HPRA, Health
      Canada, ANVISA and all other Regulatory Authorities, with respect to each Product and all Product Development and Commercialization Activities related thereto.&#160; Each Obligor has and maintains in full force and effect all the necessary and requisite
      Regulatory Approvals and Product Authorizations for its Products.&#160; Each Obligor is in compliance in all material respects with all applicable registration and listing requirements set forth in all applicable FDA, WHO, CE-Mark EMA, HPRA, Health
      Canada, ANVISA or Laws or equivalent regulation of each other Governmental Authority having jurisdiction over such Person.&#160; Each Obligor adheres in all material respects to all applicable regulations of all Regulatory Authorities with respect to its
      Products and all Product Development and Commercialization Activities related thereto.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(e)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Except as set forth on Schedule 7.19(e), (i)&#160;no Obligor has received from
      any Regulatory Authority any notice of adverse findings with respect to any Product or any Product Development and Commercialization Activities related thereto, including any FDA Form&#160;483 inspectional observations, notices of violations, warning
      letters, criminal proceeding notices under Section&#160;305 of the FD&amp;C Act, or any other similar communication from any Regulatory Authority, (ii)&#160;there have been no seizures conducted or, to each Obligor&#8217;s knowledge, threatened by any Regulatory
      Authority with respect to any Product, and no recalls, market withdrawals, field notifications, notifications of misbranding or adulteration or safety alerts conducted, requested or, to any Obligor&#8217;s knowledge, threatened by any Regulatory Authority
      with respect to any Product, and no recalls, market withdrawals, field notifications, notifications of misbranding or adulteration or safety alerts have been conducted, requested or, to each Obligor&#8217;s knowledge, threatened by any Regulatory Authority
      relating to any Product, and (iii)&#160;no Obligor has received any written notification that remains unresolved from the FDA, WHO, CE-Mark EMA, HPRA, Health Canada, ANVISA or any other Regulatory Authority indicating any breach or violation of any
      applicable Product Authorization or Regulatory Approval, including that any Product is misbranded or adulterated as defined in the FD&amp;C Act or the rules and regulations promulgated thereunder, in each case of (i), (ii) and (iii) that has had, or
      could reasonably be expected to have, a Material Adverse Effect.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 70 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(f)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Neither any Obligor nor, to any Obligor&#8217;s knowledge, any officer,
      employee or agent thereof, has made an untrue statement of a material fact or fraudulent statements to the FDA, WHO, CE-Mark EMA, HPRA, Health Canada, ANVISA or any other Regulatory Authority, failed to disclose a material fact required to be
      disclosed to the FDA, WHO, CE-Mark EMA, HPRA, Health Canada, ANVISA or any other Regulatory Authority, or committed an act, made a statement, or failed to make a statement that, at the time such disclosure was made (or was not made), would reasonably
      be expected to provide a basis for the FDA, WHO, CE-Mark EMA, HPRA, Health Canada, ANVISA or any other Regulatory Authority to invoke its policy respecting Fraud, Untrue Statements of Material Facts, Bribery and Illegal Gratuities, set forth in 56
      Fed. Reg.&#160;46191 (September&#160;10, 1991) or any similar policy.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(g)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>No Obligor has received any written notice that the FDA, WHO, CE-Mark
      EMA, HPRA, Health Canada, ANVISA or any other applicable Regulatory Authority has commenced or initiated, or, to the knowledge of any such Obligor, threatened to commence or initiate, any action to withdraw any Regulatory Approval or Product
      Authorization or requested the recall of any Products or commenced or initiated or, to the knowledge of such Obligor, threatened to commence or initiate, any action to enjoin any Product Development and Commercialization Activities of such Obligor.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(h)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The clinical, preclinical, safety and other studies and tests conducted
      by or on behalf of or sponsored by each Obligor, or in respect of which any Products or Product candidates under development have participated, were (and if still pending, are) being conducted materially in accordance with standard medical and
      scientific research procedures and all applicable Product Authorizations.&#160; Each Obligor has operated within, and currently is in compliance in all material respects with, all applicable Laws (including, without limitation, all applicable Health
      Canada Laws), Product Authorizations and Regulatory Approvals, as well as the rules and regulations of the FDA, Health Canada and each other Regulatory Authority.&#160; No Obligor has received any notices or other correspondence from the FDA, Health
      Canada, or any other Regulatory Authority requiring the termination or suspension of any clinical, preclinical, safety or other studies or tests used to support regulatory clearance of, or any Product Authorization or Regulatory Approval for, any
      Product.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(i)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>No material debarment or exclusionary Claims, actions, proceedings or
      investigations in respect of any Obligor&#8217;s business is pending, or to such Obligor&#8217;s knowledge, threatened in writing against such Obligor or its officers, employees or agents.&#160; No Obligor or, to such Obligor&#8217;s knowledge, any officer, employee or
      agent of such Obligor, has been convicted of any crime or engaged in any conduct that would reasonably be expected to result in a debarment or exclusion (i)&#160;Section&#160;335a of the FD&amp;C Act or (ii)&#160;any similar applicable Law.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 71 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;7.20.<a name="Section7.20."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Capitalization.</font>&#160; All of the issued and outstanding securities of each Obligor have been duly authorized, are validly issued, fully paid, and non&#8209;assessable.&#160; Parent has the legal right and full power and
        authority to execute and deliver, and to perform its obligations under, the Warrant Certificates.&#160; Parent has sufficient authorized but unissued share capital in Parent to satisfy in full, without the need for the passing of any further resolutions
        of its shareholders, the Warrant Certificates and the outstanding right to subscribe for shares in Parent as represented by the Warrant Certificates, without first having to offer the same to any existing shareholders of Parent or any other
        person.&#160; As of the Funding Date, except as set forth on Schedule&#160;7.20 and the Warrant Certificates, there are no outstanding or authorized options, warrants, purchase rights, subscription rights, conversion rights, exchange rights, or other
        Contracts or commitments that could require the Obligors to issue, sell, or otherwise cause to become outstanding any of their ownership interests.&#160; There are no outstanding or authorized stock appreciation, phantom stock, profit participation, or
        similar rights with respect to the Obligors (other than the Parent).&#160; There are no voting trusts, proxies, or other agreements or understandings with respect to the voting of the ownership interests of the Obligors (other than the Parent).&#160; None of
        the Equity Interests in any Obligor has been mortgaged, assigned or pledged in favor of any Person, other than pursuant to the Security Documents.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;7.21.</font><font style="font-family: 'Times New Roman';">&#160; <a name="Section7.21."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Insurance.</font>&#160; Each Obligor has obtained (and is maintaining), insurance for its assets (including the Collateral) and business as required under the Loan Documents.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;7.22<a name="Section7.22"><!--Anchor--></a>.</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Certain Fees.</font>&#160; Except as described on Schedule&#160;7.22, no broker&#8217;s or finder&#8217;s fee will be payable in connection with the execution and delivery of this Agreement.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;7.23.</font><font style="font-family: 'Times New Roman';"> <a name="Section7.23."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Trade Compliance.</font>&#160; Except as disclosed in Schedule 7.23, Obligors and, to the knowledge of the Obligors, any director, officer or employee of an Obligor acting on behalf of the Obligors, are in compliance
        with the Sanctions Laws.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;7.24.</font><font style="font-family: 'Times New Roman';"> <a name="Section7.24."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Anti&#8209;Corruption Laws.</font>&#160; No Obligor nor any of its Subsidiaries has, nor, to the knowledge of any Responsible Officer of any Obligor, has any director, officer, agent or employee of any Obligor acting on
        behalf of such Obligor (a)&#160;taken any action, directly or indirectly, that would result in a violation by such Persons of the Anti&#8209;Corruption Laws or Irish Anti-Corruption Laws, (b)&#160;made, offered to make, promised to make or authorized the payment
        or giving of, directly or indirectly, any Prohibited Payment or (c)&#160;been subject to any investigation by any Governmental Authority with regard to any actual or alleged Prohibited Payment.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;7.25.<a name="Section7.25."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Anti&#8209;Terrorism Laws.</font>&#160; The Obligors (i)&#160;have taken reasonable measures to ensure compliance with applicable Economic Sanctions Laws, Anti&#8209;Terrorism Laws and Irish Anti-Terrorism Laws, (ii)&#160;are not Designated
        Persons and (iii) have not used any part of the proceeds from any advance on behalf of any Designated Person or, has not used, directly by it or indirectly through any Subsidiary, such proceeds in connection with any investment in, or any
        transactions or dealings with, any Designated Person.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;7.26.</font><font style="font-family: 'Times New Roman';"><a name="Section7.26."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;



        <font style="font-style: italic;">Royalty and Other Payments</font>.&#160; Except as set forth on Schedule&#160;7.26 and commissions or other sales based compensation to its employees or agents, no Obligor is obligated to pay any material royalty, milestone
        payment, deferred payment or any other contingent payment in respect of any Product.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 72 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps; font-weight: bold;"><a name="Article8"><!--Anchor--></a>Article&#160;8<br>
      <br>
      Affirmative Covenants and Financial Covenants</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">Each Obligor covenants and agrees with the Administrative Agent and the Lenders that, until the Commitments have expired or been terminated and all
      Obligations (other than the Warrant Obligations and inchoate indemnity obligations) have been paid in full in cash:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;8.01.</font><font style="font-family: 'Times New Roman';"><a name="Section8.01."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Financial Statements and Other Information</font>. The Administrative Borrower will furnish to the Administrative Agent for distribution to the Lenders:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>within forty-five (45) days of the end of each fiscal Quarter, a Flash
      Financial Report.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>as soon as available and in any event within fifty-five (55)&#160;days after
      the end of the first and third fiscal quarters, sixty (60) days after the end of the second fiscal quarter and ninety (90) days after the end of the fiscal year, the consolidated balance sheets of Parent and its Subsidiaries as at the end of such
      fiscal quarter and the related consolidated statements of income, stockholders&#8217; equity and cash flows of Parent and its Subsidiaries for such fiscal quarter and for the period from the beginning of the then current fiscal year to the end of such
      fiscal quarter, setting forth in each case in comparative form the corresponding figures for the corresponding periods of the previous fiscal year and the corresponding figures from the Financial Plan for the current fiscal year, all in reasonable
      detail together with (i) a certificate of a Responsible Officer of the Administrative Borrower stating that such financial statements fairly present in all material respects the financial condition of Parent and its Subsidiaries as at such date and
      the results of operations of Parent and its Subsidiaries for the period ended on such date and have been prepared substantially in accordance with IFRS consistently applied, subject to changes resulting from normal quarterly or year&#8209;end adjustments
      and except for the absence of footnotes and (ii) a management&#8217;s discussion and analysis of the financial condition and results of operations, including Parent and its Subsidiaries&#8217; liquidity and capital resources;<font style="font-style: italic;">
        provided </font> that documents required to be furnished pursuant to this Section 8.01(b) shall be deemed furnished on the date that such documents are publicly available on &#8220;EDGAR&#8221; so long as such filings include quarterly income statements,
      balance sheets and cash flow statements.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>as soon as available and in any event within one hundred twenty (120)
      days after the end of each fiscal year, the consolidated balance sheets of Parent and its Subsidiaries as of the end of such fiscal year, and the related consolidated statements of income, shareholders&#8217; equity and cash flows of Parent and its
      Subsidiaries for such fiscal year, setting forth in each case in comparative form the corresponding figures for the previous fiscal year and the corresponding figures from the Financial Plan for the fiscal year covered by such financial statements,
      prepared substantially in accordance with IFRS consistently applied, all in reasonable detail accompanied by (i) a report and opinion thereon of Grant Thornton or another firm of independent certified public accountants of recognized national
      standing, which report and opinion shall be prepared in accordance with generally accepted auditing standards and shall not be subject to any &#8220;going concern&#8221; or like qualification or exception audit (other than solely with respect to, or resulting
      solely from the upcoming Stated Maturity Date occurring within one year from the time such report is delivered) or any qualification or exception as to the scope of such audit or related to the maturity of the Transactions and (ii) a management&#8217;s
      discussion and analysis of the financial condition and results of operations, including the Obligors&#8217; liquidity and capital resources; <font style="font-style: italic;">provided</font> that, so long as Parent is a Publicly Reporting Company,
      Parent&#8217;s filing of an Annual Report on Form 20-F with the SEC shall be deemed to satisfy the requirements of this Section 8.01(c) on the date on which such report is first available via the SEC&#8217;s EDGAR system or a successor system related thereto;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 73 -</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(d)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>concurrently with the delivery of the reports described in Section
      8.01(b) and (c), and within thirty (30) days after the end of each month which does not end at the end of a fiscal year or fiscal quarter of Parent, a compliance certificate of a Responsible Officer of the Administrative Borrower as of the end of the
      applicable accounting period (which delivery may, unless a Lender requests executed originals, be by electronic communication including email and shall be deemed to be an original authentic counterpart thereof for all purposes) in the form of
      Exhibit&#160;E (a <font style="font-style: italic;">&#8220;Compliance Certificate&#8221;</font>) which, for purposes of clarification, shall (i) confirm the Obligors&#8217; compliance with Section&#160;8.15 and (ii) for each month end that coincides with the end of a fiscal
      quarter or fiscal year of Parent, (A) confirm the Obligors&#8217; compliance with Section 8.11 and Section 8.16, (B) notify the Administrative Agent if a Subsidiary which qualified as an Immaterial Foreign Subsidiary at the time of the delivery of the
      previous Compliance Certificate ceases to qualify as an Immaterial Foreign Subsidiary, (C) state the representations and warranties made by the Obligors in Article&#160;7 are true in all material respects on and as of the date thereof; <font style="font-style: italic;">provided</font>&#160; that to the extent that such representations and warranties specifically refer to an earlier date, they shall be true and correct in all material respects as of such earlier date;<font style="font-style: italic;"> provided further</font> that any representation and warranty that is qualified as to &#8220;materiality&#8221;, &#8220;Material Adverse Effect&#8221; or similar language shall be true and correct (after giving effect to any qualification therein) in all
      respects, (D) confirm that no Default or Event of Default is continuing (and if a Default or Event of Default has occurred and is continuing state the proposed actions that the Obligors intend to take in connection with such Default or Event of
      Default), (E) provide&#160; a copy of any new Material Agreement and (F) provide updated Schedules (if any) to this Agreement;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(e)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>promptly, and in any event within five&#160;(5) Business Days after receipt
      thereof by an Obligor, copies of each notice or other correspondence received from any securities regulator or exchange to the authority of which an Obligor is subject concerning any investigation or possible investigation or other inquiry by such
      agency regarding financial or other operational results of such Obligor;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(f)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>upon any renewal or replacement, the information regarding insurance
      maintained by the Obligors as and when required under Section&#160;8.05;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(g)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>promptly following the Lenders&#8217; written request at any time, proof of the
      Obligors&#8217; compliance with Section&#160;8.15, which may include statements showing the current balance of each account of the Obligors holding Unrestricted Cash necessary to establish compliance with Section 8.15;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 74 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(h)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>within ten&#160;(10) days of delivery, copies of all periodic reports
      distributed by&#160; Parent to its shareholders generally; <font style="font-style: italic;">provided</font> that (i)&#160;any such material may be redacted by&#160; Parent to exclude information relating to the Loan Documents or the Lenders and (ii)&#160;the Lenders
      shall not be entitled to receive statements, reports and notices relating to topics that (A)&#160;are subject to attorney&#8209;client privilege or (B)&#160;present a conflict of interest for the Lenders; <font style="font-style: italic;">provided</font> that, so
      long as Parent is a Publicly Reporting Company, Parent&#8217;s filing of any such material with the SEC shall be deemed to satisfy the requirements of this Section 8.01(h) on the date on which such report is first available via the SEC&#8217;s EDGAR system or a
      successor system related thereto;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(i)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>a financial forecast for Parent and its Subsidiaries for each fiscal
      year, including forecasted balance sheets, statements of income and cash flows of the Borrower and its Subsidiaries (the &#8220;<font style="font-style: italic;">Financial Plan</font>&#8221;), all of which shall be prepared on a consolidated basis and delivered
      not later than March 31 of such fiscal year;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(j)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>within five (5) Business Days following any Lender&#8217;s written request,
      certification that such Obligor is not a passive foreign investment company (<font style="font-style: italic;">&#8220;PFIC&#8221;</font>) within the meaning of Sections&#160;1291 through 1297 of the Code, or, if such Obligor determines that it is a PFIC, such
      information as would allow the Lender to make a qualified electing fund election with respect to the Equity Interest of the Obligor;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(k)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>so long as Parent is a Publicly Reporting Company, the Administrative
      Borrower shall within five (5) Business Days of Parent filing, provide access (via posting and/or links on Parent&#8217;s web site) to all reports on Form 20-F and Form 6-K filed with the SEC, any Governmental Authority succeeding to any or all of the
      functions of the SEC or with any national securities exchange; and within five (5) Business Days of filing, provide notice and access (via posting and/or links on Parent&#8217;s web site) to all reports filed with the SEC, and copies of (or access to, via
      posting and/or links on Parent&#8217;s web site) all other reports, proxy statements and other materials filed by Parent with the SEC, any Governmental Authority succeeding to any of the functions of the SEC or with any national securities exchange; and</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(l)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>commencing with January 14, 2025 and every Tuesday thereafter, cash flow
      forecasts and accounts payable agings of Parent and its Subsidiaries, in form and substance satisfactory to the Administrative Agent.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;8.02.<a name="Section8.02."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Notices of Material Events.&#160; </font>The Administrative Borrower will furnish to the Administrative Agent for distribution to the Lenders written notice of the following events within the time frames listed below:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>promptly after the occurrence of any Default or Event of Default;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>within three (3) Business Days after the occurrence of any Casualty Event
      with respect to any Obligor&#8217;s Property;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 75 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font> (i)&#160;prior to the execution of a definitive agreement for any proposed
      Acquisition by any Obligor that would reasonably be expected to result in environmental liability under Environmental Laws in excess of $250,000, and (ii) in each case, to the extent that any of the following would reasonably be expected to result in
      liability in excess of $500,000: (A)&#160;spillage, leakage, discharge, disposal, leaching, migration or release of any Hazardous Material required to be reported to any Governmental Authority under applicable Environmental Laws, and (B)&#160;all actions,
      suits, Claims, notices of violation, hearings, investigations or proceedings pending, or threatened in writing against or affecting any Obligor or with respect to the ownership, use, maintenance and operation of their respective businesses,
      operations or properties, relating to Environmental Laws or Hazardous Material;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(d)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>within three (3) Business Days of obtaining written notice or knowledge
      thereof, the assertion of any environmental matter by any Person in writing against, or with respect to the activities of, any Obligor and any alleged violation of or non&#8209;compliance with any Environmental Laws or any Permits, licenses or
      authorizations, in each case, which would reasonably be expected to involve damages in excess of $250,000 other than any environmental matter or alleged violation that, if adversely determined, would not (either individually or in the aggregate) have
      a Material Adverse Effect;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(e)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>within three (3) Business Days of obtaining notice to an Obligor of the
      filing or commencement of any action, suit or proceeding by or before any arbitrator or Governmental Authority against or directly affecting any Obligor, in each case, that would reasonably be expected to result in a Material Adverse Effect;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(f)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font> (i)&#160;on or prior to any filing by any ERISA Affiliate of any notice of
      intent to terminate any Title&#160;IV Plan, a copy of such notice and (ii)&#160;promptly, and in any event within ten&#160;(10) days, after any Responsible Officer of any ERISA Affiliate knows or has reason to know that a request for a minimum funding waiver under
      Section&#160;412 of the Code has been filed with respect to any Title&#160;IV Plan or Multiemployer Plan, a notice (which may be made by telephone if promptly confirmed in writing) describing such waiver request and any action that any ERISA Affiliate proposes
      to take with respect thereto, together with a copy of any notice filed with the PBGC or the IRS pertaining thereto;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(g)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>within ten (10) Business Days of obtaining written notice or knowledge
      thereof, (i)&#160;the termination of any Material Agreement other than in the Ordinary Course of Business pursuant to its terms; (ii)&#160;the receipt by any Obligor of a written notice under any Material Agreement (and a copy thereof) asserting a default by
      such Obligor where such alleged default would permit such counterparty to terminate such Material Agreement; (iii)&#160;the entering into any new Material Agreement by an Obligor (and a copy thereof); or (iv) any amendment to a Material Agreement that
      would be materially adverse to the Lenders (and a copy thereof) (which includes, but is not limited to, any amendments to provisions relating to pricing and term); <font style="font-style: italic;">provided</font> that notices required under this
      subsection (g) may be delivered with the next Compliance Certificate unless any of the foregoing events would reasonably be expected to have a Material Adverse Effect;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(h)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>within three (3) Business Days of obtaining written notice or knowledge
      thereof, any product recalls, safety alerts, corrections, withdrawals, marketing suspensions, removals or the like conducted, to be undertaken or issued by any Obligor, whether or not at the request, demand or order of any Governmental Authority or
      otherwise with respect to any Product;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 76 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(i)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>within five&#160;(5) Business Days of obtaining written notice or knowledge
      thereof, any infringement or other violation by any Person of any Obligor Intellectual Property that would reasonably be expected to result in a Material Adverse Effect;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(j)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>within five&#160;(5) Business Days of obtaining written notice or knowledge
      thereof, a material licensing agreement or arrangement entered into by any Obligor in connection with any infringement or alleged infringement of the Intellectual Property of another Person that could reasonably be likely to result in a Material
      Adverse Effect;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(k)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>within five&#160;(5) Business Days of obtaining written notice or knowledge
      thereof, any written Claim by any Person that the conduct of any Obligor&#8217;s business, including the development, manufacture, use, sale or other commercialization of any Product, infringes any Intellectual Property of such Person, except to the extent
      any such Claim would not reasonably be expected to result in a Material Adverse Effect;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(l)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the distribution of the reports and notices as and when required by the
      Security Documents;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(m)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>within thirty&#160;(30) days of the date thereof, or, if earlier, on the date
      of delivery of any financial statements pursuant to Section&#160;8.01, notice of any material change in accounting policies or financial reporting practices by the Obligors;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(n)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>within thirty (30) days after the occurrence thereof, notice of any labor
      controversy resulting in or threatening to result in any strike, work stoppage, boycott, shutdown or other labor disruption against or involving an Obligor that is reasonably expected to have a Material Adverse Effect;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(o)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>within five&#160;(5) Business Days of any other development that results in,
      or would reasonably be expected to result in, a Material Adverse Effect;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(p)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>within five&#160;(5) Business Days of the failure to pay any Taxes or
      obligations in accordance with Section 8.04;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(q)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; concurrently with the delivery of financial statements under Section&#160;8.01, after the date hereof and during such
      prior fiscal year, the creation or other acquisition of any Intellectual Property by any Obligor that is registered or becomes registered or is the subject of an application for registration with the United States Copyright Office, the United States
      Patent and Trademark Office or the Canadian Intellectual Property Office, as applicable, or with any other equivalent foreign Governmental Authority; and</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(r)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>five (5) Business Days prior to any change to any Obligor&#8217;s ownership of
      Deposit Accounts, Securities Accounts and Commodity Accounts, by delivering to the Lenders an updated Schedule&#160;7 to the Security Agreements setting forth a complete and correct list of all such accounts as of the date of such change.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 77 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">The specified time periods in this Section 8.02 shall begin accruing after a Responsible Officer of an Obligor first learns of the existence of a
      circumstance requiring notice.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">Each notice delivered under this Section&#160;8.02 shall be accompanied by a statement of a Responsible Officer of the Administrative Borrower setting
      forth in reasonable detail the event or development requiring such notice and any action taken or proposed to be taken with respect thereto; <font style="font-style: italic;">provided </font>that, so long as Parent is a Publicly Reporting Company,
      Parent&#8217;s filing of notice of any such event with the SEC shall be deemed to satisfy the requirements of this Section 8.02 on the date on which such report is first available via the SEC&#8217;s EDGAR system or a successor system related thereto.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">Notwithstanding any contrary provision of this Agreement or any other Loan Document (including, without limitation, Sections 8.01 and 8.02), so long
      as Parent is a Publicly Reporting Company, in the event that the Administrative Agent provides notice to the Administrative Borrower that it no longer desires to receive any information that constitutes material non&#8209;public information, the Obligors
      shall not be required to provide any information pursuant to the terms hereof or thereof unless Parent is disclosing such information pursuant to a filing with the SEC; <font style="font-style: italic;">provided </font>that notwithstanding the
      foregoing, the Obligors shall at all times comply with Section 8.01(d) and 8.02(a).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;8.03<a name="Section8.03"><!--Anchor--></a>.</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Existence; Maintenance of Properties, Etc</font>.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each Obligor will&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;do or cause to be done all
        things necessary to preserve, renew and keep in full force and effect its legal existence; <font style="font-style: italic;">provided</font> that the foregoing shall not prohibit any merger, amalgamation, plan of arrangement, consolidation,
        liquidation or dissolution permitted under Section&#160;9.03.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each Obligor shall maintain and preserve all rights, licenses, permits,
      privileges and franchises material to the conduct of its business, and maintain and preserve all of its assets and properties, including all Product Assets, necessary to the conduct of its business in good working order and condition, ordinary wear
      and tear and damage from casualty or condemnation excepted.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each Obligor shall use commercially reasonable efforts to cause each new
      Key Employee and each contractor with access to material Obligor Intellectual Property to execute and deliver a customary confidentiality, non&#8209;disclosure and Intellectual Property assignment agreement that includes a waiver of moral rights to the
      extent permitted by Law and such agreements are customary in the applicable jurisdiction.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(d)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Parent shall maintain sufficient authorized but unissued share capital in
      Parent to satisfy in full, without the need for the passing of any further resolutions of its shareholders, the outstanding rights represented by the Warrant Certificates.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 78 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;8.04.</font><font style="font-family: 'Times New Roman';"><a name="Section8.04."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Payment of Obligations.</font>&#160; Each Obligor shall&#160; pay and discharge (a)&#160;all United States federal income and other material Taxes, fees, assessments and governmental charges or levies imposed upon it or upon its
        properties or assets prior to the date on which material penalties attach thereto, and all lawful Claims for labor, materials and supplies which, if unpaid, might become a Lien (other than a Permitted Lien) upon any properties or assets of any
        Obligor, except to the extent such Taxes, fees, assessments or governmental charges or levies, or such Claims, are being contested in good faith by appropriate proceedings and are adequately reserved against substantially in accordance with IFRS,
        (b)&#160;all lawful Claims which, if unpaid, would by Law become a Lien upon its Property not constituting a Permitted Lien and (c)&#160;all other obligations, if the failure to discharge such obligation would reasonably be expected to result in a Material
        Adverse Effect.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;8.05<a name="Section8.05"><!--Anchor--></a>.</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Insurance.</font>&#160; Each Obligor shall, at its own cost and expense obtain and maintain, with financially sound and reputable insurers, insurance of the kinds, and in the amounts, as are consistent with customary
        practices and standards of its industry in the same or similar locations, it being understood and agreed that the insurance held by the Obligors on the Sixth Amendment Restatement Date is deemed to fulfill this requirement on the date hereof.&#160; All
        of the insurance policies required pursuant to this Section&#160;8.05 with respect to the Obligors, will name the Administrative Agent as a &#8220;lender&#8217;s loss payee,&#8221; &#8220;additional insured&#8221; or &#8220;mortgagee,&#8221; as applicable and as its interests may appear.&#160; Each
        Obligor will use its commercially reasonable efforts to ensure, or to cause others to ensure, that all insurance policies required pursuant to this Section&#160;8.05 with respect to the Obligors, shall provide that they shall not be terminated or
        cancelled nor shall any policy be materially changed in a manner adverse to the insured Person without at least thirty&#160;(30) days&#8217; written notice (or ten (10) days&#8217; written notice if termination is due to non-payment) to insured Person and the
        Administrative Agent.&#160; Receipt of notice of termination or cancellation of any such insurance policies shall entitle the Administrative Agent to renew any such policies, all in accordance with the first sentence of this Section&#160;8.05 or otherwise
        obtain similar insurance in place of such policies, in each case at the expense of such Obligor (payable within three&#160;(3) Business Days of any Obligor&#8217;s receipt of written demand therefor) and, unless an Event of Default has occurred and is
        continuing, with the prior written consent of such Obligor (such consent not to be unreasonably withheld).&#160; The amount of any such expenses shall accrue interest at the Default Rate if not paid when due and shall constitute &#8220;Obligations.&#8221;&#160; All of
        the insurance policies required hereby with respect to the Obligors, will be evidenced by one or more certificates of insurance, together with appropriate lender&#8217;s loss payee or additional insured clauses or endorsements in favor of the
        Administrative Agent as required by this Section 8.05, delivered to the Administrative Agent on or prior to the date hereof and at such other times as the Administrative Agent may request from time to time.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;8.06.</font><font style="font-family: 'Times New Roman';"><a name="Section8.06."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Books and Records; Inspection Rights.</font>&#160; Each Obligor will keep proper books of record and account in which full, true and correct entries are made of all dealings and transactions in relation to its business
        and activities.&#160; It will permit any representatives designated by the Administrative Agent, upon reasonable prior notice and at reasonable times, to visit and inspect its properties, to examine and make extracts from its books and records, and to
        discuss its affairs, finances and condition with its officers and independent accountants, all at such reasonable times during normal business hours and with reasonable advance notice as the Administrative Agent may request.&#160; It will, pay all
        reasonable and documented out&#8209;of&#8209;pocket expenses incurred by the Administrative Agent (a)&#160;so long as no Default has occurred and is continuing, of two (2) such inspections each calendar year and (b)&#160;during a continuing Default, all such
        inspections.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 79 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;8.07.</font><font style="font-family: 'Times New Roman';"><a name="Section8.07."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Compliance with Laws.</font></font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each Obligor will, and will cause each of its Subsidiaries to, (i)&#160;comply
      in all material respects with all Requirements of Law (including Healthcare Laws and Environmental Laws) and (ii)&#160;comply in all material respects with all terms of outstanding Indebtedness and all Material Agreements, except (other than with respect
      to Material Intellectual Property) where the failure to do so, individually or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each Obligor will maintain all records required to be maintained by a
      Governmental Authority or otherwise under any applicable Healthcare Law, except where failure to do so, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each Obligor will maintain a Health Care Compliance Program, which will
      be reviewed and updated annually, as necessary.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;8.08.</font><font style="font-family: 'Times New Roman';">&#160; <a name="Section8.08."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Licenses.</font>&#160; Each Obligor will obtain and maintain all licenses, authorizations, consents, filings, exemptions, registrations and other Governmental Approvals necessary in connection with the execution,
        delivery and performance of the Loan Documents, the consummation of the Transactions or the operation and conduct of its business and ownership of its properties, except where failure to do so would not reasonably be expected to have a Material
        Adverse Effect.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;8.09.</font><font style="font-family: 'Times New Roman';"><a name="Section8.09."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Action under Environmental Laws.</font>&#160; Each Obligor will, upon a Responsible Officer becoming aware of the release of any Hazardous Materials or the existence of any environmental liability under applicable
        Environmental Laws with respect to their respective businesses, operations or properties, take all actions, at their cost and expense, as shall be required by applicable Law to investigate and clean up the condition of their respective businesses,
        operations or properties, including all required removal, containment and remedial actions, and restore their respective businesses, operations or properties to a condition, except where failure to do so would not reasonably be expected to have a
        Material Adverse Effect.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;8.10.</font><font style="font-family: 'Times New Roman';"><a name="Section8.10."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Use of Proceeds.</font>&#160; The proceeds of the Term Loans will be used only as provided in Section&#160;2.05.&#160; No part of the proceeds of the Term Loans will be used, whether directly or indirectly, for any purpose that
        violates any of the regulations of the Board of Governors of the Federal Reserve System, including Regulations&#160;T, U and X.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;8.11.<a name="Section8.11."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Certain Obligations Respecting Subsidiaries; Further Assurances; and Intellectual Property</font>.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 80 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Subsidiaries.</font>&#160; Each Obligor will take such action, and will cause each of
      its Subsidiaries to take such action, from time to time as shall be necessary to ensure that all Subsidiaries are &#8220;Guarantors&#8221; hereunder.&#160; Without limiting the generality of the foregoing, in the event that any Obligor or any of its Subsidiaries
      shall form or acquire any new Subsidiary, it and its Subsidiaries will promptly and in any event within fifteen&#160;(15) days (or such longer time as consented to by the Administrative Agent in writing) of the formation or Acquisition of such Subsidiary:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; cause such new Subsidiary to become a &#8220;Guarantor&#8221; hereunder, and a &#8220;Grantor&#8221; under the Security
        Documents, pursuant to a Guarantee Assumption Agreement and cause such new Subsidiary to become an &#8220;Obligor&#8221; under the Intercompany Subordination Agreement and the Luxembourg Subsidiary Intercompany Subordination Agreement;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;take such action or cause such Subsidiary to take such action (including delivering originals of
        any certificated Equity Interests of such Subsidiary, together with original, executed, undated transfer powers executed in blank and originals of any intercompany notes with undated endorsements executed in blank) as shall be necessary to create
        and perfect valid and enforceable first priority (subject to Permitted Liens) Liens on substantially all of the personal Property of such new Subsidiary as collateral security for the obligations of such new Subsidiary hereunder;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to the extent that the parent of such Subsidiary is not a party to the Security Documents or has
        not otherwise pledged Equity Interests in its Subsidiaries in accordance with the terms of the Security Documents and this Agreement, cause the parent of such Subsidiary to execute and deliver a pledge agreement in favor of the Lenders, in respect
        of all outstanding issued shares of such Subsidiary; and</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;deliver such proof of corporate action, incumbency of officers, opinions of counsel and other
        documents as is consistent with those delivered by each Obligor pursuant to Section&#160;6.01 or as the Majority Lenders shall have requested;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">provided</font> that, solely with respect to any Subsidiary that is an Immaterial Foreign Subsidiary, no such actions shall be
      required other than (x) a pledge by the owner of such Immaterial Foreign Subsidiary (to the extent such owner is a Canadian Obligor or a Borrower) of 100% of the Equity Interests of such Immaterial Foreign Subsidiary, which pledge shall not be
      required to be perfected under the Law of such Immaterial Foreign Subsidiary&#8217;s jurisdiction of formation and (y) causing such Immaterial Foreign Subsidiary to the execute a joinder to the Intercompany Subordination Agreement; <font style="font-style: italic;">provided further</font>, that at the request of the Administrative Agent, with respect to an Immaterial Foreign Subsidiary that is owned by an Irish Obligor, the owner of such Immaterial Foreign Subsidiary shall pledge
      100% of the Equity Interests of such Immaterial Foreign Subsidiary, which pledge shall be perfected under the Law of such Immaterial Foreign Subsidiary&#8217;s jurisdiction of formation.&#160; Upon the creation or designation of a Foreign Subsidiary as an
      Immaterial Foreign Subsidiary, the Administrative Borrower shall provide notice to the Administrative Agent designating such Foreign Subsidiary as an Immaterial Foreign Subsidiary.&#160; For the avoidance of doubt, in the event that any Subsidiary ceases
      to qualify as an Immaterial Foreign Subsidiary, such Foreign Subsidiary shall, at the request of the Administrative Agent, or the election of the Borrowers, promptly comply with clauses (a)(i)-(iv) hereof.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 81 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman';">On the Original Closing Date, and until such time that the Administrative Agent may request, the Luxembourg Subsidiary shall not be a Guarantor, shall not be required
      to take the actions set forth in this Section 8.11 and the owner of the Luxembourg Subsidiary shall not be required to pledge the Equity Interests of the Luxembourg Subsidiary.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Further Assurances.</font>&#160; Each Obligor will take such action from time to time
      as shall reasonably be requested in writing by the Majority Lenders to effectuate the purposes and objectives of this Agreement.&#160; Without limiting the generality of the foregoing, it will, and will cause each Person that is required to be a Guarantor
      to, take such action from time to time (including executing and delivering such assignments, security agreements, control agreements and other instruments) as shall be reasonably requested in writing by the Majority Lenders to create, in favor of the
      Lenders, perfected security interests and Liens (subject to Permitted Liens) in substantially all of the personal Property of such Obligor as collateral security for the Obligations; <font style="font-style: italic;">provided</font> that any such
      security interest or Lien shall be subject to the relevant requirements of the Security Documents.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;"><font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Intellectual Property</font>.&#160; In the
      event that any Obligor creates, develops or acquires Obligor Intellectual Property during the term of this Agreement, then the provisions of this Agreement shall automatically apply thereto and any such Obligor Intellectual Property shall
      automatically constitute part of the Collateral under the Security Documents, without further action by any party, in each case from and after the date of such creation, development or acquisition (except that any representations or warranties of any
      Obligor shall apply to any such Obligor Intellectual Property only from and after the date, if any, subsequent to such acquisition that such representations and warranties are brought down or made anew as provided herein).&#160; In the event that any
      Obligor holds or acquires Obligor Intellectual Property during the term of this Agreement, then, upon the request of the Administrative Agent, such Obligor shall take any action as shall be reasonably necessary and reasonably requested by the
      Administrative Agent to ensure that the provisions of this Agreement and the Security Agreements shall apply thereto and any such Obligor Intellectual Property shall constitute part of the Collateral under the Security Documents.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;8.12.<a name="Section8.12."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Termination of Non&#8209;Permitted Liens.</font>&#160; In the event that any Responsible Officer of any Obligor shall become aware or be notified by the Lenders of the existence of any outstanding Lien against any Property of
        any Obligor or any of its Subsidiaries, which Lien is not a Permitted Lien, such Obligor shall use its best efforts to promptly terminate or cause the termination of such Lien.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;8.13.<a name="Section8.13."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Non-Consolidation</font>.&#160; Each Obligor will maintain entity records and books of account separate from those of any other entity, other than the Obligors, which is an Affiliate of such entity.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 82 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;8.14.</font><font style="font-family: 'Times New Roman';"><a name="Section8.14."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Anti&#8209;Terrorism and Anti&#8209;Corruption Laws</font>.&#160; No Obligor nor any of its Subsidiaries shall engage in any transaction that violates any of the applicable prohibitions set forth in any Economic Sanctions Law,
        Irish Economic Sanctions Laws, Anti&#8209;Terrorism Law, Irish Anti-Terrorism Laws or the <font style="font-style: italic;">US Foreign Corrupt Practices Act of 1977</font> (15 USC. &#167;&#167;&#160;78dd&#8209;1 <font style="font-style: italic;">et&#160;seq.</font>).&#160; No
        Obligor will use any part of the proceeds from the loan on behalf of any Designated Person and will not use, directly by it or indirectly through any Subsidiary, such proceeds in connection with any investment in, or any transactions or dealings
        with, any Designated Person.&#160; None of the funds or assets of such Obligor or any Subsidiary that are used to repay the Term Loans shall constitute property of, or shall be beneficially owned by, any Designated Person or, to such Obligor&#8217;s
        knowledge, be the direct proceeds derived from any transactions that violate the prohibitions set forth in any applicable Economic Sanctions Law or Irish Economic Sanctions Laws and no Designated Person shall have any direct or indirect interest in
        such Obligor or such Subsidiary insofar as such interest would violate any Economic Sanctions Laws or Irish Economic Sanctions Laws applicable to such Obligor or such Subsidiary.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;8.15.</font><font style="font-family: 'Times New Roman';">&#160; <a name="Section8.15."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Minimum Liquidity</font>.&#160; (i) Commencing on October 1, 2025 and ending on December 31, 2025, the Obligors shall have aggregate Unrestricted Cash of not less than $1,000,000 at all times and (ii) commencing January
        1, 2026, the Obligors shall have aggregate Unrestricted Cash of not less than $3,000,000 at all times.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section 8.16.<a name="Section8.16."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Minimum Net Revenue.&#160; </font> As of the end of the fiscal quarter ended December 31, 2023, and each fiscal quarter thereafter, Parent and its Subsidiaries shall maintain, on a consolidated basis, Net Revenue for
        the twelve (12) month period most recently ended on such date of not less than the amount set forth in the table below:</font></div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman';"> <br>
      </font></div>
    <table cellspacing="0" cellpadding="0" border="0" align="center" id="z0f621a392425484f9732a5ad049f58c3" style="width: 80%; color: #000000; font-family: Arial; font-size: 10pt; text-align: left;">

        <tr>
          <td style="width: 49.48%; vertical-align: middle; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25; font-variant: small-caps;">Twelve-Month Period </div>
            <div style="text-align: center; line-height: 1.25; font-variant: small-caps;">Ended</div>
          </td>
          <td style="width: 50.52%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">
            <div style="line-height: 1.25; font-variant: small-caps;">Minimum Net Revenue</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.48%; vertical-align: middle; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25;">December&#160;31, 2023</div>
          </td>
          <td style="width: 50.52%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25;">$0</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.48%; vertical-align: middle; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25;">March&#160;31, 2024</div>
          </td>
          <td style="width: 50.52%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25;">$53,100,000</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.48%; vertical-align: middle; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25;">June&#160;30, 2024</div>
          </td>
          <td style="width: 50.52%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25;">$54,300,000</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.48%; vertical-align: middle; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25;">September&#160;30, 2024</div>
          </td>
          <td style="width: 50.52%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25;">$55,700,000</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.48%; vertical-align: middle; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25;">December&#160;31, 2024</div>
          </td>
          <td style="width: 50.52%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25;">$0</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.48%; vertical-align: middle; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25;">March&#160;31, 2025</div>
          </td>
          <td style="width: 50.52%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25;">$0</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.48%; vertical-align: middle; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25;">June&#160;30, 2025</div>
          </td>
          <td style="width: 50.52%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25;">$43,000,000</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.48%; vertical-align: middle; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25;">September&#160;30, 2025</div>
          </td>
          <td style="width: 50.52%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25;">$45,000,000</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.48%; vertical-align: middle; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25;">December 31, 2025</div>
          </td>
          <td style="width: 50.52%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25;">$47,000,000</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.48%; vertical-align: middle; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25;">March 31, 2026</div>
          </td>
          <td style="width: 50.52%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25;">$55,000,000</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.48%; vertical-align: middle; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25;">June&#160;30, 2026</div>
          </td>
          <td style="width: 50.52%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25;">$60,000,000</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 83 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;8.17.<a name="Section8.17."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Maintenance of Regulatory Approvals, Contracts, Intellectual Property, Etc.</font>&#160; With respect to each Product, each Obligor will (a)&#160;maintain in full force and effect all material Regulatory Approvals (including the
        Product Authorizations), Material Agreements, or other rights necessary for the current operations of such Obligor&#8217;s business, as the case may be, including in respect of all related Product Development and Commercialization Activities;
        (b)&#160;maintain in full force and effect all Material Intellectual Property and Material WaveForm IP that is used in and necessary for related Product Development and Commercialization Activities; and (c)&#160;use commercially reasonable efforts to pursue
        and maintain in full force and effect legal protection for all new, Material Intellectual Property and Material WaveForm IP that is used in and necessary in connection with any Product Development and Commercialization Activities relating to any
        such Product.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;8.18.</font><font style="font-family: 'Times New Roman';"> <a name="Section8.18."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Cash Management</font>.&#160; The Obligors will:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>maintain all Deposit Accounts, Securities Accounts, Commodity Accounts
      and lockboxes (other than Excluded Accounts) with a bank or financial institution that has either (i) other than in respect of any such account charged pursuant to the Irish Debenture, executed and delivered to the Administrative Agent&#160; an account
      control agreement (provided that, for greater certainty, if under the applicable laws of any Canadian jurisdiction control over Deposit Accounts is not available, then an account control agreement shall be deemed to constitute a springing blocked
      account or springing cash dominion agreement in respect of such Deposit Accounts) or (ii) in respect of any such account charged pursuant to the Irish Debenture, executed and delivered to the Administrative Agent an acknowledgment to the notice of
      assignment delivered to such bank or financial institution by the relevant Irish Obligor pursuant to the Irish Debenture, in each case in form and substance reasonably acceptable to the Administrative Agent (each such Deposit Account, Securities
      Account, Commodity Account and lockbox, a <font style="font-style: italic;">&#8220;Controlled Account&#8221;</font>);</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>deposit promptly, and in any event no later than seven&#160;(7) Business Days
      after the date of receipt thereof, all cash, checks, drafts or other similar items of payment relating to or constituting payments greater than $75,000 in the aggregate at any time made in respect of any and all accounts and other rights and
      interests into Controlled Accounts; and</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>in order to segregate and to facilitate perfection of Administrative
      Agent&#8217;s security interest in funds received by any Obligor from any Federal Health Care Programs, the applicable Obligor shall, with respect to an Obligor&#8217;s future participation in any Federal Health Care Program, prior to such Obligor&#8217;s receipt of
      payments exceeding $50,000 in any month from Federal Health Care Programs, notify all Government Authorities making any payments under any Federal Health Care Program to make any such payments only to one or more Segregated Health Care Accounts.&#160; No
      Obligor shall deposit any funds to a Segregated Health Care Account or direct or permit any other Person to deposit any funds to a Segregated Health Care Account, other than payments received from Federal Health Care Programs.&#160; The Obligors shall
      upon the date the applicable Obligor begins receiving payments from any Federal Health Care Program, to cause all amounts deposited into the Segregated Health Care Accounts to be automatically swept on a daily basis to a Controlled Account pursuant
      to a Sweep Agreement.&#160; Any such Sweep Agreement will require such depository bank to waive all of its existing and future rights of recoupment and set-off and banker&#8217;s lien against any Segregated Health Care Accounts, but shall permit such depository
      bank to maintain its existing and future rights of recoupment and set-off and banker&#8217;s lien against any Controlled Account.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 84 -</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;8.19.</font><font style="font-family: 'Times New Roman';"><a name="Section8.19."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Post Sixth Amendment Restatement Date Obligations</font>.&#160; Notwithstanding anything to the contrary set forth in this Agreement, the Obligors shall deliver to the Administrative Agent on behalf of the Lenders, the
        documents set forth on Schedule 8.19, in form and substance reasonably acceptable to the Administrative Agent, and/or take the actions set forth on Schedule 8.19, in a manner reasonably acceptable to the Administrative Agent, on or before the
        deadlines set forth in Schedule 8.19 (as such deadlines may be extended by Administrative Agent in writing in its reasonable discretion).&#160; To the extent there is any conflict between the provisions of any Loan Document and Schedule 8.19, the
        provisions of Schedule 8.19 shall control.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;8.20.</font><font style="font-family: 'Times New Roman';"> <a name="Section8.20."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">COMI</font>.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Parent and each other Irish Obligor will maintain its COMI in Ireland and not have an establishment (within the meaning of the EU Insolvency Regulation) outside Ireland.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;8.21.</font><font style="font-family: 'Times New Roman';"><a name="Section8.21."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Cashless Exercise of Warrant Certificate and Par Value.</font>&#160;&#160; If Perceptive (or its permitted successors or assigns with respect to a Warrant Certificate) exercises at any time, in whole or in part, a Warrant
        Certificate by means of the &#8220;cashless exercise&#8221; procedure specified in that Warrant Certificate, then the following shall apply.&#160; With respect to the American Depositary Shares relating to the American Depositary Receipts the subject of such
        cashless exercise (the <font style="font-style: italic;">&#8220;Relevant ADSs&#8221;</font>) the Non-EEA Obligors shall procure (on a joint and several basis) that a cash amount is paid to the Parent sufficient to ensure that, immediately following the
        exercise of such cashless exercise, the shares in the capital of the Parent represented by the Relevant ADSs are fully paid up to their par value to the extent required by the Constitution of the Parent and the Companies Act 2014 of Ireland (as
        amended).&#160; Capitalized terms used in this Section 8.21 and not otherwise defined in this Agreement have the meaning given to them in the applicable Warrant Certificate.&#160; For avoidance of doubt: (i) none of Perceptive (or its successors or assigns)
        shall be liable to account to any Obligor or other person with respect to any amount paid pursuant to this Section and (ii) notwithstanding any other provision of this Agreement, no EEA Obligor shall be liable (whether as principal or surety or
        otherwise) to make payment under this Section 8.21 in any circumstances.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 22.5pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">Section 8.22. <a name="Section8.22."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Canadian Pension Plans</font>.&#160; Maintain all
      Canadian Pension Plans relating to each Obligor in compliance with all applicable Laws in all material respects.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 22.5pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">Section&#160;8.23.<a name="Section8.23."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Payment of Warrant Stamp Amount. </font>As soon as
      possible following the Sixth Amendment Restatement Date (but in any event no less than fifteen (15) Business Days prior to the deadline for filing such return with the Irish Revenue Commissioners) the Lenders and their Affiliates shall provide the
      Parent with a draft form of stamp duty return and within ten (10) days of being provided with such draft form of stamp duty return, the Parent shall provide the Lenders and their Affiliates with its reasonable comments thereon. The Lenders and their
      Affiliates shall consider any such reasonable comments and shall ensure that the return is filed with the Irish Revenue Commissioners in advance of the deadline for filing such return.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 85 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps; font-weight: bold;"><a name="Article9"><!--Anchor--></a>Article 9<br>
      <br>
      Negative Covenants</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">Each Obligor covenants and agrees with the Administrative Agent and the Lenders that, until the Commitments have expired or have been terminated and
      all Obligations (other than the Warrant Obligations and inchoate indemnity obligations) have been paid in full in cash:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;9.01<a name="Section9.01"><!--Anchor--></a>.</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Indebtedness.</font>&#160; Each Obligor will not, and will not permit any of its Subsidiaries to, create, incur, assume or permit to exist any Indebtedness, whether directly or indirectly, except:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the Obligations;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Permitted Indebtedness and Permitted Refinancings thereof; <font style="font-style: italic;">provided</font>, that the aggregate principal amount of Permitted Indebtedness on the Original Closing Date not listed on Schedule 7.13A shall not exceed $500,000;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>accounts payable to trade creditors for goods and services and current
      operating liabilities (not the result of the borrowing of money) incurred in the Ordinary Course of Business after the Original Closing Date;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(d)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Indebtedness consisting of Guarantees resulting from endorsement of
      negotiable instruments for collection by an Obligor or any of its Subsidiaries in the Ordinary Course of Business;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(e)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Indebtedness&#160;in the form of intercompany receivables and payables:
      (i)&#160;among Obligors; (ii) among Immaterial Foreign Subsidiaries; and (iii) among Immaterial Foreign Subsidiaries and an Obligor; <font style="font-style: italic;">provided </font>that (x) all additional liabilities from an Obligor to an Immaterial
      Foreign Subsidiary (other than liabilities from an Obligor to the Brazilian Subsidiary)&#160;pursuant to clause&#160;(iii)&#160;arising after the Original Closing Date, together with the Investments in Immaterial Foreign Subsidiaries permitted pursuant to Section
      9.05(m), made after the Original Closing Date, shall in an aggregate amount not exceed $1,000,000 plus interest accrued thereon&#160;and&#160;(y)&#160;until such time as the Brazilian Subsidiary becomes a &#8220;Guarantor&#8221; hereunder, and a &#8220;Grantor&#8221; under the Security
      Documents,&#160;additional&#160;liabilities from an Obligor to&#160;the Brazilian Subsidiary, together with the Investments in the Brazilian Subsidiary permitted pursuant to Section 9.05(l) made after the Original Closing Date, shall in an aggregate amount not
      exceed $1,500,000 per fiscal year plus interest accrued thereon;&#160;<font style="font-style: italic;">provided further</font>&#160;that&#160;all such intercompany liabilities&#160;pursuant to clause&#160;(iii) shall be&#160; unsecured and subordinated in right of payment to the
      payment in full of the Obligations pursuant to the terms of&#160;the Intercompany Subordination Agreement;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(f)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Indebtedness constituting of deposits or prepayments received from
      customers in the ordinary course of business;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(g)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Guarantees by an Obligor of Indebtedness of any other Obligor;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 86 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(h)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Purchase money Indebtedness and Capital Lease Obligations; <font style="font-style: italic;">provided</font> that (i)&#160;if secured, the collateral therefor consists solely of the assets being financed, the products and proceeds thereof and books and records related thereto, (ii) in the case of purchase money
      Indebtedness, such Indebtedness shall constitute at least 75% of the aggregate consideration paid with respect to such asset and (iii)&#160;the aggregate outstanding principal amount of such Indebtedness incurred after the Original Closing Date does not
      exceed $1,500,000 at any time;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(i)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>unsecured workers&#8217; compensation Claims, payment obligations in connection
      with health, disability or other types of social security benefits, unemployment or other insurance obligations, reclamation and statutory obligations, in each case incurred in the Ordinary Course of Business;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(j)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Indebtedness under Hedging Agreements permitted pursuant to Section
      9.05(f);</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(k)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Indebtedness approved in advance in writing by the Majority Lenders;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(l)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Indebtedness of the Obligors and their Subsidiaries with respect to
      overdrafts, or corporate credit cards not to exceed $750,000 at any time outstanding;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(m)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Indebtedness incurred in connection with letters of credit, entered into
      in the Ordinary Course of Business, that are secured solely by cash or cash equivalents and issued on behalf of the Borrower in an aggregate amount outstanding not to exceed $2,000,000 at any time;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(n)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>other unsecured Indebtedness incurred after the Original Closing Date in
      an aggregate amount not to exceed $2,500,000;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(o)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Indebtedness in the form of intercompany receivables and payables among
      the Luxembourg Subsidiary and the Obligors;&#160;<font style="font-style: italic;">provided</font>&#160;that (i) the aggregate amount of all such intercompany liabilities to the Luxembourg Subsidiary shall not exceed the amounts outstanding on the Funding Date
      (plus any accrued interest thereon) and (ii) all such intercompany liabilities shall be unsecured and subordinated in right of payment to the payment in full of the Obligations pursuant to the terms of the Luxembourg Subsidiary Intercompany
      Subordination Agreement;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(p)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>[reserved];</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(q)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any &#8220;Contingent Consideration&#8221; (as such term is defined under the
      Effective Date Acquisition Agreement) owed by U.S. TRIB pursuant to the Effective Date Acquisition Agreement;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(r)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>[reserved];</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(s)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the Outstanding Convertible Notes; and</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 87 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(t)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Indebtedness pursuant to the Investor Convertible Note, in an amount not to exceed $20,000,000; <font style="font-style: italic;">provided </font>that such Indebtedness shall be unsecured and subordinated in right of payment to the payment in full of the Obligations pursuant to the terms of the Investor Subordination Agreement.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;9.02.<a name="Section9.02."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Liens.</font>&#160; Each Obligor will not, and will not permit any of its Subsidiaries to, create, incur, assume or permit to exist any Lien on any Property now owned by it, except:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Liens securing the Obligations;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any Lien on any Property of any Obligor existing on the Original Closing
      Date and set forth in Schedule&#160;7.13B; <font style="font-style: italic;">provided</font> that (i)&#160;no such Lien shall extend to any other Property of such Obligor and (ii)&#160;any such Lien shall secure only those obligations which it secures on the
      Original Closing Date and extensions, renewals and replacements thereof that do not increase the outstanding principal amount thereof;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Liens securing Indebtedness permitted under Section&#160;9.01(h); <font style="font-style: italic;">provided</font> that such Liens are restricted solely to the collateral described in Section&#160;9.01(h);</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(d)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Liens imposed by Law which were incurred in the Ordinary Course of
      Business, including (but not limited to) carriers&#8217;, warehousemen&#8217;s, landlords&#8217; and mechanics&#8217; Liens, Liens relating to leasehold improvements and other similar liens arising in the Ordinary Course of Business and which (i)&#160;do not in the aggregate
      materially detract from the value of the Property subject thereto or materially impair the use thereof in the operations of the business of such Person or (ii)&#160;are being contested in good faith by appropriate proceedings, which proceedings have the
      effect of preventing the forfeiture or sale of the Property subject to such Liens and for which adequate reserves have been made if required substantially in accordance with IFRS;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(e)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Liens, pledges or deposits made in the Ordinary Course of Business in
      connection with bids, grant applications, Contracts, leases, appeal bonds, workers&#8217; compensation, unemployment insurance or other similar social security legislation;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(f)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Liens securing Taxes, assessments and other governmental charges, the
      payment of which is not yet due or is being contested in good faith by appropriate proceedings promptly initiated and diligently conducted and for which such reserve or other appropriate provisions, if any, as shall be required by IFRS shall have
      been made;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(g)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>servitudes, easements, rights of way, restrictions and other similar
      encumbrances on real Property imposed by applicable Laws and encumbrances consisting of zoning or building restrictions, easements, licenses, restrictions on the use of Property or minor imperfections in title thereto which, in the aggregate, are not
      material, and which do not in any case materially detract from the value of the Property subject thereto or materially interfere with the ordinary conduct of the business of any of the Obligors;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 88 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(h)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>bankers&#8217; Liens, rights of setoff and similar Liens incurred in the
      Ordinary Course of Business and arising in connection with the Obligors&#8217; Deposit Accounts or Securities Accounts held at financial institutions solely to secure payment of fees and similar costs and expenses of such financial institutions with
      respect to such accounts;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(i)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Liens in connection with transfers permitted under Section&#160;9.09;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(j)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any judgment Lien or Lien arising from decrees or attachments not
      constituting an Event of Default;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(k)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>leases or subleases of real property granted in the Ordinary Course of
      Business, and leases, subleases, nonexclusive licenses or sublicenses of personal property (other than Intellectual Property) granted in the Ordinary Course of Business;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(l)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Liens in favor of customs and revenue authorities arising as a matter of
      law to secure the payment of custom duties in connection with the importation of goods in the Ordinary Course of Business;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(m)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Liens on a Deposit Account of the Obligors and the cash and cash
      equivalents therein, in each case, securing Indebtedness described in Section&#160;9.01(l);</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(n)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Permitted Licenses solely to the extent that such Permitted License would
      constitute a Lien; and</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(o)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Liens securing Indebtedness permitted pursuant to Sections 9.01(r);</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">provided</font> that no Lien otherwise permitted under any of the foregoing Sections&#160;9.02(b), (c), (d), (e), (g), (h), (i), (k), (l)
      or (m) shall apply to any Material Intellectual Property and any Material WaveForm IP.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;9.03.</font><font style="font-family: 'Times New Roman';"><a name="Section9.03."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Fundamental Changes and Acquisitions.</font>&#160; Each Obligor will not, and will not permit any of its Subsidiaries to:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>enter into or consummate any transaction of merger, amalgamation, plan of
      arrangement, or consolidation, including without limitation, a reverse&#8209;triangular merger, or other similar transaction or series of related transactions;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>liquidate, wind up or dissolve itself (or suffer any liquidation, wind up
      or dissolution) (including in connection with any division or plan of division under Delaware law or any comparable event under a different jurisdiction&#8217;s laws), except as permitted by Section 9.03(c)(v); and</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>make or consummate any Acquisition or sell or issue any Disqualified
      Equity Interests except, in each case:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Investments permitted under Section&#160;9.05;</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 89 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Permitted Acquisitions for (A) an aggregate cash consideration not to exceed $2,500,000 and (B)
        total consideration not to exceed $5,000,000, in each case, for the duration of this Agreement; <font style="font-style: italic;">provided</font>, that any Obligor may make a Permitted Acquisition in excess of the consideration amounts set forth
        above, so long as the consideration for such Acquisition is funded with the proceeds of the Delayed Draw Term Loan;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the merger, amalgamation, plan of arrangement, or consolidation of any Obligor with or into any
        other Obligor, <font style="font-style: italic;">provided</font> that if a Borrower is a party to such merger, amalgamation, plan of arrangement, or consolidation, such Borrower shall be the surviving entity;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the merger, amalgamation, plan of arrangement, or consolidation of any Immaterial Foreign
        Subsidiary with or into any other Immaterial Foreign Subsidiary;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the liquidation, winding up or dissolution of the Subsidiaries listed in Schedule 9.03, any
        Immaterial Foreign Subsidiary and the Luxembourg Subsidiary; and</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Effective Date Acquisition.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;9.04<a name="Section9.04"><!--Anchor--></a>.</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Lines of Business.</font></font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each Obligor will not, and will not permit any of its Subsidiaries to,
      engage to any material extent in any business other than (i) the business engaged in on the Sixth Amendment Restatement Date by such Obligor, or (ii) a business reasonably related, incidental or complementary thereto or reasonable extensions thereof,
      including, without limitation, the development, acquisition, manufacture or marketing of biosensor products and related services.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Parent shall not have any material liabilities (other than liabilities to
      other Obligors and liabilities arising under the Loan Documents), own any material assets (other than Investments in its Subsidiaries) or engage in any material operations or business (other than the ownership of its Subsidiaries, exercising its
      rights and performing its obligations under (i) the Loan Documents, (ii) its obligations to other Obligors and (iii)&#160; Investments in Subsidiaries and activities reasonably incident to (i), (ii) and (iii)).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>U.S. Holdings shall not have any material liabilities (other than
      liabilities to other Obligors and liabilities arising under the Loan Documents), own any material assets (other than Investments in its Subsidiaries) or engage in any material operations or business (other than the ownership of its Subsidiaries,
      exercising its rights and performing its obligations under (i) the Loan Documents, (ii) its obligations to other Obligors and (iii)&#160; Investments in Subsidiaries and&#160; activities reasonably incident to (i), (ii) and (iii)).</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 90 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;9.05.<a name="Section9.05."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Investments.</font>&#160; Each Obligor will not, and will not permit any of its Subsidiaries to, make, directly or indirectly, or permit to remain outstanding any Investments except:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Investments outstanding on the Original Closing Date and identified in
      Schedule&#160;9.05(a) and any modification, replacement, renewal or extension thereof to the extent not involving new or additional Investments;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>operating Deposit Accounts with banks, Securities Accounts and
      Commodities Accounts;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>extensions of credit in the nature of accounts receivable or notes
      receivable arising from the sales of goods or services in the Ordinary Course of Business of the relevant Obligor;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(d)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Permitted Cash Equivalent Investments;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(e)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>(i)&#160; Investments consisting of the ownership of the Equity Interests of
      its Subsidiaries, (ii) intercompany Investments by an Obligor in any other Obligor or (iii) Investments by the Obligors and its Subsidiaries consisting of 100% of the ownership of the Equity Interests of the Person acquired in connection with a
      Permitted Acquisition and the Effective Date Acquisition;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(f)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Hedging Agreements entered into in the ordinary course of any Obligor&#8217;s
      financial planning solely to hedge interest rate or foreign currency exchange risks (and not, in either case, for speculative purposes);</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(g)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Investments consisting of prepaid expenses, negotiable instruments held
      for collection or deposit, security deposits with utilities, landlords and other like Persons, and deposits in connection with workers&#8217; compensation and similar deposits, in each case made in the Ordinary Course of Business;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(h)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Investments received in connection with any Insolvency Proceedings in
      respect of any customers, suppliers or clients and in settlement of delinquent obligations of, and other disputes with, customers, suppliers or clients;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(i)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Investments permitted under Section 9.01(e), Section 9.01(o) and
      Section&#160;9.03;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(j)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Investments consisting of notes receivable of, or prepaid royalties and
      other credit extensions, to customers and suppliers who are not Affiliates, in the Ordinary Course of Business;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(k)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Investments consisting of (i)&#160;travel advances and employee relocation
      loans and other employee loans and advances in the Ordinary Course of Business, and (ii)&#160;loans to employees, officers or directors relating to the purchase of equity securities of the Obligors pursuant to employee stock purchase plans or agreements
      made after the Original Closing Date approved by an Obligor&#8217;s Board in an aggregate amount not to exceed $250,000 for subclauses&#160;(i) and (ii) in any fiscal year;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 91 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(l)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>so long as no Default or Event of Default shall have occurred and is
      continuing at the time of such Investment and until such time as the Brazilian Subsidiary becomes a &#8220;Guarantor&#8221; hereunder, and a &#8220;Grantor&#8221; under the Security Agreement, Investments by an Obligor in the Brazilian Subsidiary in an aggregate amount not
      to exceed $1,500,000 in any fiscal year;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(m)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>so long as no Default or Event of Default shall have occurred and is
      continuing at the time of such Investment, Investments by Obligors in Immaterial Foreign Subsidiaries (other than the Brazilian Subsidiary), made after the Original Closing Date, in an aggregate amount not to exceed $1,000,000 in any fiscal year;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(n)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Investments by Immaterial Foreign Subsidiaries in other Immaterial
      Foreign Subsidiaries;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(o)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>[reserved];</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(p)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>so long as no Default or Event of Default shall have occurred and is
      continuing at the time of such Investment, or after giving effect thereto, other Investments made after the Original Closing Date in an amount not to exceed $500,000 in any fiscal year; and</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(q)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the imaware Convertible Note Investment.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;9.06.</font><font style="font-family: 'Times New Roman';"><a name="Section9.06."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Restricted Payments.</font>&#160; Each Obligor will not, and will not permit any of its Subsidiaries to, declare or make, or agree to pay or make, directly or indirectly, any Restricted Payment, other than:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>dividends or distributions with respect to any Equity Interests of Parent
      payable solely in additional units or shares of its Qualified Equity Interests;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any Restricted Payment by an Obligor or a Subsidiary of an Obligor to an
      Obligor;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any purchase, redemption, retirement, or other Acquisition by Parent or
      any of its Subsidiaries units or shares of its Equity Interests with the proceeds received from a substantially concurrent issue of new units or shares of its Equity Interests;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(d)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>cashless exercises of options and warrants;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(e)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>repurchases pursuant to the terms of employee stock purchase plans,
      employee restricted stock agreements, stockholder rights plans, director or consultant stock option plans, or similar plans in an aggregate amount not to exceed $500,000 in any fiscal year;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 92 -</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(f)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the making of cash payments in lieu of the issuance of fractional shares
      upon the conversion of convertible securities (or in connection with the exercise of warrants or similar securities) not to exceed $25,000 in any fiscal year;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(g)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the issuance of the Warrant Certificates; and</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(h)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>cash payments made to redeem, purchase, repurchase or retire the Warrant
      Obligations in accordance with the terms of the Warrant Certificates.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;9.07.</font><font style="font-family: 'Times New Roman';"><a name="Section9.07."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Payments of Indebtedness.</font>&#160; Each Obligor will not, and will not permit any of its Subsidiaries to, make any payments in respect of any Material Indebtedness other than (a)&#160;payments of the Obligations and (b)
        so long as no Default or Event of Default has occurred and is continuing or would result therefrom, (i) scheduled payments of other Permitted Indebtedness and repayment of intercompany Indebtedness permitted in reliance upon Section&#160;9.01(e)
        (subject in each case to any subordination agreement entered into in connection therewith), (ii) regularly scheduled payments of interest on the Outstanding Convertible Notes and the repayment in full of the principal amount of the Outstanding
        Convertible Notes, (iii) regularly scheduled payments of interest on the Investor Convertible Note, subject to the Investor Subordination Agreement and (iv) the conversion of the principal amount of the Investor Convertible Note into Qualified
        Equity Interests of Parent.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;9.08.</font><font style="font-family: 'Times New Roman';"> <a name="Section9.08."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Change in Fiscal Year.</font>&#160; Each Obligor will not change the last day of its fiscal year from that in effect on the date hereof, without prior written notice to the Administrative Agent, except to change the
        fiscal year of a Subsidiary acquired in connection with a Permitted Acquisition to conform its fiscal year to that of Parent.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;9.09.</font><font style="font-family: 'Times New Roman';"> <a name="Section9.09."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;



        <font style="font-style: italic;">Sales of Assets, Etc.</font>&#160; Each Obligor will not, and will not permit any of its Subsidiaries to, sell, lease, exclusively license (in terms of geography or field of use), as a licensor, transfer (including in
        connection with any division or plan of division under Delaware law or any comparable event under a different jurisdiction&#8217;s laws) or otherwise dispose of any of its Property (including accounts receivable and Equity Interests of Subsidiaries), or
        forgive, release or compromise any amount owed to any Obligor or any of its Subsidiaries, in each case, in one transaction or series of transactions (any thereof, an <font style="font-style: italic;">&#8220;Asset Sale&#8221;</font>), except:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>transfers of cash in the Ordinary Course of Business for equivalent
      value;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>sales or leases of inventory in the Ordinary Course of Business;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the forgiveness, release or compromise of any amount owed to any Obligor
      or any of its Subsidiaries in the Ordinary Course of Business;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(d)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>entering into, or becoming bound, by a Permitted License to the extent
      not otherwise prohibited by this Agreement;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(e)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>development and other collaborative arrangements where such&#160; arrangements
      provide for the license or disclosure of Patents, Trademarks, Copyrights or other Intellectual Property rights of any Obligor or any of its Subsidiaries in the Ordinary Course of Business and consistent with general market practices; <font style="font-style: italic;">provided</font> that (i) such licenses must be true licenses that do not result in a legal transfer of title of the licensed Property or otherwise constitute sales transactions in substance and (ii) the aggregate amount
      of such periodic payments to the Obligors and its Subsidiaries in any fiscal year shall not exceed $500,000;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 93 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(f)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>a sale, lease, exclusive license, transfer or other disposition
      (including by way of abandonment, cancellation or trade-in) of any Property that is obsolete, worn out, surplus or no longer used or useful in connection with the business of the Obligors and its Subsidiaries or with respect to which a newer and
      improved version is available;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(g)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>dispositions resulting from Casualty Events;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(h)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any transaction permitted under Section&#160;9.02, 9.03, 9.05. 9.10 and 9.20;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(i)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>a sale, transfer or other disposition (including by way of abandonment,
      cancellation or trade-in) of any Property of an Immaterial Foreign Subsidiary in connection with the liquidation, wind up or dissolution of such Immaterial Foreign Subsidiary;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(j)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>so long as no Default or Event of Default shall have occurred and is
      continuing at the time of such Asset Sale, or after giving effect thereto, Asset Sales of other property not to exceed $3,000,000 in the aggregate per fiscal year;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(k)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the Fitzgerald and Benen Sale;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(l)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>so long as no Default or Event of Default shall have occurred and is
      continuing at the time of such Asset Sale, licenses and other Asset Sales made in connection with Partner Agreements; and</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(m)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the sale of WaveForm Slovenia to WaveForm in the event of an FDI
      Rejection (as defined in the WaveForm Slovenia Side Agreement) pursuant to the terms of the WaveForm Slovenia Side Agreement.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;9.10.</font><font style="font-family: 'Times New Roman';"><a name="Section9.10."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Transactions with Affiliates.</font>&#160; Each Obligor will not, and will not permit any of its Subsidiaries to, sell, lease, license or otherwise transfer any assets to, or purchase, lease, license or otherwise
        acquire any assets from, or otherwise engage in any other transactions with, any of its Affiliates, except:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>transactions between or among the Obligors;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any transaction permitted under Section&#160;9.01, 9.03, 9.05, 9.06 or 9.09;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>customary compensation and indemnification of, and other employment
      arrangements with, directors, officers and employees of any Obligor in the Ordinary Course of Business;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 94 -</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(d)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>transactions upon fair and reasonable terms that are no less favorable to
      any Obligor than would be obtained in a comparable arm&#8217;s&#8209;length transaction with a Person not an Affiliate;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(e)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the transactions set forth on Schedule&#160;9.10; and</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(f)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the Bray Leases.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;9.11.</font><font style="font-family: 'Times New Roman';"> <a name="Section9.11."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Restrictive Agreements.</font>&#160; Each Obligor will not, and will not permit any of its Subsidiaries to, directly or indirectly, enter into, incur or permit to exist any Restrictive Agreement other than
        (a)&#160;restrictions and conditions imposed by Law or by the Loan Documents, (b)&#160;Restrictive Agreements listed on Schedule 7.15, (c) any stockholder agreement or investor rights agreement, or other Organizational Documents of an Obligor as in effect on
        the date hereof or (d)&#160;limitations associated with Permitted Liens or with any transaction permitted under Section&#160;9.01, 9.03, 9.05, 9.06 or 9.09.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;9.12.<a name="Section9.12."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Organizational Documents, Material Agreements</font>.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each Obligor will not enter into any amendment to or modification of any
      Organizational Document without the prior written consent of the Administrative Agent.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each Obligor will not (i)&#160;enter into any material waiver, amendment or
      modification of any Material Agreement (including, but not limited to, any amendments to provisions relating to pricing and term) that would be reasonably expected to adversely affect the Lenders in any material respect or (ii)&#160;take or omit to take
      any action that results in the termination of, or permits any other Person to terminate, any Material Agreement, Material Intellectual Property or Material WaveForm IP that would be reasonably expected to have a Material Adverse Effect, without, in
      each case, the prior written consent of the Administrative Agent, such consent not to be unreasonably withheld or delayed.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each Obligor will not enter into any amendment to or modification of the
      Bray Leases, which is less favorable to the Obligors, without the prior written consent of the Administrative Agent.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(d)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each Obligor will not enter into any amendment to or modification of the
      Investor Convertible Note that is in violation of the Investor Subordination Agreement without the prior written consent of the Administrative Agent.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(e)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each Obligor will not&#160;enter into any material waiver, amendment or
      modification of the Effective Date Acquisition Agreement or the Waveform Slovenia Side Agreement (including, but not limited to, any amendments to provisions relating to pricing, term and any contingent payments) that would be reasonably expected to
      adversely affect the Lenders in any material respect, without, in each case, the prior written consent of the Administrative Agent.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;9.13.<a name="Section9.13."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">[Reserved]</font>.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;9.14.<a name="Section9.14."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Sales and Leasebacks.</font>&#160; Except as permitted by Section&#160;9.01(h), each Obligor will not, and will not permit any of its Subsidiaries to, become liable, directly or indirectly, with respect to any lease, whether
        an operating lease or a Capital Lease Obligation, of any Property (whether real, personal, or mixed), whether now owned or hereafter acquired, (i)&#160;which any Obligor or such Subsidiary has sold or transferred or is to sell or transfer to any other
        Person and (ii)&#160;which any Obligor or such Subsidiary intends to use for substantially the same purposes as Property which has been or is to be sold or transferred.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 95 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;9.15.<a name="Section9.15."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Hazardous Material.</font>&#160; Each Obligor will not, use, generate, manufacture, install, treat, release, store or dispose of any Hazardous Material, except in compliance with all applicable Environmental Laws or where
        the failure to comply would not reasonably be expected to result in a Material Adverse Change.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;9.16.</font><font style="font-family: 'Times New Roman';"> <a name="Section9.16."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;



        <font style="font-style: italic;">Accounting Changes.</font>&#160; Except as required or permitted by IFRS, each Obligor will not make any significant change in accounting treatment without the consent of the Lenders, such consent not be unreasonably
        withheld or delayed.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;9.17.</font><font style="font-family: 'Times New Roman';"><a name="Section9.17."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Compliance with ERISA.</font>&#160; No ERISA Affiliate of any Obligor shall cause (a)&#160;any event that would result in the imposition of a Lien with respect to any Title&#160;IV Plan or Multiemployer Plan or (b)&#160;any other
        ERISA Event that would, in the aggregate, have a Material Adverse Effect.&#160; No Obligor shall cause or suffer to exist any event that could result in the imposition of a Lien with respect to any Benefit Plan that would have a Material Adverse Effect.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;9.18.</font><font style="font-family: 'Times New Roman';"><a name="Section9.18."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Deposit Accounts.</font>&#160;&#160; Each Obligor will not establish or maintain any bank account (other than an Excluded Account) that is not a Controlled Account and will not deposit proceeds in a bank account that is not
        a Controlled Account (other than an Excluded Account).</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;9.19.</font><font style="font-family: 'Times New Roman';"> <a name="Section9.19."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Outbound Licenses.</font>&#160; Each Obligor will not enter into or become bound by any outbound license or agreement for use of such Obligor&#8217;s Intellectual Property unless such outbound license or agreement is a
        Permitted License.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;9.20.<a name="Section9.20."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Inbound Licenses.</font>&#160; Each Obligor will not enter into or become bound by any inbound license or agreement (other than Permitted Licenses) for aggregate consideration paid for all such inbound licenses entered
        into pursuant to this Section 9.20 in excess of $2,500,000 per fiscal year unless (a) no Default has occurred and is continuing and (b) if the license or agreement is with an Obligor, such Obligor has taken such commercially reasonable actions as
        the Administrative Agent may reasonably request to obtain the consent of, or waiver by, any Person whose consent or waiver is necessary for the Administrative Agent to be granted a valid and perfected security interest in such license or agreement
        and to allow the Administrative Agent to fully exercise its rights under any of the Loan Documents in the event of a disposition or liquidation of the rights, assets or property that is the subject of such license or agreement.&#160; The Administrative
        Borrower shall provide written notice to the Administrative Agent of the material terms of such license or agreement with a description of its anticipated and projected impact on such Person&#8217;s business or financial condition.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;9.21.</font><font style="font-family: 'Times New Roman';"><a name="Section9.21."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Non-Commingling</font>.&#160; Each Obligor will not commingle its funds or assets with those of any other entity, other than the Obligors, which is an Affiliate of such entity.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;9.22.</font><font style="font-family: 'Times New Roman';"><a name="Section9.22."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Canadian Defined Benefit Pension Plans</font>.&#160; Each Obligor will not contribute to, administrate, maintain, terminate, or underfund a Canadian Defined Benefit Pension Plan.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 96 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps; font-weight: bold;"><a name="Article10"><!--Anchor--></a>Article 10<br>
      <br>
      Events of Default</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;10.01.</font><font style="font-family: 'Times New Roman';"><a name="Section10.01."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;



        <font style="font-style: italic;">Events of Default.</font>&#160; Each of the following events shall constitute an <font style="font-style: italic;">&#8220;Event of Default&#8221;</font>:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the Borrowers shall fail to pay any principal on the Term Loans when and
      as the same shall become due and payable, whether at the due date thereof or at a date fixed for mandatory prepayment thereof or otherwise; or</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any Obligor shall fail to pay any Obligation (other than an amount
      referred to in Section&#160;10.01(a)) when and as the same shall become due and payable, and such failure shall continue unremedied for a period of three (3) Business Days; or</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any representation or warranty made by or on behalf of an Obligor or any
      of its Subsidiaries (as applicable) in or in connection with this Agreement or any other Loan Document or any amendment or modification hereof or thereof, or in any report, certificate, financial statement or other document furnished pursuant to or
      in connection with this Agreement or any other Loan Document or any amendment or modification hereof or thereof, shall: (i)&#160;prove to have been incorrect when made or deemed made to the extent that such representation or warranty contains any
      materiality or Material Adverse Effect qualifier; or (ii)&#160;prove to have been incorrect in any material respect when made or deemed made to the extent that such representation or warranty does not otherwise contain any materiality or Material Adverse
      Effect qualifier; or</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(d)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any Obligor shall fail to observe or perform any covenant, condition or
      agreement contained in Sections&#160;8.01(a)-(d), 8.02(a) and (b), 8.03(a) (with respect to such Obligor&#8217;s existence), 8.10, 8.11, 8.13, 8.15, 8.16, 8.17, 8.18, 8.19, or Article 9; or</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(e)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any Obligor shall fail to observe or perform any covenant, condition or
      agreement contained in Section 8.01 (other than in clauses (a)-(d)) and 8.02 (other than in clauses (a) and (b)), and, in the case of any failure that is capable of cure, such failure shall continue unremedied for a period of ten (10) or more days;
      or</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(f)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any Obligor shall fail to observe or perform any covenant, condition or
      agreement contained in this Agreement (other than those specified in Section&#160;10.01(a), (b), (d) or (e)) or any other Loan Document, and, in the case of any failure that is capable of cure, such failure shall continue unremedied for a period of thirty
      (30) or more days; or</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 97 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(g)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any Obligor shall fail to make any payment (whether of principal or
      interest and regardless of amount) in respect of any Material Indebtedness (other than with respect to Item 4 in Schedule 7.13A, so long as such non-payment is subject to a bona fide dispute contested in good faith by appropriate proceedings and for
      which such Obligor has set aside on its books adequate reserves with respect thereto substantially in accordance with IFRS), when and as the same shall become due and payable after giving effect to any applicable grace or cure period as originally
      provided by the terms of such Indebtedness; or</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(h)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font> (i) any material breach of, or &#8220;event of default&#8221; or similar event
      under, the Contract governing any Material Indebtedness shall occur and such breach or &#8220;event of default&#8221; or similar event shall continue unremedied, uncured or unwaived after a period of five&#160;(5) Business Days after the expiration of any cure period
      thereunder, or (ii)&#160;any event or condition occurs (A)&#160;that results in any Material Indebtedness becoming due prior to its scheduled maturity or (B)&#160;that enables or permits (with or without the giving of notice, the lapse of time or both) the holder
      or holders of such Material Indebtedness or any trustee or agent on its or their behalf to cause such Material Indebtedness to become due, or to require the prepayment, repurchase, redemption or defeasance thereof, prior to its scheduled maturity; <font style="font-style: italic;">provided</font> that this Section&#160;10.01(h) shall not apply to secured Indebtedness that becomes due as a result of the voluntary sale or transfer of the Property securing such Material Indebtedness; or</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(i)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any Obligor:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;generally does not or becomes unable to pay its debts or meet its liabilities as the same become
        due, or admits in writing its inability to pay its debts generally, or declares any general moratorium on its Indebtedness, or proposes a compromise or arrangement or deed of company arrangement between it and any class of its creditors; or</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;shall (A) voluntarily commence any proceeding or file any petition seeking liquidation,
        reorganization or other relief under any United States federal, state, provincial, territorial, Canadian federal, or other foreign bankruptcy, insolvency, receivership or similar law now or hereafter in effect, (B) consent to the institution of, or
        fail to contest in a timely and appropriate manner, any proceeding or petition described in Section 10.01(j), (C)&#160;apply for or consent to the appointment of a receiver, receiver and manager, interim receiver, manager, liquidator, trustee,
        custodian, sequestrator, conservator or similar official for an Obligor or for a substantial part of its assets, (D) file an answer admitting the material allegations of a petition filed against it in any such proceeding, (E) make a general
        assignment for the benefit of creditors or (F) take any action for the purpose of effecting any of the foregoing; or</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(j)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>an involuntary proceeding shall be commenced or an involuntary petition
      shall be filed seeking (i)&#160;liquidation, reorganization or other relief in respect of an Obligor or its debts, or of a substantial part of its assets, under any United States federal, state, provincial, territorial, Canadian federal, or other foreign
      bankruptcy, insolvency, receivership or similar law now or hereafter in effect or (ii)&#160;the appointment of a receiver, receiver and manager, interim receiver, manager, liquidator, trustee, custodian, sequestrator, conservator or similar official for
      an Obligor or for a substantial part of its assets, and, in any such case, such proceeding or petition shall continue undismissed for sixty (60)&#160;days or an order or decree approving or ordering any of the foregoing shall be entered; or</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 98 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(k)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>one or more judgments for the payment of money in an aggregate amount in
      excess of $1,000,000 (excluding any amounts covered by insurance as to which the applicable carrier has accepted coverage) shall be rendered against any Obligor or any combination thereof and the same shall remain undischarged for a period of
      forty-five (45)&#160;consecutive days during which execution shall not be effectively stayed, or any action shall be legally taken by a judgment creditor to attach or levy upon any assets of any Obligor to enforce any such judgment; or</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(l)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>(i) an ERISA Event shall have occurred that, in the reasonable opinion of
      the Lenders, when taken together with all other ERISA Events that have occurred, would reasonably be expected to have a Material Adverse Effect or (ii) the institution of any steps by any Obligor or any applicable regulatory authority to terminate a
      Canadian Pension Plan<font style="font-weight: bold;">&#160;</font>if such termination would reasonably be expected to have a Material Adverse Effect; or</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(m)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>a Change of Control shall have occurred; or</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(n)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>[Reserved]; or</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(o)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>a Material Adverse Change shall have occurred; or</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(p)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>(i)&#160;any Lien created by any of the Security Documents shall at any time
      not constitute a valid and perfected Lien in favor of the Administrative Agent on Collateral with an aggregate value in excess of $1,000,000, free and clear of all other Liens (other than Permitted Liens) except due to the action or inaction of the
      Administrative Agent or any Lender(s), (ii)&#160;except for expiration in accordance with its terms and except due to the action or inaction of the Administrative Agent or any Lender(s), the Security Documents or any Guarantee of any of the Obligations
      shall for whatever reason cease to be in full force and effect, or (iii)&#160;any of the Security Documents or any Guarantee of any of the Obligations, or the enforceability thereof, shall be repudiated or contested by any Obligor; or</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(q)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any injunction, whether temporary or permanent, shall be rendered against
      any Obligor that prevents the Obligors from selling or manufacturing any Product that has a Material Adverse Effect; or</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(r) <font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>(i)&#160;the FDA or any other Governmental Authority (A)&#160;issues a letter or
      other communication asserting that any Product lacks a required Product Authorization (other than the revocation of any emergency use authorization), including in respect of CE marks or 510(k)s or (B)&#160;initiates enforcement action against, or issues a
      warning letter with respect to, any Obligor, or any of their Products or the manufacturing facilities therefor, that causes any Obligor thereof to discontinue marketing or withdraw any of its Products, or causes a delay in the manufacture of any of
      its Products, which discontinuance, withdrawal or delay would reasonably be expected to last for more than ninety (90)&#160;days, (ii) any Permit relating to any Product (including all Product Authorizations), or any of the Obligors&#8217; material rights or
      interests thereunder, is terminated, adversely amended or otherwise determined to be ineffective in any manner materially adverse to any of the Obligors, in each case, for more than ninety (90) days,&#160; (iii)&#160;there is a recall of any Product in any
      territory in the case of (i) or (ii) that would reasonably be expected to result in a loss of revenue equal to at least $3,000,000 over the twelve (12) month period following such event or (iv)&#160;any Obligor thereof enters into a settlement agreement
      with the FDA or any other Governmental Authority that results in aggregate liability as to any single or related series of transactions, incidents or conditions, in excess of $3,000,000 and such settlement remains unpaid past the payment date
      therefor.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 99 -</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;10.02.</font><font style="font-family: 'Times New Roman';"><a name="Section10.02."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;



        <font style="font-style: italic;">Remedies</font>.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Upon the occurrence of any Event of Default, then, and in every such
      event (other than an Event of Default described in Section&#160;10.01(i) or (j)), and at any time thereafter during the continuance of such event, the Majority Lenders may, by notice to the Administrative Borrower, take either or both of the following
      actions, at the same or different times: (i) terminate the Commitments, and thereupon the Commitments shall terminate immediately, and (ii) declare the Term Loans then outstanding to be due and payable in whole (or in part, in which case any
      principal not so declared to be due and payable may thereafter be declared to be due and payable), and thereupon the principal of the Term Loans so declared to be due and payable, together with accrued interest thereon and all fees and other
      Obligations, shall become due and payable immediately (in the case of the Term Loans, at the Redemption Price therefor), without presentment, demand, protest or other notice of any kind, all of which are hereby waived by each Obligor.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Upon the occurrence of any Event of Default described in Section&#160;10.01(i)
      or (j), the Commitments shall automatically terminate and the principal amount of the Term Loans then outstanding, together with accrued interest thereon and all fees and other Obligations, shall automatically become due and payable immediately (in
      the case of the Term Loans, at the Redemption Price therefor), without presentment, demand, protest or other notice of any kind, all of which are hereby waived by each Obligor.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If any Lender collects any money or property pursuant to this Article 10,
      they shall pay out the money or property in the order set forth in Section&#160;4.01(b).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;10.03.<a name="Section10.03."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Prepayment Premium and Redemption Price.</font>&#160; For the avoidance of doubt, the Prepayment Premium (as a component of the Redemption Price) shall be due and payable at any time the Term Loans become due and
        payable prior to the Stated Maturity Date for any reason, whether due to acceleration pursuant to the terms of this Agreement (in which case it shall be due immediately, upon the giving of notice to the Administrative Borrower in accordance with
        Section&#160;10.02(a), or automatically, in accordance with Section&#160;10.02(b)), by operation of law or otherwise (including, without limitation, on account of any bankruptcy filing).&#160; In view of the impracticability and extreme difficulty of ascertaining
        the actual amount of damages to the Lenders or profits lost by the Lenders as a result of such acceleration, and by mutual agreement of the parties as to a reasonable estimation and calculation of the lost profits or damages of the Lenders, and any
        Prepayment Premium shall be due and payable upon such date.&#160; Each Obligor hereby waives any defense to payment, whether such defense may be based in public policy, ambiguity, or otherwise.&#160; The Obligors and the Lenders acknowledge and agree that
        any Prepayment Premium due and payable in accordance with this Agreement shall not constitute unmatured interest, whether under Section&#160;502(b)(2) of the Bankruptcy Code or otherwise.&#160; Each Obligor further acknowledges and agrees, and waives any
        argument to the contrary, that payment of such amount does not constitute a penalty or an otherwise unenforceable or invalid obligation.</font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 100 -</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps; font-weight: bold;"><a name="Article11"><!--Anchor--></a>Article&#160;11<br>
      <br>
      Guarantee</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;11.01.<a name="Section11.01."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;



        <font style="font-style: italic;">The Guarantee.</font>&#160; The Guarantors hereby jointly and severally guarantee to the Administrative Agent and each Lender, and their respective successors and assigns, the prompt payment in full when due (whether at
        stated maturity, by acceleration or otherwise) of the principal of and interest on the Term Loans, all fees and other amounts and Obligations from time to time owing to the Administrative Agent and any Lender by the Borrowers under this Agreement
        or under any other Loan Document and by any other Obligor under any of the Loan Documents, in each case strictly in accordance with the terms thereof (such obligations being herein collectively called the <font style="font-style: italic;">&#8220;Guaranteed


          Obligations&#8221;</font>).&#160; The Guarantors hereby further jointly and severally agree that if the Borrowers shall fail to pay in full when due (whether at stated maturity, by acceleration or otherwise) any of the Guaranteed Obligations, the Guarantors
        will promptly pay the same, without any demand or notice whatsoever, and that in the case of any extension of time of payment or renewal of any of the Guaranteed Obligations, the same will be promptly paid in full when due (whether at extended
        maturity, by acceleration or otherwise) in accordance with the terms of such extension or renewal.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;11.02.<a name="Section11.02."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Obligations Unconditional.</font>&#160; The Obligations of the Guarantors under Section&#160;11.01 are irrevocable, continuing, absolute and unconditional, joint and several, irrespective of the value, genuineness, validity,
        regularity or enforceability of the obligations of the Borrowers under this Agreement or any other agreement or instrument referred to herein, or any substitution, release or exchange of any other guarantee of or security for any of the Guaranteed
        Obligations, and, to the fullest extent permitted by applicable Law, irrespective of any other circumstance whatsoever that might otherwise constitute a legal or equitable discharge or defense of a surety or Guarantor, it being the intent of this
        Section&#160;11.02 that the Obligations of the Guarantors hereunder shall be absolute and unconditional, joint and several, under any and all circumstances.&#160; Without limiting the generality of the foregoing, it is agreed that the occurrence of any one
        or more of the following shall not alter or impair the liability of the Guarantors hereunder, which shall remain absolute and unconditional as described above:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>at any time or from time to time, without notice to the Guarantors, the
      time for any performance of or compliance with any of the Guaranteed Obligations shall be extended, or such performance or compliance shall be waived;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any of the acts mentioned in any of the provisions of this Agreement or
      any other agreement or instrument referred to herein shall be done or omitted;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 101 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the maturity of any of the Guaranteed Obligations shall be accelerated,
      or any of the Guaranteed Obligations shall be modified, supplemented or amended in any respect (including, without limitation, any modification, supplement, or amendment that results in any increase in the Guaranteed Obligations, any change in the
      interest or fees payable, any renewal, extension, amendment, rescission, waiver, release, discharge, indulgence, compromise, arrangement, or any other variation in connection with the Guaranteed Obligations, any Loan Document, or any other
      agreement), or any right under this Agreement or any other agreement or instrument referred to herein shall be waived or any other Guarantee of any of the Guaranteed Obligations or any security therefor shall be released or exchanged in whole or in
      part or otherwise dealt with;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(d)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any Lien or security interest granted to, or in favor of, any Lender as
      security for any of the Guaranteed Obligations shall fail to be perfected or otherwise be taken, exchanged, substituted, varied, released, impaired, or subordinated;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(e) <font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any Guarantee of the Guaranteed Obligations shall be taken, released,
      impaired, amended, waived or otherwise modified;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(f)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any of the Guaranteed Obligations, any Loan Document, or any related
      agreement, security, or instrument shall be illegal, invalid or unenforceable for any reason whatsoever;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(g)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any Collateral or other assets shall be sold or disposed, and/or the
      proceeds of such sale or disposition applied, to satisfy all or part of the Guaranteed Obligations;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(h)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any of the security or Collateral held for the Guaranteed Obligations
      shall lose or diminish in value, whether such loss or diminution arises from any act or omission of the Administrative Agent or any Lender;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(i)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>there shall be any Default, failure, or delay, willful or otherwise, in
      the payment and/or performance of the Guaranteed Obligations;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(j)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>there shall be any change, restructuring or termination of the corporate
      structure, ownership or existence of any Obligor or any of its Subsidiaries or any insolvency, bankruptcy, reorganization or other similar proceeding affecting any Obligor or its assets or any resulting restructuring, compromise, release or discharge
      of any Guaranteed Obligations;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(k)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>there shall be any failure of any of the Administrative Agent or any
      Lender to disclose to any Obligor any information relating to the business, condition (financial or otherwise), operations, performance, properties or prospects of any other Obligor, or any other information now or hereafter known to the
      Administrative Agent or such Lender;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(l)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any person shall fail to execute or deliver this Agreement (including the
      Guarantee in this Article 11) or any other&#160;Guarantee&#160;or agreement or the release or reduction of liability of any Obligor or surety with respect to the Guaranteed Obligations;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 102 -</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(m)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any of the Administrative Agent or any Lender shall fail to assert any
      claim or demand or to exercise or enforce any right or remedy under the provisions of any Loan Document or otherwise;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(n)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any Obligor shall assert any defense, set-off or counterclaim (other than
      a defense of payment or performance) that may at any time be available to, or be asserted by, such against any of the Administrative Agent or any Lender; or</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(o)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>any other circumstance (including, without limitation, any statute of
      limitations) or manner of administering the Guaranteed Obligations shall exist or occur, or any of the Administrative Agent or any Lender shall rely on any representation, in each case, that might vary the risk of any Obligor or otherwise operate as
      a defense available to, or a legal or equitable discharge of, any Obligor or surety.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">The Guarantors hereby expressly waive diligence, presentment, demand of payment, demand for performance, protest, dishonor, promptness, presentment,
      default, acceleration, and all notices whatsoever (including, without limitation, notice of non-performance and notice of acceptance), and any requirement that the Administrative Agent or any Lender exhaust any right, power or remedy or proceed
      against the Borrowers under this Agreement or any other agreement or instrument referred to herein, or against any other Person under any other Guarantee of, or security for, any of the Guaranteed Obligations. Without limiting the generality of the
      foregoing, the Administrative Agent and the Lenders may resort to the Guarantors for payment and performance of the Guaranteed Obligations whether or not the Administrative Agent and the Lenders shall have resorted to any Collateral therefor or shall
      have proceeded against any Borrower or any other Obligors or guarantors with respect to the Guaranteed Obligations. The Administrative Agent and the Lenders may, at their option, proceed against the Guarantors and the Borrowers, jointly and
      severally, or against one or more Guarantors only without having obtained a judgment against any Borrower.&#160;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;11.03.<a name="Section11.03."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;



        <font style="font-style: italic;">Reinstatement.</font>&#160; The obligations of the Guarantors under this Article&#160;11 shall be automatically reinstated if and to the extent that for any reason any payment by or on behalf of the Borrowers in respect of
        the Guaranteed Obligations is rescinded or must be otherwise restored by any holder of any of the Guaranteed Obligations, whether as a result of any proceedings in bankruptcy or reorganization or otherwise, and the Guarantors jointly and severally
        agree that they will indemnify the Administrative Agent and each Lender on demand for all reasonable costs and expenses (including reasonable fees of counsel) incurred by such Persons in connection with such rescission or restoration, including any
        such reasonable costs and expenses incurred in defending against any Claim alleging that such payment constituted a preference, fraudulent transfer or similar payment under any bankruptcy, insolvency or similar Law.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;11.04.</font><font style="font-family: 'Times New Roman';"><a name="Section11.04."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Subrogation.</font>&#160; The Guarantors hereby jointly and severally agree that, until the payment and satisfaction in full of all Guaranteed Obligations (other than the Warrant Obligations and inchoate indemnity
        obligations) and the expiration and termination of the Commitments, they shall not exercise any right or remedy arising by reason of any performance by them of their Guarantee in Section&#160;11.01, whether by subrogation or otherwise, against the
        Borrowers or any other guarantor of any of the Guaranteed Obligations or any security for any of the Guaranteed Obligations.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 103 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;11.05.</font><font style="font-family: 'Times New Roman';"><a name="Section11.05."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Remedies.</font>&#160; The Guarantors jointly and severally agree that, as between the Guarantors, on one hand, and the Lenders, on the other hand, the obligations of the Borrowers under this Agreement and under the other
        Loan Documents may be declared to be forthwith due and payable as provided in Article&#160;10 (and shall be deemed to have become automatically due and payable in the circumstances provided in Article&#160;10) for purposes of Section&#160;11.01 notwithstanding
        any stay, injunction or other prohibition preventing such declaration (or such obligations from becoming automatically due and payable) as against the Borrowers and that, in the event of such declaration (or such obligations being deemed to have
        become automatically due and payable), such obligations (whether or not due and payable by the Borrowers) shall forthwith become due and payable by the Guarantors for purposes of Section&#160;11.01.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;11.06.</font><font style="font-family: 'Times New Roman';"> <a name="Section11.06."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Instrument for the Payment of Money.</font>&#160; Each Guarantor hereby acknowledges that the Guarantee in this Article&#160;11 constitutes an instrument for the payment of money, and consents and agrees that each Lender, at
        its sole option, in the event of a dispute by such Guarantor in the payment of any moneys due hereunder, shall have the right to proceed by motion for summary judgment in lieu of complaint pursuant to N.Y. Civ. Prac. L&amp;R &#167;&#160;3213.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;11.07.</font><font style="font-family: 'Times New Roman';"><a name="Section11.07."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Continuing Guarantee.</font>&#160; The Guarantee in this Article&#160;11 is a continuing guarantee, and shall apply to all Guaranteed Obligations whenever arising. Without limiting the generality of the foregoing, the Guarantors
        hereby unconditionally and irrevocably waive any right to revoke this&#160;Guarantee in this Article 11&#160;and acknowledge that the Guarantee in this Article 11 is continuing in nature, shall&#160;guarantee&#160;any ultimate balance owing to any of the
        Administrative Agent or any Lender, and applies to all presently existing and future Guaranteed Obligations, until the complete, irrevocable and indefeasible payment and satisfaction in full of the Guaranteed Obligations.&#160;The Guarantee in this
        Article 11 shall continue to apply to all Guaranteed Obligations owing to the Administrative Agent and the Lenders by any entity resulting from any Obligor merging, amalgamating, or otherwise entering into any other business combination transaction
        with one or more other entities.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;11.08.<a name="Section11.08."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;



        <font style="font-style: italic;">Rights of Contribution.</font>&#160; The Guarantors hereby agree, as between themselves, that if any Guarantor shall become an Excess Funding Guarantor (as defined below) by reason of the payment by such Guarantor of
        any Guaranteed Obligations, each other Guarantor shall, on demand of such Excess Funding Guarantor (but subject to the next sentence), pay to such Excess Funding Guarantor an amount equal to such Guarantor&#8217;s Pro Rata Share (as defined below and
        determined, for this purpose, without reference to the properties, debts and liabilities of such Excess Funding Guarantor) of the Excess Payment (as defined below) in respect of such Guaranteed Obligations.&#160; The payment obligation of a Guarantor to
        any Excess Funding Guarantor under this Section&#160;11.08 shall be subordinate and subject in right of payment to the prior payment in full of the obligations of such Guarantor under the other provisions of this Article&#160;11 and such Excess Funding
        Guarantor shall not exercise any right or remedy with respect to such excess until payment and satisfaction in full of all of such obligations.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 104 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">For purposes of this Section&#160;11.08, (a) <font style="font-style: italic;">&#8220;Excess Funding Guarantor&#8221;</font> means, in respect of any Guaranteed
      Obligations, a Guarantor that has paid an amount in excess of its Pro Rata Share of such Guaranteed Obligations, (b) <font style="font-style: italic;">&#8220;Excess Payment&#8221;</font> means, in respect of any Guaranteed Obligations, the amount paid by an
      Excess Funding Guarantor in excess of its Pro Rata Share of such Guaranteed Obligations and (c) <font style="font-style: italic;">&#8220;Pro Rata Share&#8221;</font> means, as of the date of determination, for any Guarantor, the ratio (expressed as a
      percentage) of (i)&#160;the amount by which the aggregate present fair saleable value of all properties of such Guarantor (excluding any shares of stock of any other Guarantor) exceeds the amount of all the debts and liabilities of such Guarantor
      (including contingent, subordinated, unmatured and unliquidated liabilities, but excluding the obligations of such Guarantor hereunder and any obligations of any other Guarantor that have been guaranteed by such Guarantor) to (ii)&#160;the amount by which
      the aggregate fair saleable value of all properties of all of the Guarantors exceeds the amount of all the debts and liabilities (including contingent, subordinated, unmatured and unliquidated liabilities, but excluding the obligations of the
      Borrowers and the Guarantors hereunder and under the other Loan Documents) of all of the Guarantors, determined (A)&#160;with respect to any Guarantor that is a party hereto on the Original Closing Date, as of such date, and (B)&#160;with respect to any other
      Guarantor, as of the date such Guarantor becomes a Guarantor hereunder.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;11.09.<a name="Section11.09."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">General Limitation on Guarantee Obligations.</font>&#160; In any action or proceeding involving any provincial, territorial, foreign or state corporate Law, or any state, federal, provincial, territorial, or foreign
        bankruptcy, insolvency, reorganization or other Law affecting the rights of creditors generally, if the obligations of any Guarantor under Section&#160;11.01 would otherwise, taking into account the provisions of Section&#160;11.08, be held or determined to
        be void, invalid or unenforceable, or subordinated to the Claims of any other creditors, on account of the amount of its liability under Section&#160;11.01, then, notwithstanding any other provision hereof to the contrary, the amount of such liability
        shall, without any further action by such Guarantor, the Administrative Agent, the Lenders or any other Person, be automatically limited and reduced to the highest amount that is valid and enforceable and not subordinated to the Claims of other
        creditors as determined in such action or proceeding.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section 11.10.<a name="Section11.10."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;



        <font style="font-style: italic;">Irish Limitation on Guarantee Obligations</font>.&#160; The obligations of each Irish Obligor under Section 11.01 shall be deemed not to be undertaken or incurred to the extent the same would:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>constitute unlawful financial assistance prohibited by section 82 of the
      Companies Act 2014 of Ireland; or</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>constitute a breach of section 239 of the Companies Act 2014 of Ireland,</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-style: italic;">provided </font>that (in the case of both (a) and (b) above), for the avoidance of doubt, to the extent that any such obligations
      under Section 11.01 have been validated by a summary approval procedure in accordance with the Companies Act 2014 of Ireland, they shall not constitute unlawful financial assistance under the said section 82 or a breach of the said section 239 (as
      applicable).</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 105 -</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps; font-weight: bold;"><a name="Article12"><!--Anchor--></a>Article&#160;12<br>
      <br>
      Administrative Agent</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;12.01.<a name="Section12.01."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Appointment</font>.&#160; Each of the Lenders hereby irrevocably appoints Perceptive to act on its behalf as the Administrative Agent hereunder and under the other Loan Documents and authorizes the Administrative Agent
        to take such actions on its behalf and to exercise such powers as are delegated to the Administrative Agent by the terms hereof or thereof, together with such actions and powers as are reasonably incidental thereto.&#160; The provisions of this
        Article&#160;12 are solely for the benefit of the Administrative Agent and the Lenders, and neither the Borrowers nor any other Obligor will have rights as a third&#8209;party beneficiary of any of such provisions.&#160; It is understood and agreed that the use of
        the term &#8220;agent&#8221; herein or in any other Loan Documents (or any other similar term) with reference to the Administrative Agent is not intended to connote any fiduciary or other implied (or express) obligations arising under agency doctrine of any
        applicable Law.&#160; Instead, such term is used as a matter of market custom, and is intended to create or reflect only an administrative relationship between contracting parties.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;12.02<a name="Section12.02"><!--Anchor--></a>.</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Rights as a Lender</font>.&#160; The Person serving as the Administrative Agent hereunder will have the same rights and powers in its capacity as a Lender as any other Lender and may exercise the same as though it were
        not the Administrative Agent, and the term &#8220;Lender&#8221; or &#8220;Lenders&#8221; will, unless otherwise expressly indicated or unless the context otherwise requires, include the Person serving as the Administrative Agent hereunder in its individual capacity to the
        extent such Person is a Lender.&#160; The Lenders acknowledge and agree that such Person and its Affiliates may accept deposits from, lend money to, own securities of, act as the financial advisor or in any other advisory capacity for, and generally
        engage in any kind of business with, the Borrowers, the other Obligors or any other Subsidiaries or Affiliates of the Obligors as if such Person were not the Administrative Agent hereunder and without any duty to account therefor to the Lenders.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;12.03.<a name="Section12.03."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;



        <font style="font-style: italic;">Exculpatory Provisions</font>.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Administrative Agent will not have any duties or obligations except
      those expressly set forth herein and in the other Loan Documents, and its duties hereunder are administrative in nature.&#160; Without limiting the generality of the foregoing, the Administrative Agent:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;will not be subject to any fiduciary or other implied duties, regardless of whether a Default has
        occurred and is continuing;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;will not have any duty to take any discretionary action or exercise any discretionary powers,
        except discretionary rights and powers expressly contemplated hereby or by the other Loan Documents that the Administrative Agent is required to exercise as directed in writing by the Majority Lenders (or such other number or percentage of the
        Lenders as will be expressly provided for herein or in the other Loan Documents); <font style="font-style: italic;">provided</font> that the Administrative Agent will not be required to take any action that, in its opinion or the opinion of its
        counsel, may expose the Administrative Agent to liability or that is contrary to any Loan Document or applicable Law, including any action that may be in violation of the automatic stay under any Insolvency Proceeding; and</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 106 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;will not, except as expressly set forth herein and in the other Loan Documents, have any duty to
        disclose, and will not be liable for the failure to disclose, any information relating to the Obligors or any of its Subsidiaries or Affiliates, that is communicated to or obtained by the Person serving as the Administrative Agent or any of its
        Affiliates in any capacity.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Administrative Agent will not be liable for any action taken or not
      taken by it (i)&#160;with the consent or at the request of the Majority Lenders (or such other number or percentage of the Lenders as will be necessary, or as the Administrative Agent believes in good faith will be necessary, under the circumstances), or
      (ii)&#160;in the absence of its own gross negligence or willful misconduct as determined by a court of competent jurisdiction by final and non&#8209;appealable judgment.&#160; The Administrative Agent will be deemed not to have knowledge of any Default unless and
      until notice describing such Default is given to the Administrative Agent in writing by the Borrowers or a Lender.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Administrative Agent will not be responsible for or have any duty to
      ascertain or inquire into (i)&#160;any statement, warranty or representation made in or in connection with this Agreement or any other Loan Document, (ii)&#160;the contents of any certificate, report or other document delivered hereunder or thereunder or in
      connection herewith or therewith, (iii)&#160;the performance or observance of any of the covenants, agreements or other terms or conditions set forth herein or therein or the occurrence of any Default, (iv)&#160;the validity, enforceability, effectiveness or
      genuineness of this Agreement, any other Loan Document or any other agreement, instrument or document or (v)&#160;the satisfaction of any condition set forth in Article&#160;6 or elsewhere herein, other than to confirm receipt of items expressly required to be
      delivered to the Administrative Agent.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;12.04.<a name="Section12.04."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Reliance by Administrative Agent</font>.&#160; The Administrative Agent will be entitled to rely upon, and will not incur any liability for relying upon, any notice, request, certificate, consent, statement, instrument,
        document or other writing (including any electronic message, Internet or intranet website posting or other distribution) believed by it to be genuine and to have been signed, sent or otherwise authenticated by the proper Person.&#160; The Administrative
        Agent also may rely upon any statement made to it orally or by telephone and believed by it to have been made by the proper Person, and will not incur any liability for relying thereon.&#160; In determining compliance with any condition hereunder to the
        making of the Term Loans that by its terms must be fulfilled to the satisfaction of a Lender, the Administrative Agent may presume that such condition is satisfactory to such Lender unless the Administrative Agent has received notice to the
        contrary from such Lender prior to the making of the Term Loans.&#160; The Administrative Agent may consult with legal counsel (who may be counsel for the Borrowers), independent accountants and other experts selected by it, and will not be liable for
        any action taken or not taken by it in accordance with the advice of any such counsel, accountants or experts.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 107 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;12.05.<a name="Section12.05."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Delegation of Duties</font>.&#160; The Administrative Agent may perform any and all of its duties and exercise its rights and powers hereunder or under any other Loan Document by or through any one or more sub&#8209;agents
        appointed by the Administrative Agent.&#160; The Administrative Agent and any such sub&#8209;agent may perform any and all of its duties and exercise its rights and powers by or through their respective Affiliates.&#160; The exculpatory provisions of this Article
        12&#160;will apply to any such sub&#8209;agent and to the Affiliates of the Administrative Agent and any such sub&#8209;agent, and will apply to their respective activities in connection with the syndication of the facility as well as activities as Administrative
        Agent.&#160; The Administrative Agent will not be responsible for the negligence or misconduct of any sub&#8209;agents except to the extent that a court of competent jurisdiction determines in a final and non&#8209;appealable judgment that the Administrative Agent
        acted with gross negligence or willful misconduct in the selection of such sub&#8209;agents.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;12.06.</font><font style="font-family: 'Times New Roman';"> <a name="Section12.06."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;



        <font style="font-style: italic;">Resignation of Agent</font>.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Administrative Agent may at any time give notice of its resignation
      to the Lenders and the Administrative Borrower, which notice shall set forth the effective date of such resignation (the <font style="font-style: italic;">&#8220;Resignation Effective Date&#8221;</font>), such date not to be earlier than the thirtieth (30<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>) day following the date of such notice.&#160; The Majority Lenders and the Administrative Borrower shall mutually agree upon a successor to the Administrative Agent.&#160; If the
      Majority Lenders and the Administrative Borrower are unable to so mutually agree and no successor shall have been appointed within twenty&#8209;five&#160;(25) days after the retiring Administrative Agent gives notice of its resignation, then the retiring
      Administrative Agent may (but will not be obligated to), on behalf of the Lenders, appoint a successor Administrative Agent it shall designate (in its reasonable discretion after consultation with the Borrowers and the Majority Lenders).&#160; Whether or
      not a successor has been appointed, such resignation will become effective in accordance with such notice on the Resignation Effective Date.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>With effect from the Resignation Effective Date (i)&#160;the retiring
      Administrative Agent will be discharged from its duties and obligations hereunder and under the other Loan Documents (except that in the case of any Collateral held by the Administrative Agent on behalf of the Lenders under any of the Loan Documents,
      the retiring Administrative Agent will continue to hold such Collateral until such time as a successor Administrative Agent is appointed) and (ii)&#160;except for any indemnity payments owed to the retiring Administrative Agent, all payments,
      communications and determinations provided to be made by, to or through the Administrative Agent will instead be made by or to each Lender directly, until such time, if any, as the Majority Lenders appoint a successor Administrative Agent as provided
      for above.&#160; Upon the acceptance of a successor&#8217;s appointment as Administrative Agent hereunder, such successor will succeed to and become vested with all of the rights, powers, privileges and duties of the retiring Administrative Agent (other than
      any rights to indemnity payments owed to the retiring Administrative Agent), and the retiring Administrative Agent will be discharged from all of its duties and obligations hereunder or under the other Loan Documents.&#160; The fees payable by the
      Borrowers to a successor Administrative Agent will be the same as those payable to its predecessor unless otherwise agreed between the Administrative Borrower and such successor.&#160; After the retiring Administrative Agent&#8217;s resignation hereunder and
      under the other Loan Documents, the provisions of this Article&#160;12 and Sections&#160;13.03 and 13.06 will continue in effect for the benefit of such retiring Administrative Agent, its sub&#8209;agents and their respective Affiliates in respect of any actions
      taken or omitted to be taken by any of them while the retiring Administrative Agent was acting as Administrative Agent.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 108 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;12.07.</font><font style="font-family: 'Times New Roman';"><a name="Section12.07."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Non&#8209;Reliance on Administrative Agent and Other Lenders</font>.&#160; Each Lender acknowledges that it has, independently and without reliance upon the Administrative Agent or any other Lender or any of their Affiliates
        and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Agreement.&#160; Each Lender also acknowledges that it will, independently and without reliance upon the
        Administrative Agent or any other Lender or any of their Affiliates and based on such documents and information as it will from time to time deem appropriate, continue to make its own decisions in taking or not taking action under or based upon
        this Agreement, any other Loan Document or any related agreement or any document furnished hereunder or thereunder.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;12.08<a name="Section12.08"><!--Anchor--></a>.</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Administrative Agent May File Proofs of Claim</font>.&#160; In case of the pendency of any Insolvency Proceeding or any other judicial proceeding relative to the Borrowers, the Administrative Agent (irrespective of
        whether the principal of the Term Loans will then be due and payable as herein expressed or by declaration or otherwise and irrespective of whether the Administrative Agent has made any demand on the Borrowers) will be entitled and empowered (but
        not obligated), by intervention in such proceeding or otherwise:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>to file and prove a Claim for the whole amount of the principal and
      interest owing and unpaid in respect of the Term Loans and all other Obligations that are owing and unpaid hereunder or under any other Loan Document and to file such other documents as may be necessary or advisable in order to have the Claims of the
      Lenders and the Administrative Agent (including any Claim for the reasonable compensation, expenses, disbursements and advances of the Lenders and the Administrative Agent and their respective agents and counsel and all other amounts due the Lenders
      and the Administrative Agent under this Agreement or any other Loan Document) allowed in such judicial proceeding; and</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>to collect and receive any monies or other property payable or
      deliverable on any such Claims and to distribute the same.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">Any custodian, receiver, receiver and manager, interim receiver, manager, assignee, trustee, liquidator, sequestrator or other similar official in
      any such judicial proceeding is hereby authorized by each Lender to make any payments of the type described above in this Section&#160;12.08 to the Administrative Agent and, in the event that the Administrative Agent consents to the making of such
      payments directly to the Lenders, to pay to the Administrative Agent any amount due for the reasonable compensation, expenses, disbursements and advances of the Administrative Agent and its agents and counsel, and any other amounts due the
      Administrative Agent under this Agreement or any other Loan Document.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 109 -</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;12.09.</font><font style="font-family: 'Times New Roman';"> <a name="Section12.09."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Collateral and Guaranty Matters; Appointment of Collateral Agent</font>.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Without limiting the provisions of Section&#160;12.08, the Lenders irrevocably
      agree as follows:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Administrative Agent is authorized, at its option and in its discretion, to release any Lien
        on any property granted to or held by the Administrative Agent under any Loan Document (A)&#160;on the date when all Obligations have been satisfied in full in cash (other than Warrant Obligations and contingent obligations as to which no Claims have
        been asserted), (B)&#160;that is sold or otherwise disposed of or to be sold or otherwise disposed of as part of or in connection with any sale or other disposition permitted under the Loan Documents, or (C)&#160;subject to Sections&#160;13.01 and 13.04, if
        approved, authorized or ratified in writing by the Majority Lenders; and</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Administrative Agent is authorized, at its option and discretion, to release any Guarantor,
        from its obligations hereunder if such Person ceases to be a Subsidiary as a result of a transaction permitted under the Loan Documents.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">Upon request by the Administrative Agent at any time, each Lender will confirm in writing the Administrative Agent&#8217;s authority to release or
      subordinate its interest in particular types or items of Collateral, or to release any Guarantor from its obligations under its guaranty pursuant to this Section&#160;12.09.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Administrative Agent will not be responsible for or have a duty to
      ascertain or inquire into any representation or warranty regarding the existence, value or collectability of the Collateral, the existence, priority or perfection of the Administrative Agent&#8217;s Lien thereon, or any certificate prepared by any Obligor
      in connection therewith, nor will the Administrative Agent be responsible or liable to the Lenders for any failure to monitor or maintain any portion of the Collateral.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each Lender hereby appoints the Administrative Agent as its collateral
      agent under each of the Security Documents and agrees that, in so acting, the Administrative Agent will have all of the rights, protections, exculpations, indemnities and other benefits provided to the Administrative Agent under this Agreement, and
      hereby authorizes and directs the Administrative Agent, on behalf of such Lender and all Lenders, without the necessity of any notice to or further consent from any of the Lenders, from time to time to (i)&#160;take any action with respect to any
      Collateral or any Security Document which may be necessary to perfect and maintain perfected the Liens on the Collateral granted pursuant to any such Security Document or protect and preserve the Administrative Agent&#8217;s ability to enforce the Liens or
      realize upon the Collateral, (ii)&#160;act as collateral agent for each Lender for purposes of acquiring, holding, enforcing and perfecting all Liens created by the Loan Documents and all other purposes stated therein, (iii)&#160;enter into intercreditor or
      subordination agreements, as the case may be, in connection with Indebtedness permitted pursuant to Sections&#160;9.01(e), (iv)&#160;enter into non&#8209;disturbance or similar agreements in connection with licensing agreements and arrangements permitted by this
      Agreement and the other Loan Documents and (v)&#160;otherwise to take or refrain from taking any and all action that the Administrative Agent shall deem necessary or advisable in fulfilling its role as collateral agent under any of the Security Documents.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 110 -</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps; font-weight: bold;"><a name="Article13"><!--Anchor--></a>Article&#160;13<br>
      <br>
      Miscellaneous</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;13.01.</font><font style="font-family: 'Times New Roman';"><a name="Section13.01."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">No Waiver.</font>&#160; No failure on the part of the Administrative Agent or the Lenders to exercise and no delay in exercising, and no course of dealing with respect to, any right, power or privilege under any Loan
        Document shall operate as a waiver thereof, nor shall any single or partial exercise of any right, power or privilege under any Loan Document preclude any other or further exercise thereof or the exercise of any other right, power or privilege.&#160;
        The remedies provided herein are cumulative and not exclusive of any remedies provided by Law.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;13.02.<a name="Section13.02."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Notices.</font>&#160; All notices, requests, instructions, directions and other communications provided for herein (including any modifications of, or waivers, requests or consents under, the Loan Documents) shall be given
        or made in writing (including by telecopy or electronic mail) delivered, if to the Administrative Borrower, another Obligor, the Administrative Agent or the Lenders, to its address specified on Schedule 2 hereto or its Guarantee Assumption
        Agreement, as the case may be, or at such other address as shall be designated by such party in a notice to the other parties.&#160; Except as otherwise provided in this Agreement, all such communications shall be deemed to have been duly given upon
        receipt of a legible copy thereof, in each case given or addressed as aforesaid.&#160; All such communications provided for herein by telecopy or electronic mail shall be confirmed in writing promptly after the delivery of such communication (it being
        understood that non&#8209;receipt of written confirmation of such communication shall not invalidate such communication).</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;13.03.</font><font style="font-family: 'Times New Roman';"><a name="Section13.03."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;



        <font style="font-style: italic;">Expenses, Indemnification, Etc</font>.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;"><font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Expenses.&#160; </font>Each Obligor agrees
      to pay or reimburse (i)&#160;the Administrative Agent and the Lenders for all of their reasonable and documented out of pocket costs and expenses (including the reasonable and documented fees and expenses of Chapman and Cutler LLP, counsel to the
      Administrative Agent) in connection with (A)&#160;the negotiation, preparation, execution and delivery of the Original Credit Agreement, the Second A&amp;R Credit Agreement, the Third A&amp;R Credit Agreement, the Fourth A&amp;R Credit Agreement, the
      Fifth A&amp;R Credit Agreement, this Agreement and the other Loan Documents and (B) the discussions regarding, and the negotiation or preparation of, any amendment, modification, supplement or waiver of any of the terms of this Agreement or any of
      the other Loan Documents (whether or not documented or consummated, including the reasonable fees and expenses of legal counsel) and (ii)&#160;the Administrative Agent and the Lenders for all of their reasonable and documented out of pocket costs and
      expenses (including the reasonable fees and expenses of legal counsel) in connection with any enforcement or collection proceedings resulting from the occurrence of an Event of Default.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Indemnification.&#160; </font>Each Obligor hereby indemnifies the Administrative
      Agent, the Lenders, their respective Affiliates, and their respective directors, officers, employees, attorneys, agents and advisors (each, an <font style="font-style: italic;">&#8220;Indemnified Party&#8221;</font>) from and against, and agrees to hold them
      harmless against, any and all Claims and Losses of any kind (including reasonable fees and disbursements of counsel), joint or several, that is incurred by or asserted or awarded against any Indemnified Party, in each case arising out of or in
      connection with or relating to any investigation, litigation or proceeding or the preparation of any defense with respect thereto arising out of or in connection with or relating to this Agreement or any of the other Loan Documents or the
      Transactions or any use made or proposed to be made with the proceeds of the Term Loans, whether or not such investigation, litigation or proceeding is brought by an Obligor, any of its shareholders or creditors, an Indemnified Party or any other
      Person, or an Indemnified Party is otherwise a party thereto, and whether or not any of the conditions precedent set forth in Article&#160;6 are satisfied or the other Transactions contemplated by this Agreement are consummated, except to the extent such
      Claim or Loss is found in a final, non&#8209;appealable judgment by a court of competent jurisdiction to have resulted from any Indemnified Party&#8217;s gross negligence or willful misconduct.&#160; No Obligor shall assert any Claim against any Indemnified Party, on
      any theory of liability, for consequential, indirect, special or punitive damages arising out of or otherwise relating to this Agreement or any of the other Loan Documents or any of the Transactions or the actual or proposed use of the proceeds of
      the Term Loans.&#160; This Section shall not apply to Taxes other than Taxes relating to a non&#8209;Tax Claim or Loss governed by this Section&#160;13.03(b).</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 111 -</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;13.04<a name="Section13.04"><!--Anchor--></a>.</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Amendments, Etc</font>.&#160; Except as otherwise expressly provided in this Agreement, any provision of this Agreement or any other Loan Document (except for the Warrant Certificates, which may be amended, modified,
        waived or supplemented in accordance with the terms thereof) may be amended, modified, waived or supplemented only by an instrument in writing signed by the Borrowers, the Administrative Agent and the Majority Lenders; <font style="font-style: italic;">provided</font> that:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>no amendment, waiver or consent shall, unless in writing and signed by
      all of the Lenders, do any of the following at any time:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;change the number of Lenders or the percentage of (A)&#160;the Commitments or (B)&#160;the aggregate unpaid
        principal amount of the Term Loans that, in each case, shall be required for the Lenders or any of them to take any action hereunder (including pursuant to any change to the definition of <font style="font-style: italic;">&#8220;Majority Lenders&#8221;</font>);</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;release one or more Guarantors (or otherwise limit such Guarantors&#8217; liability with respect to the
        Obligations owing to the Lenders under the Guarantees) if such release or limitation is in respect of all or substantially all of the value represented by the Guarantees to the Lenders;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;release, or subordinate the Lenders&#8217; Liens in, all or substantially all of the Collateral in any
        transaction or series of related transactions (other than in connection with any sale of Collateral permitted herein); or</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;amend any provision of this Section&#160;13.04;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>no amendment, waiver or consent shall, unless in writing and signed by
      each Lender specified below for such amendment, waiver or consent:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;increase the Commitments of a Lender without the consent of such Lender;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;reduce the principal of, or stated rate of interest on, or any Prepayment Premium payable on, the
        Term Loans owed to a Lender or any fees or other amounts stated to be payable hereunder or under the other Loan Documents to such Lender without the consent of such Lender;</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 112 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;postpone any date scheduled for any payment of principal of, or interest on, the Term Loans, any
        date scheduled for payment or for any date fixed for any payment of fees hereunder (excluding the due date of any mandatory prepayment of the Term Loans), in each case payable to a Lender without the consent of such Lender;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;change the order of application of prepayment of the Term Loans from the application thereof set
        forth in the applicable provisions of Section&#160;4.01(b) in any manner that adversely affects the Lenders without the consent of holders of a majority of the Commitments or Term Loans outstanding or otherwise change any provision requiring the pro
        rata distributions hereunder among the Lenders without all Lenders&#8217; consent; or</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;modify Section&#160;2.02 without the consent of each Lender directly and adversely affected thereby.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;13.05.<a name="Section13.05."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;



        <font style="font-style: italic;">Successors and Assigns</font>.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;"><font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>General.</font>&#160; The provisions of this
      Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns permitted hereby, except that (i)&#160;no Obligor may assign or otherwise transfer any of its rights or obligations hereunder
      without the prior written consent of the Administrative Agent and each Lender (and any attempted assignment or transfer by such Obligor without such consent shall be null and void) and (ii)&#160;no Lender may assign or otherwise transfer its rights or
      obligations hereunder except in accordance with this Section.&#160; Nothing in this Agreement, expressed or implied, shall be construed to confer upon any Person (other than the parties hereto, their respective successors and assigns permitted hereby,
      Participants (to the extent provided in paragraph&#160;(e) of this Section) and, to the extent expressly contemplated hereby, the Indemnified Parties of the Lenders) any legal or equitable right, remedy or Claim under or by reason of this Agreement.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Amendments to Loan Documents; Majority Lender Vote.</font>&#160; Each of the Lenders
      and the Obligors agrees to enter into such amendments to the Loan Documents, and such additional Security Documents and other instruments and agreements, in each case in form and substance reasonably acceptable to the Lenders and the Obligors, as
      shall reasonably be necessary to implement and give effect to any assignment made by any Lender (or any direct or indirect assignee thereof) from time to time under this Section&#160;13.05.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 113 -</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;"><font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Assignments by Lenders</font>.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to the conditions set forth in paragraph&#160;(c)(ii) below, any Lender may assign to one or
        more Persons (other than an Ineligible Assignee) all or a portion of its rights and obligations under the Loan Documents (including all or a portion of its Commitment and the Term Loans at the time owing to it) (A) with the prior written consent
        (such consent not to be unreasonably withheld) of the Administrative Agent and (B) so long as no Default shall have occurred and is continuing, upon notice to the Administrative Borrower; <font style="font-style: italic;">provided</font> that no
        consent of the Administrative Agent nor notice to the Administrative Borrower shall be required for an assignment of any Commitment or of all or any portion of the Term Loans to a Lender, an Affiliate of a Lender or an Approved Fund.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Assignments shall be subject to the following additional conditions:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 103.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(A)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;except in the case of an assignment to a Lender or an Affiliate of a Lender or an assignment of the
        entire remaining amount of the assigning Lender&#8217;s Commitment or Term Loan, the amount of the Commitment or Term Loan of the assigning Lender subject to each such assignment (determined as of the date the Assignment Agreement with respect to such
        assignment is delivered to the Administrative Agent) shall not be less than $500,000, unless the Administrative Agent otherwise consents;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 103.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(B)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;each partial assignment shall be made as an assignment of a proportionate part of all the assigning
        Lender&#8217;s rights and obligations under this Agreement and the other Loan Documents; and</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 103.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(C)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the parties to each assignment shall execute and deliver to the Administrative Agent an Assignment
        Agreement in form and substance reasonably satisfactory to Administrative Agent.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to acceptance and recording thereof pursuant to paragraph (d) of this Section, from and
        after the effective date specified in each Assignment Agreement, the assignee thereunder shall be a party hereto and, to the extent of the interest assigned by such Assignment Agreement, have the rights and obligations of a Lender under the Loan
        Documents, and the assigning Lender thereunder shall, to the extent of the interest assigned by such Assignment Agreement, be released from its obligations under the Loan Documents (and, in the case of an Assignment Agreement covering all of the
        assigning Lender&#8217;s rights and obligations under the Loan Documents, such Lender shall cease to be a party hereto).&#160; Any assignment or transfer by a Lender of rights or obligations under the Loan Documents that does not comply with this
        Section&#160;13.05 shall be treated for purposes of the Loan Documents as a sale by such Lender of a participation in such rights and obligations in accordance with paragraph (e) of this Section.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 114 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(d)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Register.</font>&#160; The Administrative Agent, acting for this purpose as a
      non&#8209;fiduciary agent of the Borrowers, shall maintain at one of its offices a copy of each Assignment Agreement delivered to it and a register for the recordation of the names and addresses of the Lenders, and the Commitment of, and principal amount
      (and stated interest) of the Term Loans owing to, each Lender pursuant to the terms hereof from time to time (the &#8220;<font style="font-style: italic;">Register</font>&#8221;).&#160; The entries in the Register shall be conclusive absent manifest error, and the
      Borrowers, the Administrative Agent, and the Lenders shall treat each Person whose name is recorded in the Register pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement, notwithstanding notice to the contrary.&#160; The
      Register shall be available for inspection by the Borrowers and any Lender, at any reasonable time and from time to time upon reasonable prior notice.&#160; No assignment shall be effective for purposes of this Agreement unless (i) it has been recorded in
      the Register as provided in this paragraph and (ii) any written consent to such assignment required by paragraph (b) of this Section has been obtained.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(e)<font style="font-style: italic;"><font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Participations.</font>&#160; Any Lender may
      at any time, without the consent of, or notice to, the Borrowers, sell participations to any Person (a &#8220;<font style="font-style: italic;">Participant</font>&#8221;), other than a natural person, in all or a portion of such Lender&#8217;s rights and obligations
      under the Loan Documents (including all or a portion of its Commitment and the Term Loans owing to it); <font style="font-style: italic;">provided</font> that (i)&#160;such Lender&#8217;s obligations under the Loan Documents shall remain unchanged, (ii)&#160;such
      Lender shall remain solely responsible to the other parties hereto for the performance of such obligations and (iii)&#160;the Borrowers shall continue to deal solely and directly with such Lender in connection therewith.</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 115 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(f)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any agreement or instrument pursuant to which a Lender sells such a
      participation shall provide that such Lender shall retain the sole right to enforce this Agreement and to approve any amendment, modification or waiver of any provision of this Agreement; <font style="font-style: italic;">provided</font> that such
      agreement or instrument may provide that such Lender will not, without the consent of the Participant, agree to any amendment, modification or waiver that would (i)&#160;increase or extend the term of such Lender&#8217;s Commitment, (ii)&#160;extend the date fixed
      for the payment of principal of or interest on the Term Loans or any portion of any fee hereunder payable to the Participant, (iii)&#160;reduce the amount of any such payment of principal, or (iv)&#160;reduce the rate at which interest is payable thereon to a
      level below the rate at which the Participant is entitled to receive such interest. The Borrowers agree that each Participant shall be entitled to the benefits of Section&#160;5.03 (subject to the requirements and limitations therein, including the
      requirements under Section&#160;5.03(f) (it being understood that the documentation required under Section&#160;5.03(f) shall be delivered to the Borrowers and the participating Lender)) to the same extent as if it were a Lender and had acquired its interest
      by assignment pursuant to Section&#160;13.05(a), <font style="font-style: italic;">provided</font> that such Participant (A)&#160;agrees to be subject to the provisions of Section&#160;5.03(h) as if it were an assignee under Section&#160;13.05(a); and (B)&#160;shall not be
      entitled to receive any greater payment under Section&#160;5.03, with respect to any participation, than its participating Lender would have been entitled to receive, unless the sale of the participation to such Participant is made with the Administrative
      Borrower&#8217;s prior written consent.&#160; To the extent permitted by Law, each Participant also shall be entitled to the benefits of Section&#160;4.04(a) as though it were a Lender.&#160; Each Lender that sells a participation shall, acting solely for this purpose as
      a non&#8209;fiduciary agent of the Borrowers, maintain a register on which it enters the name and address of each Participant and the principal amounts (and stated interest) of each Participant&#8217;s interest in the Term Loans or other obligations under the
      Loan Documents (the <font style="font-style: italic;">&#8220;Participant Register&#8221;</font>); <font style="font-style: italic;">provided</font> that no Lender shall have any obligation to disclose all or any portion of the Participant Register (including
      the identity of any Participant or any information relating to a Participant&#8217;s interest in any commitments, loans, letters of credit or its other obligations under any Loan Document) to any Person except to the extent that such disclosure is
      necessary to establish that such commitment, loan, letter of credit or other obligation is in registered form under Section 5f.103&#8209;1(c) of the United States Treasury Regulations.&#160; The entries in the Participant Register shall be conclusive absent
      manifest error, and such Lender shall treat each Person whose name is recorded in the Participant Register as the owner of such participation for all purposes of this Agreement notwithstanding any notice to the contrary.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(g)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Certain Pledges.</font>&#160; Subject to Section&#160;13.05(c), the Lenders may at any time
      pledge or assign a security interest in all or any portion of its rights under this Agreement and any other Loan Document to secure obligations of the Lenders, including any pledge or assignment to secure obligations to a Federal Reserve Bank or
      another central bank; <font style="font-style: italic;">provided</font> that no such pledge or assignment shall release the Lenders from any of their obligations hereunder or substitute any such pledgee or assignee for the Lenders as a party hereto.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;13.06.<a name="Section13.06."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Survival.</font>&#160; The obligations of the Borrowers under Sections&#160;5.01, 5.02, 5.03, 13.03, 13.05, 13.09, 13.10, 13.11, 13.12, 13.13, 13.14, 13.15 and Article&#160;11 (solely to the extent guaranteeing any of the
        obligations under the foregoing Sections) shall survive the repayment of the Obligations and the termination of the Commitments and, in the case of any Lender&#8217;s assignment of any interest in the Commitments or the Term Loans hereunder, shall
        survive, in the case of any event or circumstance that occurred prior to the effective date of such assignment, the making of such assignment, notwithstanding that such Lenders may cease to be a &#8220;Lender&#8221; hereunder.&#160; In addition, each representation
        and warranty made, or deemed to be made by a notice of the Term Loans, herein or pursuant hereto shall survive the making of such representation and warranty.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;13.07.</font><font style="font-family: 'Times New Roman';"><a name="Section13.07."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;



        <font style="font-style: italic;">Captions.</font>&#160; The table of contents and captions and section headings appearing herein are included solely for convenience of reference and are not intended to affect the interpretation of any provision of this
        Agreement.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;13.08.</font><font style="font-family: 'Times New Roman';"> <a name="Section13.08."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">Counterparts.</font>&#160; This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument and any of the parties hereto may execute this Agreement
        by signing any such counterpart.&#160; Delivery of an executed signature page of this Agreement by facsimile transmission or electronic transmission (in PDF or DocuSign format) shall be effective as delivery of a manually executed counterpart hereof.&#160;
        The words &#8220;execution,&#8221; &#8220;signed,&#8221; &#8220;signature,&#8221; and words of like import in this Agreement shall be deemed to include electronic signatures or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or
        enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable Law, including the Federal Electronic Signatures in Global and National
        Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 116 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;13.09<a name="Section13.09"><!--Anchor--></a>.</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">GOVERNING LAW.</font>&#160; <font style="font-variant: small-caps;">THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS (OTHER THAN THE CANADIAN SECURITY AGREEMENT, IRISH DEBENTURE AND ANY OTHER LOAN DOCUMENTS WHICH ARE
          SPECIFICALLY GOVERNED BY THE LAWS OF ANOTHER JURISDICTION), THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER AND THEREUNDER, AND ALL CLAIMS, DISPUTES AND MATTERS ARISING HEREUNDER OR THEREUNDER OR RELATED HERETO OR THERETO, SHALL BE GOVERNED
          BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW&#160;YORK APPLICABLE TO CONTRACTS EXECUTED IN AND TO BE PERFORMED ENTIRELY WITHIN THAT STATE, WITHOUT REFERENCE TO CONFLICTS OF LAWS PROVISIONS (OTHER THAN SECTION&#160;5&#8209;1401 OF THE
          NEW&#160;YORK GENERAL OBLIGATIONS LAW).</font></font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;13.10.</font><font style="font-family: 'Times New Roman';"> <a name="Section13.10."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">JURISDICTION, SERVICE OF PROCESS AND VENUE</font>.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;"><font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>SUBMISSION TO JURISDICTION.</font>&#160; <font style="font-variant: small-caps;">EACH OBLIGOR AGREES THAT ANY SUIT, ACTION OR PROCEEDING WITH RESPECT TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT TO WHICH IT IS A PARTY OR ANY JUDGMENT ENTERED BY ANY COURT IN RESPECT THEREOF SHALL BE BROUGHT IN
        THE SUPREME COURT OF THE STATE OF NEW&#160;YORK OR IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK, IN EITHER CASE, SITTING IN NEW&#160;YORK COUNTY </font>(EXCEPT, WITH RESPECT TO THE CANADIAN SECURITY AGREEMENT, IRISH DEBENTURE
      AND ANY OTHER LOAN DOCUMENT, AS OTHERWISE EXPRESSLY PROVIDED THEREIN) <font style="font-variant: small-caps;">AND IRREVOCABLY SUBMITS TO THE NON-EXCLUSIVE JURISDICTION OF EACH SUCH COURT FOR THE PURPOSE OF ANY SUCH SUIT, ACTION, PROCEEDING OR
        JUDGMENT</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;"><font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Alternative Process.</font> Each party
      to this Agreement irrevocably consents to service of process in the manner provided for notices in Section 13.02.&#160; Nothing herein shall in any way be deemed to limit the ability of any party to this Agreement to serve any process in any other manner
      permitted by applicable Law.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic; font-variant: small-caps;"><font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>WAIVER OF
        VENUE, ETC.</font><font style="font-variant: small-caps;">&#160; EACH OBLIGOR IRREVOCABLY WAIVES TO THE FULLEST EXTENT PERMITTED BY LAW ANY OBJECTION THAT IT MAY NOW OR HEREAFTER HAVE TO THE LAYING OF THE VENUE OF ANY SUIT, ACTION OR PROCEEDING ARISING
        OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT IN ANY COURT PERMITTED BY SECTION 13.10(A) AND HEREBY FURTHER IRREVOCABLY WAIVES TO THE FULLEST EXTENT PERMITTED BY LAW ANY CLAIM THAT ANY SUCH SUIT, ACTION OR PROCEEDING BROUGHT IN
        ANY SUCH COURT HAS BEEN BROUGHT IN AN INCONVENIENT FORUM.&#160; A FINAL JUDGMENT (IN RESPECT OF WHICH TIME FOR ALL APPEALS HAS ELAPSED) IN ANY SUCH SUIT, ACTION OR PROCEEDING SHALL BE CONCLUSIVE AND MAY BE ENFORCED IN ANY COURT TO THE JURISDICTION OF
        WHICH SUCH OBLIGOR IS OR MAY BE SUBJECT, BY SUIT UPON JUDGMENT.</font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 117 -</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;13.11.</font><font style="font-family: 'Times New Roman';"><a name="Section13.11."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">WAIVER OF JURY TRIAL</font>. <font style="font-variant: small-caps;">EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY SUIT,
          ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT, THE OTHER LOAN DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.</font></font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;13.12.</font><font style="font-family: 'Times New Roman';"><a name="Section13.12."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic; font-variant: small-caps;">WAIVER OF IMMUNITY</font>.&#160; <font style="font-variant: small-caps;">TO THE EXTENT THAT ANY OBLIGOR MAY BE OR BECOME ENTITLED TO CLAIM FOR ITSELF OR ITS PROPERTY OR REVENUE ANY IMMUNITY ON
          THE GROUND OF SOVEREIGNTY OR THE LIKE FROM SUIT, COURT JURISDICTION, ATTACHMENT PRIOR TO JUDGMENT, ATTACHMENT IN AID OF EXECUTION OF A JUDGMENT OR EXECUTION OF A JUDGMENT, AND TO THE EXTENT THAT IN ANY SUCH JURISDICTION THERE MAY BE ATTRIBUTED
          SUCH AN IMMUNITY (WHETHER OR NOT CLAIMED), SUCH OBLIGOR HEREBY IRREVOCABLY AGREES NOT TO CLAIM AND HEREBY IRREVOCABLY WAIVES SUCH IMMUNITY WITH RESPECT TO ITS OBLIGATIONS UNDER THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS.</font></font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;13.13.</font><font style="font-family: 'Times New Roman';"><a name="Section13.13."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Entire Agreement.</font>&#160; This Agreement and the other Loan Documents constitute the entire agreement among the parties with respect to the subject matter hereof and thereof and supersede any and all previous
        agreements and understandings, oral or written, relating to the subject matter hereof.&#160; Each Obligor acknowledges, represents and warrants that in deciding to enter into this Agreement and the other Loan Documents or in taking or not taking any
        action hereunder or thereunder, it has not relied, and will not rely, on any statement, representation, warranty, covenant, agreement or understanding, whether written or oral, of or with the Lenders other than those expressly set forth in this
        Agreement and the other Loan Documents.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;13.14.</font><font style="font-family: 'Times New Roman';"><a name="Section13.14."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160; <font style="font-style: italic;">Severability.</font>&#160; If any provision hereof is found by a court to be invalid or unenforceable, to the fullest extent permitted by applicable Law the parties agree that such invalidity or unenforceability shall not
        impair the validity or enforceability of any other provision hereof.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;13.15.</font><font style="font-family: 'Times New Roman';"> <a name="Section13.15."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;


        <font style="font-style: italic;">No Fiduciary Relationship. </font> The Administrative Agent, each Lender and their Affiliates (collectively, solely for purposes of this paragraph, the &#8220;<font style="font-style: italic;">Lenders</font>&#8221;), may have
        economic interests that conflict with those of the Obligors, their stockholders or equity holders and/or their Affiliates (collectively, solely for purposes of this paragraph, the &#8220;<font style="font-style: italic;">Obligors</font>&#8221;). The Obligors
        acknowledge that the Lenders have no fiduciary relationship with, or fiduciary duty to, any Obligor arising out of or in connection with this Agreement or the other Loan Documents, and the relationship between each Lender and each Obligor are
        solely that of creditors and debtors.&#160; This Agreement and the other Loan Documents do not create a joint venture among the parties.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;13.16.<a name="Section13.16."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">USA Patriot Act</font>.&#160; The Administrative Agent and the Lenders hereby notify the Obligors that pursuant to the requirements of the <font style="font-variant: small-caps;">USA PATRIOT</font> Act (Title&#160;III of
        Pub. L. 107&#8209;56 (signed into law October&#160;26, 2001)) (the <font style="font-style: italic;">&#8220;Act&#8221;</font>) and 31 C.F.R. &#167; 1010.230 (the &#8220;<font style="font-style: italic;">Beneficial Ownership Regulation</font>&#8221;), they are required to obtain, verify
        and record information that identifies the Obligors, which information includes the name and address of each Obligor and other information that will allow the Administrative Agent and such Lender to identify each Obligor in accordance with the Act
        and Beneficial Ownership Regulation, including a beneficial ownership certification in form and substance acceptable to the Administrative Agent.</font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 118 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;13.17.<a name="Section13.17."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Treatment of Certain Information; Confidentiality.</font>&#160; The Lenders agree to maintain the confidentiality of the Information (as defined below), except that Information may be disclosed to (a)&#160;its Affiliates and
        to its and its Affiliates&#8217; respective partners, directors, officers, employees, agents, trustees, advisors and representatives (collectively, <font style="font-style: italic;">&#8220;Representatives&#8221;</font>) (it being understood that the Persons to whom
        such disclosure is made will be informed of the confidential nature of such information and instructed to keep such Information confidential), (b)&#160;to the extent requested by any regulatory authority purporting to have jurisdiction over it
        (including any self&#8209;regulatory authority, such as FINRA or the National Association of Insurance Commissioners) or any exchange, (c)&#160;to the extent required by the applicable Laws or by any subpoena or similar legal process, (d)&#160;to any other party
        hereto, (e)&#160;in connection with the exercise of any remedies hereunder or under any other Loan Document or any action or proceeding relating to this Agreement or any other Loan Document or the enforcement of rights hereunder or thereunder,
        (f)&#160;subject to an agreement containing provisions substantially the same as those in this Section 13.17, to (i)&#160;any assignee of or Participant in, or any prospective assignee of or Participant in, any of its rights or obligations under this
        Agreement or (ii)&#160;any actual or prospective counterparty (or its advisors) to any swap or derivative transaction relating to the Borrowers or any Guarantor and its obligation, (g)&#160;with the consent of the Borrowers or (h)&#160;to the extent such
        Information (i)&#160;becomes publicly available other than as a result of a breach of this Section 13.17&#160; or (ii)&#160;becomes available to the Lender, or any of its respective Representatives on a nonconfidential basis from a source other than the Borrowers
        or any other Obligor.&#160; For purposes of this Section 13.17, <font style="font-style: italic;">&#8220;Information&#8221;</font> means all information received from an Obligor relating to such Obligor or its Subsidiary or any of their respective businesses,
        except that the term &#8220;Information&#8221; shall not include, and the Lenders shall not be subject to any confidentiality obligation with respect to any information that (A)&#160;is or becomes available to the Lender or any of its Representatives on a
        nonconfidential basis prior to disclosure by an Obligor or its Subsidiary, (B)&#160;becomes available to a Lender or any of its Representatives after disclosure by an Obligor or its Subsidiary from a source that, to the knowledge of such Lender, is not
        subject to a confidentiality obligation to such Obligor or Subsidiary (C)&#160;is or becomes publicly available other than as a result of a breach by such Lender, or (D)&#160;is developed by a Lender or any of its Representatives.&#160; Any Person required to
        maintain the confidentiality of Information as provided in this Section 13.17 shall be considered to have complied with its obligation to do so if such Person has exercised the same degree of care to maintain the confidentiality of such Information
        as such Person would accord to its own confidential information.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';">In the case of any Lender that has elected to receive material non&#8209;public information pursuant to Section&#160;8.02, such Lender acknowledges that
      (x)&#160;the Information may include material non&#8209;public information concerning an Obligor or its Subsidiary, as the case may be, (y)&#160;it has developed compliance procedures regarding the use of material non&#8209;public information and (z)&#160;it will handle such
      material non&#8209;public information in accordance with applicable Law, including United States federal and state securities Laws.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 119 -</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;13.18.</font><font style="font-family: 'Times New Roman';"> <a name="Section13.18."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;



        <font style="font-style: italic;">Releases of Guarantees and Liens</font>.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Notwithstanding anything to the contrary contained herein or in any other
      Loan Document, each Lender agrees, and the Administrative Agent is hereby irrevocably authorized by each Lender and given a limited power of attorney by each Lender to perform the actions described hereafter in this Section&#160;13.18 (without requirement
      of notice to or consent of any Lender except as expressly required by Section&#160;13.04) to take any action reasonably requested by the Borrowers having the effect of releasing any Collateral or Obligations (i)&#160;to the extent necessary to permit
      consummation of any transaction not prohibited by any Loan Document or that has been consented to by the Lenders or (ii)&#160;under the circumstances described in paragraph&#160;(b) below.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>At such time as the Term Loans and the other Obligations (other than the
      inchoate indemnity obligations and Warrant Obligations) under the Loan Documents shall have been paid in full in cash and the Commitments have been terminated, the Collateral shall be released from the Liens created by the Security Documents, and the
      Security Documents and all obligations (other than those expressly stated to survive such termination) of the Administrative Agent and each Obligor under the Security Documents shall terminate, all without delivery of any instrument or performance of
      any act by any Person.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;13.19.</font><font style="font-family: 'Times New Roman';"><a name="Section13.19."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Acknowledgement and Consent to Bail&#8209;In of Affected Financial Institutions</font>.&#160; Notwithstanding anything to the contrary in any Loan Document or in any other agreement, arrangement or understanding among any
        such parties, each party hereto acknowledges that any liability of any Affected Financial Institution arising under any Loan Document, to the extent such liability is unsecured, may be subject to the Write&#8209;Down and Conversion Powers of the
        applicable Resolution Authority and agrees and consents to, and acknowledges and agrees to be bound by:</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the application of any Write&#8209;Down and Conversion Powers by the applicable
      Resolution Authority to any such liabilities arising hereunder which may be payable to it by any party hereto that is an Affected Financial Institution; and</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the effects of any Bail&#8209;In Action on any such liability, including, if
      applicable:</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a reduction in full or in part or cancellation of any such liability;</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a conversion of all, or a portion of, such liability into shares or other instruments of
        ownership in such Affected Financial Institution, its parent undertaking, or a bridge institution that may be issued to it or otherwise conferred on it, and that such shares or other instruments of ownership will be accepted by it in lieu of any
        rights with respect to any such liability under this Agreement or any other Loan Document; or</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 40.5pt; margin-left: 58.5pt; line-height: 1.25;"><font style="font-family: 'Times New Roman';">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the variation of the terms of such liability in connection with the exercise of the Write&#8209;Down
        and Conversion Powers of the applicable Resolution Authority.</font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 120 -</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;13.20.</font><font style="font-family: 'Times New Roman';"> <a name="Section13.20."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-style: italic;"> Judgment Currency.</font></font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The obligations of any Obligor under this Agreement and the other Loan
      Documents to make payments in Dollars shall not be discharged or satisfied by any tender or recovery pursuant to any judgment expressed in or converted into any currency other than Dollars, except to the extent that such tender or recovery results in
      the effective receipt by the Administrative Agent or Lender of the full amount of Dollars expressed to be payable to the Administrative Agent or such Lender under this Agreement or the other Loan Documents.&#160; If, for the purpose of obtaining or
      enforcing a judgment against any Obligor in any court or in any jurisdiction, it becomes necessary to convert into or from any currency other than Dollars (such other currency, the &#8220;<font style="font-style: italic;">Judgment Currency</font>&#8221;) an
      amount due in Dollars, the conversion shall be made at the rate of exchange quoted by the Administrative Agent, determined, in each case, as of the Business Day immediately preceding the day on which the judgment is given (such Business Day, the &#8220;<font style="font-style: italic;">Judgment Currency Conversion Date</font>&#8221;).</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If there is a change in the rate of exchange prevailing between the
      Judgment Currency Conversion Date and the date of actual payment of the amount due, each Obligor covenants and agrees to pay, or cause to be paid, such additional amounts, if any (but in any event not a lesser amount), as may be necessary to ensure
      that the amount paid in the Judgment Currency, when converted at the rate of exchange prevailing on the actual date of payment, will produce the amount of Dollars that could have been purchased with the amount of the Judgment Currency stipulated in
      the judgment or judicial award at the rate of exchange prevailing on the Judgment Currency Conversion Date.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>For purposes of determining any rate of exchange for this Section 13.20,
      such amounts shall include any premium and costs payable in connection with the purchase of Dollars.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;13.21<a name="Section13.21"><!--Anchor--></a>.</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Administrative Borrower.&#160; </font>Each Borrower hereby designates U.S. Holdings as the administrative Borrower (in such capacity, the <font style="font-style: italic;">&#8220;Administrative Borrower&#8221;</font>) to act as
        its representative and agent on its behalf, for the purposes of giving instructions with respect to the disbursement of the proceeds of the Term Loans, giving and receiving all notices and consents hereunder or under any of the other Loan Documents
        and taking all other actions on behalf of each Borrower under the Loan Documents.&#160; The Administrative Agent and each Lender may regard any notice or other communication pursuant to any Loan Document from U.S. Holdings in its capacity as
        Administrative Borrower as a notice or communication from each Borrower.&#160; Each warranty, covenant, agreement and undertaking made on behalf of each Borrower by U.S. Holdings in its capacity as Administrative Borrower for the Borrowers shall be
        deemed for all purposes to have been made by each Borrower and shall be binding upon and enforceable against each Borrower to the same extent as it if the same had been made directly by each Borrower.&#160; Such appointment shall remain in full force
        and effect unless and until the Administrative Agent shall have received written notice signed by each Borrower terminating such appointment.&#160; Borrowers shall have the right, to appoint another Borrower as the Administrative Borrower with the prior
        written consent of the Administrative Agent (such consent not to be unreasonably withheld or delayed).&#160; It is understood that the handling of the loan account and Collateral of the Borrowers in a combined fashion, as more fully set forth herein, is
        done solely as an accommodation to the Borrowers in order to utilize the collective borrowing powers of the Borrowers in the most efficient and economical manner and at their request, and that neither the Administrative Agent nor the Lenders shall
        incur liability to the Borrowers as a result hereof.&#160; Each Borrower expects to derive benefit, directly or indirectly, from the handling of the loan account and the Collateral in a combined fashion since the successful operation of each Borrower is
        dependent on the continued successful performance of the integrated group.&#160; To induce the Administrative Agent and the Lenders to do so, and in consideration thereof, each Borrower hereby jointly and severally agrees to indemnify the Administrative
        Agent and hold each Indemnified Party harmless against any and all liability, expense, loss or claim of damage or injury, made against such Indemnified Party by any Borrower or by any third party whosoever, arising from or incurred by reason of
        (a)&#160;the handling of the loan account and Collateral of the Borrowers as herein provided, (b)&#160;the Administrative Agent and the Lenders relying on any instructions of the Administrative Borrower, or (c)&#160;any other action taken by the Administrative
        Agent or any Lender hereunder or under the other Loan Documents.</font></div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 121 -</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;13.22<a name="Section13.22"><!--Anchor--></a>.</font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Joint and Several Liability of Borrowers.</font></font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each Borrower is accepting joint and several liability hereunder and
      under the other Loan Documents in consideration of the financial accommodations to be provided by the Administrative Agent and the Lenders under the Loan Documents, for the mutual benefit, directly and indirectly, of each Borrower and in
      consideration of the undertakings of the Borrowers to accept joint and several liability for the Obligations.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each Borrower, jointly and severally, hereby irrevocably and
      conditionally accepts, not merely as a surety but also as a co&#8209;debtor, joint and several liability with the other Borrower, with respect to the payment and performance of all of the Obligations (including any Obligations arising under this
      Section&#160;13.22), it being the intention of the parties hereto that all the Obligations shall be the joint and several obligations of each Borrower without preferences or distinction among them.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If and to the extent that any Borrower shall fail to make any payment
      with respect to any of the Obligations as and when due or to perform any of the Obligations in accordance with the terms thereof, then in each such event the other Borrower will make such payment with respect to, or perform, such Obligation until
      such time as all of the Obligations are paid in full.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(d)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Obligations of each Borrower under the provisions of this
      Section&#160;13.22 constitute the absolute and unconditional, full recourse Obligations of each Borrower enforceable against each Borrower to the full extent of its properties and assets, irrespective of the validity, regularity or enforceability of the
      provisions of this Agreement (other than this Section&#160;13.22(d)) or any other circumstances whatsoever.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(e)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Except as otherwise expressly provided in this Agreement, each Borrower
      hereby waives notice of acceptance of its joint and several liability, notice of any Term Loans, notice of the occurrence of any Default, Event of Default, or of any demand for any payment under this Agreement, notice of any action at any time taken
      or omitted by the Administrative Agent or the&#160; Lenders under or in respect of any of the Obligations, any requirement of diligence or to mitigate damages and, generally, to the extent permitted by applicable law, all demands, notices and other
      formalities of every kind in connection with this Agreement (except as otherwise provided in this Agreement).&#160; Each Borrower hereby assents to, and waives notice of, any extension or postponement of the time for the payment of any of the Obligations,
      the acceptance of any payment of any of the Obligations, the acceptance of any partial payment thereon, any waiver, consent or other action or acquiescence by the Administrative Agent or the Lenders at any time or times in respect of any default by
      any Borrower in the performance or satisfaction of any term, covenant, condition or provision of this Agreement, any and all other indulgences whatsoever by the Administrative Agent or the Lenders in respect of any of the Obligations, and the taking,
      addition, substitution or release, in whole or in part, at any time or times, of any security for any of the Obligations or the addition, substitution or release, in whole or in part, of any Borrower.&#160; Without limiting the generality of the
      foregoing, each Borrower assents to any other action or delay in acting or failure to act on the part of the Administrative Agent or a Lender with respect to the failure by any Borrower to comply with any of its respective Obligations, including,
      without limitation, any failure strictly or diligently to assert any right or to pursue any remedy or to comply fully with applicable laws or regulations thereunder, which would, but for the provisions of this Section&#160;13.22 afford grounds for
      terminating, discharging or relieving any Borrower, in whole or in part, from any of its Obligations under this Section&#160;13.22, it being the intention of each Borrower that, so long as any of the Obligations hereunder remain unsatisfied, the
      Obligations of each Borrower under this Section&#160;13.22 shall not be discharged except by performance and then only to the extent of such performance.&#160; The Obligations of each Borrower under this Section&#160;13.22 shall not be diminished or rendered
      unenforceable by any winding up, reorganization, arrangement, liquidation, reconstruction or similar proceeding with respect to any other Borrower or the Administrative Agent or a Lender.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 122 -</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(f)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each Borrower represents and warrants to the Administrative Agent and the
      Lenders that such Borrower is currently informed of the financial condition of the Borrowers and of all other circumstances which a diligent inquiry would reveal and which bear upon the risk of nonpayment of the Obligations.&#160; Each Borrower further
      represents and warrants to the Administrative Agent and the Lenders that such Borrower has read and understands the terms and conditions of the Loan Documents.&#160; Each Borrower hereby covenants that such Borrower will continue to keep informed of the
      other Borrower&#8217;s financial condition and of all other circumstances which bear upon the risk of nonpayment or nonperformance of the Obligations.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(g)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The provisions of this Section&#160;13.22 are made for the benefit of the
      Administrative Agent and each Lender, and their successors and assigns, and may be enforced by it or them from time to time against any or all of the Borrowers as often as occasion therefor may arise and without requirement on the part of the
      Administrative Agent or each Lender, or any of their successors or assigns first to marshal any of its or their claims or to exercise any of its or their rights against any Borrower or to exhaust any remedies available to it or them against any
      Borrower or to resort to any other source or means of obtaining payment of any of the Obligations hereunder or to elect any other remedy.&#160; The provisions of this Section&#160;13.22 shall remain in effect until all of the Obligations shall have been paid
      in full or otherwise fully satisfied.&#160; If at any time, any payment, or any part thereof, made in respect of any of the Obligations, is rescinded or must otherwise be restored or returned by the Administrative Agent or any Lender upon the insolvency,
      bankruptcy or reorganization of any Borrower, or otherwise, the provisions of this Section&#160;13.22 will forthwith be reinstated in effect, as though such payment had not been made.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(h)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each Borrower hereby agrees that it will not enforce any of its rights of
      contribution or subrogation against the other Borrower with respect to any liability incurred by it hereunder or under any of the other Loan Documents, any payments made by it to the Administrative Agent or the Lenders with respect to any of the
      Obligations or any collateral security therefor until such time as all of the Obligations have been paid in full in cash.&#160; Any claim which the Administrative Agent or a Lender may have against any Borrower with respect to any payments to the
      Administrative Agent or any Lender hereunder are hereby expressly made subordinate and junior in right of payment, without limitation as to any increases in the Obligations arising hereunder or thereunder, to the prior payment in full in cash of the
      Obligations and, in the event of any insolvency, bankruptcy, receivership, liquidation, reorganization or other similar proceeding under the laws of any jurisdiction relating to any Borrower, its debts or its assets, whether voluntary or involuntary,
      all such Obligations shall be paid in full in cash before any payment or distribution of any character, whether in cash, securities or other property, shall be made to any Borrower therefor.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(i)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each Borrower hereby agrees that after the occurrence and during the
      continuance of any Default or Event of Default, such Borrower will not demand, sue for or otherwise attempt to collect any Indebtedness of any other Borrower owing to such Borrower until the Obligations shall have been paid in full in cash.&#160; If,
      notwithstanding the foregoing sentence, such Borrower shall collect, enforce or receive any amounts in respect of such Indebtedness, such amounts shall be collected, enforced and received by such Borrower as trustee for the Administrative Agent, and
      such Borrower shall deliver any such amounts to the Administrative Agent for application to the Obligations in accordance with this Agreement.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;13.23.<a name="Section13.23."><!--Anchor--></a></font><font style="font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Amendment and Restatement.&#160; </font>This Agreement shall become effective on the Sixth Amendment Restatement Date and amends, restates and replaces in its entirety the Fifth A&amp;R Credit Agreement as of the Sixth
        Amendment Restatement Date.&#160; From and after the Sixth Amendment Restatement Date all references made to the &#8220;Credit Agreement&#8221; in any Loan Document or in any other instrument or document shall, without further action, be deemed to refer to this
        Agreement.&#160; All Exhibits and Schedules to the Fifth A&amp;R Credit Agreement are hereby incorporated by reference and shall be deemed to be Exhibits and Schedules to this Agreement. The Exhibits to the Fifth A&amp;R Credit Agreement are hereby
        amended by adding Exhibit R at the conclusion thereof. The Schedules to the Fifth A&amp;R Credit Agreement are hereby restated or supplemented by the Schedules attached hereto. Each of the parties hereto acknowledges and agrees that this Agreement
        amends, restates and replaces the Fifth A&amp;R Credit Agreement and this Agreement does not constitute or operate as a novation or an accord and satisfaction of the Fifth A&amp;R Credit Agreement or the indebtedness, obligations and liabilities of
        the Obligors evidenced or provided for thereunder.&#160; For the avoidance of doubt, the grant of security interest in the Collateral in favor of the Administrative Agent pursuant to the Security Documents continues in full force and effect.</font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; text-indent: 18pt;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; text-indent: 18pt;"><font style="font-family: 'Times New Roman'; font-style: italic;">Section&#160;13.24.</font><font style="font-family: 'Times New Roman';"><a name="Section13.24."><!--Anchor--></a>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
        <font style="font-style: italic;">Reaffirmation and Consent.</font></font></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(a)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each of the Obligors hereby (i) reaffirms its obligations under the Fifth
      A&amp;R Credit Agreement, as amended and restated hereby, and each and every other Loan Document to which it is a party (whether those Loan Documents are, or are not, being amended and/or restated in connection herewith), (ii) reaffirms all Liens on
      the Collateral and all guaranties which have been granted by it in favor of the Administrative Agent pursuant to any of the Loan Documents and (iii) confirms and agrees that each of the Security Documents continues to secure the payment and
      performance of the Obligations.&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 123 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(b)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The parties hereto hereby irrevocably confirm that the security
      constituted by the Loan Documents or pursuant thereto prior to the date hereof shall not be impaired, affected or discharged (whether in whole or in part) by or as a result of this Agreement.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(c)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The parties hereto acknowledge and agree that all loans, advances and
      other &#8220;Obligations&#8221; of any kind outstanding under the Fifth A&amp;R Credit Agreement immediately prior to the effectiveness of this Agreement shall constitute &#8220;Term Loans&#8221; and &#8220;Obligations&#8221; made hereunder.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(d)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The parties hereto confirm that this Agreement shall not constitute or
      effect a novation of the obligations of each Obligor under the Fifth A&amp;R Credit Agreement and other Loan Documents and in any event, the Administrative Agent and all other parties to this Agreement expressly reserve all guarantees and all other
      security interests or other security granted in favor of the Agent pursuant to the Fifth A&amp;R Credit Agreement and other Loan Documents (whether those Loan Documents are, or are not, being amended and/or restated in connection herewith), which
      guarantees and all other security interests or other security (whether being amended and/or restated in connection herewith), shall continue to remain in full force and effect.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 28.8pt; margin-left: 18pt; line-height: 1.25; font-family: 'Times New Roman';">(e)<font style="font-style: italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>In addition, unless specifically amended, or amended and restated, hereby
      or contemporaneously herewith, each of the &#8220;Loan Documents&#8221; (as defined in the Existing Credit&#160; Agreement) shall continue in full force and effect and that, from and after the Sixth Amendment Restatement Date, (i) all references to loans to, or notes
      issued by, the Borrowers therein shall be deemed to refer to the loans to, or notes issued by, the Borrowers hereunder, and (ii) all references to the &#8220;Loan Documents&#8221; contained therein shall be deemed to refer to the Loan Documents as defined in
      this Agreement.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman'; font-style: italic;">[Remainder of the Page Intentionally Left Blank; Signature Pages Follow]</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';"><br style="line-height: 1.25;">
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; color: #000000; font-weight: normal; font-style: normal;" class="BRPFPageNumber">- 124 -</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-variant: small-caps;">In Witness Whereof,</font> the parties hereto have caused this Agreement to be duly executed and delivered
      as of the day and year first above written.</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 10pt; color: #000000; width: 100%;" id="zdc11b734745b47fdb35bf6ba11f1d305">

          <tr>
            <td style="width: 50.00%;">
              <div>&#160;</div>
            </td>
            <td style="width: 50%;">
              <div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;">Borrowers:</div>
                <div style="line-height: 1.25; font-family: 'Times New Roman';"><br style="line-height: 1.25;">
                </div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;">Trinity Biotech, Inc.</div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps; text-indent: -18pt; margin-left: 18pt;">Clark Laboratories, Inc. (d/b/a Trinity Biotech (USA))</div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;">Biopool U.S., Inc. (d/b/a Trinity Biotech</div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;">Distribution)</div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;">Primus Corporation</div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;">MarDx Diagnostics, Inc.</div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;">IMMCO Diagnostics, Inc.</div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;">TRIB Biosensors Inc.</div>
                <div style="line-height: 1.25; font-family: 'Times New Roman'; text-align: left;">&#160;</div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman';">By:/<u>s/ John Gillard</u></div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160; Name: John Gillard</div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman';">&#160;&#160;&#160;&#160;&#160;&#160; Title: Treasurer</div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">
      <div style="text-align: center; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: center; line-height: 1.25;">[<font style="font-style: italic;">Signature Page to Sixth Amended and Restated Credit Agreement and Guaranty</font>]</div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="text-indent: -18pt; margin-left: 252pt; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;"> <br>
    </div>
    <div style="line-height: 1.25; font-variant: normal;">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 10pt; color: #000000; width: 100%;" id="z769af4db2ad14049a5c0089389fa803c">

          <tr>
            <td style="width: 50.00%;">
              <div>&#160;</div>
            </td>
            <td style="width: 50%;">
              <div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;">Guarantors:</div>
                <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;">Trinity Biotech plc</div>
                <div style="text-align: left; text-indent: -18pt; margin-left: 252pt; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;"> <br>
                </div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;"> By: /<u>s/ John Gillard</u></div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;">
                  <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160; Name: John Gillard</div>
                  <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160; Title: Director</div>
                  <div style="line-height: 1.25;">&#160;</div>
                  <div style="line-height: 1.25; font-variant: small-caps;">Trinity Research Limited</div>
                  <div style="line-height: 1.25; font-variant: small-caps;"> <br>
                  </div>
                  <div style="line-height: 1.25; font-variant: small-caps;">By: /<u>s/ John Gillard</u> </div>
                  <div style="line-height: 1.25; font-variant: small-caps;">
                    <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160; Name: John Gillard</div>
                    <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160; Title: Director</div>
                    <div style="line-height: 1.25;">&#160;</div>
                    <div style="line-height: 1.25; font-variant: small-caps;">Trinity Biotech Financial Services Limited</div>
                    <div style="line-height: 1.25; font-variant: small-caps;"> <br>
                    </div>
                    <div style="line-height: 1.25; font-variant: small-caps;">By: /<u>s/ John Gillard</u> </div>
                    <div style="line-height: 1.25; font-variant: small-caps;">
                      <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160; Name: John Gillard</div>
                      <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160; Title: Director</div>
                      <div style="line-height: 1.25;">&#160;</div>
                      <div style="line-height: 1.25; font-variant: small-caps;">Trinity Biotech Manufacturing Limited</div>
                      <div style="text-indent: -18pt; margin-left: 252pt; line-height: 1.25; font-variant: small-caps;"> <br>
                      </div>
                      <div style="line-height: 1.25; font-variant: small-caps;">By: /<u>s/ John Gillard</u><br>
                        <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160; Name: John Gillard</div>
                        <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160; Title: Director</div>
                        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
                        </div>
                        <div style="line-height: 1.25; font-variant: small-caps;">Trinity Biotech Manufacturing Services Limited</div>
                        <div style="text-indent: -18pt; margin-left: 252pt; line-height: 1.25; font-variant: small-caps;"> <br>
                        </div>
                        <div style="line-height: 1.25; font-variant: small-caps;">By: /<u>s/ John Gillard</u> </div>
                        <div style="line-height: 1.25; font-variant: small-caps;">
                          <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160; Name: John Gillard</div>
                          <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160; Title: Director</div>
                          <div style="line-height: 1.25;">&#160;</div>
                          <div style="line-height: 1.25; font-variant: small-caps;">Trinity Biotech (Joint Venture) Limited</div>
                          <div style="line-height: 1.25; font-variant: small-caps;"> <br>
                          </div>
                          <div style="line-height: 1.25; font-variant: small-caps;">By: /<u>s/ John Gillard</u> </div>
                          <div style="line-height: 1.25; font-variant: small-caps;">
                            <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160; Name: John Gillard</div>
                            <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160; Title: Director</div>
                          </div>
                        </div>
                      </div>
                    </div>
                  </div>
                </div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-indent: -18pt; margin-left: 252pt; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;"> <br>
    </div>
    <div style="line-height: 1.25; font-variant: normal;">
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman';">[<font style="font-style: italic;">Signature Page to Sixth Amended and Restated Credit Agreement and Guaranty</font>]</div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 10pt; color: #000000; width: 100%;" id="za653c4e4b811451f9cb6e22d9b159866">

          <tr>
            <td style="width: 50.00%;">
              <div>&#160;</div>
            </td>
            <td style="width: 50%;">
              <div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;">Phoenix Bio-tech Corp.</div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;"> <br>
                </div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;">By: /<u>s/ Ronan O&#8217;Caoimh</u> </div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;">
                  <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160; Name: Ronan O&#8217;Caoimh</div>
                  <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160; Title: Director</div>
                  <div style="line-height: 1.25;"><br style="line-height: 1.25;">
                  </div>
                  <div style="line-height: 1.25; font-variant: small-caps;">Immco Diagnostics (Canada) Inc.</div>
                  <div style="line-height: 1.25; font-variant: small-caps;"> <br>
                  </div>
                  <div style="line-height: 1.25; font-variant: small-caps;">By: <u>/s/ Ronan O&#8217;Caoimh</u> </div>
                  <div style="line-height: 1.25; font-variant: small-caps;">
                    <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160; Name: Ronan O&#8217;Caoimh</div>
                    <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160; Title: CEO</div>
                    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
                    </div>
                    <div style="line-height: 1.25; font-variant: small-caps;">Nova Century Scientific Inc.</div>
                    <div style="line-height: 1.25; font-variant: small-caps;"> <br>
                    </div>
                    <div style="line-height: 1.25; font-variant: small-caps;">By: <u>/s/ Ronan O&#8217;Caoimh</u> </div>
                    <div style="line-height: 1.25; font-variant: small-caps;">
                      <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160; Name: Ronan O&#8217;Caoimh</div>
                      <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160; Title: CEO</div>
                      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
                      </div>
                      <div style="line-height: 1.25; font-variant: small-caps;">Konamite Limited</div>
                      <div style="line-height: 1.25; font-variant: small-caps;"> <br>
                      </div>
                      <div style="line-height: 1.25; font-variant: small-caps;">By: <u>/s/ John Gillard</u> </div>
                      <div style="line-height: 1.25; font-variant: small-caps;">
                        <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160; Name: John Gillard</div>
                        <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160; Title: Director</div>
                        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
                        </div>
                        <div style="line-height: 1.25; font-variant: small-caps;">Metabolomic Diagnostics Limited</div>
                        <div style="text-indent: -4.5pt; margin-left: 238.5pt; line-height: 1.25; font-variant: small-caps;"> <br>
                        </div>
                        <div style="line-height: 1.25; font-variant: small-caps;">By: <u>/s/ Gary Keating</u> </div>
                        <div style="line-height: 1.25; font-variant: small-caps;">
                          <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160; Name: Gary Keating</div>
                          <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160; Title: Director</div>
                          <u> </u></div>
                        <u> </u></div>
                    </div>
                  </div>
                </div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">
      <div style="text-align: center; line-height: 1.25;"> <br>
      </div>
      <div style="text-align: center; line-height: 1.25;">[<font style="font-style: italic;">Signature Page to Sixth Amended and Restated Credit Agreement and Guaranty</font>]</div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 10pt; color: #000000; width: 100%;" id="za425fcabc5514078bb44ee5f48692be1">

          <tr>
            <td style="width: 50.00%;">
              <div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;">Perceptive Credit Holdings III, LP</div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman';">as Administrative Agent and Lender</div>
                <div style="line-height: 1.25; font-family: 'Times New Roman';"><br style="line-height: 1.25;">
                </div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman';"><font style="font-variant: small-caps;">B</font>y: Perceptive Credit Opportunities GP, LLC,</div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman';">its general partner</div>
                <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
                <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman';">By: <u>/s/ Sandeep Dixit</u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<br>
                    Name: Sandeep Dixit<br>
                    Title: Chief Credit Officer</font></div>
                <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
                <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman';">By:<u> /s/ Sam Chawla</u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<br>
                    Name: Sam Chawla<br>
                    Title: Portfolio Manager</font></div>
              </div>
            </td>
            <td style="width: 50.00%;">
              <div>&#160;</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;"> <br>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">
      <div style="text-align: center; line-height: 1.25;">[<font style="font-style: italic;">Signature Page to Sixth Amended and Restated Credit Agreement and Guaranty</font>]</div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps; font-weight: bold;"><a name="Schedule1"><!--Anchor--></a>Schedule 1<br>
      to<br>
      Sixth Amended and Restated Credit Agreement and Guaranty</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps; font-weight: bold;">Sixth Amendment Term Loan Commitments</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" border="0" align="center" id="za8e42519a5f94bbf98d064ea71a48f7c" style="width: 70%; color: #000000; font-family: Arial; font-size: 10pt; text-align: left;">

        <tr>
          <td style="width: 53.95%; vertical-align: bottom; text-align: center;">
            <div style="line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps;">Lender</div>
          </td>
          <td style="width: 46.05%; vertical-align: bottom; font-family: 'Times New Roman'; text-align: center;">
            <div style="line-height: 1.25; font-variant: small-caps;">Sixth Amendment Term Loan </div>
            <div style="line-height: 1.25; font-variant: small-caps;">Commitment</div>
          </td>
        </tr>
        <tr>
          <td style="width: 53.95%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25; font-variant: small-caps;">Perceptive Credit Holdings III, LP</div>
          </td>
          <td style="width: 46.05%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25;">$2,000,000</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman';"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman'; font-variant: small-caps; font-weight: bold;">Warrant Shares</div>
    <div style="line-height: 1.25; font-family: 'Times New Roman';"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z95bb3771facc408ab52a196eecd28f4d" style="font-family: Arial; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 19.01%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25; font-variant: small-caps;">Lender</div>
          </td>
          <td style="width: 22.17%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25; font-variant: small-caps;">Number of Warrant American Depositary Shares (represented by American Depositary Receipts) granted under the Existing Warrant Certificate</div>
          </td>
          <td style="width: 22.2%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25; font-variant: small-caps;">Number of Warrant American Depositary Shares (represented by American Depositary Receipts) granted under the Effective Date Warrant Certificate</div>
          </td>
          <td style="width: 19.36%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25; font-variant: small-caps;">Number of Warrant American Depositary Shares (represented by American Depositary Receipts) granted under the Third Amendment Warrant Certificate</div>
          </td>
          <td style="width: 17.26%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25; font-variant: small-caps;">Number of Warrant American Depositary Shares (represented by American Depositary Receipts) granted under the Sixth Amendment Warrant Certificate</div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.01%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25; font-variant: small-caps;">Perceptive Credit Holdings III, LP</div>
          </td>
          <td style="width: 22.17%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25;">500,000<sup style="font-family: Symbol, serif; vertical-align: text-top; line-height: 1; font-size: smaller;">*</sup></div>
          </td>
          <td style="width: 22.2%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25;">500,000<sup style="font-family: Symbol, serif; vertical-align: text-top; line-height: 1; font-size: smaller;">*</sup></div>
          </td>
          <td style="width: 19.36%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25;">1,000,000</div>
          </td>
          <td style="width: 17.26%; vertical-align: top; font-family: 'Times New Roman';">
            <div style="text-align: center; line-height: 1.25;">750,000</div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.01%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
          <td style="width: 22.17%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
          <td style="width: 22.2%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
          <td style="width: 19.36%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
          <td style="width: 17.26%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25; font-family: 'Times New Roman';"><br style="line-height: 1.25;">
    </div>
    <hr noshade="noshade" align="left" style="background-color: #000000; border: 0px; height: 1px; width: 2in; margin-left: 0pt; margin-right: auto; color: #000000;">
    <div style="text-align: justify; text-indent: -54pt; margin-left: 54pt; line-height: 1.25; font-family: 'Times New Roman';">&#8727; Reflects the revised ADS Ratio effective as of February 23, 2024, such that the Existing Warrant Certificate for 2,500,000
      ADSs is now a warrant for 500,000 ADSs.</div>
    <div style="text-align: justify; text-indent: -54pt; margin-left: 54pt; line-height: 1.25; font-family: 'Times New Roman';">&#8727; Reflects the revised ADS Ratio effective as of February 23, 2024, such that the Effective Date Warrant Certificate for
      2,500,000 ADSs is now a warrant for 500,000 ADSs.</div>
    <div style="text-align: justify; text-indent: -36pt; margin-left: 36pt; line-height: 1.25; font-family: 'Times New Roman';"> <br>
    </div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
  </div>
  <font style="font-family: 'Times New Roman';"> </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>exhibit_99-3.htm
<DESCRIPTION>EXHIBIT 99.3
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div style="text-align: right;"><font style="font-weight: bold;"><u>Exhibit 99.3</u></font><br>
    </div>
    <div class="BRPFPageHeader">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE
      UPON AN EXEMPTION FROM REGISTRATION UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE&#160;&#8220;<u>SECURITIES ACT</u>&#8221;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
      UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS MAY BE REQUIRED TO BE EVIDENCED BY
      A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY.&#160; THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE
      MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN &#8220;ACCREDITED INVESTOR&#8221; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">WARRANT TO PURCHASE AMERICAN DEPOSITARY SHARES<br>
      REPRESENTED BY AMERICAN DEPOSITARY RECEIPTS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">TRINITY BIOTECH PLC</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">Warrant ADSs: 750,000&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Issue Date: August 7, 2025</div>
    <div style="line-height: 1.25;">Warrant No. 4</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">THIS WARRANT TO PURCHASE AMERICAN DEPOSITARY SHARES REPRESENTED BY AMERICAN DEPOSITARY RECEIPTS (this&#160;&#8220;<u>Warrant</u>&#8221; or &#8220;<u>Warrant Certificate</u>&#8221;) certifies that, for value
      received, Perceptive Credit Holdings III, LP or its assigns (the&#160;&#8220;<u>Holder</u>&#8221;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof, and on or
      prior to the close of business on August 7, 2032, (the&#160;&#8220;<u>Expiration Date</u>&#8221;), but not thereafter, to purchase from Trinity Biotech PLC, a public limited company organized and existing under the laws of Ireland (the&#160;&#8220;<u>Company</u>&#8221;), and the
      Company shall be obliged to cause the issuance, of up to seven hundred fifty thousand (750,00) American Depositary Shares of the Company (&#8220;<u>ADSs</u>&#8221;), with each ADS being represented by one American Depositary Receipt issued by the Depositary (&#8220;<u>ADR</u>&#8221;),

      each of which in turn&#160; represents four &#8220;A&#8221; Ordinary Shares of the Company (the &#8220;<u>ADS Ratio</u>&#8221;) (as subject to adjustment hereunder the &#8220;Warrants ADSs&#8221;).&#160; The purchase price of one ADS, represented by one ADR, issuable under this Warrant shall be
      equal to the Exercise Price, as defined in <u>Section&#160;2(b)</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">This Warrant is issued pursuant to that certain Sixth Amended and Restated Credit Agreement and Guaranty dated as of August 7, 2025 (the&#160;&#8220;<u>Credit Agreement</u>&#8221;) by and among Trinity Biotech, Inc.,
      a Delaware corporation (&#8220;<u>U.S. Holdings</u>&#8221;), &#160;Fitzgerald Industries International, Inc.,&#160; a Delaware corporation (&#8220;<u>U.S. Fitzgerald</u>&#8221;), Clark Laboratories, Inc. (d/b/a as Trinity Biotech (USA)), a New York corporation (&#8220;<u>U.S. Clark</u>&#8221;),&#160;
      MarDx Diagnostics, Inc., a California corporation (&#8220;<u>U.S. MarD</u><font style="font-style: italic;">x</font>&#8221;), Biopool U.S., Inc., a Delaware corporation (d/b/a Trinity Biotech Distribution)&#160; (&#8220;<u>U.S. Biopool</u>&#8221;), Primus Corporation, a Missouri
      corporation (&#8220;<u>U.S. Primus</u>&#8221;), IMMCO Diagnostics, Inc., a Delaware corporation (&#8220;<u>U.S. Immco</u>&#8221;), TRIB Biosensors Inc., a Delaware corporation (&#8220;<u>U.S. TRIB</u>&#8221; and together with U.S. Holdings, U.S. Fitzgerald, U.S. Clark, U.S. Mardx, U.S.
      Biopool, U.S. Primus and U.S. Immco, each a &#8220;<u>Borrower</u>&#8221; and collectively, the&#160;<font style="font-style: italic;">&#8220;</font><u>Borrowers</u><font style="font-style: italic;">&#8221;</font>), certain guarantors party thereto from time to time, the lenders
      from time to time party thereto, and Perceptive Credit Holdings III, LP, as administrative agent (in such capacity, together with its successors and assigns,&#160;<font style="font-style: italic;">&#8220;</font><u>Administrative Agent</u><font style="font-style: italic;">&#8221;</font>).&#160;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div style="text-indent: 36pt; line-height: 1.25;"><u>Section 1.</u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Definitions</u>.&#160; For the purposes hereof, in addition to the terms defined elsewhere in this Warrant, (a)&#160;capitalized terms used and not otherwise defined herein shall
      have the meanings set forth in the Credit Agreement, and (b)&#160;the following terms shall have the following meanings:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<u>Affiliate</u>&#8221; means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such
      terms are used in and construed under Rule 405 under the Securities Act.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<u>Commission</u>&#8221; means the United States Securities and Exchange Commission.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<u>Companies Act</u>&#8221; means the Companies Act of 2014 of Ireland (as amended).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<u>Convertible Securities</u>&#8221; means any debt, equity or other securities that are, directly or indirectly, convertible into or exchangeable for Ordinary Shares or ADSs or ADRs.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<u>Depositary</u>&#8221; means The Bank of New York Mellon, a New York banking corporation, as depositary for the ADSs and the issuer of the ADRs.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<u>Excluded Issuance</u>&#8221; means the issuance of (a)&#160;Ordinary Shares or ADSs (or options with respect thereto) issued or issuable to employees or directors of, or consultants to,
      the Company or any of its subsidiaries pursuant to a plan, agreement or arrangement approved by the Board of Directors of the Company, (b)&#160;warrants issued pursuant to the Credit Agreement and/or other securities exercisable or exchangeable for or
      convertible into Ordinary Shares or ADSs issued and outstanding on the date of this Warrant, <font style="font-style: italic;">provided</font> that such securities have not been amended since the date of this Warrant to increase the number of such
      securities or to decrease the exercise price, exchange price or conversion price of such securities (for purposes of clarity, any decrease in the exercise price, exchange price or conversion price of such securities shall not be deemed an amendment
      thereto, if such decrease is as a result of any price-based anti-dilution provision contained in such securities prior to the date hereof), and (c)&#160;other securities issued to financial institutions, institutional investors or lessors in connection
      with credit arrangements, equipment financings or similar transactions (and not for the purpose of raising capital) approved by a majority of disinterested directors of the Company.&#160; In addition, for the avoidance of doubt, &#8220;Excluded Issuances&#8221; also
      include the filing of any registration statement of the Company with the Commission registering securities of the Company, or the filing of any amendments or supplements thereto, provided that the determination of whether sales under any such
      registration statement is an Excluded Issuance will be determined based on the preceding clauses (a) to (c) hereof.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">2</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<u>Fundamental Transaction</u>&#8221; means (a)&#160;the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into
      another Person, (b)&#160;the Company, directly or indirectly, effects any sale, lease, exclusive license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (c)&#160;any,
      direct or indirect, purchase offer, scheme of arrangement, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Ordinary Shares, ADRs or ADSs are permitted to sell, tender, agree to
      cancel or exchange their shares for other securities, cash or property and has been accepted by the holders of fifty percent (50%) or more of the outstanding security holders of the Company (or, in the case of a scheme of arrangement, the requisite
      majority to approve such scheme), (d)&#160;the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Ordinary Shares or ADSs (but, for the avoidance of doubt, excluding
      any transaction, event or occurrence covered by <u>Section&#160;3(a)</u>) or any compulsory share exchange pursuant to which the Ordinary Shares or ADSs are effectively converted into or exchanged for other securities, cash or property, (e)&#160;the Company,
      directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with
      another Person whereby such other Person acquires more than fifty percent (50%) of the outstanding voting shares of the Company (not including any shares held by the other Person or other Persons making or party to, or associated or affiliated with
      the other Persons making or party to, such stock or share purchase agreement or other business combination).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<u>Marketable Securities</u>&#8221; means securities that (a)&#160;are tradable on an established national U.S. stock exchange or reported through an established over-the-counter trading
      system and (b)&#160;are not subject to restrictions on transfer under the Securities Act, the Companies Act or contractual restrictions on transfer.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<u>Options</u>&#8221; means any warrants or other rights or options to subscribe for or purchase Ordinary Shares or Convertible Securities.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<u>Ordinary Shares</u>&#8221; means the &#8220;A&#8221; ordinary shares of the Company, par value USD $0.0109 per share, and any other class of securities into which such securities may hereafter
      be reclassified or changed.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<u>Person</u>&#8221; means any individual, sole proprietorship, partnership, limited liability company, corporation, joint venture, trust, incorporated organization or government or
      department or agency thereof.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<u>Prospectus</u>&#8221; means the prospectus or prospectuses included in any Registration Statement, as amended or supplemented by any prospectus supplement with respect to the terms
      of the offering of any portion of the Registrable Securities covered by such Registration Statement and by all other amendments and supplements to the prospectus, including post-effective amendments and all material incorporated by reference in such
      prospectus or prospectuses.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">3</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<u>Registrable Securities</u>&#8221; means (a)&#160;any ADSs (represented by ADRs), or Ordinary Shares held by Holder or issuable upon conversion, exercise or exchange of any securities
      owned by Holder at any time (including Warrant ADSs exercisable upon exercise of this Warrant), and (b)&#160;any ADSs (represented by ADRs) or Ordinary Shares issued or issuable with respect to any shares described in subsection (a)&#160;above by way of a
      stock dividend or stock split or in connection with a combination of shares, recapitalization, merger, consolidation or other reorganization (it being understood that for purposes of this Warrant, Holder shall be deemed to be a holder of Registrable
      Securities whenever Holder has the right to then acquire or obtain from the Company any Registrable Securities, whether or not such acquisition has actually been effected).&#160; As to any particular Registrable Securities, such securities shall cease to
      be Registrable Securities when (i)&#160;a Registration Statement covering such securities has been declared effective by the SEC and such securities have been disposed of pursuant to such effective Registration Statement, (ii)&#160;such securities are sold
      under circumstances in which all of the applicable conditions of Rule 144 (or any similar provisions then in force) under the Securities Act are met, (iii)&#160;such securities are otherwise transferred and such securities may be resold without subsequent
      registration under the Securities Act, or (iv)&#160;such securities shall have ceased to be outstanding.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<u>Registration Statement</u>&#8221; means any registration statement of the Company which covers any of the Registrable Securities pursuant to the provisions of this Warrant, including
      the Prospectus, amendments and supplements to or replacements of such Registration Statement, including post-effective amendments, all exhibits and all materials incorporated by reference in such Registration Statement.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<u>Rule 144</u>&#8221; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation
      hereafter adopted by the Commission having substantially the same effect as such Rule.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<u>Share Equivalents</u>&#8221; means any securities of the Company or its wholly owned subsidiaries which would entitle the holder thereof to acquire at any time Ordinary Shares or
      ADSs, including, without limitation, any debt, preferred stock, right, option, warrant, ADR or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Ordinary
      Shares or ADSs.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<u>Stock Deemed Outstanding</u>&#8221; means, at any given time, the sum of (i)&#160;the number of Ordinary Shares and ADSs actually outstanding at such time, plus (ii)&#160;the number of
      Ordinary Shares issuable upon exercise of Options actually outstanding at such time, plus (iii)&#160;the number of Ordinary Shares issuable upon conversion or exchange of Convertible Securities (including ADSs) actually outstanding at such time (treating
      as actually outstanding any Convertible Securities issuable upon exercise of Options actually outstanding at such time), in each case, regardless of whether the Options or Convertible Securities are actually exercisable at such time; <font style="font-style: italic;">provided</font> that Stock Deemed Outstanding at any given time shall not include shares owned or held by or for the account of the Company or any of its wholly owned subsidiaries.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<u>Trading Day</u>&#8221; means a day on which the principal Trading Market is open for trading.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<u>Trading Market</u>&#8221; means the Nasdaq Global Market (or any successor to the Nasdaq Global Market), or any national securities exchange registered with the Commission on which
      the ADSs are listed and which is then the primary trading market for the ADSs.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">4</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<u>Transfer Agent</u>&#8221; means Computershare Investor Services (Ireland) Limited, the current transfer agent of the Company, and any successor transfer agent of the Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#8220;<u>VWAP</u>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (a) if the ADSs are then listed or quoted on the Trading Market, the
      daily volume weighted average price of the ADSs for such date on the Trading Market on which the ADSs are then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:00 p.m. (New York City
      time)), (b) if the ADSs are not then listed or quoted for trading on the Trading Market and if prices for the ADSs are then reported on the &#8220;Pink Market&#8221; of the OTC Markets Group, Inc. (or a similar organization or agency succeeding to its functions
      of reporting prices), the most recent bid price per ADS as reported, or (c) in all other cases, the fair market value of one ADS as determined by the Company and the Holder, provided that if the Company and the Holder cannot agree on the fair market
      value of one ADS, such value shall be determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company, the reasonable, actual and documented fees and reasonable, actual and documented out-of-pocket
      expenses of which shall be paid by the Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;"><u>Section 2.</u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Exercise</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Exercise of Warrant</u>.&#160; Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times before the Expiration
      Date by delivery to the Company (or such other office or agency of the Company as it may designate by notice in writing to the registered Holder at the address of the Holder appearing on the books of the Company) of a duly executed electronic copy of
      the Notice of Exercise in the form annexed hereto (the&#160;&#8220;<u>Notice of Exercise</u>&#8221;) and within one&#160;(1) Trading Day of the date said Notice of Exercise is delivered to the Company, the Company shall have received payment of the aggregate Exercise
      Price of the Warrant ADSs thereby purchased by wire transfer or cashier&#8217;s check drawn on a United States bank or pursuant to the cashless exercise procedure specified in <u>Section&#160;2(c)</u> below.&#160; No ink-original Notice of Exercise shall be
      required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required.&#160; Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this
      Warrant to the Company until the Holder has purchased all of the Warrant ADSs available hereunder and this Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three&#160;(3)
      Trading Days of the date the final Notice of Exercise is delivered to the Company.&#160; Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant ADSs available hereunder shall have the effect of lowering the
      outstanding number of Warrant ADSs purchasable hereunder in an amount equal to the applicable number of Warrant ADSs purchased.&#160; The Holder and the Company shall maintain records showing the number of Warrant ADSs purchased and the date of such
      purchases.&#160; <font style="font-weight: bold;">The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant ADSs hereunder,
        the number of Warrant ADSs available for purchase hereunder at any given time may be different than the amount stated on the face hereof.&#160; For the avoidance of doubt, the Holder may request a new Warrant upon the partial exercise of this Warrant.</font></div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">5</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">In the event that immediately prior to the close of business on the Expiration Date, the VWAP of one ADS is greater than the then applicable Exercise Price, this Warrant shall be
      deemed to be automatically exercised as a &#8220;cashless exercise&#8221; pursuant to <u>Section&#160;2(c)</u> below, and the Company or the Depositary, as applicable, shall deliver the applicable number of ADSs (represented by ADRs) to the Holder pursuant to the
      provisions of <u>Section&#160;2(d) </u>below.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Exercise Price</u>.&#160; The exercise price per ADS under this Warrant shall be $0.86, subject to adjustment hereunder (the &#8220;<u>Exercise Price</u>&#8221;).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Cashless Exercise</u>.&#160; This Warrant may be exercised, in whole or in part, at any time by means of a &#8220;cashless exercise&#8221; in which the Holder shall be entitled to
      receive a number of Warrant ADSs (represented by ADRs) equal to the quotient obtained by dividing [(A-B) (X)] by (A) (a &#8220;<u>Cashless Exercise</u>&#8221;), where:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 108pt; line-height: 1.25;">(A) = the VWAP on the Trading Day immediately preceding the date on which Holder elects to exercise this Warrant by means of a &#8220;cashless exercise,&#8221; as set forth in the applicable
      Notice of Exercise;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 108pt; line-height: 1.25;">(B) = the Exercise Price, as adjusted hereunder; and</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 108pt; line-height: 1.25;">(X) = the number of Warrant ADSs (represented by ADRs) that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by
      means of a cash exercise rather than a cashless exercise or, if only a portion of this Warrant is being exercised, the portion of this Warrant being cancelled.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Notwithstanding any other provision of this Warrant, the issue of any Warrant ADSs (represented by ADRs) (or shares underlying such Warrant ADSs) pursuant to any exercise or
      redemption of this Warrant (including any exercise or redemption made on a cashless basis pursuant to this Section 2(c) or otherwise) shall be conditional on the payment to the Company by the Holder, whether by payment of the Exercise Price in cash
      or otherwise, of an amount in cash at least equal to the product of the nominal value of the &#8220;A&#8221; Ordinary Shares of the Company underlying the Warrant ADSs, the number of Warrant ADSs (represented by ADRs) to be issued and the ADS Ratio.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If Warrant ADSs (represented by ADRs) are issued in such a cashless exercise, the parties acknowledge and agree that, in accordance with Section&#160;3(a)(9) of the Securities Act, the
      Warrant ADSs (represented by ADRs) shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant ADSs (represented by ADRs) being issued may be tacked on to the holding period of this Warrant commencing as
      of the Issue Date. The Company agrees not to take any position contrary to this <u>Section&#160;2(c)</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">6</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Mechanics of Exercise</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Delivery of Warrant ADSs Upon Exercise</u>.&#160; Warrant ADSs (represented by ADRs) purchased hereunder shall be transmitted by the Depositary to the Holder by crediting
      the account of the Holder&#8217;s prime broker with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&#8220;<u>DWAC</u>&#8221;) and the Warrant ADSs (represented by ADRs) are eligible for resale by the Holder without volume or
      manner-of-sale limitations pursuant to Rule 144 or an available Registration Statement, and otherwise by physical delivery to the address specified by the Holder in the Notice of Exercise by the date that is two&#160;(2) Trading Days after the delivery to
      the Company, by 11 a.m. (local time in New York City, New York) on a Trading Day, of the Notice of Exercise and payment of the aggregate Exercise Price as set forth above (including by Cashless Exercise) (such date, the&#160;&#8220;<u>Warrant ADS Delivery Date</u>&#8221;).&#160;

      The Warrant ADSs (represented by ADRs) shall be deemed to have been issued, and the Holder or any other person so designated to be named therein shall be deemed to have become a holder of record of such Warrant ADSs (represented by ADRs) for all
      purposes, as of the date this Warrant has been exercised, with payment to the Company of the Exercise Price (or by Cashless Exercise) and all taxes required to be paid by the Holder, if any, pursuant to <u>Section&#160;2(d)(v)</u> prior to the issuance
      of such Warrant ADSs (represented by ADRs), having been paid.&#160; If the Company fails for any reason to deliver to the Holder the Warrant ADSs (represented by ADRs) subject to a Notice of Exercise by the Warrant ADS Delivery Date, other than a failure
      to deliver caused by the Holder&#8217;s failure to pay the applicable Exercise Price for such Warrant ADSs or to timely take such actions as are necessary to post such Warrant ADSs (represented by ADRs) in DWAC, the Company shall pay to the Holder, in
      cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant ADSs (represented by ADRs) subject to such exercise (based on the VWAP on the date of the applicable Notice of Exercise) $0.86 per Trading Day for each Trading Day after
      such Warrant ADS Delivery Date until such Warrant ADSs (represented by ADRs) are delivered or Holder rescinds such exercise.&#160; The Company agrees to maintain a registrar (which may be the Depositary) that is a participant in the &#8220;FAST&#8221; program for so
      long as this Warrant remains outstanding and exercisable.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Delivery of New Warrants Upon Exercise</u>.&#160; If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of
      this Warrant certificate, at or promptly after the time of delivery of the Warrant ADSs (represented by ADRs), deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant ADSs called for by this
      Warrant, which new Warrant shall in all other respects be identical with this Warrant.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Rescission Rights</u>.&#160; If the Company fails to cause the Depositary to transmit to the Holder the Warrant ADSs (represented by ADRs) pursuant to <u>Section&#160;2(d)(i)</u>
      by the Warrant ADS Delivery Date, other than a failure to deliver caused by the Holder&#8217;s failure to pay the applicable Exercise Price for such Warrant ADSs or to timely take such actions as are necessary to post such Warrant ADSs (represented by
      ADRs) in DWAC, then the Holder will have the right to rescind such exercise and have its Exercise Price, if any, refunded by the Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">7</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Compensation for Buy-In on Failure to Timely Deliver Warrant ADSs Upon Exercise</u>.&#160; In addition to any other rights available to the Holder, if the Company fails
      to cause the Depositary to transmit to the Holder the Warrant ADSs (represented by ADRs) pursuant to an exercise on or before the Warrant ADS Delivery Date and such failure is not caused by any act or omission of the Holder, and if after such date
      the Holder is required by its broker to purchase (in an open market transaction or otherwise) ADSs (represented by ADRs) to deliver in satisfaction of a sale by the Holder of the Warrant ADS (represented by ADRs) which the Holder anticipated
      receiving upon such exercise (a&#160;&#8220;<u>Buy-In</u>&#8221;), then the Company shall (A)&#160;pay in cash to the Holder the amount, if any, by which (x)&#160;the Holder&#8217;s total purchase price (including brokerage commissions, if any) for the ADSs (represented by ADRs) so
      purchased (<font style="font-style: italic;">provided</font>, Holder exercises reasonable efforts to minimize the amount of such purchase price) exceeds (y)&#160;the amount obtained by multiplying (1)&#160;the number of Warrant ADSs (represented by ADRs) that
      the Company was required to deliver to the Holder in connection with the exercise at issue by (2)&#160;the actual sale price at which the sell order giving rise to such purchase obligation was executed, and (B)&#160;at the option of the Holder, either
      reinstate the portion of the Warrant and equivalent number of Warrant ADSs for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of ADSs (represented by ADRs) that would
      have been issued had the Company timely complied with its exercise and delivery obligations hereunder.&#160; For example, if the Holder purchases ADSs (represented by ADRs) having a total purchase price of $11,000 to cover a Buy-In with respect to an
      attempted exercise to acquire Warrant ADSs (represented by ADRs) with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder
      $1,000.&#160; The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss.&#160; Nothing herein shall limit a Holder&#8217;s right to
      pursue any other remedies available to it hereunder, at law or in equity, including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&#8217;s failure to timely deliver Warrant ADSs (represented by
      ADRs) upon exercise of the Warrant as required pursuant to the terms hereof.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Fractional ADSs or Scrip</u>.&#160; No fractional ADSs (represented by ADRs) or scrip representing fractional ADSs (represented by ADRs) shall be issued upon the
      exercise of this Warrant.&#160; As to any fraction of an ADS which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall round up to the next whole ADS (represented by and ADR).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Charges, Taxes and Expenses</u>.&#160; Subject to applicable law or regulation, the issuance of this Warrant and the Warrant ADSs (represented by ADRs) shall be made
      without charge to the Holder for any stamp duty, issue or transfer tax or other incidental expense in respect of the issuance of this Warrant and Warrant ADSs (represented by ADRs) (but not any subsequent transfer of this Warrant or any Warrant ADSs
      (represented by ADRs) so issued), all of which taxes and expenses shall be paid by the Company, and such Warrant ADSs (represented by ADRs) shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <font style="font-style: italic;">provided</font>, <font style="font-style: italic;">however</font>, that in the event that Warrant ADSs (represented by ADRs) are to be issued in a name other than the name of the Holder, this Warrant when surrendered
      for exercise shall be accompanied by a completed Assignment Form in the form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax
      incidental thereto.&#160; The Company shall pay all fees of the Depositary required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions)
      required for same-day electronic delivery of the Warrant ADSs (represented by ADRs).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">8</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(vii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Closing of Books</u>.&#160; The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant, pursuant to the
      terms hereof.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Holder&#8217;s Exercise Limitations</u>.&#160; The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this
      Warrant, pursuant to this <u>Section&#160;2</u> or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&#8217;s Affiliates, and any other
      Persons acting as a group together with the Holder or any of the Holder&#8217;s Affiliates), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&#160; For purposes of the foregoing sentence, the number of Ordinary Shares
      beneficially owned by the Holder and its Affiliates shall include the number of Ordinary Shares underlying the Warrant ADSs with respect to which such determination is being made, but shall exclude the number of Ordinary Shares underlying the Warrant
      ADSs which would be issuable upon (i)&#160;exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates, and (ii)&#160;exercise or conversion of the unexercised or nonconverted portion of any other
      securities of the Company (including, without limitation, any other Share Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates.&#160; Except
      as set forth in the preceding sentence, for purposes of this <u>Section&#160;2(f)</u>, beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
      acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance
      therewith.&#160; To the extent that the limitation contained in this <u>Section&#160;2(f)</u> applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates) and of which
      portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&#8217;s determination of whether this Warrant is exercisable (in relation to other securities
      owned by the Holder together with any Affiliates) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such
      determination.&#160; In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.&#160; For purposes of this <u>Section&#160;2(f)</u>,
      in determining the number of outstanding Ordinary Shares, a Holder may rely on the number of outstanding shares of Ordinary Shares as reflected in (A)&#160;the Company&#8217;s most recent periodic or annual report filed with the Commission, as the case may be,
      (B)&#160;a more recent public announcement by the Company, or (C)&#160;a more recent written notice from the Company or the Transfer Agent or the Depositary setting forth the number of Ordinary Shares outstanding.&#160; Upon the written request of a Holder, the
      Company shall within one&#160;(1) Trading Day confirm orally and in writing to the Holder the number of Ordinary Shares then outstanding.&#160; In any case, the number of outstanding Ordinary Shares shall be determined after giving effect to the conversion or
      exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates since the date as of which such number of outstanding Ordinary Shares was reported.&#160; The&#160;&#8220;<u>Beneficial Ownership Limitation</u>&#8221; shall be 9.99% of the
      number of Ordinary Shares outstanding immediately after giving effect to the applicable issuance of the Warrant ADSs (represented by ADRs)issuable upon exercise of this Warrant, <font style="font-style: italic;">provided </font>that the Holder may
      decrease such Beneficial Ownership Limitation upon written notice to the Company.&#160; The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this <u>Section&#160;2(f)</u> to
      correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such
      limitation.&#160; The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Violation</u>.&#160; The Company shall take all such actions as may be necessary to ensure that all such Warrant ADSs (represented by ADRs) are issued without any
      rights of pre-emption in favor of any other person and without violation by the Company of any applicable law or governmental regulation or of any requirements of any domestic securities exchange upon which Ordinary Shares, ADSs (represented by
      ADRs), or other securities constituting Warrant ADSs (represented by ADRs) or into which such Warrant ADSs (represented by ADRs) may be converted or exchanged may be listed at the time of such exercise (except for official notice of issuance which
      shall be immediately delivered by the Company upon each such issuance).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Listing</u>.&#160; Promptly following the date of this Warrant Certificate the Company shall cause the Warrant ADSs (represented by ADRs) to be listed on the Trading
      Market, and shall maintain such listing through the time of such exercise and the holding of the Warrant ADSs by the Holder, and shall assure that it and the Depositary shall, at all times maintain, for the benefit of the Holder, (i) that number of
      ADSs underlying the Warrant ADSs available for issuance in connection with the exercise of this Warrant Certificate under a registration statement on Form F-3 in accordance with Section 4, and (ii) that number of ADRs available for issuance in
      connection with the exercise of this Warrant Certificate under a registration statement on Form F-6.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">9</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt; line-height: 1.25;"><u>Section 3.</u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Certain Adjustments</u>.&#160; In order to prevent dilution of the purchase rights granted under this Warrant Certificate, the Exercise Price and the number of Warrant ADSs
      (represented by ADRs) issuable upon exercise of this Warrant Certificate shall be subject to adjustment from time to time as provided in this <u>Section&#160;3</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Adjustment to Exercise Price Upon Issuance of Ordinary Shares or ADSs</u>.&#160; Subject to <u>Section&#160;3(c)</u>, if the Company shall, at any time after the date hereof
      (the&#160;&#8220;<u>Issue Date</u>&#8221;), issue or sell any Ordinary Shares, whether directly or indirectly by way of Options or Convertible Securities (including through the issuance of ADSs (represented by ADRs)(other than in an Excluded Issuance or any event
      described in <u>Section&#160;3(d)</u> or <u>(e)</u>), without consideration or for consideration per share less than the Exercise Price in effect immediately prior to such issuance or sale, then immediately upon such issuance or sale, the Exercise Price
      in effect immediately prior to such issuance or sale shall be reduced (and in no event increased) to an Exercise Price equal to the quotient obtained by dividing:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the sum of (A)&#160;the product obtained by multiplying the Stock Deemed Outstanding immediately prior to such issuance or sale (or deemed issuance or sale) by the Exercise
      Price then in effect plus (B)&#160;the aggregate consideration, if any, received by the Company upon such issuance or sale (or deemed issuance or sale); by</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the sum of (A)&#160;the Stock Deemed Outstanding immediately prior to such issuance or sale (or deemed issuance or sale) plus (B)&#160;the aggregate number of Ordinary Shares
      issued or sold (or deemed issued or sold) by the Company in such issuance or sale (or deemed issuance or sale);</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; line-height: 1.25;"><font style="font-style: italic;">provided</font>, for the avoidance of doubt, the number of Warrant ADSs (represented by ADRs) issued pursuant to this Warrant
      Certificate will not be adjusted in the event that the Exercise Price is adjusted under <u>Section 3(a)</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Effect of Certain Events on Adjustment to Exercise Price</u>.&#160; For purposes of determining the adjusted Exercise Price under <u>Section&#160;3(a)</u>, the following shall
      be applicable:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Issuance of Options</u>.&#160; If the Company shall, at any time or from time to time after the date hereof, in any manner grant or sell (whether directly or by assumption
      in a merger or otherwise) any Options, whether or not such Options or the right to convert or exchange any Convertible Securities issuable upon the exercise of such Options are immediately exercisable, and the price per share (determined as provided
      in this <u>Section&#160;3(b)(i)</u> and in <u>Section&#160;3(b)(v)</u>) for which Ordinary Shares (or equivalent securities) are issuable upon the exercise of such Options or upon the conversion or exchange of Convertible Securities issuable upon the
      exercise of such Options is less than the Exercise Price in effect immediately prior to the time of the granting or sale of such Options, then the total maximum number of Ordinary Shares (or equivalent securities) issuable upon the exercise of such
      Options or upon conversion or exchange of the total maximum amount of Convertible Securities issuable upon the exercise of such Options shall be deemed to have been issued as of the date of granting or sale of such Options (and thereafter shall be
      deemed to be outstanding for purposes of adjusting the Exercise Price under <u>Section&#160;3(a)</u>), at a price per share equal to the quotient obtained by <u>dividing</u>:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">(A)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the sum (which sum shall constitute the applicable consideration received for purposes of <u>Section&#160;3(a)</u>) of (1)&#160;the total amount, if any, received or receivable
      by the Company as consideration for the granting or sale of all such Options, <u>plus</u> (2)&#160;the minimum aggregate amount of additional consideration payable to the Company upon the exercise of all such Options, <u>plus</u> (3), in the case of
      such Options which relate to Convertible Securities, the minimum aggregate amount of additional consideration, if any, payable to the Company upon the issuance or sale of all such Convertible Securities and the conversion or exchange of all such
      Convertible Securities, <u>by</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">(B)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the total maximum number of Ordinary Shares issuable upon the exercise of all such Options or upon the conversion or exchange of all Convertible Securities issuable
      upon the exercise of all such Options.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 72pt; line-height: 1.25;">Except as otherwise provided in <u>Section&#160;3(b)(iii)</u>, no further adjustment of the Exercise Price shall be made upon the actual issuance of Ordinary Shares (or equivalents) or
      of Convertible Securities upon exercise of such Options or upon the actual issuance of Ordinary Shares (or equivalents) upon conversion or exchange of Convertible Securities issuable upon exercise of such Options.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Issuance of Convertible Securities</u>.&#160; If the Company shall, at any time or from time to time after the Issue Date, in any manner grant or sell (whether directly
      or by assumption in a merger or otherwise) any Convertible Securities, whether or not the right to convert or exchange any such Convertible Securities is immediately exercisable, and the price per share (determined as provided in this <u>Section&#160;3(b)(ii)</u>
      and in <u>Section&#160;3(b)(v)</u>) for which Ordinary Shares (or equivalent securities) are issuable upon the conversion or exchange of such Convertible Securities is less than the Exercise Price in effect immediately prior to the time of the granting
      or sale of such Convertible Securities, then the total maximum number of Ordinary Shares issuable upon conversion or exchange of the total maximum amount of such Convertible Securities shall be deemed to have been issued as of the date of granting or
      sale of such Convertible Securities (and thereafter shall be deemed to be outstanding for purposes of adjusting the Exercise Price pursuant to Section&#160;3(a)), at a price per share equal to the quotient obtained by <u>dividing</u>:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">(A)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the sum (which sum shall constitute the applicable consideration received for purposes of <u>Section 3(a)</u>) of (1)&#160;the total amount, if any, received or receivable
      by the Company as consideration for the granting or sale of such Convertible Securities, <u>plus</u> (2)&#160;the minimum aggregate amount of additional consideration, if any, payable to the Company upon the conversion or exchange of all such Convertible
      Securities, <u>by</u></div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">10</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt; margin-left: 108pt; line-height: 1.25;">(B)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the total maximum number of Ordinary Shares (or equivalent securities) issuable upon the conversion or exchange of all such Convertible Securities.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 72pt; line-height: 1.25;">Except as otherwise provided in <u>Section&#160;3(b)(iii)</u>, (A)&#160;no further adjustment of the Exercise Price shall be made upon the actual issuance of Ordinary Shares (or
      equivalents) upon conversion or exchange of such Convertible Securities and (B)&#160;no further adjustment of the Exercise Price shall be made by reason of the issue or sale of Convertible Securities upon exercise of any Options to purchase any such
      Convertible Securities for which adjustments of the Exercise Price have been made pursuant to the other provisions of this <u>Section 3(b)</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Change in Terms of Options or Convertible Securities</u>.&#160; Upon any change in any of (A)&#160;the total amount received or receivable by the Company as consideration for
      the granting or sale of any Options or Convertible Securities referred to in <u>Section&#160;3(b)(i)</u> or <u>(ii)</u>, (B)&#160;the minimum aggregate amount of additional consideration, if any, payable to the Company upon the exercise of any Options or
      upon the issuance, conversion or exchange of any Convertible Securities referred to in <u>Section&#160;3(b)(i)</u> or <u>(ii)</u>, (C)&#160;the rate at which Convertible Securities referred to in <u>Section&#160;3(b)(i)</u> or <u>(ii)</u> are convertible into
      or exchangeable for Ordinary Shares (or equivalent securities), or (D)&#160;the maximum number of Ordinary Shares (or equivalent securities) issuable in connection with any Options referred to in <u>Section&#160;3(b)(i)</u> or any Convertible Securities
      referred to in <u>Section&#160;3(b)(ii)</u> (in each case, other than in connection with an Excluded Issuance), then (whether or not the original issuance or sale of such Options or Convertible Securities resulted in an adjustment to the Exercise Price
      pursuant to this <u>Section&#160;3</u>) the Exercise Price in effect at the time of such change shall be adjusted or readjusted, as applicable, to the Exercise Price which would have been in effect at such time pursuant to the provisions of this <u>Section&#160;3</u>
      had such Options or Convertible Securities still outstanding provided for such changed consideration, conversion rate or maximum number of shares, as the case may be, at the time initially granted, issued or sold, but only if as a result of such
      adjustment or readjustment the Exercise Price then in effect is reduced.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Treatment of Expired or Terminated Options or Convertible Securities</u>.&#160; Upon the expiration or termination of any unexercised Option (or portion thereof) or any
      unconverted or unexchanged Convertible Security (or portion thereof) for which any adjustment (either upon its original issuance or upon a revision of its terms) was made pursuant to this <u>Section&#160;3</u> (including without limitation upon the
      redemption or purchase for consideration of all or any portion of such Option or Convertible Security by the Company), the Exercise Price then in effect hereunder automatically shall be changed to the Exercise Price which would have been in effect at
      the time of such expiration or termination had such unexercised Option (or portion thereof) or unconverted or unexchanged Convertible Security (or portion thereof), to the extent outstanding immediately prior to such expiration or termination, never
      been issued.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">11</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Calculation of Consideration Received</u>.&#160; If the Company shall, at any time or from time to time after the Issue Date, issue or sell, or pursuant to <u>Section&#160;3(b)</u>
      be deemed to have issued or sold, any Ordinary Shares, Options or Convertible Securities: (A)&#160;for cash, the consideration received therefor shall be deemed to be the net amount received by the Company therefor; (B)&#160;for Marketable Securities, the
      amount of consideration received therefor shall be deemed to be the market price (as reflected on any securities exchange, quotation system or association or similar pricing system covering such security) for such securities as of the end of business
      on the date of receipt of such securities; (C)&#160;for consideration other than cash or Marketable Securities, the amount of consideration received therefor shall be deemed to be the fair value of such consideration; (D)&#160;for no specifically allocated
      consideration in connection with an issuance or sale of other securities of the Company, together comprising one integrated transaction, the amount of consideration received therefor shall be deemed to be to be the fair value of such portion of the
      aggregate consideration received by the Company in such transaction as is attributable to such Ordinary Shares, Options or Convertible Securities, as the case may be, issued in such transaction; or (E)&#160;to the owners of the non&#8209;surviving entity in
      connection with any merger in which the Company is the surviving corporation, the amount of consideration received therefor shall be deemed to be the fair value of such portion of the net assets and business of the non-surviving entity as is
      attributable to such Ordinary Shares, Options or Convertible Securities, as the case may be, issued to such owners.&#160; The net amount of any cash consideration and the fair value of any consideration other than cash or Marketable Securities shall be
      determined in accordance with Section 1028 of the Companies Act and, to the extent necessary or required, in good faith jointly by the Board of Directors of the Company and the Holder.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Record Date</u>.&#160; For purposes of any adjustment to the Exercise Price or the number of Warrant ADSs in accordance with this <u>Section&#160;3</u>, or any adjustment to
      the number of Warrant ADSs pursuant to <u>Section&#160;3(c</u>) or <u>3(d</u>), in case the Company shall take a record of the holders of its Ordinary Shares (or equivalent securities) for the purpose of entitling them (A)&#160;to receive a dividend or other
      distribution payable in Ordinary Shares, Options or Convertible Securities or (B)&#160;to subscribe for or purchase Ordinary Shares, Options or Convertible Securities, then such record date shall be deemed to be the date of the issue or sale of the
      Ordinary Shares deemed to have been issued or sold upon the declaration of such dividend or the making of such other distribution or the date of the granting of such right of subscription or purchase, as the case may be.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(vii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Treasury Shares</u>.&#160; The number of Ordinary Shares (or equivalent securities) outstanding at any given time shall not include shares owned or held by or for the
      account of the Company or any of its wholly-owned subsidiaries, and the disposition of any such shares (other than the cancellation or retirement thereof or the transfer of such shares among the Company and its wholly-owned subsidiaries) shall be
      considered an issue or sale of Ordinary Shares for the purpose of this <u>Section&#160;3</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">12</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Adjustment to Exercise Price and Warrant ADSs Upon Dividend, Subdivision or Combination of Ordinary Shares</u>.&#160; If the Company shall, at any time or from time to
      time after the Issue Date, (i)&#160;pay a dividend or make any other distribution upon the Ordinary Shares or any other capital stock of the Company payable in Ordinary Shares or in Options or Convertible Securities, or (ii)&#160;subdivide (by any stock split,
      recapitalization or otherwise) its outstanding Ordinary Shares (or equivalent securities) into a greater number of shares, the Exercise Price in effect immediately prior to any such dividend, distribution or subdivision shall be proportionately
      reduced and the number of Warrant ADSs (represented by ADRs) issuable upon exercise of this Warrant Certificate shall be proportionately increased.&#160; If the Company at any time combines (by combination, reverse stock split or otherwise) its
      outstanding Ordinary Shares (or equivalent securities) into a smaller number of shares, the Exercise Price in effect immediately prior to such combination shall be proportionately increased and the number of Warrant ADSs (represented by ADRs)
      issuable upon exercise of this Warrant Certificate shall be proportionately decreased.&#160; Any adjustment under this <u>Section&#160;3(c)</u> shall become effective at the close of business on the date the dividend, subdivision or combination becomes
      effective.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Adjustment to Exercise Price and Warrant ADSs Upon Reorganization, Reclassification, Consolidation or Merger</u>.&#160; Unless the Holder otherwise consents (in its sole
      discretion), in the event of any (A)&#160;capital reorganization of the Company, (B)&#160;reclassification of the stock of the Company (other than a change in par value or from par value to no par value or from no par value to par value or as a result of a
      stock dividend or subdivision, split-up or combination of shares), (C)&#160;Fundamental Transaction or (D)&#160;other similar transaction (other than any such transaction covered by <u>Section&#160;3(c)</u>), in each case which entitles the holders of Ordinary
      Shares (or equivalent securities) to receive (either directly or upon subsequent liquidation) stock, securities or assets with respect to or in exchange for Ordinary Shares (or equivalent securities):</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;this Warrant Certificate shall, immediately after such transaction, remain outstanding and shall thereafter, in lieu of or in addition to (as the case may be) the number
      of Warrant ADSs (represented by ADRs) then exercisable under this Warrant Certificate, be exercisable for the kind and number of shares of stock or other securities or assets of the Company or of the successor Person resulting from such transaction
      to which the Holder would have been entitled upon such transaction if the Holder had exercised this Warrant Certificate in full immediately prior to the time of such transaction and acquired the applicable number of Warrant ADSs (represented by ADRs)
      then issuable hereunder as a result of such exercise (without taking into account any limitations or restrictions on the exercisability of this Warrant Certificate); and</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">13</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;appropriate adjustment (in form and substance satisfactory to the Holder) shall be made with respect to the Holder&#8217;s rights under this Warrant Certificate to insure
      that the provisions of this <u>Section&#160;3</u> shall thereafter be applicable, as nearly as possible, to this Warrant Certificate in relation to any shares of stock, securities or assets thereafter acquirable upon exercise of this Warrant Certificate
      (including, in the case of any transaction in which the successor or purchasing Person is other than the Company, an immediate adjustment in the Exercise Price to the value per share for the Ordinary Shares (or equivalent securities) reflected by the
      terms of such transaction, and a corresponding adjustment immediately shall be made to the number of Warrant ADSs acquirable upon exercise of this Warrant Certificate, without regard to any limitations or restrictions on exercise, if the value so
      reflected is less than the Exercise Price in effect immediately prior to such transaction).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The provisions of this <u>Section&#160;3(d)</u> shall similarly apply to successive reorganizations, reclassifications, Fundamental Transactions or similar transactions.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Notwithstanding anything to the contrary contained herein, with respect to any corporate event or other transaction contemplated by this <u>Section&#160;3(d)</u>, the Holder shall have
      the right to elect, prior to the consummation of such event or transaction, to exercise this Warrant instead of giving effect to <u>Section&#160;3(d)</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Other Dividends and Distributions</u>.&#160; If the Company shall, at any time or from time to time after the Issue Date, make or declare, or fix a record date for the
      determination of holders of Ordinary Shares (or equivalent securities) entitled to receive, a dividend or any other distribution payable in cash, securities of the Company (other than a dividend or distribution of shares of Ordinary Shares, Options
      or Convertible Securities in respect of outstanding Ordinary Shares (or equivalent securities)) or other property, then, and in each such event, the Company shall ensure that provisions are made so that the Holder shall receive upon exercise of this
      Warrant Certificate, in addition to the number of Warrant ADSs (represented by ADRs) receivable thereupon, the kind and amount of cash, securities of the Company or other property which the Holder would have been entitled to receive had this Warrant
      Certificate been exercised in full into Warrant ADSs (represented by ADRs) on the date of such event and had the Holder thereafter, during the period from the date of such event to and including the date of exercise, retained such cash, securities or
      other property receivable by them as aforesaid during such period, giving application to all adjustments called for during such period under this <u>Section 3</u> with respect to the rights of the Holder; <font style="font-style: italic;">provided</font>
      that no such provision shall be made if the Holder receives, simultaneously with the distribution to the holders of Ordinary Shares (or equivalent securities), a dividend or other distribution of such securities, cash or other property in an amount
      equal to the amount of such securities, cash or other property as the Holder would have received if this Warrant Certificate had been exercised in full into Warrant ADSs (represented by ADRs) on the date of such event.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">14</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Certain Events</u>.&#160; If any event of the type contemplated by the provisions of this <u>Section&#160;3</u> but not expressly provided for by such provisions (including,
      without limitation, the granting of stock appreciation rights, phantom stock rights or other rights with equity features in each case, other than with respect to any Excluded Issuance) occurs, then the Board of Directors of the Company shall make an
      appropriate adjustment in the Exercise Price of this Warrant Certificate so as to protect the rights of the Holder in a manner consistent with the provisions of this <u>Section&#160;3</u>; <font style="font-style: italic;">provided</font> that (i)&#160;no
      such adjustment pursuant to this <u>Section&#160;3(f)</u> shall increase the Exercise Price or decrease the number of Warrant ADSs (represented by ADRs) issuable as otherwise determined pursuant to this <u>Section&#160;3</u> and (ii)&#160;for the avoidance of
      doubt, no adjustment pursuant to this <u>Section&#160;3(f)</u> shall be made in connection with an Excluded Issuance.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Certificate as to Adjustment</u>.&#160; As promptly as reasonably practicable following any adjustment of the Exercise Price, but in any event not later than three
      business days thereafter, the Company shall furnish to the Holder a certificate of an executive officer setting forth in reasonable detail such adjustment and the facts upon which it is based and certifying the calculation thereof.&#160; As promptly as
      reasonably practicable following the receipt by the Company of a written request by the Holder, but in any event not later than three business days thereafter, the Company shall furnish to the Holder a certificate of an executive officer certifying
      the Exercise Price then in effect and the number of Warrant ADSs or the amount, if any, of other shares of stock, securities or assets then issuable upon exercise of this Warrant Certificate.&#160; Upon request of the Holder, the Company shall issue a
      replacement Warrant Certificate reflecting the as-adjusted number of Warrant ADSs and the then-applicable Exercise Price, as set forth in Section 5(b)(iii).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Change in ADS Ratio</u>.&#160; If, after the Issue Date, the ADS Ratio is increased or reduced, then the number of Warrant ADSs (represented by ADRs) to be issued on
      exercise of this Warrant Certificate will be reduced or increased (respectively) in inverse proportion to the change in the ADS Ratio, and the Exercise Price per Warrant ADS will be increased or reduced (respectively) in proportion to the change in
      the number Ordinary Shares issuable per ADS, so that the aggregate Exercise Price remains unchanged.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Fundamental Transaction</u>.&#160; If, at any time while this Warrant is outstanding, the Company effects a Fundamental Transaction, then, upon any subsequent exercise of
      this Warrant, the Holder shall have the right to receive, for each Warrant ADS (represented by an ADR) that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder
      (without regard to any limitation in <u>Section&#160;2(e)</u> on the exercise of this Warrant), the number of Ordinary Shares (or other securities) of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any
      additional consideration (the&#160;&#8220;<u>Alternate Consideration</u>&#8221;) receivable as a result of such Fundamental Transaction by a holder of the number of Ordinary Shares (or equivalent securities) for which this Warrant is exercisable immediately prior to
      such Fundamental Transaction (without regard to any limitation in <u>Section&#160;2(e)</u> on the exercise of this Warrant).&#160; For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such
      Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one (1)&#160;Ordinary Share in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable
      manner reflecting the relative value of any different components of the Alternate Consideration.&#160; If holders of Ordinary Shares (or equivalent securities) are given any choice as to the securities, cash or property to be received in a Fundamental
      Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.&#160; The Company shall cause any successor entity in a Fundamental
      Transaction in which the Company is not the survivor (the&#160;&#8220;<u>Successor Entity</u>&#8221;) to assume in writing all of the obligations of the Company under this Warrant pursuant to written agreements in form and substance reasonably satisfactory to the
      Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written
      instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the Ordinary Shares (or equivalent
      securities) acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the Exercise Price hereunder to
      such shares of capital stock (but taking into account the relative value of the Ordinary Shares (or equivalent securities) pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock
      and such Exercise Price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder.&#160; Upon the
      occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring to the &#8220;Company&#8221; shall refer
      instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant with the same effect as if such Successor Entity had been named as the Company herein.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Calculations</u>.&#160; All calculations under this <u>Section&#160;3</u> shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be.&#160; For
      purposes of this <u>Section&#160;3</u>, the number of Ordinary Shares (or equivalent securities) deemed to be issued and outstanding as of a given date shall be the sum of the number of Ordinary Shares (or equivalent securities) (excluding treasury
      shares, if any) issued and outstanding.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">15</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notice to Allow Exercise by Holder</u>.&#160; If (A)&#160;the Company shall declare a dividend (or any other distribution in whatever form) on its Ordinary Shares (or
      equivalent securities), (B)&#160;the Company shall declare a special nonrecurring cash dividend on or a redemption of its Ordinary Shares (or equivalent securities), (C)&#160;the Company shall authorize the granting to all holders of its Ordinary Shares (or
      equivalent securities) rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D)&#160;the approval of any stockholders of the Company shall be required in connection with any reclassification of its
      Ordinary Shares (or equivalent securities), any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby its Ordinary Shares (or
      equivalent securities) are converted into other securities, cash or property, (E)&#160;the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, or (F)&#160;the Company seeks to engage in a
      Fundamental Transaction, then, in each case, the Company shall cause to be mailed to the Holder at its last address as it shall appear upon the Warrant Register (as defined below) of the Company, at least twenty&#160;(20) calendar days prior to the
      applicable record or effective date hereinafter specified, a notice stating (x)&#160;the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as
      of which the holders of its Ordinary Shares of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y)&#160;the date on which such Fundamental Transaction, reclassification, consolidation, merger,
      sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of its Ordinary Shares (or equivalent securities) of record shall be entitled to exchange their Ordinary Shares (or
      equivalent securities) for securities, cash or other property deliverable upon such Fundamental Transaction, reclassification, consolidation, merger, sale, transfer or share exchange; <font style="font-style: italic;">provided</font> that the
      failure to mail such notice or any defect therein or in the mailing thereof shall not affect the validity of the corporate action required to be specified in such notice.&#160; To the extent that any notice required to be provided hereunder may contain
      information that constitutes material, non-public information regarding the Company or any of its subsidiaries, the Company shall obtain the Holder&#8217;s prior consent to receipt of such notice.&#160; If the Holder declines to receive any such notice pursuant
      to the immediately preceding sentence, the Company shall not be deemed to have breached its obligation to deliver such notice hereunder.&#160; The Holder shall remain entitled to exercise this Warrant during the 20-day period commencing on the date of
      such notice through the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;"><u>Section 4.</u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Registration Rights</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Registration</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company shall prepare and file or cause to be prepared and filed with the Commission, no later than December 31, 2025 (the &#8220;<u>Filing Deadline</u>&#8221;), a registration
      statement for an offering to be made on a continuous basis pursuant to Rule 415 of the Securities Act registering the resale from time to time by the Holder of all Registrable Securities held by the Holder (the &#8220;<u>Resale Registration Statement</u>&#8221;).

      The Resale Registration Statement shall be on Form F-3 or, if the use of Form F-3 is not then available to the Company, on Form F-1 or such other appropriate form permitting registration of such Registrable Securities for resale by the Holder. The
      Company shall use reasonable best efforts to cause the Resale Registration Statement to be declared effective as soon as possible after filing, but in no event shall the Resale Registration Statement be declared effective later than the earlier of
      (i) sixty (60) days following the Filing Deadline or (ii) ten (10) Business Days after the Commission notifies the Company that it will not review the Resale Shelf Registration Statement, if applicable (the &#8220;<u>Effectiveness Deadline</u>&#8221;); provided,
      that the Effectiveness Deadline shall be extended by no more than ninety (90) days after the Filing Deadline if the Registration Statement is reviewed by, and receives comments from, the Commission.&#160; Once effective, the Company shall keep the Resale
      Registration Statement continuously effective and supplemented and amended to the extent necessary to ensure that such Registration Statement is available or, if not available, to ensure that another registration statement is available, under the
      Securities Act at all times until such date as all Registrable Securities covered by the Resale Registration Statement have been disposed of in accordance with the intended method(s) of distribution set forth in such Registration Statement or such
      securities have been withdrawn (the &#8220;<u>Effectiveness Period</u>&#8221;).&#160; The Resale Registration Statement shall contain a prospectus in such form as to permit the Holder to sell such Registrable Securities pursuant to Rule 415 under the Securities Act
      (or any successor or similar provision adopted by the Commission then in effect) at any time beginning on the effective date for such Registration Statement, and shall provide that such Registrable Securities may be sold pursuant to any method or
      combination of methods legally available to, and requested by, the Holder.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company shall notify the Holder in writing of the effectiveness of the Resale Registration Statement as soon as practicable, and in any event within one (1)
      Business Day after the Resale Registration Statement becomes effective, and shall furnish to Holder, without charge, such number of copies of the Resale Registration Statement (including any amendments, supplements and exhibits), the prospectus
      contained therein (including each preliminary prospectus and all related amendments and supplements) and any documents incorporated by reference in the Resale Shelf Registration Statement or such other documents as the Holder may reasonably request
      in order to facilitate the sale of the Registrable Securities in the manner described in the Resale Registration Statement.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">16</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to the provisions of <u>Section 4(a)(i)</u> above, the Company shall promptly prepare and file with the Commission from time to time such amendments and
      supplements to (or replacements of) the Resale Registration Statement and prospectus used in connection therewith as may be necessary to keep the Resale Registration Statement (or replacements thereof) effective and to comply with the provisions of
      the Securities Act with respect to the disposition of all the Registrable Securities during the Effectiveness Period.&#160; If any Resale Registration Statement filed pursuant to <u>Section 4(a)(i)</u> is filed on Form F-3 and thereafter the Company
      becomes ineligible to use such registration statement&#160; for secondary sales, the Company shall promptly notify the Holder of such ineligibility and shall file a shelf registration on Form F-1 or other appropriate form as promptly as practicable (but
      no later than 14 calendar days after becoming ineligible to use Form F-3) to replace the Resale Registration Statement and use its best efforts to have the such replacement Resale Registration Statement declared effective as promptly as practicable
      and shall cause such replacement Resale Registration Statement to remain effective, and to be supplemented and amended to the extent necessary to ensure that such Resale Shelf Registration Statement is available or, if not available, that another
      Resale Registration Statement is available, for the resale of all the Registrable Securities held by the Holder until all such Registrable Securities have been sold; provided, however, that at any time the Company once again becomes eligible to use
      Form F-3, the Company shall cause such replacement Resale Registration Statement to be amended, or shall file a new replacement Resale Registration Statement, such that the Resale Registration Statement is once again on Form F-3.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company represents and warrants that there are sufficient ADRs registered on a registration statement on Form F-6 and available for issuance in respect of all
      Warrant ADSs issuable hereunder, and the Company covenants that it will cause a sufficient number of ADRs to remain registered on a registration statement on Form F-6 and available for issuance to satisfy the Company&#8217;s obligations hereunder at all
      times that this Warrant is outstanding.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Rule 144 Reporting.</u>&#160; With a view to making available to the Holder the benefits of Rule 144 and any other rule or regulation of the Commission that may at any
      time permit the Holder to sell securities of the Company to the public without registration or pursuant to a registration on a Shelf Form, the Company shall make and keep available adequate current public information, as those terms are understood
      and defined in Rule 144.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;"><u>Section 5.</u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Transfer of Warrant</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Transferability</u>.&#160; Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder (including, without limitation, any
      registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto
      duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer.&#160; Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or
      Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so
      assigned, and this Warrant shall promptly be cancelled.&#160; Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in
      which case, the Holder shall surrender this Warrant to the Company within two&#160;(2) Trading Days of the date the Holder delivers to the Company a completed Assignment Form in the form attached hereto duly executed by the Holder assigning all or any
      portion of this Warrant.&#160; This Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant ADSs (represented by ADRs) without having a new Warrant issued.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">17</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Replacement Warrants</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying
      the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney.&#160; Subject to compliance with <u>Section&#160;5(a)</u>, as to any transfer which may be involved in such division or combination, the Company
      shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice.&#160; All Warrants issued on transfers or exchanges shall be dated as of the Issue Date and shall be
      identical with this Warrant except as to the number of Warrant ADSs (represented by ADRs) issuable pursuant thereto.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and upon delivery of an indemnity
      reasonably satisfactory to it (it being understood that a written indemnification agreement or affidavit of loss of the Holder shall be a sufficient indemnity) and, in case of mutilation, upon surrender of such Warrant for cancellation to the
      Company, the Company at its own expense shall execute and deliver to the Holder, in lieu hereof, a new Warrant of like tenor and exercisable for an equivalent number of Warrant ADSs (represented by ADRs) as this Warrant so lost, stolen, mutilated or
      destroyed; <font style="font-style: italic;">provided that</font>, in the case of mutilation, no indemnity shall be required if this Warrant in identifiable form is surrendered to the Company for cancellation.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Upon request by the Holder and surrender of this Warrant Certificate to the Company for replacement, the Company, at its own expense, shall execute and deliver to the
      Holder in replacement of this Warrant Certificate a new Warrant Certificate of like tenor and exercisable for such number of Warrant ADSs (represented by ADRs) and at such Exercise Price as this Warrant shall be exercisable for immediately prior to
      such request, after taking into account any adjustments to the number of Warrant ADSs and the Exercise Price has may have been made pursuant to the terms hereof.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Transferee Representations</u>.&#160; If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall
      not be eligible for resale without volume or manner-of-sale restrictions or current public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this
      Warrant, as the case may be, deliver a written statement from the transferee to the Company certifying that the transferee is an &#8220;accredited investor&#8221; as defined in Rule 501(a) under the Securities Act, making the representations and certifications
      set forth in&#160;<u>Section&#160;5(e)</u> of this Warrant and making such additional representations as the Company may, after consultation with its counsel, require in order to confirm compliance with applicable securities laws.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Warrant Register</u>.&#160; The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the&#160;&#8220;<u>Warrant Register</u>&#8221;), in the
      name of the record Holder hereof from time to time.&#160; The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
      purposes, absent actual notice to the contrary.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">18</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Representation by the Holder</u>.&#160; The Holder, by the acceptance hereof, represents and warrants that (i) it is an &#8220;accredited investor&#8221; as defined in Rule 501(a)
      under the Securities Act and (ii) it is acquiring this Warrant and, upon any exercise hereof, will acquire the Warrant ADSs (represented by ADRs) issuable upon such exercise, for its own account and not with a view to or for distributing or reselling
      such Warrant ADSs (represented by ADRs) or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant to sales registered or exempted under the Securities Act.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;"><u>Section 6.</u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Miscellaneous</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Rights as Stockholder Until Exercise; No Settlement in Cash</u>.&#160; This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a
      stockholder of the Company prior to the exercise hereof as set forth herein.&#160; Without limiting the rights of a Holder to receive Warrant ADSs (represented by ADRs) on a &#8220;cashless exercise,&#8221; in no event will the Company be required to net cash settle
      an exercise of this Warrant.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Removal of Restrictive Legends</u>.&#160; Neither this Warrant nor any certificates or ADRs evidencing Warrant ADSs shall contain any legend restricting the transfer
      thereof in any of the following circumstances: (A) following any sale of this Warrant or such Warrant ADSs (represented by ADRs) issued or delivered to the Holder under or in connection herewith pursuant to Rule&#160;144, (B) if this Warrant or such
      Warrant ADSs (represented by ADRs) are eligible for sale under Rule&#160;144(b)(1), or (C) if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the
      Commission and including due to such securities being covered by a valid registration statement) (collectively, the&#160;&#8220;<u>Unrestricted Conditions</u>&#8221;).&#160; In such circumstances, the Company shall seek to cause its counsel to issue a legal opinion to the
      Transfer Agent or Depositary, as applicable, if required by such Transfer Agent or Depositary to effect the issuance of Warrant ADSs (represented by ADRs), without a restrictive legend or removal of the legend hereunder.&#160; If the Unrestricted
      Conditions are met at the time of issuance of this Warrant, the Warrant ADSs or such other securities of the Company issuable in connection with this Warrant, then this Warrant, Warrant ADSs or other securities, as the case may be, shall be issued
      free of all legends.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Replacement Warrant</u>.&#160; The Company agrees that at such time as the Unrestricted Conditions have been satisfied it shall promptly (but in any event within ten&#160;(10)
      business days) following written request from the Holder issue a replacement Warrant or replacement Warrant ADSs (represented by ADRs), or replacement shares in respect of such other securities, as the case may be, free of all restrictive legends (&#8220;<u>Unlegended

        Shares</u>&#8221;).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">19</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Authorized Shares</u>.&#160; The Company covenants that, during the period this Warrant is outstanding, it will reserve from its authorized and unissued Ordinary Shares a
      sufficient number of Ordinary Shares to provide for the issuance of the Ordinary Shares and ADSs underlying this Warrant upon the exercise of any purchase rights under this Warrant.&#160; The Company further covenants that its issuance of this Warrant
      shall constitute full authority to its officers who are charged with the duty of issuing the necessary Ordinary Shares and ADSs upon the exercise of the purchase rights under this Warrant.&#160; The Company will take all such action as may be necessary,
      including giving directions to the Depositary, to assure that the Warrant ADSs (represented by ADRs) and the underlying Ordinary Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of
      the Trading Market upon which the ADSs (represented by ADRs) are then listed.&#160; The Company covenants that all Warrant ADSs (represented by ADRs) and all Ordinary Shares underlying the Warrant ADSs will, upon exercise of the purchase rights
      represented by this Warrant and payment for such Warrant ADSs in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, rights of pre-emption, liens and charges created by the Company in respect
      of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Impairment</u>.&#160; Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its
      certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of
      this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment.&#160;
      Without limiting the generality of the foregoing, the Company will (i)&#160;&#160;take all such action as may be necessary or appropriate in order that the Company may validly and legally issue unrestricted, fully paid and nonassessable Warrant ADSs
      (represented by ADRs) upon the exercise of this Warrant, and (ii)&#160;use best efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be necessary to enable the Company to
      perform its obligations under this Warrant.&#160; Before taking any action which would result in an adjustment in the number of Warrant ADSs for which this Warrant is exercisable or in the Exercise Price, the Company shall obtain all such authorizations
      or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Rule 144 Compliance</u>.&#160; With a view to making available to the Holder the benefits of Rule 144 under the Securities Act and any other rule or regulation of the SEC
      that may at any time permit a holder to sell securities of the Company to the public without registration or pursuant to a Registration Statement, the Company shall:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;make and keep public information available, as those terms are understood and defined in Rule 144 under the Securities Act;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;use reasonable best efforts to file with the SEC in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange
      Act; and</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">20</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt; margin-left: 72pt; line-height: 1.25;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;furnish to the Holder, promptly upon request, a written statement by the Company as to its compliance with the reporting requirements of Rule 144 under the Securities
      Act and of the Securities Act and the Exchange Act, a copy of the most recent annual or quarterly report of the Company, and such other reports and documents so filed or furnished by the Company as such holder may reasonably request in connection
      with the sale of Warrant ADSs (represented by ADRs) without registration.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Governing Law</u>.&#160; This Warrant and the rights and obligations of the parties hereunder shall be governed by, and construed in accordance with, the law of the State
      of New York, without regard to principles of conflicts of laws that would result in the application of the laws of any other jurisdiction.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Submission to Jurisdiction</u>.&#160; The Company agrees that any suit, action or proceeding with respect to this Warrant or any judgment entered by any court in respect
      thereof may be brought initially in the federal or state courts in New&#160;York, New&#160;York or in the courts of its own corporate domicile and irrevocably submits to the exclusive jurisdiction of each such court for the purpose of any such suit, action,
      proceeding or judgment.&#160; This Section is for the benefit of the Holder only and, as a result, the Holder shall not be prevented from taking proceedings in any other courts with jurisdiction.&#160; To the extent allowed by any applicable law, the Holder
      may take concurrent proceedings in any number of jurisdictions.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Waiver of Venue, Etc</u>.&#160; The Company irrevocably waives to the fullest extent permitted by law any objection that it may now or hereafter have to the laying of the
      venue of any suit, action or proceeding arising out of or relating to this Warrant and hereby further irrevocably waives to the fullest extent permitted by law any claim that any such suit, action or proceeding brought in any such court has been
      brought in an inconvenient forum.&#160; A final judgment (in respect of which time for all appeals has elapsed) in any such suit, action or proceeding shall be conclusive and may be enforced in any court to the jurisdiction of which the Company is or may
      be subject, by suit upon judgment.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Waiver of Jury Trial</u>.&#160; THE COMPANY AND THE HOLDER HEREBY IRREVOCABLY WAIVE, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY
      IN ANY SUIT, ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS WARRANT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Waiver</u>.&#160; No failure on the part of the Holder to exercise and no delay in exercising, and no course of dealing with respect to, any right, power or privilege
      under this Warrant shall operate as a waiver thereof, nor shall any single or partial exercise of any right, power or privilege under this Warrant preclude any other or further exercise thereof or the exercise of any other right, power or privilege.&#160;
      The remedies provided herein are cumulative and not exclusive of any remedies provided by law.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">21</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Expenses</u>.&#160; If the Company fails to comply with any provision of this Warrant, which results in any material damages to the Holder, the Company shall pay to the
      Holder such amounts as shall be sufficient to cover any actual, reasonable and documented attorneys&#8217; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of
      its rights, powers or remedies hereunder.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(m)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notices</u>.&#160; All notices, requests, instructions, directions and other communications provided for herein (including any modifications of, or waivers, requests or
      consents under, this Warrant) shall be given or made in writing (including by telecopy or email) delivered, if to the Company or the Holder, to its address specified on the signature pages hereto, or at such other address as shall be designated by
      such party in a written notice to the other party.&#160; Except as otherwise provided in this Warrant, all such communications shall be deemed to have been duly given upon receipt of a legible copy thereof, in each case given or addressed as aforesaid.&#160;
      All such communications provided for herein by telecopy shall be confirmed in writing promptly after the delivery of such communication (it being understood that non-receipt of written confirmation of such communication shall not invalidate such
      communication).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Limitation of Liability</u>.&#160; No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant ADSs
      (represented by ADRs), and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any ADSs (represented by ADRs) or any Ordinary Shares or as a stockholder of the
      Company, whether such liability is asserted by the Company or by creditors of the Company.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(o)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Remedies</u>.&#160; The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to seek specific
      performance of its rights under this Warrant.&#160; The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
      assert the defense in any action for specific performance that a remedy at law would be adequate.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(p)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Successors and Assigns</u>.&#160; Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall be binding upon and inure to
      the benefit of the successors and permitted assigns of the Company and the successors and permitted assigns of the Holder.&#160; The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be
      enforceable by the Holder or any holder of Warrant ADSs (represented by ADRs).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(q)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Amendments, Etc</u>.&#160; Except as otherwise expressly provided in this Warrant, any provision of this Warrant may be modified or supplemented only by an instrument in
      writing signed by the Company and the Holder.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(r)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Severability</u>.&#160; If any provision hereof is found by a court to be invalid or unenforceable, to the fullest extent permitted by any applicable law the parties agree
      that such invalidity or unenforceability shall not impair the validity or enforceability of any other provision hereof.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(s)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Currency</u>.&#160; Unless otherwise indicated, all dollar amounts referred to in this Warrant are in United States Dollars (&#8220;<u>US Dollars</u>&#8221;).&#160; All amounts owing under
      this Warrant shall be paid in US Dollars.&#160; All amounts denominated in other currencies shall be converted in the US Dollar equivalent amount in accordance with the Exchange Rate on the date of calculation.&#160; &#8220;<u>Exchange Rate</u>&#8221; means, in relation
      to any amount of currency to be converted into US Dollars pursuant to this Warrant, the US Dollar exchange rate as published in the Wall Street Journal (NY edition) on the relevant date of calculation.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Captions</u>.&#160; The captions and section headings appearing herein are included solely for convenience of reference and are not intended to affect the interpretation
      of any provision of this Warrant.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; margin-left: 36pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Counterparts</u>.&#160; This Warrant may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument and any of the
      parties hereto may execute this Warrant by signing any such counterpart.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25;">(Signature Page Follows)</div>
    <div style="line-height: 1.25">&#160;</div>
  </div>
  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div class="BRPFPageNumberArea" style="text-align: center;"><font class="BRPFPageNumber" style="font-weight: normal; font-style: normal;">22</font></div>
    <div class="BRPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
  </div>
  <div>
    <div style="text-indent: 36pt; line-height: 1.25;">IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as a Deed on the date first above indicated.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z84b42f7821e94906b1255fb2012ca34e" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25; font-variant: small-caps; font-weight: bold;">GIVEN under the Common Seal of</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
            <div style="line-height: 1.25; font-variant: small-caps; font-weight: bold;">Trinity Biotech PLC</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td rowspan="1" colspan="1" style="width: 50%; vertical-align: top; text-align: right; padding-bottom: 2px;">&#160;By:&#160;&#160; <br>
          </td>
          <td rowspan="1" style="width: 25%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">/s/ John Gillard</td>
          <td rowspan="1" style="width: 25%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td rowspan="1" colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td colspan="2" rowspan="1" style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;Name: John Gillard</div>
            <div style="line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;Title: Director</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">Address for Notices:</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
            <div style="text-align: justify; line-height: 1.25;">Trinity Biotech plc</div>
            <div style="text-align: justify; line-height: 1.25;">IDA Business Park,</div>
            <div style="text-align: justify; line-height: 1.25;">Bray, Co. Wicklow, Ireland</div>
            <div style="text-align: justify; line-height: 1.25;">A98 H5C8</div>
            <div style="text-align: justify; line-height: 1.25;">Attention: John Gillard, CEO</div>
            <div style="text-align: justify; line-height: 1.25;">Telephone: +353 1 276 9800</div>
            <div style="text-align: justify; line-height: 1.25;">Email: Lennotice@trinitybiotech.com</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
            <div style="line-height: 1.25;">With a copy to (which shall not constitute notice):</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
            <div style="text-align: justify; line-height: 1.25;">Carter Ledyard &amp; Milburn LLP</div>
            <div style="text-align: justify; line-height: 1.25;">2 Wall Street, New York, NY 10005</div>
            <div style="text-align: justify; line-height: 1.25;">Attention: Steven J. Glusband, Esq.</div>
            <div style="text-align: justify; line-height: 1.25;">Email: glusband@clm.com</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;">Accepted and Agreed,</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">Perceptive Credit Holdings III, LP</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z3d5579fbe2e947fb9024c116264d165e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 27pt; vertical-align: top;">By:</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Perceptive Credit Opportunities GP, LLC, its general partner</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">By: <u>/s/ Sandeep Dixit &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160;</u> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <br>
    </div>
    <div style="text-align: justify; text-indent: 0pt; margin-left: 18pt; line-height: 1.25;">Name: Sandeep Dixit</div>
    <div style="text-align: justify; text-indent: 0pt; margin-left: 18pt; line-height: 1.25;">Title: Chief Credit Officer</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">By: <u>/s/Sam Chawla</u><u> &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160;</u> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <br>
    </div>
    <div style="text-align: justify; text-indent: 0pt; margin-left: 18pt; line-height: 1.25;">Name: Sam Chawla</div>
    <div style="text-indent: 0pt; margin-left: 18pt; line-height: 1.25;">Title: Portfolio Manager</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: -18pt; margin-left: 18pt; line-height: 1.25;">Address for Notices:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">c/o Perceptive Advisors LLC</div>
    <div style="text-align: justify; line-height: 1.25;">51 Astor Place, 10th Floor</div>
    <div style="text-align: justify; line-height: 1.25;">New&#160;York, NY&#160; 10003</div>
    <div style="text-align: justify; line-height: 1.25;">Attn: Sandeep Dixit</div>
    <div style="text-indent: -18pt; margin-left: 18pt; line-height: 1.25;">Email: Sandeep@perceptivelife.com</div>
    <div style="text-indent: -36pt; margin-left: 36pt; line-height: 1.25;"><u>PCOFReporting@perceptivelife.com</u></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">with a copy to (which shall not constitute&#160;notice):&#160;</div>
    <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Chapman and Cutler LLP&#160;&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">1270 Avenue of the Americas&#160;&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">30th Floor&#160;&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">New York, New York 10020-1708&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Attention: Nicholas Whitney&#160;&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">E-mail:&#160;Whitney@chapman.com</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">NOTICE OF EXERCISE</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">TO:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;TRINITY BIOTECH PLC</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 36pt; line-height: 1.25;">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The undersigned hereby elects to purchase ________ American Depositary Receipts pursuant to the terms of the attached Warrant and tenders herewith payment of the exercise price in full,
      together with all applicable transfer taxes, if any.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Payment shall take the form of (check applicable box):</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="margin-left: 72pt; line-height: 1.25;">&#9744; in lawful money of the United States; or</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 72pt; line-height: 1.25;">&#9744; the cancellation of such number of Warrant ADSs as is necessary, in accordance with the formula set forth in <u>subsection 2(c)</u>, to exercise this Warrant with respect to the maximum number of
      Warrant ADSs purchasable pursuant to the cashless exercise procedure set forth in <u>subsection 2(c)</u>.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">(3)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Please issue said Warrant ADSs (represented by ADRs) in the name of the undersigned or in such other name as is specified below:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 108pt; line-height: 1.25;">_______________________________</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">Check applicable box and fill in information:</div>
    <div style="line-height: 1.25;"> <br>
    </div>
    <div style="text-indent: 36pt; line-height: 1.25;">&#9744; The Warrant ADSs (represented by ADRs) shall be delivered to the following DWAC Account Number:</div>
    <div style="text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div style="text-indent: 108pt; line-height: 1.25;">DTC Participant #: ____________________________________</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 108pt; line-height: 1.25;">Undersigned&#8217;s Account #_______________________________</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 108pt; line-height: 1.25;">_______________________________</div>
    <div style="text-indent: 36pt; line-height: 1.25;"> <br>
    </div>
    <div style="text-indent: 36pt; line-height: 1.25;">&#9744; The Warrant ADSs (represented by ADRs) shall be delivered by physical delivery of ADRs to:</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 108pt; line-height: 1.25;">_______________________________</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 108pt; line-height: 1.25;">_______________________________</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 108pt; line-height: 1.25;">_______________________________</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">[SIGNATURE OF HOLDER]</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">Name of Investing Entity: ______________________________________________________________</div>
    <div style="line-height: 1.25;"><font style="font-style: italic;">Signature of Authorized Signatory of Investing Entity</font>: ________________________________________</div>
    <div style="line-height: 1.25;">Name of Authorized Signatory: __________________________________________________________</div>
    <div style="line-height: 1.25;">Title of Authorized Signatory: ___________________________________________________________</div>
    <div style="line-height: 1.25;">Date: ______________________________________________________________________________</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">ASSIGNMENT FORM</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-indent: 10.5pt; line-height: 1.25; font-style: italic;">(To assign the foregoing Warrant, execute this form and supply required information.&#160; Do not use this form to purchase shares.)</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 10.5pt; line-height: 1.25;">FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" id="z11a85f7aa0b345798475cf43f385d751" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 30%; vertical-align: top; padding-bottom: 2px;">
            <div style="line-height: 1.25;">Name of Person to Whom Warrant is being Transferred:</div>
          </td>
          <td style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
          </td>
          <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
          <td style="width: 20%; vertical-align: top;"><br>
          </td>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top; padding-bottom: 2px;">
            <div style="line-height: 1.25;">Address of Person to Whom Warrant is being Transferred:</div>
          </td>
          <td style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
          </td>
          <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 30%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td rowspan="1" style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td rowspan="1" style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 30%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td rowspan="1" style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td rowspan="1" style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
          <td style="width: 20%; vertical-align: top;"><br>
          </td>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top; padding-bottom: 2px;">
            <div style="line-height: 1.25;">Number of Shares Subject to Warrant being Transferred:</div>
          </td>
          <td style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
          </td>
          <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 30%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">
            <div style="line-height: 1.25;">Dated: _______________ __, ______</div>
          </td>
          <td style="width: 20%; vertical-align: top;"><br>
          </td>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 30%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top; padding-bottom: 2px;">
            <div style="line-height: 1.25;">Holder&#8217;s Name:</div>
          </td>
          <td style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
          </td>
          <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 30%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top; padding-bottom: 2px;">
            <div style="line-height: 1.25;">Holder&#8217;s Signature:</div>
          </td>
          <td style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
          </td>
          <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top;">&#160;</td>
          <td style="width: 20%; vertical-align: top;"><br>
          </td>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top; padding-bottom: 2px;">
            <div style="line-height: 1.25;">Name of Authorized Signatory:</div>
          </td>
          <td style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
          </td>
          <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 30%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top; padding-bottom: 2px;">
            <div style="line-height: 1.25;">Title of Authorized Signatory:</div>
          </td>
          <td style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
          </td>
          <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 30%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 20%; vertical-align: top;">&#160;</td>
          <td rowspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 30%; vertical-align: top; padding-bottom: 2px;">
            <div style="line-height: 1.25;">Holder&#8217;s Address:</div>
          </td>
          <td style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><br>
          </td>
          <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td rowspan="1" style="width: 30%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td rowspan="1" style="width: 20%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td rowspan="1" style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $$ \P# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***0
MG'.">>PS^.!S^0/KTS0 M%(3@$\X'/0Y_+_/KTJ(3*3C#=NV>IQV)/\ 7TS@
MX-;7Z+6_0:3>R;MY?UW)J* <^OX@C]#S10(**0G R<X'HI8_DH)/X#WI: "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4F(!@>_(Q4U"DI;.]O7^M1Z^?]?UKYZ;H****8!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\_Y- !1132X7.0_ R<([<<GC:IW'Y3\JY;H,99<@#J*C)))QNQCGY3E?O#*
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MM)7NS,><X+'/8!1D$-\HPV=^YRQD:6FK_:5GU6]OGU]1Z]59]@HHHH ****
M"BBB@ HIC$C)YV@9.!D\;B<*$8D], $DG  S]Z$R+V8DY^[C&03P>8AD'(]>
M"<,QX9/F?P)3>EU>UKVW=K+=_-6%*4(VYYQC?:]]>NFFK5]MRS14&XN 5P1N
MY^8C'WB"/W1.3QQP"#U/\<].ZO:ZYEO&Z;7K;Y_<"=]4O=Z2NFG]W]>G4HHH
MH&%%%% !1110 4444 %%%% !1110 4444 %%!_+W';WYR/S!IBL0=K;B1P&P
MQW !1N8B-45B3]T<8Y' (4#7L/HHII!)!W, !]T!<'D')RI;/!'# 8)XS@@
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MX7,LOQ&*7-S4:.,P]6LN623O3A.52R;M\*U:5FV?:B%CD'D<X)/S'EN"/*0
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MJ,</3U7-B\--2Q,EI%7A[>G&3LXI2CS-7TLR1K!;JJRR.N\,#(2S$N_S?-Y
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M*J^^2<1WG]F\?E6P<3H-I)?_ %7F'#AAG]W&V6=GD39ER6D*;W:17N?YL_\
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M(W5X@/*1H'.G?>>#V>Y+DV%S99I7I1E4M!*=2$':?U=6M-ZW;LM%RWN]US?
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M:W6*!'BF6<W"LH06O\?G_!3ZV=?VX?VBFNRS*_Q3U@1(2'3<MMIQ*JNS]VH
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M?8C@_4X./\:6GT^;_3^MOOZ);R]5^7S_ $[VUO*M+DELC@+\IP3R0<C_ %)
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M_9CUOY2?^*H\']$Y'_$]@&3_ *.V1SRO.[.W:^[RYO9X;26?Y(K:/-,'=?\
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MJ.3<69WJVU@#<)D;@B[5P6.T2#>9&#%UD)G_ ,SC_@H5\4/BM-^T-XHMM/\
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M2;<8J+YN5_ZE&FZK'K&G1:MIOEW%C<IYMO++%Y+3HN,/+%)!')&5V?*K",J
M"P7_ )9W1=/&MN[)AILJPV %G^4)DB$=AQ]PX_AP"8_D[]ADZH/V7?A(-=FF
MFU7_ (1F,:AYUPUXYQ>7!,C3%IC(1_STS_#QC9^[X7]NK]LKP#^QO\-KOQ7X
MBU,0:OXGT;QM%X5M=0T'Q'K5E=ZWX8T2VU(6[IH%LDUI#F_MEEEFN;<E&Q%/
M$\;R1?ACRZM+-<5EF#YL6X8QX>C)1YOAFHOX>G+JN^^S;?\ 0U3/,!A\H6=Y
MC7J8&DL)1Q#I222<I^S?(E.*DG>IRR<KO5Q<4YMOZ^\?_%#PI\,M-M]5\87T
MFG64XO7$D6GZGJ!\O3H%N+OY+"TN)%:.)PR[U!D(*HC'=L^(/'G_  56_8^\
M$#;>?$/4(YD>X65)?A_\09P#!;K<8!MO#X7)5LXWDG& O#%?X-?VO_\ @H+\
M8OVH?B/XA\67?B"YT#PGK6KW.H>'H/"&J>-M'LIGOM.M+.\@&EZKKU_):6Z"
MW5E22& F4L79TXB\(\!_ KX__%];>^\,7&M:Y9:GY'V>74/&MK:,ZW4IM(RJ
MZK?0M&6=#'LE3;A07VJH*?NF6>#&"65T,QSW/%@JE5)RPW[FARMSY5&]=REM
M9Z[[IV:1_.N=_2!S"ICZN"X:R!8NG2DE];Y:^,53E4.91I8?V;B^9R4O??*H
MVL]3^]:#_@MG^QI/+&D?Q"N'5G4';\-?B<K%6) (+:#@;<'<V& Q@JIW;/I;
MX;_\%)_V5/B>MC'X8\>7]]>7OV8+&W@;QS81%[NZ-I;HLE]H48S)+\N68!<%
MFPO(_@'E_P"";7[:"07#Q^%2-/L(9+B6X_X65X1\WRHP69BO]MDYB53M54R6
M& H. /G;Q?X ^-?P(U.V_P"$KUOQ)H.+\6T TWQD;HM/91I?O'_Q)KV7RUCA
M=) V(PS$A/G4D==?PFX5K*G1P?$,?K-=M4H+$82J[J"LKQ44T_BO:.ZOMKYB
M\>N+L'RU,QX6J>QC=S4<'C:+Y=N95IN<'>\7RN'N+F6K2<O]5O2/$5CK]E!J
M&D2?:;2XW&*62*XMRZHYC<^5/''*I$BE0&3)ZXP<B[+?LC; $+YV[<28W$<*
M2%.WGJ6X[<=:_P Z?]BC_@K+\8/V:_%?A_3]9U#2_$'@K6[SP[X<&H>+9?B!
MXBOTLX_$0U'4KNWM[#Q%$(;X03,GF2V!CN(U6)8I,&O[Q/V8OVDO!_[3_P -
M/#OQ#\*WD-['K5G=:C^ZT76-(@-O;ZA-IRND.M1BY ,D84I(V_(+85-H/Y)Q
MGP)FO"%25.=2IB:$JBC#$\L6ES)3C=QCRJ\5=/[7V=))G[=P%XEY-Q_AJ<\-
M?+L8DXSP<ZT)2E.$G&<5>$9N49QLTHMQ5U*S4K_2PO'50LBIYQ&/+0N5WY^Z
M& 8''\0'W2>3CDR?:7(950><B;F0A]HXR,.!M8=B5)VGC!X)SF)2X+SH TX"
MP@*2K,.02%B;#;?XG)W<*,8Q7YL_\%%/V]_"/[&7PY74[VZTX>(?$MYXD\+:
M7;ZGX>\4ZM!+K5KX5NM:LK=9?#GV?[,&,:K+<S70B1,H#'*0Q^4R_ 8S,\9A
M\%A(3J5)I<[BKZVB]>7:ZET7Q62W9]OF><X/)L!B<RS2<<+AJ$I4XRE)1524
M6TW%S7O.ROI=;Z=3[_\ &?Q1\)?#O3/[5\8W\NFVN9U#PZ?J%\6:VM6O)U6.
MRMKF0[+='DR%.XC8!O*A_A?QO_P5@_8X\'2+!/\ $34_M"RA9T?X=_$2<*C6
MQN 5:W\.[3QC)5Y#S@(6*@_P3?M'?\% ?CQ^TAXFNM7\0ZQ_PCNG7L]O>6MK
MX/UCQGIMHUT-+&F7%N;/5?$>J>7;^6TKG<O^N+$NZ-Y<GCG@7X(_M ?&5U?P
M@VIZY'=0JRO?>,;2Q9H7N%T\-MU/4;<[O/81G*[@,-RC;9/WG*_!O!PPE+%9
MUG#P\I6<J?[K#\JELG[5S3:5G\TM6S^;<U^D'C<1F57 <)9%_:E*DVEB)>VQ
M/.H.*;7U>,$[OFC=-V:2E9WYO[WX_P#@M5^QK<7*[?B%<M8,8PDG_"L_B8)G
MW%1)\LF@G&U277<B[AZ_*']S\'?\%/\ ]CSQPD/]B_$74[R2=F!3_A7?CFW#
MJ;A;>-6:Y\-QC(>4#C(R1RRD-+_!O;_\$Q_VX!!)!#X07R(8)723_A9O@YI7
M8$K(K-_;.2,DL-JG/0;P0)/'/$'[,O[6GPB62U\06U]I20D6IDMOB!87<R,\
M+:B55M-UJ09,2-*-O5OD*N[*LG;5\)."O?A'BV5.I%4VG]9P,U*55*2CS*"3
M45T23B^97=F<-/QKX]PTYRQ_"JC2=:*YW@L?AX.$4[\M:K5J4[[1E'E;LVFW
M9\W^G5X1^*G@KQ[:K?\ AG4I[ZUF28P3RZ1?63N8IQ:R*R76GI( DLNU3L^=
M6##<C9DR/CLC2_"#XA*R ?\ %$>,.57JO_".ZD!N/D38X/!(&<\&3[LG^=9^
MP-\8?CIHOQ_TSP?'XM\27\5M-X22[M=0\8>()XQ::EXVT!YF"+JAM9)7\_85
M6.0NLK*RRARD_P#HH_%^&6W^#WQ)250]RO@[QNX5D$@\M]&U22+&(I%8^6RJ
M>8V"_*0Q)$GYCQCP5_J9G>64\'CZ>8T,3.-:G5YJ<I2C%X=J_LYVLU65]+ZQ
MM*S/V7@[C>KQIDF<XRME:P<\'3]FTI2FGSQQ$96DXQYFYT?>CH_LMMW9_EF_
M%-,>-[X_,^=%\/[V.6.[^Q[)D48B8G.,;MKEEP2SB16E_KC_ .#>_P"(G@_P
MI\'=/N->O9+6YM?A[\01>)'IU]> (WQ)\/S##VMM.TH**68;IRV,'=(P,W\C
MWQ0+2?$6_382SZ'X;Q'&NU3G2;'. %VD99E4[6!!Y9U<F:32OBE\3/!]O%H7
MA;5;_2X)FFM2FG:OK&FEHKQQ-+$RV-[;0NK2NI 9'0R%'D#NRF?^H>*>'J_$
M?#,*%5T<KPLOJG-*%HJ5Z:;E>K*W6<DK::)_"N;^+N".+*W"/&&)S##X%8^M
M.3O"3E?=R:M37,Y-I:72:CZ'^DOXR_X*9_LB^ MW]O?$'4K>=I(8=L?@'QS=
M;GGM)KZ!5:R\/2^8K1(SAU9E 8 ;I'C%QX/<_P#!:/\ 8V@= OQ$N&1]F&/P
MU^)P()4%@5&@D]\J5W DB-=[-"9_X'=$^!W[1GQ.NC-HUYKVLLT7FJ+OQQ;Q
M*XMIHM/E8_;]17]X)+E(F.Y]XF+IYT;_ .D>C)^P#^V3J+SN_AG%O @D,D7Q
M'\,H0T95'1P=:E)W>8P!*,7+;V,@EVWGYK3\(>$<.G3K<1^UG=)3EB\$V[.S
M2]R*OIJWOJ[/5G[1/QUXWQ-I8?A3V%-1C)\N"S"5HM1L]9OF=VF^Z;U/[W/!
MG_!6G]C#QO>C3K+XDZBUV8#(T(^&_P 0HE<-=6UBBJ]WX;PP,EX@*J6)+QE<
MQ']_][^$?B#X:\?:='JOA2[;4;&9[^/SI["ZL6D.GS-;7*>3=V,<I2.YG6)?
ME.\'>AF5@;C_ "OOB!\-/C#\'+A5\>7>K>&[3[7:6EM=:5XKAO+RZU.^LI=3
MM[)O[+N[IO):T@O9RRP^4)H(!YC32J+W[5_84_X*4_%[]ECQ-8W=YK$6O>$]
M9L;CP?#/XQO/'7B.4W>N^-_#'B+49(['3/$$+)>0PZ+>PP7,EJ\#P23P2)=2
M7RK=^5G/@M2E@:N-R#-)X[V$XRG3A*AB/W<5*-2[HI:.7(HV6G-&Z3DK^GD?
MT@,;'-,/E_$N44\![?DC&I.-?#IRFN>$8K$-Q=1PA/FAS734E;H?Z3Z?:'F=
M7B3R2LAW[$+2#^"-@$8E"))L-MR<+D$'-WHIPO<\MU '5B< !5&!T4X^88;<
MV=Q\'^ ?QG\/_'KX=V?Q)\+W*7FDZKJWB32K6:+3M0TZ-AH6L76DR;K75(6N
MDD,D!W2%##(6W1(ZN@F]V@!6,#G@MP001\QR.0,C.=IQ@KC#./G;^?ZE*O1K
M5J.(A[&MAZM6E.D[I^[)*,FGK=)6>MN;F5D]9?T[0Q%'%0I8C"S5;#XBDJD*
ML6G%:0?+[K<7=3YKK];N6BBBD= 4444 %%%% !14#; ['G<-K,-N0%W1_-_J
MV_NGYLY.T@L/*!B@E<L=L938656+9 0;3C:-H[KGD\;1M8 [[=-OE<H)U+.T
MDMUJD^CO9NUO)BE*$5&3E[KER-VT4K7L]>U^O36RNU=/0YZ8.?IWK*V[CYEN
M%D4E4_>)M"[-FY\&&+;(K#:0K;LQB,D;/]%@2YC2>;3XPSM;1^8[.C"14E5)
M%_Y91P;6+'"Y15\L8"[&:#\C/^"E7_!3CX8_L;^"M9\+V^K6C_$F34)?"DVE
M:OX2\::C86D_BGX::OXHT#R-3T :7");B6712US_ &BT%M%).DRV]S;--8=>
M69;B\ZQ5'"Y?0JU,9.2BN2G*JJ=)M<\I*%FTIN&G-&3NMF['F9[FV R# U<?
MF5:-*E22G!2J*G*HI1YM&_A=E>WO-K56:ER]I_P40_X*.?#7]C7P1K=O?:I;
M+XXN;J;PO_9NJ>&/&.I6,-]KGP[U?Q+H.RZT..Q0/++#IJS7!OS!;QRR1SR6
M\L326/\  ?\ M-?M7?$W]K'XDZSX^\=7L-C!JZ>%'72- N_$D.@VUSX8\*:5
MX326RTS7M8U>6*:>RTXRWTIE3S+B:XEC,$(:*VYWX_\ Q_\ BC^TMX\U;XB?
M$6XBAO=:3PVLFF:/J&MR:)9S^&/#.F^$+66UL]<U75[B&>XL=+$MW-)<LYNF
MN2IMXBEO9^*W4'V:WAM=H41S*T96,>8LCESL8K"HV%AM9OE5=@0F)48V7]B\
M"^'."X6PM+%U5&IF%6A"IBJ\TH.C4FH5*L/97YG:7-%1YU;X;WOR?P-XG^*V
M,XWS.K@<-)_V72J3IT*-.JK1Y&X1E.HDE*7*E&W+=N3:2LE%'A@2\D>#=]G1
M(Y(.%C'FHJLZ&)8$VJ948@>6FT*5PC(SVUP.U\WGWP2"!XP(/(4MFX3<@5U:
M-U&67(+^3@J KQJ@$$$]O=PH'F@B1&E"1;2G+EB"/EC7!*@AB-FPKC<OEHMK
M7D\E;BWL"[+>W-S;65O H'DFZO95BM-[>4J+YLDD8;,@6%02S1^6RVOZ'4A&
MO;%XNIR4L/)>S:]V*LTXVO=_95D]6HZ[NWXW3I3JU%AX+VE>:?LZ:BY5-'%-
MRDG[\E97TLV]DTK6%B2)[=;O?%)?W<.G6@CX62_NY%BM8'VQ$1))(R REA&N
MTY=#N\G]\O\ @F/_ ,$9/$G[1?\ 8GQ?^*MOXFTKP==#6TMF\->*_A_+$VJ^
M"_'5OIGV>32M8TG7KY();;2[K[5YL<1F8$131!D2#TS_ ()$_P#!(:_^-,F@
M_'[XQVWB#3/"]Q%KPT\:#XE\!W>FOX@\ ?$JUL;6!]%U30==U.*"XM= G-Y-
MO@\]FE6WN+430QVW]K7A?PIHWA32(-(\.Z=8Z7I%H;B:!;.RL[+;-/*\]T7M
M[2SMXE2:=Y))56*-V<-+(^]MZ?@WB;XI_5)RRC(:L(555G3Q%3G]HG.G>G.7
M+%0Y>:3=ES-I)QNI7Y?ZG\'O!F>+EAL]S^+IT98>C6CAY4&E5=1TJD>2<Y62
MY5).3YN9SBVHI>]YU\#_ (!^ /@/X*L/!O@32X4LK.ZUF:.\N]/T.#45_MO4
M)=2NT>72-'TN(QK=2,5CCBC;Y$,HD=3(GN$-N805/,84DRG#RJQ(#8S#D*<#
MC'R@9#<;42US*!.Z+C)7"H3C!"@JIA#X8C+$E2,;F '"Z7X5_-&)J8G$XB6)
MK5'.K.3E4G/WN:3?-=+1IJ[T;OMMI;^P\-AL+A*<*&$IJEAZ480ITXZ<L8)1
MM=+5)17*UHFK[I)985XFS!M:'.6:10H&!EW8^6B@#  P2!].(G*L(<SQLQ4K
MLVA,*A4!20@B!7I@_.,8SG .W1  Z #Z #^51NB[5544*IP !C:/]D <#UP.
M.#C^)8:G/1M:VLWNOAYM>S2:MZ/?1:O]VI.FM)?$I7DVKK16MVOVND^BM0D*
M(C%R50AN0I=N3@''EDD\<DD8 R3A<I_-I_P6O^%41@O?B%;Q.DEWKOP]T?<K
M:?Y(CM]&N4!6);078;$9SYDWEL 2O0;/Z5%A1@R,HR,X)C7Y02" NZ,+T&.%
M! XP#C'YD_\ !4#X8_\ "<?L]S1VUMYT]IXJT_4R<V$1CCTW1]6(^:YM9&)P
MOW RR$9" !1M_3?!;B*7#OB3DN87M#%UHY=4?-R<KG6P\U)N[4KNGI%VO\-[
M[_B?TA^%I\4^$W$N64*7M\1AL'/$8:T7/EKT\-B*2JQBH\RY?:RA9-/WKMZ-
M'\5[1Y&['W">2"R\ XS^[^7.!D #&>_\+XIA$#N7[W&2N_@C:&SY:OCMG ^;
ML,;EKP,WD31OM#+=78SY:Y7RYG7#MY;;ON]. !@,% ^4A"=.<9)P0/0<@B,9
M!P,$  ],]Z_U?HQO0I*M'WX5)U8M-Z2GR..CL_<:E&]];MWC;W?\#JL7A*U6
MG*/[W#XB22_DY+J4;6>^EG[EK15F_@^F_P!D?X@3?#3XUZ5X@MW5&GLTTP>:
MEW(H&H:CI\;_ "68BGW,#P7<(,9D$@YK^]'POK$.K:382JV_S;.V8@0W  _T
M6!V.9 Q!W/R&?@D%23R?\Z'1]0N-*US2;A,1M#J^CR;@DH=2-2MI>3&BL00F
M0JLH/3;G"G^[;]B'X@1_$KX(V&NAUF*^(]<TPRK!=18;38M-B;(O#--C+X)/
ME!R<H.Y_BSZ6N1R4>'.(W'EC&>*P.,K<ONN53ZI+#RYEK"T85I6=[ZN^DC_3
M7Z _$[>'XIX7G4]YU,!F.#@YI.$4\3#%04%9R3=2@N:\>1\J:=TE]B0,0Y0(
M  6)^5P5YXQ^Z7/OE5QGDY(WVU4+A5'"_P"R% SDY7"@$DGYL'Z\GG,9&#C"
M<#+'Y/X6;YB 82Q![D+G!.0X/S7UC7S/- SP "0!C@C*CRP<G."=_3&."0?X
MD@FDVY7]Z4=;-JW+97YGNMFKZ1M:UVO]*I:RMHK1A)/923BGHGYV3WUUT>T]
M%%%6 4444 %?GU_P4J&?V8];^4G_ (JCP?T3D?\ $]@&3_H[9'/*\[L[=K[O
M+F_06OS\_P""E@_XQAUGY0/^*I\)?=7=][6[8?\ /)N6S@KSN+;/+GW>3+[7
M#?\ R4&2?]C3!?\ IZ/FOS7JCPN)_P#DG<Z_[%N,?W4*BMM;K^&SZ?YC>HC/
M]N?)G'BC6#TX'_$Q;D#RVR1NPHV');H=_P#I7]O?_!NI\O[/=UQC_B^OQ<;"
MH6!_XMS\*CNR(LEOFZ G[Y.1OW77\0^JKC^V\* /^$GUH#"\<ZH!@'RCNSNQ
MCS)<[MNR3?Y5Q_;O_P &Z0(_9WF^4C/QV^+Q.5Y/_%N/A802?)Y!+94[VQO_
M -<?,_TO^J/%N7_&&M]Z="V__0/B7WMTZ+UO:Z_BCP,7_&?:?:GCY7MMRXS+
M=-%=WYNLNEM5HOZ82IC8A 3DNY. "I;?RN(L8!;!"]<EF8NQ$U.4@1W/3/V>
M<]NIB8+_  ]3DX);<<Y#D/F>ZRC=]U<X8_ZOYN/-Y!^SG@;R.A^_WW$2QW2*
M+>Y(09$%R<E NTF.;+*?+3+-N.XY'#$[OF)D_CAR_AK3W:D(R=E[VL;:W5G>
M.K=^RWLO[Q;O)SN[1A.BHZ;N*O+>^JEJGKHG?E/\XG_@LJ9)_P!KS1997:2,
M?!/P\AWN903_ ,+3^,F$"R(Q(1I"%&"HSC<Y;==>H?\ !##X1>"_BY^TKX5T
M[Q]:OJ.D3)\:(+J-K/3+]Q'IWPN@OK>1(M4TC5HI9(Y;J1HT>"1D=]T6QY-]
M]Y=_P6,&?VN-% 56_P"+)Z&P&,]?BG\9QN V3[B0PPVV7?N \Z?S1]O^EO\
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M/LUG%]LD9=^ (2&)P=[$8'<0L9%G 16977J-O/7<&8-EAC.1A>/E?/3\./\
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MKL/RNJY_=#:1SD9PN%QM52(?]$#_ (+9@?\ #%GQV_[(OXS/,9^8BYTL[O\
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MDK;0*./+2"-%$7K$O@_PHT*J/#'AQ8,%)E71=,*M"0@=77^SB, [LC&W"[F
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MPV+J.GVVKQMIMS%YME,8Q<HR"0MY3B1,J]LT>,J-P99%(X&W[U;;!6 < '8
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MS?'KX3$C:X!V^*@00PA0J4*8!W@KL&"I4BS_ -+-%,GP!O\ 'SC_ (0;6U+
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M;+'^,#_@VC_Y*[X@QR&_9Z^*B@LG#9^,_P 'LHHVL''SC;A)\F0-Y3;QY_\
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M4 %?GE_P4M/E?LN:Z\B@8\7>#L%E&,'7[8!CF _WLG.,\KMD#%9?T-K\\/\
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M%M!YE*B3&9#,?M?]ET"$LV[YB'E8\8SE<B0 1RG]X23PQ5P?O2K(QO/XQ?\
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M(^5OA;\/F+87S2,GD X.U@=TIVF?]!:_/G_@G0&?]G^/"JQ-]X:/(!&#\*O
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MO0P^"WQ7*J6/_"_(& (.?^2->!>03 Q)Z9 !))+%I&.9OZB(@\DN9(PORL
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MVE#QG&5V H5S$UF=P@94%PN2R1KA2V  "Q7E1M Y*YP"?+P-O\]/AW_@X/\
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M8=UL%*R;ED,00< Y.5?^U!VN8F ,$+!GV^8RX)7J3D */EW -M8J/X7/W_\
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MZJ\=5:3N?Y:'Q'@4^/=2;,@SX<\.  <D;M(L25QY$K?/N .58LK?*)@=\_\
M8M_P;D_-\,-)4]_AU\0 >!V^)GAL@%?F5C\W&]"0/NJ [M+_ !U_$R. >.]0
MC+2?+X>\/CHP+8T>R8+^[@?&Y6^8KN7+  /O;S?[$/\ @W(<?\*QTC:"V/AW
M\0/F(X;=\3?#1"# R0,D@KOX<G8"=TO])^)[OP+52LE>C;776C55_GN[>CC>
MZ/Y'\#U->)&+=2#45AZJ7NRLK5J5[7VM:V^M[O5:?U%(Q);C@ 8/S9)RV005
M'3J"&;(.2 -K/)44:D,QP.0HW<9."QP<(O"[OERS<$G"DEI):_D6B_W<>O\
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M&(NL8M+2VCN-H RLC( F0'..:^6EAGAT-/$9C62R>\DTUII5R3,K!&(BV"4
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M35N9WOH<N-PU+&87$8.M&K[+$TIT:M2E\4*<[1GJXSC>2>EUJHM=S^&G5/\
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M'W\J"P*D,&3,;'(QQM/)X&#\ZQ-&?,4A0R2_,X95# X4A@/(#!AMZ'+YX8
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M:?3]4WPR:G)):Q00D7%L92;;^F=4D0RM(B+$BIY110KF(%<C 4>4X$49RH0
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MJLGO-I1Y6VM6[Q7HO*]_TOV;C*G&"4:=**IPA;2,8I)12OI%*]KJZ:>]U?\
M.[]NW]@_X>_MG?#V?0/$W]OV>KZ;H_Q &AR>&KKPKI5S-JWC'1M)TZ22[O?$
M7A/6Q&\?]AV8MIA]G>!C*TTC*D7V+^43XI?\&\_[0_A;6KRT\!:3J&L^&8KJ
MX@T^\\1?%'X=-J;V%M%"Z3RBVT'2XX[EG9Q)MLX-ZQILCC*,MO\ WBSD!ESP
M=^4^0MN8*N%SY6,]^7^ZK-D!"T4 @\TGSX("NT;<Q1,6W,-X?S(B1\L:<;%#
M$<E2H$7V?#_'N>\-05'"5\-/"I)>PKQFY6E[]GR54VE*]K13UBM7>3_/^+/#
M'A?BVM6Q&/I8J.-K>RE.KAY0C']W3ITXM)T)I-4X16LG=^MG_GM_\.&/VQ!,
MBV_ABR\E9!F3_A:7@=6\L28W+FW7.P[CMX)\HG]VJ 0>M^#?^#>O]H[Q)J&E
MKXMT2[MM-%S8R75QI/Q1^'9NX899FBO3";C1KT)-%!'&T!\L$/TC9?D@_O'^
MQQJZJEG9E> 7\B)6* @G=MAVJP/(P,';PH8GRGM;I'CR8(0HY.8D3!X.01#Q
M@\]!VY&/D^I_XC5Q5*$H8>G@J<94W"+A"K!PV3:E.<[\W-)I:R;D];WO\AAO
M +@[#5*=:I7S/$3IN+C&52C*R22>D<-S6Y'RMMMV:3<D]?S[_P"">_[(<W[(
M/P5\,?#$W6OW:>'?"&G>'8?[=UO2=<G'V'4M1O"&N='TG2[*2;_3,M/':QQL
M J*L!0[/MGQ%X5TOQAH^I^'_ !)8VMQINH:=>Z:Y-M;7$Z0WT)MKKROM=G>1
M))Y!4;FMV3*+OC(0!>K41#.%=6R" (V"$C  /[K&!COA<#'RA<*FUCN\Q$"C
MDND:C@ $Y8IC*JH'*XX!^4KA/R[&XW&8W&U\PQ,U1K5ZKJSE'3FJO6][N]GU
M=EHNMD?L.795@<'EU++<'R/#4Z?LE0KM-SBI<W*E[FK>FSWO=JZ?\S?[='_!
M!+P?\;?$FK^-_AC=?$&/5-4U/5]3GL+?QC\-_#>CKC2+2WTZ&"VG^'RS0PO<
M0.)(#>$J/WBM!NQ'^-FN?\&_W[4V@W,EOI7AT7$43,D$]]\4/ +RMMC20)(U
MOIUN&._=N.U&VK@A<?)_?R# 00O3 P&&%('0;?+PHZ\<<<Y&"50PV[;0]M V
M2.3 I)XQU\LY.T+CCH/8[?O,G\4N(LGP].A"OA\9"E",*4<0W>"5G[KC42NG
M>UULK'YUGO@MPGGV(K8BK@ZN75*TW.H\+4HIS;MUE2D[[NU]&W=WLS_/+O/^
M"%G[:]O</._A32!#<'$1'Q1\%DDKR5VJ %(ZY<$O@8^52$W=#_X()_M<:RX-
M_P"&(5.(SMM_BEX' R[[6!,UG*5P!N#*><$D#^'_ $$FTZ!9"_V6U?>0"'A@
M("@] 3%P0.>0<XP,#I(+*U(RMK;@C) $$*@D<*#^X#$ @8^Z.GM7N?\ $=>*
MGSTW2R^E6E?WXPK-VO&2N_;6;<4K+2SOUN?/+Z/'!M*TUB\UG%0A&SK4)624
M8).V%3?+;2]Y)6>^_P#$;\*?^#<7XD:Q?K_PLN#Q7I=F$M)&?P]\3/AE))DW
MA2[4)<>$]6(6.TP\3!!OE[D$)7],O[!G[!?@S]B;P79^&/"6J>,]3NE\/?\
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MNTHRAR5%S><=+[;KKKZ;V]:,JQ$K'*61Y,$;!E1MVYP_D  @]. V!NRNTE+
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M%V0NTDY7Y) ?+!0AODQ$@#*'+*&*[@H3=''$#%="JN=JA<G)P ,D +DXZG:
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M?;HU9^J:>ENUO743;M9*'FVI7:WM=25NOW];6=-D=R<@[6X+ A6QC!_@^]M
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MK11&*CLV[[\SYGM9:^F_?3:P>;;;V_NI>4;::_\ !N]0HHHJ@"BBB@ HHHH
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MB<*,91E!5G4>LI2O;5]TDGI>ZWOM\3YM&BBB@U"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@""1#D
MM@$>H"LR\ ?*OD2,<]\DX'/3@0E/]G ']V,Y7/\ <(M>=W\7I5S)ST_G_A_6
MF-$&)8DY[?+&=O&#@LA//?)/MBD[3M>_NNWW6OO^FC>C\C^N_6/_ ,CI^%K1
M<<]XBN<(< 9)VYYYZ?Z,N<<9P#COGI54 NIBV)O#%EP/NAA@9'ED$GG(R%/H
M6&*US" /EX]/DB^7_= B/7O_ $H56!+,B<9V[5RPXQE<#/S=""WX@<5E.E[6
M4'S-.E?3J^?D;UM>6L;:6TOJF[*.7]Y";7.DN5PU=W+EU=GT2DKV=KIZ7=LD
MP)%#MN(4DQ(2-\?FDYQL9<1,N2<C&=W7 ;/)%;0PPA88L*)6<@(B_,V,MA8"
M#GNH4;ASM?.&O.CD;G1-H[F-2W7 P@0L<YY7/3GD<%8XV\PG 167 *JO'4Y&
M8RG))[8/7)/WK?MURKGO!22FE%:I:<VCUWT32MNG=7%&E1C-PY.:HH^T55:V
M^%<FUKV2UOY7N]%AX&[:3M)/*-\N0WW-MON);/S8(X.?FSNDLAV+ %0/[Q_>
M8 ^;&TF)58G R-PVYZGY=R>2O8X_NX2+Y,YR5S&>6W'.<Y_$Y41*K!ACCE1L
MC 4G=DJ0@8%MQSSS^+9O_@?^V_Y/_@77+J_Z^Y>7E;KIII?]W)1110(****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!,<Y[_3
M_)I:**+6V6[N_4!" 1@__7_#TJ$VZ$8Y W;N F2?KMS]?7OQFIZ*3BGTWWW5
M_7N"TDI+2232?6SLW^2(5A55V@G'/9,\Y]$ '7L!Z]227+&%.03U)Y"GK[[<
M_K]>]2455W:W33\+?/H"]U-+1.[:]=PI&&Y2N2,]P%)'T#!E_,$4M%( HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
>HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image1.jpg
<TEXT>
begin 644 image1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %2 E@# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **:[I&K/(RQHHRSNP55
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5IR6\9TYJ,HR7:23"BBBK,@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BN6\0>-?"_A>)I=;UF
MRLRH)$)E5[EL=E@0M(3VY4?6OG'Q=^TJQ\ZS\%Z2S.5(35=44K%CIOAM1R?5
M?-..G%>3F6>Y5E,7+'8RE2DE=48OVE>79*E"\]>CDHQ[R1[V4<,YWGDXQR_
M5JE-O7$3BZ6&BNKE7J6@[)WM%RDUM%GU-JFKZ9HMI)?:M?VNGVD2EGGNIDA0
M!1DX+D%CC^%02?2OC'XE_M<V]H;C2?AIIIU:[3S(I==U!#%80,"5W6D)^:Z8
M$$@N GJ!W^=_&7B+Q5XLN?M?B+5[C464YCMWD:.S3J<1VR$1KZ#()P!R>:Y"
MRT<R&:5DC7>1\N1T/.(U' SW)_\ U_E6>^).)K*>'R:B\)!WB\36Y98F2VYJ
M<-:=%]+OVDNJ<6?M7#7A/EV#]GC.(*ZS&JN5K!T7*G@XRNK*K)\M:NO*U.&C
MO&:,+Q#JWBOQU<OJOBW6;_5KMY#)Y#2LMK$-W"Q6X(B15!PH5>G?/-7+'P['
M*\2) V&VL[$%A'M ^4<8W?K]*[:Q\/3+O!C4[F'EKQ@#J2>^$&01^N.*[6RT
M;RD7:BOM.X\<'Z#C"_Y)P:_,:D\7CZSK8FI5K5)OFG4J.52<G?7WI-MW6NCM
M9Z=#]=A6P>7X>%#"4J-"E!<M.E1A"E2IQ<8M)0@HQC9WML[[WLSC+'P^J[$7
M**#P222_'7'7Z<C(Y'7%=?9:,L>P[,G  W GH>IXQ7616*O"DC1%"O5@HZ@X
M&3Q@?Y%:$48SM,8##&=A! &.ISUZ>_->AA\OC%QYM6[--IJ][-:;)KO_ )7/
M'Q&:5*BLF]')2BFM+6OKUOUUZ[*]GCPVJP*#L5T9L_,#QCHHQTS[Y'-3/;QN
M258H2!^[8\?\ (Z'W/'Y&MLQ1;.06=<D G'IP#W '..HK$8RJ[<JJACR0K,"
M>RD^GZ^E>RL-RPBMUI9):QT6M_76U[6W/-IU'5E*5W&2MK)Z2C=/1:OHE=16
MNPJQB/#*48<A@P /3G)Z'W)_'TJFR8DS%&#(0&W 9/?^Z0/YU4OKAH]Q7/3:
MQ V_-WQ@@8(Y_4>E9]MJ,,1D9VD# ?*7)X ] 3TSGTX[9IJ//)4[<NNKOHM%
M\-[ZZ=]^QT^RE"G*K;F=DDK.[U7Q)6VOVU7S+MWJ1LXY))I/+V [A( .QP1W
MQUYX'0FO-['QG%J>O7MC#*)#;1Q!E!!V.X+\GIG&!W_2JWC;74>TNV29B%C;
M=EL*2%;()X 4C Y^N1BO@OX"?%>/6/&WC^*XNB?L?BJ_TZ$L22(;!A $P2QP
M&1P.W]WUKY_-<?5P^/R_"P=Z52M/VDKZJ$:<K7OH[R<;>:;/N.'N'5C\IS?'
MR@_:X/#4IPI*&\JM6G'?1^[#F=NW71GZ@65_$;>1V\H.C1H?G*3,KYQ)$ /F
M10,.WN 1R36[:7-KD95'0X+-@98MSW)./3&, CN*\-C\0V[1B3=G<!M.XD=
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MG%*$Y*'V51117Z*?B 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MRBENG8_N;#T</@\LHX3"TU#"8##TL/2A"UI>RIQA&'6]K)RLO>E)WUCK]/\
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MD2P7,+1RQ,.,-&X[@D@<_??P@_;G^-7@&.RTOQ:EMX^T.#9$\]X/L'B1;4*
MJ)JD"FVNY%X(:^LI)).CW'(8:%_\+=)U*=K:TM_.F"9;R3N\N+'RM(Q!"AFX
MC&=[X.!BN#O_ (3W%GYVZSD4#(5C&594R<=OO'OZ=\=**N*PN,CR8BG"HEI>
M2UC=J_))>]&_6SULE;1E4L+BL(W/"UITI*S?+K&6SM*#O&7;WEZ,_5KX7?M_
M?"#Q3+!:ZEK-_P"!K]S&JV_B^U6UM))6'S+%K%E)>Z<%W' >[DL\XW$*.GZ
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M<@FM33O@9\&M)M+BPL?A?X&BM+M'BN89/#6EW*S1R)Y;H[75M,^UD # , <
M]0#7LQ\*L1)RC4S6AR/:4:-5S\KQ<DEYVD]^I\5_Q,AE--0G2X8Q\JUX\\9X
MS"PA:ZYE&I&E.3=EH_9QN][:W_F"^$_C2[UK6WUF=V$;2E+7>>%A1@0=A!PT
MC#<1D8!Y)YK[[\+^,]\44<K%N%)^89(SQTX[@' YY/7IZ=\=O^"<D?AI[OQA
M^SVER]HC2W=]\/[FZDN+N#EY7_X1J[F/F7<0!*IIEY-)=JJQPVDMP9-B? MO
MXAU#P[>M8ZM%=6%U:3O;W-O=126]Q!-$VR2&:-U22)PP*E' 8-QR>*^#S+(<
MSX4K>QQ-)^SG)N%>G>5"K?EUA4:2;27O1DE.+M>*YM?VS*.*N&O$W"1Q>3XF
M#JT81C5P%;EI8_!-+2%:@I-I/WN6K3<Z%1IN$W9V_0W3O%:2B-6;@."5 '7J
M"<9.&XSU] ,8SZ#8ZT3(N3N4@!B3]Y"1PHYP6R">I .#S7PWX8\=VLSJJW"[
ME/!W@Y48*_0X!QQP>O.#7OGA[Q1%<*JF9#TVG?D]!G.>!Z\@<G(R1FM<!F<I
MR2E*SO'3K965OP^_I;?P\XX65",I>R<4HMN\6M_M+O;OY>1[_J%C9:K $RQW
MY!!.X*S*JC!)R,8R1@GW!S7C=UX8E\,>(K#7D+PV]K<M;7TD+[&AL;K8&G4K
MM;_0I0ER&!#*(6P:]&TW6(& 7S",$]&!.1DYXX4X/(R>>];T\-OJED[RHLD4
MFZW?<% <LAY/S=57&5..,$D#D?3T>2K.%>BU'$4I1J4Y+:\>5VDD]5I:6R:;
M6E[GY]/VN$C4PM:\L'7BZ52$M)6JKE]UO2]F^66Z:3ULSWCP/\5-2T#R--\4
M33:MHQ2,6^K+F>]LHBH\MY7&Y[^T*E6WDO<(A#(TR@1#Z=L[RUU"U@O;*XBN
MK2YC6:WN('$D4L;#*LCJ2".Q[@@J0""*_-WPMKJZ5>R^%-2,DD$1_P")/<R?
MO$-L4&^PED/(:!]WV4DL#"RQ$YC3/N_@OQH?!-\D4L[S>%]1D#7=OR_]F3R'
M:;^U&<J!\IO(0-LT0$JKYT8W_H^3\0PK1C&M-.FI.G4<I7J86LK*5.H_M4U+
MX9V34'&>L&N7\4XKX(E3G4KX*ER8CD]O"G3A:AF%&2YE4HQBK4<2XWYJ2]V=
M2,J=E53E/ZTHID<B2QI+$ZR12HLD<B,&22-U#(Z,I(964AE8$@@@@XI]?8GY
M,%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MSU^/7_!03P%\,_@3XB^*/@K1=6\2>)9+C]IWPUX#T'7],O-*TC6/'/[+%O\
M$)O'NGZ_J%I)<7.DZ'<7/PT\11Z+JD,-Q)JL9L7A@B-V GH?A3]NS]GWQA\=
M/^&?=)UW53XPN/%/C+X?Z+K<VFQ1^#/$_P 2/ASI=YK/C_P%H&JK?/J4VO>%
MK#2M>DNKC4-%T[0-3F\.>(++P_K>L7VD7EM& ?8]%%% !1110 4444 %%%%
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MC]5/VKO$TEWX+UG1(-W^EV,XN(U.!Y9C(2,XZ*!\Q'<XS7X^Z7X%DDLVVPY
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M2C4L]GUZ^7Y^>E[:'T^8)RA*H]W;1MVM;5K9]/\ ,]NLXDGA5)5 (') ;GC
MS@G../E^7N>.AHZYH=I-;F, ;6/RQ-S][._[I) 7!(R!SP*TM$G220J'CWG
M*E=V6] !N;&>?E3/8'C)W+I'N96M;-/M4RE,HJ[PC$ 8D=U?8%/1&/F;0 5S
MS7H5(TYTKRLW\*=ES76UDF[^GEM;;Y&JYTJZ47**LJC;;4;7CK=JR5]4^ST:
M/A;XE^!;.^%R! "1OC20IEO,!)C P#DL6'0L6  !. *ZS]@WPI\5?@)\=-8^
M*,6@Q#P-KG@_5?"^N:/?WLFFZAK<D]S;7^C75E +>X91IVIV4,CW5Y#&K6,]
M[%:K))*K+]K:#\+X9;I=3U.WBFN"0Z;E A@;/)BC(V[NN),;CSSUKU5-*L[%
M3&MNH0(!OC 8J.#D'IR",\\8.!6V1T,9EV+I9C3JO#3I3YJ+Y$V[IK6,XRBX
MN.CBU9IM-M71Y'$./R[-,MQ&2XJE''T<72]GB8.I-)14HOW9PG"<9QDE*,H2
M4E**<5LSF?B9X[^)GQ01[35M:ETO0IM^?#NA/<Z=ICQE@!'?RQN;S567@,+R
M=K8MG9;19Q7CNG_!O3516%M#&KDC>(U"J5*Y((!P-V[.%.2,D\XKW9KF*&90
M8E9(P#E^6RQ'.,$,[$Y;Y>,C..:FO;J**/*$"4AF"C/4YP,*H0'!5V9>PP$W
M';7U53%/%5)8G&5ZF)J_S59RDTGRV44](IZ\L8)):M)6L?)X:C#+L/3P.682
MAE^$NVH8>G&G%O?FJ<J4IS2<>:K5<IN_O.3=SSG3?AYH.FV^_P"SQ3,3\@6,
M&1VR>@X(!(ZGH223U%8"^!)_B#JDFC6T1L_#MM*%U.[B B-V58%K&VV LNUE
MVW,F\'&4"\JPWM<U>>UB&9/(C<1PS3O(L;CS65'$2D+^\"N"K<LH)=0#@#W+
MPG=6]II<<]K!$$D3S?,B"B(B3)#J%.3D<G.3W;<S%JZ<%1HYO5GA*C]G0HPC
M.M1C=/$1DTHP;MS>S;3Y^DE:-VKFN(Q57(*7]H4DL1CL0W3P=>JU..$K+E?M
MHQ?NRKQ37LKWY96J<O,H6Z#PAX&T#PKIMO:6-E;6T-LH2)(T5%!  S\HY.>I
M^O.22=K4-1B@)6':-IP3Q\N.R@"N/O/$I<E(Y,D_>8$_+U^50. ,8^HQV(K!
MN]87!W, Q]3D#C...>F#C'L37T5:<*%*-&C&-.$$HQC"*BHJ-E%))65EHDOA
M5EW9\5#"8C%8J6+QLIUZU:3J3E4;E.4I/FE.;?,W=MN[U>[1U=WJH>)B6^8Y
MY'<'TZD]C^=>?:KJ2Q'S%8I)&Z21L#\P9"/7&-P[8)YP:S[O61&C%G!&"<]N
M,_3IWYP!ZFO.VO\ 4/$6LVNBZ+;S7U_?W<5G!%"I=WDFD 55 S@^_0=6( )'
MSV,J2J)0BG.<FHP44W.4FTDHI7NVVN7K>S\CZ3!X:%"%2I-QA1I0<ZDY6C3C
M3BKRYF[1Y$KMW5N6Y^J/PPNWO? /ABYD8NSZ>4W-U*PW$\,?Y)&H'L!7>5S'
M@K0I/#'A/P_H,KB2?3-+M;:Y=>5:ZV;[HH>Z?:'DV'NN">373U^R8*$Z>#PE
M.JK5*>&H0J)ZVG&E",]>OO)ZG\IYA4IU<?CJM'6C4QF)J4FE9.G.M.4&EI:\
M6M+(****Z3C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH KW=U#96MS>7#"."U@E
MN)G) "Q0HTCDDX'"J:_G]^._C"?Q[\2/$6N2N9(&U"9;8[\HMM#(8X H/3*J
M" ,#T/K^OG[4WC=_!7PDUQ[:0)J&MA=(M &VOLG_ ./ET_B.R(8./[U?AI&[
M7=XY9?,\R7Y\@G(ZCKU.?Q'?GI^3^)^:^SPV&RRG)J567MZW;E^&FG_Y-)KT
M[G[]X)9'[2OCL]JQTI_[)AF^C7).M)/SO"*:_EE<Z?PW;2/=1NK%5P<A0=I^
M7G\1^/)Z'J/<M TM4B27:&\UE5U8?.RD\,H[9ZY'.1C/3'GGAO3U>- H*.1R
M1Q\H8YP!Z+QD\=N1U]PT*S/EQ;3EC^[4MU1>S'V('![-W[U^*X:+=1+5[N_G
MILKO796M9W^[]\S"LE"5VEROE::6RZW5NM_--7OM>S;V1M9GD8EA\H4]QP<Y
MX[#D8_/BM))%7>(V')Y4#G(&3P>F1D\  '(QGFI)(U5&C8D^60/G'RN<_+A@
M>F>!@]ORRI)5C\TJ&$CL-I/1,8SM)X 4@<=Q]<UZDH\J2V^)N[=UU:O\DM]6
M?.WDWJV[\MF]$U[MFUTZOK;7U+$DD<KLJ;L*H+L<<CJP'?)]#C/KWJA+#"I5
MN&=S^[4]0G(!)Z;@>/\ )RCDGH520@%I%((;CGC@$#J,]#D>M2I\X(;:?D'E
ML?NGV)_AW=1Z'UQD<LFWNES:V;>BU5M.C2TU5FWNV5HK.+ERZ75]7?EUOUN[
MO2SLGL5)H7;:(UR0"6/ ''WH_<,.F3G/?-1,H9?E!:*-1NB/.03R#C^)#Z<^
MG!Q5]K=V4+'(5E#;@3DJ0.L9QG) Z$]_T$"X=0N,G<X/7=TRN.O/IVSGO24;
MM-W5]-;:M)66W1_$I*SCTV-(U&HJSNXO7H]U=Z]&M(M:W3U5[F!/#)&/,B'G
M1RJ&"# :,=FB/]Y>K*<9 YR",:NDW+D&"XC6XB.&8[1YN"<=.[+CGOV[5=N+
M:%(P6/E7*CS&7>%BD3'!0= V.OU]:PF6.+-Y#.UK(K9SC"OW"RCISR"PX/<G
MM<.:A5C*#[-QYDKQM'FNI)IM-ZPD]+Z22WT595Z4H26[<83Y974FTHVE'[E.
M";=[R6FFOJUNZ1&:P@^TV<@VSQ-Q.,\;U0Y.%]!^O;RZ>YAMKI8_-\MPS-$X
M!5A@_,CKG((Z<CM] ?7=%U)-19DDDABF4@,C$@$^HY *M[<'/3%8GB?X?QZL
MUQ>1J+.[,8,$T1)AD;_IJN<#=Z>G?U]FISXFA&I02FD]:=N6*VYN5J[@W;X9
M/26TD[WO*YX?"XETL=)THM)*K?FDW=*+FGI423OS05^1>]%JS4^B7OVF*,.Z
MMQM4#Y@3CJ<?AZ]>E?G[^W7\&]=NO VM>.?"-S>6J6=K<R^(]%TX%7U"W$9Q
M<_NOWA*G'FHI^9<YKZHT[6M0\,ZD=/U)6B*ML+C_ %9VG =2>BL!DGC&0:].
M^WZ;XDLKJRN%@N+>\MY()H9=LD<L<Z,C1LIR&#*2"#ZYI8/&QE:$9RIUHWC*
M+;3Z+EE:S::5FMO6R9[&,RNI0JJNJ<*^$GR5%.*4XRC>ZE%V<8M.5U)7?R/X
MMIOA^]P))F@(>=VD?*XY=F8@@\D\\]_QK'F^'\L16..(2*S*74@LN#\O''!S
MS_7/7^A#QA_P3A\:>*/&>O-\+-#DUW3#(VI&S@:)9K!+N5F:)(RREX8W8JA4
M< _A47AS_@E%\?=9O?L\O@2[LE).Z:]\JWB4 '.9'?'7@?CCW]W#9;FF,C"K
M1PU>I3J:1G"E.46T[27,E:ZE%IW>Z?2]N;&<6\.Y6ZN'QN8X/#UJ,8N=&K7I
MQJJ,XJ4&X.7/:46G&RLXM6/YT/$7@9;*RNKI(1LA@>5P4Y&P-PN1SD@*![]*
M^%[/PS/J.MZ]XEU"W*S3W+65J)(\"&SM>.%V\%G)8^I'/K7^@Y\!/^"*?@6V
MN[75_CVUEK-C');SR>$=.8F&^6-A(UKJ-VA79 [*%E6%O,925#+UK^6'_@H5
M\$=#^%7[6?[0/A3PYX9MO#/AC3?B'KJ^'] LK=X;'3]*DE$EE!:1L21!'"RF
M,EB#G=SG)]ZOD^.RO+H8G%)4W6K1I>R?\1+E<[RW44^1+E;;?5:'R&5<9Y-Q
M/GU?+\ME4KQPN&>*>(Y>6C)JK3I<E-MJ4W[_ #<RCRI;2>I^+NO:!#'>V\DJ
MCRC=0-("OWH_-7>3P%P%R>N<"OT'^&6D""SC5EQ&47R\< 1;5\M_=6!4DCJO
M7H ?D3QAIL@EE B.]=P4;<=.<#MVZ\=/3-?;'@;SVT?0-2A *:CI%E/L5A)&
MO[A4D13@9$;*RMD<%<<D"O%QE5O#P;N^1VZO^6S6W9+5>6Y]UA:,:6*3LE[2
M-M=WR\OE;9M_?H=_=Z,UQ V 'C*G(P-V /8<X)SC&,>F<GQ);N_^'OC*T\1Z
M6KHB2;+R!>1=6,CK]I@8 G)VCS(B"2DJH>@8'ZK\/VWVU%#@^9AE^4#J<C'/
M\1'7/&#QCD5S?B?X6ZIXAOK33M!TC4=9U:^F$%EIFEV5Q?ZC=S2,%2&WM;5)
M9Y"6(7Y(RN#ER .."&(C).,_@E%I\WP\KTUO_GH?0.AM:]_=E'Y6=]%IRZ?T
MK'Z'? ;Q_;:C9:=>6]P)(;RT@E@;( 9)%#*0<YW <'CY3N7')6OTZ^%6K7FM
M-%:65M)>3A 7$.2L2GC?.XS'#&W0LVW., 'I7PC^Q1_P3G^/RV]I?_%PP> /
M!QF%W8:"MTE[XY:"0AVMI[>*.;3=%BDD!?-S=7-[;)(P^Q*QQ'^\O@KX1^%/
M &D6NC:%IR6MM&%\QRS375S)@9EO;I]UQ<SMC):1F&.%"J M?/U:%2I6E[%Q
ME2C*ZJ?9=[:+2S\W%N*=TG*Q..S[!8;#JC4:JXEQ47"$KJ/(DN:33M?M!:]^
M7<YWPQX'O[H1_:#Y8=%,L=KO5 , \S#8Q+="45!@D'((Q[;IOAVPTF"-8X@#
MQD*H W9 RV.2YSR>2<^^:UH(%MH(H;6,(" 6=5'R+CDMT^7/"_Q'D#DDC*U6
M[,7E.DC$K*L<@))^5QM\QQP1L;!0C'7."JFO3C2IX>'/)>TJ)+WFE:*]UODT
MV2]YZ62?W?G>(S+%9C5]G&?LZ+;2BG*[Y4DN:SLK[1^UIUW-FXE6&'8C(DG0
MJJJ01C"YR!MQQP,;AG).*PKB_CDB!D;RY8F03CYL)MSM P>5< ,F !CC@JV*
M,ET\R^6NV-R>9"0S C)VX'REL#Y@.G.>.:Y77 ]D]G))*=LDIM+B9F B1+N/
M,8N &#E#<>6I*?-'D8*AFJ:N*J.\U%>S2497=HI72O=O1K5R:LE'F3L_>66'
MPL+JG*5JDG*4;*\I.U[*RLU*W+%7<K\G*FK)]%<ZGI:PO&V$<KD-N4F5CD *
MV/W97D8YW*><C(KGSJJL7BM+N"1MF=DOR/%CYE";@8_D.<L3DL1\PXQYCK6I
M303 .-NUFCE0$R+& V-^\ 8.,%6P?E'S?,*PY]8D@G8 @216_F1D?>D\P#>T
MIY#2!F5D!QD8V@<UB\R<YI6Y>2T':\7:R:VMKNM5NM5S-L[Z>4J*YE4<W4O-
M*;4H77+:][MJ]F[2MRNZ?+%16SXPU^T%E<Z?<69DEFMY8AE )I)=^\-;3M\@
M8$GB/"YQG(4D4/@1\8#JEO>^#]5E9+[3@39M(#']HLU<A'4G:K@*-OR@ %&
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M5:EHRG"]VH)*#U;]HK2"BBBOHSX **** "BBB@ HHHH **** "BBB@ HHHH
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MR(SL8HU)."$&%' X''6MCPU8<13D (Q#<'(+$8ST^]CGG )SVKC-,M)9'*[
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M\UEU;;UOH)*ZN4!E7)W;#'C+=2<Y ./7^IK.D9$=D62-BQ^9<C.3Z@9''?\
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M+S"W7#^4J2$8)XZ $GY1Z\'VYI]R1*ILH3^\DQN,;E7C0\%MRYQTQSUSTXJ
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ML/..),[SZ:GFN85\6E\%.34:,-O@I0481>BNTKNRNPHHHKL/#"BBB@ HHHH
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M_E37/4P6'KQ4*M"C525I1=.,D^;>*332TE);*_-*_P 3OS9^'WP]MK."R@\
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MQ%()$D(I^H?#CX7W'@CPK\.-0\!>%M;\"^!]-T;2O"GAG6]%LM<TK1+3P]I
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M 'P*TG^PCI?P8^%>F_\ "+ZS=>(O#?V#X?\ A6T_L'7KZ6SFN]8T?[/I4?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH^D7'BZ":XTK39YHK9I(I9K&UEECD!!#QR/$SHX/\2D-[T45]OP[_O\ A_\
M'#\XGYSQE_R*,;_UXG_[<?M11117ZV?SD%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
